0001558370-23-010200.txt : 20230518 0001558370-23-010200.hdr.sgml : 20230518 20230518164121 ACCESSION NUMBER: 0001558370-23-010200 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 66 CONFORMED PERIOD OF REPORT: 20230331 FILED AS OF DATE: 20230518 DATE AS OF CHANGE: 20230518 FILER: COMPANY DATA: COMPANY CONFORMED NAME: XCel Brands, Inc. CENTRAL INDEX KEY: 0001083220 STANDARD INDUSTRIAL CLASSIFICATION: PATENT OWNERS & LESSORS [6794] IRS NUMBER: 760307819 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-37527 FILM NUMBER: 23936720 BUSINESS ADDRESS: STREET 1: 1333 BROADWAY STREET 2: 10TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10018 BUSINESS PHONE: (347) 727-2474 MAIL ADDRESS: STREET 1: 1333 BROADWAY STREET 2: 10TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10018 FORMER COMPANY: FORMER CONFORMED NAME: NETFABRIC HOLDINGS, INC DATE OF NAME CHANGE: 20050516 FORMER COMPANY: FORMER CONFORMED NAME: HOUSTON OPERATING CO DATE OF NAME CHANGE: 19990402 10-Q 1 xelb-20230331x10q.htm 10-Q
0.290.1819633194195711190001083220--12-312023Q1false001963319419624860P6YP25YP20YP10YP25YP20YP25YP5YP5YP5YP5Y0001083220xelb:ImWhpLlcMemberxelb:BusinessVentureAgreementMember2022-05-310001083220xelb:BusinessVentureAgreementMember2022-05-310001083220xelb:HalstonBrandMembersrt:MinimumMemberus-gaap:SubsequentEventMember2023-05-152023-05-150001083220xelb:HalstonBrandMembersrt:MaximumMemberus-gaap:SubsequentEventMember2023-05-152023-05-150001083220us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMemberxelb:IsaacMizrahiSaleTransactionWithImTopcoMember2022-05-312022-05-310001083220xelb:ImWhpLlcMemberus-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMemberxelb:IsaacMizrahiSaleTransactionWithImTopcoMember2022-01-012022-12-310001083220xelb:ImWhpLlcMemberxelb:BusinessVentureAgreementMember2022-05-312022-05-310001083220xelb:BusinessVentureAgreementMember2022-05-312022-05-310001083220xelb:LoriGoldsteinBrandMember2021-04-012021-04-010001083220xelb:LoriGoldsteinBrandMember2023-01-012023-03-310001083220xelb:LoriGoldsteinBrandMember2022-01-012022-12-3100010832202022-01-012022-12-310001083220xelb:ImWhpLlcMemberus-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMemberxelb:IsaacMizrahiSaleTransactionWithImTopcoMember2022-12-310001083220xelb:HalstonBrandMemberus-gaap:SubsequentEventMember2023-05-152023-05-150001083220xelb:HalstonBrandMemberus-gaap:SubsequentEventMember2023-05-150001083220us-gaap:VariableInterestEntityPrimaryBeneficiaryMemberxelb:QOptixLlcMember2023-01-012023-03-310001083220us-gaap:VariableInterestEntityPrimaryBeneficiaryMemberxelb:LongabergerLicensingLLCMember2023-01-012023-03-310001083220us-gaap:CommonStockMember2023-01-012023-03-310001083220us-gaap:RetainedEarningsMember2023-03-310001083220us-gaap:NoncontrollingInterestMember2023-03-310001083220us-gaap:AdditionalPaidInCapitalMember2023-03-310001083220us-gaap:RetainedEarningsMember2022-12-310001083220us-gaap:NoncontrollingInterestMember2022-12-310001083220us-gaap:AdditionalPaidInCapitalMember2022-12-310001083220us-gaap:RetainedEarningsMember2022-03-310001083220us-gaap:NoncontrollingInterestMember2022-03-310001083220us-gaap:AdditionalPaidInCapitalMember2022-03-310001083220us-gaap:RetainedEarningsMember2021-12-310001083220us-gaap:NoncontrollingInterestMember2021-12-310001083220us-gaap:AdditionalPaidInCapitalMember2021-12-310001083220us-gaap:CommonStockMember2023-03-310001083220us-gaap:CommonStockMember2022-12-310001083220us-gaap:CommonStockMember2022-03-310001083220us-gaap:CommonStockMember2021-12-310001083220us-gaap:EmployeeStockOptionMember2022-01-012022-12-310001083220us-gaap:EmployeeStockOptionMember2022-12-310001083220us-gaap:EmployeeStockOptionMember2023-03-310001083220us-gaap:EmployeeStockOptionMember2022-12-310001083220xelb:UnexercisedStockOptionsMemberxelb:EquityIncentivePlan2011Member2023-03-310001083220us-gaap:RestrictedStockMember2022-12-310001083220xelb:ConsultantMemberus-gaap:RestrictedStockMember2022-04-202022-04-200001083220xelb:ImTopcoMemberxelb:LicenseAgreementMember2023-03-310001083220srt:MaximumMemberus-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMemberxelb:IsaacMizrahiSaleTransactionWithImTopcoMember2022-05-310001083220xelb:ImTopcoMemberxelb:LicenseAgreementMember2023-01-012023-03-310001083220xelb:ImTopcoMemberxelb:ServicesAgreementMember2023-01-012023-03-310001083220xelb:QurateRetailGroupMemberus-gaap:LicenseMemberus-gaap:SalesMemberus-gaap:CustomerConcentrationRiskMember2023-01-012023-03-310001083220us-gaap:ProductMember2023-01-012023-03-310001083220us-gaap:LicenseMember2023-01-012023-03-310001083220xelb:QurateRetailGroupMemberus-gaap:LicenseMemberus-gaap:SalesMemberus-gaap:CustomerConcentrationRiskMember2022-01-012022-03-310001083220us-gaap:ProductMember2022-01-012022-03-310001083220us-gaap:LicenseMember2022-01-012022-03-310001083220us-gaap:RetainedEarningsMember2023-01-012023-03-310001083220us-gaap:NoncontrollingInterestMember2023-01-012023-03-310001083220us-gaap:RetainedEarningsMember2022-01-012022-03-310001083220us-gaap:NoncontrollingInterestMember2022-01-012022-03-310001083220us-gaap:SellingGeneralAndAdministrativeExpensesMember2023-01-012023-03-310001083220us-gaap:SellingGeneralAndAdministrativeExpensesMember2022-01-012022-03-310001083220xelb:IMTopcoLLCMember2022-05-310001083220srt:MinimumMember2023-03-310001083220srt:MaximumMember2023-03-310001083220xelb:IMTopcoLLCMember2023-01-012023-03-310001083220xelb:IMTopcoLLCMember2023-01-012023-03-310001083220us-gaap:TrademarksMember2023-01-012023-03-310001083220us-gaap:IntellectualPropertyMember2023-01-012023-03-310001083220us-gaap:TrademarksMember2022-01-012022-12-310001083220us-gaap:IntellectualPropertyMember2022-01-012022-12-310001083220us-gaap:TrademarksMember2023-03-310001083220us-gaap:IntellectualPropertyMember2023-03-310001083220us-gaap:TrademarksMember2022-12-310001083220us-gaap:IntellectualPropertyMember2022-12-310001083220xelb:IMTopcoLLCMemberus-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMemberxelb:IsaacMizrahiBrandTrademarksAndOtherIntellectualPropertyMember2022-05-270001083220us-gaap:EmployeeStockOptionMember2023-03-3100010832202022-01-012023-03-310001083220xelb:ImTopcoMemberxelb:ServicesAgreementMember2022-05-310001083220us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMemberxelb:IsaacMizrahiSaleTransactionWithImTopcoMember2022-05-310001083220xelb:QurateRetailGroupMemberus-gaap:SalesMemberus-gaap:CustomerConcentrationRiskMember2023-01-012023-03-310001083220xelb:QurateRetailGroupMemberus-gaap:AccountsReceivableMemberus-gaap:CustomerConcentrationRiskMember2023-01-012023-03-310001083220xelb:QurateRetailGroupMemberus-gaap:AccountsReceivableMemberus-gaap:CustomerConcentrationRiskMember2022-01-012022-12-310001083220xelb:QurateRetailGroupMemberus-gaap:SalesMemberus-gaap:CustomerConcentrationRiskMember2022-01-012022-03-310001083220us-gaap:RestrictedStockMember2023-03-310001083220us-gaap:EmployeeStockOptionMemberxelb:EquityIncentivePlan2021Member2023-03-310001083220xelb:EquityIncentivePlan2021Member2023-03-310001083220us-gaap:WarrantMember2023-03-310001083220us-gaap:WarrantMember2022-12-310001083220xelb:HalstonBrandMemberus-gaap:WarrantMemberus-gaap:SubsequentEventMember2023-05-1500010832202021-12-3100010832202022-03-310001083220xelb:LoriGoldsteinBrandMember2023-03-310001083220xelb:LoriGoldsteinBrandMember2022-12-310001083220us-gaap:WarrantMember2023-01-012023-03-310001083220us-gaap:EmployeeStockOptionMember2023-01-012023-03-310001083220us-gaap:WarrantMember2022-01-012022-03-310001083220us-gaap:EmployeeStockOptionMember2022-01-012022-03-310001083220us-gaap:WarrantMember2023-01-012023-03-310001083220us-gaap:RestrictedStockMember2023-01-012023-03-310001083220us-gaap:EmployeeStockOptionMember2023-01-012023-03-310001083220us-gaap:WarrantMember2022-01-012022-12-310001083220xelb:NonManagementDirectorsMember2022-01-012022-03-310001083220xelb:EmployeeMember2022-01-012022-03-310001083220us-gaap:RestrictedStockMember2022-01-012022-03-310001083220us-gaap:EmployeeStockOptionMember2022-01-012022-03-310001083220us-gaap:AdditionalPaidInCapitalMember2023-01-012023-03-310001083220us-gaap:AdditionalPaidInCapitalMember2022-01-012022-03-3100010832202022-01-012022-03-310001083220xelb:QurateRetailGroupMemberus-gaap:AccountsReceivableMemberus-gaap:CustomerConcentrationRiskMember2023-03-310001083220xelb:QurateRetailGroupMemberus-gaap:AccountsReceivableMemberus-gaap:CustomerConcentrationRiskMember2022-12-3100010832202023-03-3100010832202022-12-3100010832202023-05-1500010832202023-01-012023-03-31xbrli:sharesiso4217:USDiso4217:USDxbrli:sharesxbrli:purexelb:item

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 10-Q

    QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended March 31, 2023

or

    TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE

ACT OF 1934

For the transition period from ___ to ___

Commission File Number: 001-37527

XCEL BRANDS, INC.

(Exact name of registrant as specified in its charter)

Delaware

    

76-0307819

(State or Other Jurisdiction of

 

(I.R.S. Employer

Incorporation or Organization)

 

Identification No.)

 

1333 Broadway, 10th Floor, New York, NY 10018

 

 

(Address of Principal Executive Offices)

 

(347) 727-2474

(Issuer’s Telephone Number, Including Area Code)

Securities registered pursuant to Section 12(b) of the Act:

Title of each class

    

Trading Symbol

    

Name of each exchange on which registered

Common Stock, $0.001 par value per share

XELB

NASDAQ Global Market

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes         No   

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes       No   

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer 

Accelerated filer 

Non-accelerated filer 

Smaller reporting company   

 

Emerging growth company   

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  

Indicate by a check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes       No   

As of May 15, 2023, there were 19,683,194 shares of common stock, $.001 par value per share, of the issuer outstanding.

XCEL BRANDS, INC.

INDEX

a

Page

PART I - FINANCIAL INFORMATION

3

Item 1.

Financial Statements

3

Unaudited Condensed Consolidated Balance Sheets

3

Unaudited Condensed Consolidated Statements of Operations

4

Unaudited Condensed Consolidated Statements of Stockholders’ Equity

5

Unaudited Condensed Consolidated Statements of Cash Flows

6

Notes to Unaudited Condensed Consolidated Financial Statements

7

Item 2.

Management’s Discussion and Analysis of Financial Condition and Results of Operations

19

Item 3.

Quantitative and Qualitative Disclosures About Market Risk

26

Item 4.

Controls and Procedures

26

PART II - OTHER INFORMATION

27

Item 1.

Legal Proceedings

27

Item 1A.

Risk Factors

27

Item 2.

Unregistered Sales of Equity Securities and Use of Proceeds

27

Item 3.

Defaults Upon Senior Securities

27

Item 4.

Mine Safety Disclosures

27

Item 5.

Other Information

27

Item 6.

Exhibits

28

Signatures

28

2

PART I. FINANCIAL INFORMATION

ITEM 1.    FINANCIAL STATEMENTS

Xcel Brands, Inc. and Subsidiaries

Unaudited Condensed Consolidated Balance Sheets

(in thousands, except share and per share data)

    

March 31, 2023

    

December 31, 2022

(Unaudited)

(Note 1)

Assets

 

  

 

  

Current Assets:

 

  

 

  

Cash and cash equivalents

$

1,612

$

4,608

Accounts receivable, net

 

5,969

 

5,110

Inventory

 

3,099

 

2,845

Prepaid expenses and other current assets

 

1,032

 

1,457

Total current assets

 

11,712

 

14,020

Non-current Assets:

Property and equipment, net

 

1,237

 

1,418

Operating lease right-of-use assets

5,185

5,420

Trademarks and other intangibles, net

 

46,130

 

47,665

Equity method investment

18,680

19,195

Deferred tax assets, net

1,107

1,107

Other assets

 

110

 

110

Total non-current assets

 

72,449

 

74,915

Total Assets

$

84,161

$

88,935

Liabilities and Stockholders' Equity

 

  

 

  

Current Liabilities:

 

  

 

  

Accounts payable, accrued expenses and other current liabilities

$

5,549

$

3,958

Accrued income taxes payable

555

568

Accrued payroll

 

477

 

416

Current portion of operating lease obligations

1,395

1,376

Current portion of contingent obligations

 

 

243

Total current liabilities

 

7,976

 

6,561

Long-Term Liabilities:

 

  

 

  

Long-term portion of operating lease obligations

5,531

5,839

Long-term portion of contingent obligations

6,396

6,396

Total long-term liabilities

 

11,927

 

12,235

Total Liabilities

 

19,903

 

18,796

Commitments and Contingencies

 

  

 

  

Stockholders' Equity:

 

  

 

  

Preferred stock, $.001 par value, 1,000,000 shares authorized, none issued and outstanding

 

 

Common stock, $.001 par value, 50,000,000 shares authorized, and 19,633,194 and 19,624,860 shares issued and outstanding at March 31, 2023 and December 31, 2022, respectively

 

20

 

20

Paid-in capital

 

103,649

 

103,592

Accumulated deficit

 

(38,440)

 

(32,797)

Total Xcel Brands, Inc. stockholders' equity

 

65,229

 

70,815

Noncontrolling interest

(971)

(676)

Total Stockholders' Equity

 

64,258

 

70,139

Total Liabilities and Stockholders' Equity

$

84,161

$

88,935

See accompanying Notes to Unaudited Condensed Consolidated Financial Statements.

3

Xcel Brands, Inc. and Subsidiaries

Unaudited Condensed Consolidated Statements of Operations

(in thousands, except share and per share data)

For the Three Months Ended

March 31, 

    

2023

    

2022

Revenues

  

 

  

Net licensing revenue

$

2,222

$

5,961

Net sales

 

3,828

 

2,786

Net revenue

 

6,050

 

8,747

Cost of goods sold

 

2,693

 

1,680

Gross profit

 

3,357

 

7,067

Operating costs and expenses

 

  

 

  

Salaries, benefits and employment taxes

 

3,465

 

4,861

Other selling, general and administrative expenses

 

3,493

 

3,416

Total operating costs and expenses

 

6,958

 

8,277

Operating loss before other expense (income), including non-cash expenses

(3,601)

(1,210)

Other expense (income), including non-cash expenses

Depreciation and amortization

 

1,797

 

1,820

Loss from equity method investment

515

Total other expense (income), including non-cash expenses

2,312

1,820

Operating loss

 

(5,913)

 

(3,030)

Interest and finance expense

 

  

 

  

Interest expense - term loan debt

 

 

708

Other interest and finance charges, net

 

25

 

1

Total interest and finance expense

 

25

 

709

Loss before income taxes

 

(5,938)

 

(3,739)

Income tax benefit

 

 

Net loss

(5,938)

(3,739)

Net loss attributable to noncontrolling interest

(295)

(252)

Net loss attributable to Xcel Brands, Inc. stockholders

$

(5,643)

$

(3,487)

Loss per common share attributable to Xcel Brands, Inc. stockholders:

 

  

 

  

Basic and diluted net loss per share

$

(0.29)

$

(0.18)

Weighted average number of common shares outstanding:

 

  

 

  

Basic and diluted weighted average common shares outstanding

 

19,633,194

 

19,571,119

See accompanying Notes to Unaudited Condensed Consolidated Financial Statements.

4

Xcel Brands, Inc. and Subsidiaries

Unaudited Condensed Consolidated Statements of Stockholders’ Equity

(in thousands, except share data)

Xcel Brands, Inc. Stockholders

Common Stock

Number of

Paid-In

Accumulated

Noncontrolling

Total

    

Shares

    

Amount

    

Capital

    

Deficit

    

Interest

Equity

Balance as of December 31, 2021

 

19,571,119

$

20

$

103,039

$

(28,779)

$

662

$

74,942

Compensation expense related to stock options and restricted stock

30

30

Net loss

 

 

 

 

(3,487)

(252)

 

(3,739)

Balance as of March 31, 2022

 

19,571,119

$

20

$

103,069

$

(32,266)

$

410

$

71,233

Balance as of December 31, 2022

 

19,624,860

$

20

$

103,592

$

(32,797)

$

(676)

$

70,139

Compensation expense related to stock options and restricted stock

51

51

Shares issued to consultant in connection with stock grant

 

8,334

 

 

6

 

 

 

6

Net loss

 

 

 

 

(5,643)

(295)

 

(5,938)

Balance as of March 31, 2023

 

19,633,194

$

20

$

103,649

$

(38,440)

$

(971)

$

64,258

See accompanying Notes to Unaudited Condensed Consolidated Financial Statements.

5

Xcel Brands, Inc. and Subsidiaries

Unaudited Condensed Consolidated Statements of Cash Flows

(in thousands)

For the Three Months Ended March 31, 

    

2023

    

2022

Cash flows from operating activities

 

  

 

  

Net loss

$

(5,938)

$

(3,739)

Adjustments to reconcile net loss to net cash used in operating activities:

 

 

  

Depreciation and amortization expense

 

1,797

 

1,820

Amortization of deferred finance costs included in interest expense

 

 

91

Stock-based compensation

 

57

 

32

Undistributed proportional share of net loss of equity method investee

515

Changes in operating assets and liabilities:

 

 

Accounts receivable

 

(859)

 

(1,036)

Inventory

 

(254)

 

(566)

Prepaid expenses and other current and non-current assets

 

425

 

15

Accounts payable, accrued expenses, accrued payroll, accrued income taxes payable, and other current liabilities

 

1,396

 

2,620

Lease-related assets and liabilities

(54)

(128)

Net cash used in operating activities

 

(2,915)

 

(891)

Cash flows from investing activities

 

  

 

  

Purchase of property and equipment

 

(81)

 

(35)

Net cash used in investing activities

 

(81)

 

(35)

Cash flows from financing activities

 

  

 

  

Payment of long-term debt

 

 

(625)

Net cash used in financing activities

 

 

(625)

Net decrease in cash, cash equivalents, and restricted cash

 

(2,996)

 

(1,551)

Cash, cash equivalents, and restricted cash at beginning of period

4,608

5,222

Cash, cash equivalents, and restricted cash at end of period

$

1,612

$

3,671

Reconciliation to amounts on consolidated balance sheets:

 

  

 

  

Cash and cash equivalents

$

1,612

$

3,063

Restricted cash

 

 

608

Total cash, cash equivalents, and restricted cash

$

1,612

$

3,671

Supplemental disclosure of cash flow information:

 

  

 

  

Cash paid during the period for interest

$

$

623

Cash paid during the period for income taxes

$

16

$

See accompanying Notes to Unaudited Condensed Consolidated Financial Statements.

6

Table of Contents

XCEL BRANDS, INC. AND SUBSIDIARIES

Notes to Unaudited Condensed Consolidated Financial Statements

March 31, 2023

(Unaudited)

1. Nature of Operations, Background, and Basis of Presentation

The accompanying condensed consolidated balance sheet as of December 31, 2022 (which has been derived from audited financial statements) and the unaudited interim condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States (“GAAP”) for interim financial information and pursuant to the instructions to Form 10-Q and Article 8 of Regulation S-X promulgated by the United States Securities and Exchange Commission (“SEC”). Certain information or footnote disclosures normally included in financial statements prepared in accordance with GAAP have been condensed or omitted, pursuant to the rules and regulations of the SEC for interim financial reporting. Accordingly, they do not include all the information and footnotes necessary for a comprehensive presentation of financial position, results of operations, or cash flows.

In the opinion of management, the accompanying unaudited condensed consolidated financial statements were prepared following the same policies and procedures used in the preparation of the audited consolidated financial statements and reflect all adjustments (consisting of normal recurring adjustments) necessary to present fairly the results of operations, financial position, and cash flows of Xcel Brands, Inc. and its subsidiaries (the “Company” or "Xcel"). The results of operations for the interim periods presented herein are not necessarily indicative of the results for the entire fiscal year or for any future interim periods. These unaudited condensed consolidated financial statements should be read in conjunction with the Company’s Annual Report on Form 10-K for the year ended December 31, 2022, as filed with the SEC on April 17, 2023.

The Company is a media and consumer products company engaged in the design, production, marketing, live streaming, wholesale distribution, and direct-to-consumer sales of branded apparel, footwear, accessories, fine jewelry, home goods and other consumer products, and the acquisition of dynamic consumer lifestyle brands.

Currently, the Company’s brand portfolio consists of the LOGO by Lori Goldstein brand (the “Lori Goldstein Brand”), the Halston brands (the "Halston Brand"), the Judith Ripka brands (the "Ripka Brand"), the C Wonder brands (the "C Wonder Brand"), the Longaberger brand (the “Longaberger Brand”), the Isaac Mizrahi brands (the "Isaac Mizrahi Brand"), and other proprietary brands.

The Lori Goldstein Brand, Halston Brand, Ripka Brand, and C Wonder Brand are wholly owned by the Company.
The Company manages the Longaberger Brand through its 50% ownership interest in Longaberger Licensing, LLC; the Company consolidates Longaberger Licensing, LLC and recognizes noncontrolling interest for the remaining ownership interest held by a third party.
The Company manages the Q Optix business through its 50% ownership interest in Q Optix, LLC; the Company consolidates Q Optix, LLC and recognizes noncontrolling interest for the remaining ownership interest held by a third party.
The Company wholly owned and managed the Isaac Mizrahi Brand through May 31, 2022. On May 31, 2022, the Company sold to a third party a majority interest in a newly-created subsidiary that was formed to hold the Isaac Mizrahi Brand trademarks, but retained a noncontrolling interest in the brand through a 30% ownership interest in IM Topco, LLC, and continues to contribute to the operations of the brand through a service agreement (see Note 2 and Note 11 for additional details). The Company accounts for its interest in IM Topco, LLC using the equity method of accounting.

7

Table of Contents

XCEL BRANDS, INC. AND SUBSIDIARIES

Notes to Unaudited Condensed Consolidated Financial Statements

March 31, 2023

(Unaudited)

The Company designs, produces, markets, and distributes products, licenses its brands to third parties, and generates licensing revenues through contractual arrangements with manufacturers and retailers. The Company and its licensees distribute through an omni-channel retail sales strategy, which includes distribution through interactive television, digital live-stream shopping, brick-and-mortar retail, wholesale, and e-commerce channels to be everywhere its customers shop.

The Company’s wholesale and direct-to-consumer operations are presented as "Net sales" and "Cost of goods sold" in the Condensed Consolidated Statements of Operations, separately from the Company’s net licensing revenue.

Liquidity and Management’s Plans  

The Company incurred a net loss of approximately $5.6 million during the three months ended March 31, 2023 (which included non-cash expenses of approximately $2.4 million), and had an accumulated deficit of approximately $38.4 million as of March 31, 2023. Net cash used in operating activities was approximately $2.9 million for the three months ended March 31, 2023. The Company had working capital (current assets less current liabilities, excluding the current portion of lease obligations and any contingent obligations payable in common stock) of approximately $5.1 million as of March 31, 2023. The Company’s cash and cash equivalents were approximately $1.6 million as of March 31, 2023. The aforementioned factors raise uncertainties about the Company’s ability to continue as a going concern.

Management plans to mitigate an expected shortfall of capital and to support future operations by shifting the business from a wholesale/licensing hybrid model into a “licensing-plus” business model. In the first quarter of 2023, the Company began to restructure its business operations by entering into new licensing agreements and joint venture arrangements with best-in-class business partners. The Company entered into a new interactive television licensing agreement with America’s Collectibles Network, Inc. d/b/a Jewelry Television (“JTV”) for the Ripka Brand, and a separate license with JTV for the Ripka Brand’s e-commerce business. For apparel, similar transactions have recently been executed. In conjunction with the launch of the C Wonder Brand on HSN, the Company licensed the wholesale operations related to the brand to One Jeanswear Group, LLC (“OJG”); this new license with OJG also includes certain other new celebrity brands that the Company plans to launch in 2023 and beyond. For the Halston Brand, on May 15, 2023 the Company entered into a new master license agreement for men’s, women’s, and children’s apparel, fashion accessories, and other product categories with an industry-leading wholesale apparel company for distribution through department stores, e-commerce, and other retailers (see Note 13). This new master license for the Halston Brand provides for an upfront cash payment and royalties, including certain guaranteed minimum royalties to the Company, includes significant annual minimum net sales requirements, and has a twenty-five-year term (consisting of an initial five-year period, followed by a twenty-year period), subject to the licensee’s right to terminate with at least 120 days’ notice prior to the end of each five-year period during the term.

Management expects the transition of these operating businesses to be completed by the end of the second quarter of 2023. Management believes that this evolution of the Company’s operating model will provide the Company with significant cost savings and allow the Company to reduce and better manage its exposure to operating risks. As of March 31, 2023, the Company took steps that will reduce payroll costs by $6 million and operating expenses by $7 million over the next twelve months.

Based on these recent events and changes in the Company’s business model, management expects to generate adequate cash flows to meet the Company’s operating and capital expenditure needs, for at least the twelve months subsequent to the filing date of this Quarterly Report on Form 10-Q, and therefore, such conditions and uncertainties with respect to the Company’s ability to continue as a going concern as of March 31, 2023, have subsequently been alleviated.

8

Table of Contents

XCEL BRANDS, INC. AND SUBSIDIARIES

Notes to Unaudited Condensed Consolidated Financial Statements

March 31, 2023

(Unaudited)

Recently Adopted Accounting Pronouncements

The Company adopted the provisions of Accounting Standards Update (“ASU”) No. 2016-13, "Financial Instruments – Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments" (as amended by ASU No. 2018-19 in November 2018, ASU No. 2019-05 in May 2019, ASU No. 2019-10 and 2019-11 in November 2019, ASU No. 2020-02 in February 2020, and ASU No. 2022-02 in March 2022) effective January 1, 2023. This ASU requires entities to estimate lifetime expected credit losses for financial instruments, including trade and other receivables, which will result in earlier recognition of credit losses. The adoption of this new guidance did not have a significant impact on the Company’s results of operations, cash flows, or financial condition.

2.      Equity Method Investment

IM Topco, LLC

On May 27, 2022, Xcel (along with IM Topco, LLC (“IM Topco”) and IM Brands, LLC (“IMB”), both wholly owned subsidiaries of the Company) and IM WHP, LLC (“WHP”), a subsidiary of WHP Global, a private equity-backed brand management and licensing company, entered into a membership purchase agreement. Pursuant to this agreement, on May 31, 2022, (i) the Company contributed assets owned by IMB, including the Isaac Mizrahi Brand trademarks and other intellectual property rights relating thereto into IM Topco, and (ii) the Company sold 70% of the membership interests of IM Topco to WHP. The Company accounts for its 30% interest in the ongoing operations of IM Topco as other expense (income) under the equity method of accounting.

Pursuant to the business venture agreement between the Company and WHP governing the operation of IM Topco, IM Topco’s net cash flow (as defined in the agreement) shall be distributed to the members during each fiscal year no less than once per fiscal quarter, as follows:

(i)first, 100% to WHP, until WHP has received an aggregate amount during such fiscal year equal to $8,852,000 (subject to adjustment in certain circumstances as set forth in the agreement);
(ii)second, 100% to Xcel, until Xcel has received an aggregate amount during such fiscal year equal to $1,316,200 (subject to adjustment in certain circumstances as set forth in the agreement); and
(iii)thereafter, in proportion to the members’ respective percentage interests.

The Company recognized an equity method loss of $0.52 million related to its investment for the three months ended March 31, 2023, based on the distribution provisions described above.

Summarized financial information for IM Topco for the three months ended March 31, 2023 is as follows:

($ in thousands)

Revenues

$

3,346

Gross profit

3,346

Loss from continuing operations

(143)

Net loss

(143)

9

Table of Contents

XCEL BRANDS, INC. AND SUBSIDIARIES

Notes to Unaudited Condensed Consolidated Financial Statements

March 31, 2023

(Unaudited)

3.      Trademarks and Other Intangibles  

Trademarks and other intangibles, net consist of the following:

    

Weighted

    

    

    

 

Average

 

March 31, 2023

 

Amortization

Gross Carrying

Accumulated

Net Carrying

($ in thousands)

Period

Amount

Amortization

Amount

Trademarks (finite-lived)

 

15 years

 

68,880

 

22,866

 

46,014

Copyrights and other intellectual property

 

8 years

 

429

 

313

 

116

Total

$

69,309

$

23,179

$

46,130

    

Weighted

    

    

    

 

Average

 

December 31, 2022

 

Amortization

 

Gross Carrying

Accumulated

Net Carrying

($ in thousands)

Period

Amount

Amortization

Amount

Trademarks (finite-lived)

 

15 years

 

68,880

 

21,346

 

47,534

Copyrights and other intellectual property

 

8 years

 

429

 

298

 

131

Total

 

  

$

69,309

$

21,644

$

47,665

Amortization expense for intangible assets was approximately $1.54 million for the three-month period ended March 31, 2023 (the "current quarter") and was approximately $1.53 million for the three-month period ended March 31, 2022 (the "prior year quarter").

4.      Significant Contracts and Concentrations

Qurate Agreements

Under the Company’s agreements with Qurate Retail Group (“Qurate”), collectively referred to as the Qurate Agreements, Qurate is obligated to make payments to the Company on a quarterly basis, based primarily upon a percentage of net retail sales of certain specified branded merchandise. Net retail sales are defined as the aggregate amount of all revenue generated through the sale of the specified branded products by Qurate and its subsidiaries under the Qurate Agreements, net of customer returns, and excluding freight, shipping and handling charges, and sales, use, or other taxes. Net licensing revenue from the Qurate Agreements represents a significant portion of the Company’s total net revenue.

Net licensing revenue from the Qurate Agreements totaled $1.52 million and $5.01 million for the current quarter and prior year quarter, respectively, representing approximately 25% and 57% of the Company’s total net revenue for the current quarter and prior year quarter, respectively. The prior year quarter included revenues from Qurate Agreement related to the Isaac Mizrahi Brand; such agreement was assigned to IM Topco on May 31, 2022.
As of March 31, 2023 and December 31, 2022, the Company had receivables from Qurate of $1.5 million and $0.9 million, respectively, representing approximately 25% and 17% of the Company’s total net accounts receivable, respectively.

5. Accounts Receivable

Accounts receivable are presented on the Company’s condensed consolidated balance sheets net of allowances for credit losses. Such allowances were approximately $0.0 million as of both March 31, 2023 and December 31, 2022. The

10

Table of Contents

XCEL BRANDS, INC. AND SUBSIDIARIES

Notes to Unaudited Condensed Consolidated Financial Statements

March 31, 2023

(Unaudited)

Company did not recognize any credit loss expense in the current quarter or prior year quarter. For the current quarter, there were no significant write-offs or recoveries.

The allowance for credit losses is determined based upon a variety of judgments and factors. Factors considered in determining the allowance include historical collection, write-off experience, and management's assessment of collectibility from customers, including current conditions, reasonable forecasts, and expectations of future collectibility and collection efforts. Management continuously assesses the collectibility of receivables and adjusts estimates based on actual experience and future expectations based on economic indicators. Management also monitors the aging analysis of receivables to determine if there are changes in the collections of accounts receivable. Receivable balances are written-off against the allowance for credit losses when such balances are deemed to be uncollectible.

Also, as of March 31, 2023 and December 31, 2022, approximately $1.86 million and $1.65 million, respectively, of the Company's outstanding receivables were assigned to a third-party agent pursuant to a services agreement entered into during the third quarter of 2022, under which the Company assigned, for purposes of collection only, the right to collect certain specified receivables on the Company's behalf and solely for the Company's benefit. Under such agreement, the Company retains ownership of such assigned receivables, and receives payment from the agent (less certain fees charged by the agent) upon the agent's collection of the receivables from customers. During the current quarter, the Company paid approximately $0.05 million in fees to the agent under the aforementioned services agreement.

6. Leases

The Company has an operating lease for its corporate offices and operations facility, as well as certain equipment with a term of 12 months or less. The Company also has an operating lease for its former retail store location, which was closed in 2022; the Company is currently in the process of negotiating the termination of this lease.

As of March 31, 2023, the Company’s real estate leases have remaining lease terms of 46 years, with a weighted average remaining lease term of approximately 4.7 years and a weighted average discount rate of 6.25%.

Lease expense included in selling, general and administrative expenses on the Company’s unaudited condensed consolidated statements of operations was approximately $0.4 million for both the current quarter and prior year quarter.

Cash paid for amounts included in the measurement of operating lease liabilities was $0.4 million and $0.6 million in the current quarter and prior year quarter, respectively.

As of March 31, 2023, the maturities of lease obligations were as follows:

($ in thousands)

    

2023 (April 1 through December 31)

$

1,290

2024

1,711

2025

 

1,711

2026

 

1,711

2027

 

1,452

Thereafter (through 2028)

 

158

Total lease payments

8,033

Less: Discount

1,107

Present value of lease liabilities

6,926

Current portion of lease liabilities

1,395

Non-current portion of lease liabilities

$

5,531

11

Table of Contents

XCEL BRANDS, INC. AND SUBSIDIARIES

Notes to Unaudited Condensed Consolidated Financial Statements

March 31, 2023

(Unaudited)

7. Debt

The Company did not have any debt obligations as of March 31, 2023 or December 31, 2022.

From December 30, 2021 through May 31, 2022, the Company had term loan debt outstanding pursuant to an agreement with First Eagle Alternative Credit Agent, LLC (“FEAC”); this debt was repaid in full and extinguished on May 31, 2022. For the prior year quarter, the Company incurred interest expense (including both interest paid in cash and the amortization of deferred finance costs) related to term loan debt of approximately $0.71 million, and the effective interest rate related to term loan debt was approximately 9.8%.

8. Stockholders’ Equity

Equity Incentive Plans

A total of 4,000,000 shares of common stock are eligible for issuance under the Company’s 2021 Equity Incentive Plan (the “2021 Plan”). The 2021 Plan provides for the grant of any or all of the following types of awards: stock options (incentive or non-qualified), restricted stock, restricted stock units, performance awards, or cash awards. The 2021 Plan is administered by the Company’s Board of Directors, or, at the Board’s discretion, a committee of the Board.

In addition, stock-based awards (including options, warrants, and restricted stock) previously granted under the Company’s 2011 Equity Incentive Plan (the “2011 Plan”) remain outstanding and shares of common stock may be issued to satisfy options or warrants previously granted under the 2011 Plan, although no new awards may be granted under the 2011 Plan.

Stock-based Compensation

The Company accounts for stock-based compensation in accordance with Accounting Standards Codification (“ASC”) Topic 718, “Compensation - Stock Compensation,” by recognizing the fair value of stock-based compensation as an operating expense over the service period of the award or term of the corresponding contract, as applicable. Forfeitures are accounted for as a reduction of compensation cost in the period when such forfeitures occur. For stock option awards for which vesting is contingent upon the achievement of certain performance targets, the timing and amount of compensation expense recognized is based upon the Company’s projections and estimates of the relevant performance metric(s) until the time the performance obligation is satisfied. Expense for such awards is recognized only to the extent that the achievement of the specified performance target(s) has been met or is considered probable.

Total expense recognized in the current quarter and prior year quarter for all forms of stock-based compensation was approximately $0.06 million and $0.03 million, respectively. Of the current quarter expense amount, substantially all of the expense related to directors and consultants, and was recorded within other selling, general and administrative expenses in the accompanying condensed consolidated statements of operations. Of the prior year quarter expense amount, approximately $0.01 million related to employees and was recorded within salaries, benefits and expenses, while approximately $0.02 million related to directors and consultants and was recorded within other selling, general and administrative expenses.

12

Table of Contents

XCEL BRANDS, INC. AND SUBSIDIARIES

Notes to Unaudited Condensed Consolidated Financial Statements

March 31, 2023

(Unaudited)

Stock Options

A summary of the Company’s stock options activity for the current quarter is as follows:

Weighted

Average

Weighted

Remaining

Average

Contractual

Aggregate

Number of

Exercise

Life

Intrinsic

    

Options

    

Price

    

(in Years)

    

Value

Outstanding at January 1, 2023

 

5,614,310

$

2.12

 

4.76

$

Granted

 

 

 

  

 

  

Canceled

 

 

 

  

 

  

Exercised

 

 

 

  

 

  

Expired/Forfeited

 

(245,530)

 

3.84

 

  

 

  

Outstanding at March 31, 2023, and expected to vest

 

5,368,780

$

2.04

 

4.69

$

Exercisable at March 31, 2023

 

1,671,280

$

2.76

 

2.22

$

Compensation expense related to stock options for the current quarter and the prior year quarter was approximately $0.03 million and $0.02 million, respectively. Total unrecognized compensation expense related to unvested stock options at March 31, 2023 was approximately $0.06 million and is expected to be recognized over a weighted average period of approximately 1.01 years.

A summary of the Company’s non-vested stock options activity for the current quarter is as follows:

    

    

Weighted

 Average 

Number of

Grant Date 

    

Options

    

Fair Value

Balance at January 1, 2023

 

3,697,500

$

0.05

Granted

 

 

Vested

 

Forfeited or Canceled

 

 

Balance at March 31, 2023

 

3,697,500

$

0.05

Warrants

A summary of the Company’s warrants activity for the current quarter is as follows:

Weighted

Average

Weighted

Remaining

 

Average

 

Contractual

Aggregate

Number of

Exercise

 

Life

Intrinsic

    

Warrants

    

Price

    

(in Years)

    

Value

Outstanding and exercisable at January 1, 2023

 

116,065

$

3.15

 

1.57

$

Granted

 

 

 

 

  

Canceled

 

 

 

 

  

Exercised

 

 

 

 

  

Expired/Forfeited

 

 

 

 

  

Outstanding and exercisable at March 31, 2023

 

116,065

$

3.15

 

1.32

$

13

Table of Contents

XCEL BRANDS, INC. AND SUBSIDIARIES

Notes to Unaudited Condensed Consolidated Financial Statements

March 31, 2023

(Unaudited)

No compensation expense related to warrants was recognized in the current quarter or prior year quarter.

Stock Awards

A summary of the Company’s restricted stock activity for the current quarter is as follows:  

Weighted

Number of

Average

Restricted

Grant Date

    

Shares

    

Fair Value

Outstanding at January 1, 2023

 

333,333

$

3.71

Granted

 

8,334

 

0.75

Canceled

 

 

Vested

 

(8,334)

 

0.75

Expired/Forfeited

 

 

Outstanding at March 31, 2023

 

333,333

$

3.71

On January 1, 2023, the Company issued 8,334 shares of common stock to a consultant, which vested immediately.

Compensation expense related to stock awards was approximately $0.03 million for the current quarter and approximately $0.01 million for the prior year quarter. Total unrecognized compensation expense related to unvested restricted stock grants at March 31, 2023 was approximately $0.04 million and is expected to be recognized over a weighted average period of approximately 1.04 years.

Restricted Stock Units

There were no restricted stock units outstanding as of March 31, 2023 and December 31, 2022, and no restricted stock units have been issued since the inception of the 2021 Plan.

Shares Available Under the Company’s Equity Incentive Plans

As of March 31, 2023, there were 3,321,075 shares of common stock available for award grants under the 2021 Plan.

Shares Reserved for Issuance

As of March 31, 2023, there were 8,805,920 shares of common stock reserved for issuance, including 5,484,845 shares reserved pursuant to unexercised warrants and stock options previously granted under the 2011 Plan, 376,850 shares reserved pursuant to unexercised stock options granted under the 2021 Plan, and 3,321,075 shares available for issuance under the 2021 Plan.

9.    Earnings (Loss) Per Share

Basic earnings (loss) per share (“EPS”) is computed by dividing net income (loss) available to common stockholders by the weighted average number of common shares outstanding during the period. Diluted EPS gives effect to all potentially dilutive common shares outstanding during the period, including stock options and warrants, using the treasury stock method. Diluted EPS excludes all potentially dilutive shares of common stock if their effect is anti-dilutive. The following

14

Table of Contents

XCEL BRANDS, INC. AND SUBSIDIARIES

Notes to Unaudited Condensed Consolidated Financial Statements

March 31, 2023

(Unaudited)

table is a reconciliation of the numerator and denominator of the basic and diluted net (loss) income per share computations for the three months ended March 31, 2023 and 2022:

Three Months Ended

March 31, 

    

2023

    

2022

Numerator:

Net loss attributable to Xcel Brands, Inc. stockholders (in thousands)

$

(5,643)

$

(3,487)

Denominator:

Basic weighted average number of shares outstanding

19,633,194

 

19,571,119

 

Add: Effect of warrants

 

 

Add: Effect of stock options

Diluted weighted average number of shares outstanding

19,633,194

 

19,571,119

Basic net loss per share

$

(0.29)

$

(0.18)

Diluted net loss per share

$

(0.29)

$

(0.18)

As a result of the net loss for the current quarter and prior year quarter, the Company calculated diluted EPS using basic weighted average shares outstanding for such periods, as utilizing diluted shares would be anti-dilutive to loss per share.

The computation of diluted EPS excludes the following potentially dilutive securities because their inclusion would be anti-dilutive:  

Three Months Ended

March 31, 

    

2023

    

2022

Stock options

5,368,780

5,266,660

Warrants

116,065

116,065

Total

5,484,845

 

5,382,725

 

10.    Income Taxes

The estimated annual effective income tax rate for the current quarter and the prior year quarter was approximately 0% for both periods, resulting in an income tax benefit of $0 for both periods.

For both the current quarter and the prior year quarter, the federal statutory rate differed from the effective tax rate due to the recording of a valuation allowance against the benefit that would have otherwise been recognized, as it was considered not more likely than not that the net operating losses generated during each period will be utilized in future periods.

11.    Related Party Transactions

IM Topco, LLC

The Company holds a noncontrolling interest in IM Topco, which is accounted for under the equity method of accounting.

On May 31, 2022, the Company entered into a services agreement with IM Topco, pursuant to which the Company provides certain design and support services (including assistance with the operations of the interactive television business

15

Table of Contents

XCEL BRANDS, INC. AND SUBSIDIARIES

Notes to Unaudited Condensed Consolidated Financial Statements

March 31, 2023

(Unaudited)

and related talent support) to IM Topco in exchange for payments of $300,000 per year. For the three months ended March 31, 2023, the Company recognized service fee income related to this agreement of $75,000.

On May 31, 2022, the Company entered into a license agreement with IM Topco, pursuant to which IM Topco granted the Company a license to use certain Isaac Mizrahi trademarks on and in connection with the design, manufacture, distribution, sale, and promotion of women’s sportswear products in the United States and Canada during the term of the agreement, in exchange for the payment of royalties in connection therewith. The initial term of this agreement was set to end on December 31, 2026, and provided guaranteed royalties to IM Topco of $400,000 per year. Effective December 16, 2022, the license agreement between IM Topco and Xcel was terminated in favor of a new similar license agreement between IM Topco and an unrelated third party. However, as part of the termination of the May 31, 2022 license agreement, Xcel provided a guarantee to IM Topco for the payment of any difference between (i) the royalties received by IM Topco from the unrelated third party under the new agreement and (ii) the amount of guaranteed royalties that IM Topco would have received from Xcel under the May 31, 2022 agreement. For the three months ended March 31, 2023, the estimated amount of such shortfall was approximately $60,000, which the Company recognized as royalty expense in the condensed consolidated statements of operations.

12.    Commitments and Contingencies

Contingent Obligation – Lori Goldstein Earn-Out

In connection with the April 1, 2021 purchase of the Lori Goldstein trademarks, the Company agreed to pay the seller additional cash consideration (the “Lori Goldstein Earn-Out”) of up to $12.5 million, based on royalties earned during the six calendar year period commencing in 2021. The Lori Goldstein Earn-Out was initially recorded as a liability of $6.6 million, based on the difference between the fair value of the acquired assets of the Lori Goldstein brand and the total consideration paid, in accordance with the guidance in Accounting Standards Codification Subtopic 805-50. Based on the performance of the Lori Goldstein brand through December 31, 2022, approximately $0.2 million of additional consideration has been earned by the seller to date, and this amount was paid to the seller in the current quarter. At December 31, 2022, $0.2 million of the balance was recorded as a current liability and $6.4 million was recorded as a long-term liability; at March 31, 2023, the entire remaining balance of $6.4 million is recorded as a long-term liability.

Contingent Obligation – Isaac Mizrahi Transaction

In connection with the May 31, 2022 transaction related to the sale of a majority interest in the Isaac Mizrahi Brand (see Note 2), the Company agreed with WHP that, in the event that IM Topco receives less than $13.3 million in aggregate royalties for any four consecutive calendar quarters over a three-year period ending on May 31, 2025, WHP will be entitled to receive from the Company up to $16 million, less all amounts of net cash flow distributed to WHP on an accumulated basis, as an adjustment to the purchase price previously paid by WHP. Such amount would be payable by the Company in either cash or equity interests in IM Topco held by the Company. No amount has been recorded in the accompanying condensed consolidated balance sheets related to this contingent obligation, and management believes the likelihood of any such payment is remote. Based on IM Topco’s earnings from May 31, 2022 through March 31, 2023 and the applicable distribution provisions, WHP earned $5.89 million in cash flow, which reduces the maximum potential purchase price adjustment to $10.11 million.

16

Table of Contents

XCEL BRANDS, INC. AND SUBSIDIARIES

Notes to Unaudited Condensed Consolidated Financial Statements

March 31, 2023

(Unaudited)

Legal Proceedings

From time to time, the Company becomes involved in legal claims and litigation in the ordinary course of business. In the opinion of management, based on consultations with legal counsel, the disposition of litigation currently pending against the Company is unlikely to have, individually or in the aggregate, a materially adverse effect on the Company’s business, financial position, results of operations, or cash flows. The Company routinely assesses all its litigation and threatened litigation as to the probability of ultimately incurring a liability, and records its best estimate of the ultimate loss in situations where it assesses the likelihood of loss as probable.

Other Matters

On November 22, 2022, the Company received a letter from the Listing Qualifications Department of The Nasdaq Stock Market (“Nasdaq”) notifying the Company that the minimum bid price per share for its common stock fell below $1.00 for a period of 30 consecutive business days. Therefore, the Company did not meet the minimum bid price requirement set forth in the Nasdaq Listing Rules.

The letter also states that pursuant to Nasdaq Listing Rules 5810(c)(3)(A), the Company will be provided 180 calendar days to regain compliance with the minimum bid price requirement, or until May 22, 2022.

In accordance with Nasdaq Listing Rule 5810(c)(3)(A), the Company can regain compliance if, at any time during the Tolling Period or such 180-day period, the closing bid price of the Company’s common stock is at least $1.00 for a minimum period of 10 consecutive business days. If by May 22, 2023, the Company does not regain compliance with the Nasdaq Listing Rules, the Company may be eligible for additional time to regain compliance pursuant to Nasdaq Listing Rule 5810(c)(3)(A)(ii). To qualify, the Company would need to submit a transfer application and a $5,000 application fee. The Company would also need to provide written notice to Nasdaq of its intention to cure the minimum bid price deficiency during the second compliance period by effecting a reverse stock split, if necessary. As part of its review process, the Nasdaq staff will make a determination of whether it believes the Company will be able to cure this deficiency. Should the Nasdaq staff conclude that the Company will not be able to cure the deficiency, or should the Company determine not to submit a transfer application or make the required representation, Nasdaq will provide notice that the Company’s shares of common stock will be subject to delisting.

If the Company does not regain compliance within the allotted compliance period, including any extensions that may be granted by Nasdaq, Nasdaq will provide notice that the Company’s shares of common stock will be subject to delisting from the Nasdaq Global Market. At such time, the Company may appeal the delisting determination to a hearings panel.

The Company intends to monitor its closing bid price and the market value of its publicly held common stock between now and May 22, 2023, and will consider available options to resolve the Company’s noncompliance with the minimum bid price requirement, as may be necessary. There can be no assurance that the Company will be able to regain compliance with the minimum bid price requirement or will otherwise be in compliance with other Nasdaq listing criteria.

17

Table of Contents

XCEL BRANDS, INC. AND SUBSIDIARIES

Notes to Unaudited Condensed Consolidated Financial Statements

March 31, 2023

(Unaudited)

13.    Subsequent Events

On May 15, 2023, the Company, through its subsidiaries, H Halston, LLC and H Heritage Licensing, LLC (collectively, the “Licensor”), entered into a master license agreement relating to the Halston Brand (the “Halston Master License”) with an industry-leading wholesale apparel company, for men’s and women’s apparel, men’s and women’s fashion accessories, children’s apparel and accessories, home, airline amenity and amenity kits, and such other product categories as mutually agreed upon. The Halston Master License provides for an upfront cash payment and royalties payable to the Company, including certain guaranteed minimum royalties, includes significant annual minimum net sales requirements, and has a twenty-five-year term (consisting of an initial five-year period, followed by a twenty-year period), subject to the licensee’s right to terminate with at least 120 days’ notice prior to the end of each five-year period during the term. The licensee has an option to purchase the Halston Brand for $5.0 million at the end of the twenty-five-year term, which right may be accelerated under certain conditions associated with an uncured material breach of the Halston Master License in accordance with the terms of the Halston Master License. The Licensor granted to the licensee a security interest in the Halston trademarks to secure the Licensor’s obligations under the Halston Master License, including to honor the obligations under the purchase option. In connection with the Halston Master License, the Company issued to the licensee a ten-year warrant to purchase up to 1,000,000 shares of the Company’s common stock at an exercise price of $1.50 per share, which vest based upon certain annual royalty targets being satisfied.

18

ITEM 2.    MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995. The statements that are not historical facts contained in this report are forward-looking statements that involve a number of known and unknown risks, uncertainties and other factors, all of which are difficult or impossible to predict and many of which are beyond our control, which may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. These risks are detailed in the Risk Factors section of our Form 10-K for the fiscal year ended December 31, 2022, as filed with the SEC on April 17, 2023. The words “believe,” “anticipate,” “expect,” “continue,” “estimate,” “appear,” “suggest,” “goal,” “potential,” “predicts,” “seek,” “will,” “confident,” “project,” “provide,” “plan,” “likely,” “future,” “ongoing,” “intend,” “may,” “should,” “would,” “could,” “guidance,” and similar expressions identify forward-looking statements.

Overview

Xcel Brands, Inc. (“Xcel,” the “Company,” “we,” “us,” or “our”) is a media and consumer products company engaged in the design, production, marketing, live streaming, wholesale distribution, and direct-to-consumer sales of branded apparel, footwear, accessories, fine jewelry, home goods and other consumer products, and the acquisition of dynamic consumer lifestyle brands. Xcel was founded in 2011 with a vision to reimagine shopping, entertainment, and social media as one thing. Currently, the Company’s brand portfolio consists of the LOGO by Lori Goldstein brand (the “Lori Goldstein Brand”), the Halston brands (the "Halston Brand"), the Judith Ripka brands (the "Ripka Brand"), the C Wonder brands (the "C Wonder Brand"), the Longaberger brand (the “Longaberger Brand”), the Isaac Mizrahi brands (the "Isaac Mizrahi Brand"), and other proprietary brands.

The Lori Goldstein Brand, Halston Brand, Ripka Brand, and C Wonder Brand are wholly owned by the Company.
We manage the Longaberger Brand through our 50% ownership interest in Longaberger Licensing, LLC.
We manage the Q Optix business through our 50% ownership interest in Q Optix, LLC.
The Company wholly owned and managed the Isaac Mizrahi Brand through May 31, 2022. On May 31, 2022, we sold a majority interest in the brand to a third party, but retained a 30% noncontrolling interest in the brand and continue to contribute to the operations of the brand through a service agreement.

Xcel continues to pioneer a true omni-channel sales strategy which includes the promotion and sale of products under its brands through interactive television, digital live-stream shopping, brick-and-mortar retail, wholesale, and e-commerce channels to be everywhere its customers shop. Our brands have generated over $3 billion in retail sales via live streaming in interactive television and digital channels alone

Our objective is to build a diversified portfolio of lifestyle consumer brands through organic growth and the strategic acquisition of new brands. To grow our brands, we are focused on the following primary strategies:

distribution and/or licensing of our brands for sale through interactive television (i.e., QVC, HSN, The Shopping Channel, TVSN, CJO, JTV, etc.);
wholesale distribution through joint ventures or licensing of our brands to retailers that sell to the end consumer;
direct-to-consumer distribution of our brands through e-commerce and live streaming;
licensing our brands to manufacturers and retailers for promotion and distribution through e-commerce, social commerce, and traditional brick-and-mortar retail channels whereby we provide certain design services; and

19

acquiring additional consumer brands and integrating them into our operating platform and leveraging our operating infrastructure and distribution relationships.

We believe that Xcel offers a unique value proposition to our retail and direct-to-consumer customers and our licensees for the following reasons:

our management team, including our officers’ and directors’ experience in, and relationships within the industry;
our deep knowledge , expertise, and proprietary technology in live streaming;
our design, production, sales, marketing, and supply chain and integrated technology platform that enables us to design and distribute trend-right product; and
our significant media and internet presence.

We utilize state-of-the-art supply chain management technology, trend analytics, and data science to actively monitor fashion trends and read and react to customer demands.

Summary of Operating Results

Three months ended March 31, 2023 (the “current quarter”) compared with the three months ended March 31, 2022 (the “prior year quarter”)

Revenues

Current quarter net revenue decreased approximately $2.7 million to $6.1 million from $8.7 million for the prior year quarter.

Net licensing revenue decreased by approximately $3.7 million in the current quarter to $2.2 million, compared with $6.0 million in the prior year quarter. This decrease in licensing revenue was primarily attributable to the May 31, 2022 sale of a majority interest in the Isaac Mizrahi brand through the sale of a 70% interest in IM Topco, LLC to WHP. Since the closing of such sale, we no longer record Isaac Mizrahi brand licensing revenue as part of our revenues.

Net sales increased by approximately $1.0 million in the current quarter to $3.8 million, compared with $2.8 million in the prior year quarter. This increase was primarily attributable to sale of all of our C Wonder apparel inventory to HSN as part of the restructuring and transformation of our business operating model, which we began in the current quarter and expect to complete by the end of the second quarter of 2023.

Cost of Goods Sold

Current quarter cost of goods sold was $2.7 million, compared with $1.7 million for the prior year quarter.

Gross profit margin from net product sales (net sales less cost of goods sold, divided by net sales) decreased from approximately 40% in the prior year quarter to approximately 30% in the current quarter.

Gross profit (net revenue less cost of goods sold) decreased approximately $3.7 million to $3.4 million from $7.1 million in the prior year quarter, primarily driven by the aforementioned decrease in net licensing revenue.

20

Operating Costs and Expenses

Operating costs and expenses decreased approximately $1.3 million from $8.3 million in the prior year quarter to $7.0 million in the current quarter. This decrease was primarily attributable to lower salaries, benefits and employment costs, driven by the combination of (i) the May 31, 2022 sale of a majority interest in the Isaac Mizrahi brand and the transfer of the employees associated with the Isaac Mizrahi brand to the IM Topco, LLC business venture, and (ii) reductions in staffing levels during the current quarter related to the restructuring and transformation of our business operating model.

Other Expense (Income), Including Non-cash Expenses

We account for our interest in the ongoing operations of IM Topco, LLC using the equity method of accounting. We recognized an equity method loss of $0.52 million related to our investment for the current quarter, based on the distribution provisions set forth in the related business venture agreement.

Depreciation and amortization was approximately $1.8 million in both the current quarter and prior year quarter.

Interest and Finance Expense

Interest and finance expense for the current quarter was approximately $0.0 million, compared with $0.7 million for the prior year quarter. This decrease was attributable to the May 31, 2022 repayment of all of our outstanding term loan debt.

Income Tax Benefit

The estimated annual effective income tax rate for the current quarter and the prior year quarter was approximately 0% for both periods, resulting in an income tax benefit of $0 for both periods.

For both the current quarter and the prior year quarter, the federal statutory rate differed from the effective tax rate due to the recording of a valuation allowance against the benefit that would have otherwise been recognized, as it was considered not more likely than not that the net operating losses generated during each period will be utilized in future periods.

Net Loss Attributable to Xcel Brands, Inc. Stockholders

We had a net loss of $5.6 million for the current quarter, compared with a net loss of $3.5 million for the prior year quarter, due to the combination of the factors outlined above.

Non-GAAP Net (Loss) Income, Non-GAAP Diluted EPS, and Adjusted EBITDA

We had a non-GAAP net loss of approximately $3.6 million, or $0.18 per diluted share (“non-GAAP diluted EPS”), for the current quarter and a non-GAAP net loss of $1.9 million, or $0.10 per diluted share, for the prior year quarter. Non-GAAP net (loss) income is a non-GAAP unaudited term, which we define as net (loss) income attributable to Xcel Brands, Inc. stockholders, exclusive of amortization of trademarks, our proportional share of trademark amortization of equity method investees, stock-based compensation, loss on extinguishment of debt, gain on sales of assets, gain on reduction of contingent obligations, costs (recoveries) in connection with potential acquisitions, certain adjustments to the provision for doubtful accounts related to the bankruptcy of and economic impact on certain retail customers due to the COVID-19 pandemic, asset impairments, and income taxes. Non-GAAP net income and non-GAAP diluted EPS measures do not include the tax effect of the aforementioned adjusting items, due to the nature of these items and the Company’s tax strategy.

We had Adjusted EBITDA of approximately $(3.2) million for the current quarter, compared with approximately $(0.9) million for the prior year quarter. Adjusted EBITDA is a non-GAAP unaudited measure, which we define as net (loss) income attributable to Xcel Brands, Inc. stockholders before depreciation and amortization, our proportional share of trademark amortization of equity method investees, interest and finance expenses (including loss on extinguishment of debt, if any), income taxes, other state and local franchise taxes, stock-based compensation, gains on reduction of contingent obligations, gains on sale of assets, costs (recoveries) in connection with potential acquisitions, asset

21

impairments, and certain adjustments to the provision for doubtful accounts related to the bankruptcy of and economic impact on certain retail customers due to the COVID-19 pandemic.

Management uses non-GAAP net income, non-GAAP diluted EPS, and Adjusted EBITDA as measures of operating performance to assist in comparing performance from period to period on a consistent basis and to identify business trends relating to the Company’s results of operations. Management believes non-GAAP net income, non-GAAP diluted EPS, and Adjusted EBITDA are also useful because these measures adjust for certain costs and other events that management believes are not representative of our core business operating results, and thus, these non-GAAP measures provide supplemental information to assist investors in evaluating the Company’s financial results.

Non-GAAP net income, non-GAAP diluted EPS, and Adjusted EBITDA should not be considered in isolation or as alternatives to net income, earnings per share, or any other measure of financial performance calculated and presented in accordance with GAAP. Given that non-GAAP net income, non-GAAP diluted EPS, and Adjusted EBITDA are financial measures not deemed to be in accordance with GAAP and are susceptible to varying calculations, our non-GAAP net income, non-GAAP diluted EPS, and Adjusted EBITDA may not be comparable to similarly titled measures of other companies, including companies in our industry, because other companies may calculate non-GAAP net income, non-GAAP diluted EPS, and Adjusted EBITDA in a different manner than we calculate these measures.

In evaluating non-GAAP net income, non-GAAP diluted EPS, and Adjusted EBITDA, you should be aware that in the future we may or may not incur expenses similar to some of the adjustments in this report. Our presentation of non-GAAP net income, non-GAAP diluted EPS, and Adjusted EBITDA does not imply that our future results will be unaffected by these expenses or any other unusual or non-recurring items. When evaluating our performance, you should consider non-GAAP net income, non-GAAP diluted EPS, and Adjusted EBITDA alongside other financial performance measures, including our net income and other GAAP results, and not rely on any single financial measure.

The following table is a reconciliation of net loss attributable to Xcel Brands, Inc. stockholders (our most directly comparable financial measure presented in accordance with GAAP) to non-GAAP net (loss) income:

 

Three Months Ended

March 31, 

($ in thousands)

    

2023

    

2022

Net loss attributable to Xcel Brands, Inc. stockholders

$

(5,643)

$

(3,487)

Amortization of trademarks

 

1,520

 

1,514

Proportional share of trademark amortization of equity method investee

515

Stock-based compensation

 

57

 

32

Non-GAAP net (loss) income

$

(3,551)

$

(1,941)

The following table is a reconciliation of diluted loss per share (our most directly comparable financial measure presented in accordance with GAAP) to non-GAAP diluted EPS:

Three Months Ended

March 31, 

    

2023

    

2022

Diluted loss per share

$

(0.29)

$

(0.18)

Amortization of trademarks

 

0.08

 

0.08

Proportional share of trademark amortization of equity method investee

0.03

Stock-based compensation

 

0.00

 

0.00

Non-GAAP diluted EPS

$

(0.18)

$

(0.10)

Non-GAAP weighted average diluted shares

 

19,633,194

 

19,571,119

22

The following table is a reconciliation of net loss attributable to Xcel Brands, Inc. stockholders (our most directly comparable financial measure presented in accordance with GAAP) to Adjusted EBITDA:

Three Months Ended

March 31, 

($ in thousands)

    

2023

    

2022

Net loss attributable to Xcel Brands, Inc. stockholders

$

(5,643)

$

(3,487)

Depreciation and amortization

 

1,797

 

1,820

Proportional share of trademark amortization of equity method investee

515

Interest and finance expense

 

25

 

709

State and local franchise taxes

 

21

 

36

Stock-based compensation

 

57

 

32

Adjusted EBITDA

$

(3,228)

$

(890)

Liquidity and Capital Resources

General

As of March 31, 2023 and December 31, 2022, our cash and cash equivalents were $1.6 million and $4.6 million, respectively.

Our principal capital requirements have been to fund working capital needs, acquire new brands, and to a lesser extent, capital expenditures. Notwithstanding our recent investments in our ERP system and our brick-and-mortal retail store in 2020 and 2021, respectively, our business operating model generally does not require material capital expenditures, and as of March 31, 2023, we have no significant commitments for future capital expenditures.

Working Capital

Our working capital (current assets less current liabilities, excluding the current portion of operating lease obligations and any contingent obligations payable in common stock) was $5.1 million and $8.8 million as of March 31, 2023 and December 31, 2022, respectively.

Liquidity and Management’s Plans  

We incurred a net loss of approximately $5.6 million during the three months ended March 31, 2023 (which included non-cash expenses of approximately $2.4 million), and had an accumulated deficit of approximately $38.4 million as of March 31, 2023. Net cash used in operating activities was approximately $2.9 million for the three months ended March 31, 2023. These factors, along with our current levels of cash and working capital, raise uncertainties about the Company’s ability to continue as a going concern.

Management plans to mitigate an expected shortfall of capital and to support future operations by shifting the business from a wholesale/licensing hybrid model into a “licensing-plus” business model. In the first quarter of 2023, we began to restructure our business operations by entering into new licensing agreements and joint venture arrangements with best-in-class business partners. We entered into a new interactive television licensing agreement with America’s Collectibles Network, Inc. d/b/a Jewelry Television (“JTV”) for the Ripka Brand, and a separate license with JTV for the Ripka Brand’s e-commerce business. For apparel, similar transactions have recently been executed. In conjunction with the launch of the C Wonder Brand on HSN, we licensed the wholesale operations related to the brand to One Jeanswear Group, LLC (“OJG”); this new license with OJG also includes other new celebrity brands that we plan to launch in 2023 and beyond. For the Halston Brand, on May 15, 2023 we entered into a new master license agreement for men’s, women’s, and children’s apparel, fashion accessories, and other product categories with an industry-leading wholesale apparel company for distribution through department stores, e-commerce, and other retailers. This new master license for the Halston Brand provides for an upfront cash payment and royalties to the Company, including certain guaranteed minimum royalties, includes significant annual minimum net sales requirements, and has a twenty-five-year term (consisting of an initial five-

23

year period, followed by a twenty-year period), subject to the licensee’s right to terminate with at least 120 days’ notice prior to the end of each five-year period during the term.

Management expects the transition of these operating businesses to be completed by the end of the second quarter of 2023. We believe that this evolution of our operating model will provide significant cost savings and allow us to reduce and better manage our exposure to operating risks. As of March 31, 2023, the Company has taken steps that will reduce payroll costs by $6 million and operating expenses by $7 million over the next twelve months.

Based on these recent events and changes in our business model, management expects to generate adequate cash flows to meet the Company’s operating and capital expenditure needs, for at least the twelve months subsequent to the filing date of this Quarterly Report on Form 10-Q, and therefore, such conditions and uncertainties with respect to the Company’s ability to continue as a going concern as of March 31, 2023, have subsequently been alleviated.

Commentary on the components of our cash flows for the current quarter as compared with the prior year quarter is set forth below.

Operating Activities

Net cash used in operating activities was approximately $2.92 million in the current quarter, compared with approximately $0.89 million in the prior year nine months.

The current quarter cash used in operating activities was primarily attributable to the combination of the net loss of $(5.94) million plus non-cash items of approximately $2.37 million and the net change in operating assets and liabilities of approximately $0.65 million. Non-cash items were primarily comprised of $1.80 million of depreciation and amortization and the $0.52 million undistributed proportional share of net loss of equity method investee. The net change in operating assets and liabilities was primarily comprised of increases in various operating liabilities of approximately $1.40 million, partially offset by an increase in accounts receivable of $(0.86) million.

The prior year quarter cash used in operating activities was primarily attributable to the combination of the net loss of $(3.74) million plus non-cash expenses of approximately $1.94 million and the net change in operating assets and liabilities of approximately $0.91 million. Non-cash net expenses were primarily comprised of $1.82 million of depreciation and amortization and $0.09 million of amortization of deferred finance costs. The net change in operating assets and liabilities was primarily comprised of an increase in various operating liabilities of $2.62 million, partially offset by an increase in accounts receivable of $(1.04) million and an increase in inventory of $(0.57) million.

Investing Activities

Net cash used in investing activities for the current quarter consisted of approximately $0.08 million of capital expenditures, primarily related to software. Net cash used in the investing activities for the prior year quarter consisted of approximately $0.04 million of capital expenditures.

Financing Activities

Net cash used in financing activities for the prior year quarter consisted of approximately $(0.63) million of scheduled principal payments on term loan debt. There was no cash used in or provided by financing activities in the current quarter.

Other Factors

We continue to seek to expand and diversify the types of licensed products being produced under our brands. We plan to continue to diversify the distribution channels within which licensed products are sold, in an effort to reduce dependence on any particular retailer, consumer, or market sector within each of our brands. The Lori Goldstein brand, Halston brand, and C Wonder brand have a core business in fashion apparel and accessories. The Ripka brand is a fine jewelry business which we believe helps diversify our industry focus while at the same time complements our business operations and relationships.

24

While the recent sale of a majority interest in the Isaac Mizrahi brand has resulted in a short-term decrease in our revenues, as that brand represented a significant portion of our historical revenues, we are taking actions to replace those revenues in the long-term with new strategic business initiatives, as we concentrate our resources on growing our brands, launching new brands, and entering into new business partnerships. We continue to seek new opportunities, including expansion through interactive television, live streaming, additional domestic and international licensing arrangements, and acquiring additional brands, including recent launches of our Victor Glemaud and C Wonder by Christian Siriano businesses on HSN.

In the first quarter of 2023, we began to restructure our business operations by shifting our business from a wholesale/licensing hybrid model into a “licensing-plus” business model. These efforts include entering into new structured contractual arrangements with best-in-class business partners in order to more efficiently operate our wholesale and e-commerce businesses and reduce and better manage our exposure to operating risks.

At the same time, we continue to face a number of headwinds in the current macroeconomic environment. The global shipping industry has experienced and continues to experience challenges related to port delays and reduced availability for carriers and containers. This situation has negatively impacted our supply chain partners, including third party manufacturers, logistics providers, and other vendors, as well as the supply chains of our licensees, and has resulted in increased cost of supply and freight costs for us and our licensees. Such higher costs are currently expected to continue for at least some portion of 2023.

Further, the cost of raw materials, labor, manufacturing, energy, fuel, shipping and logistics, and other inputs related to the production and distribution of our products have increased and may continue to increase unexpectedly. Beginning in the first quarter of 2022, input costs increased significantly. We expect the pressures of input cost inflation to continue for at least the majority of 2023. We may not be able to mitigate the impact of inflation and cost increases or pass these costs along to our customers.

Also, poor economic and market conditions, including a potential recession, may negatively impact market sentiment, decreasing the demand for apparel, footwear, accessories, fine jewelry, home goods, and other consumer products, which would adversely affect our operating income and results of operations. If we are unable to take effective measures in a timely manner to mitigate the impact of inflation as well as a potential recession, our business, financial condition, and results of operations could be adversely affected.

Our long-term success, however, will still remain largely dependent on our ability to build and maintain our brands’ awareness and continue to attract wholesale and direct-to-consumer customers, and contract with and retain key licensees and business partners, as well as our and our licensees’ ability to accurately predict upcoming fashion and design trends within their respective customer bases and fulfill the product requirements of the particular retail channels within the global marketplace. Unanticipated changes in consumer fashion preferences and purchasing patterns, slowdowns in the U.S. economy, changes in the prices of supplies, consolidation of retail establishments, and other factors noted in Item 1A of our most recent Annual Report on Form 10-K could adversely affect our licensees’ ability to meet and/or exceed their contractual commitments to us and thereby adversely affect our future operating results.

Off-Balance Sheet Arrangements

We do not have any off-balance sheet arrangements that have or are reasonably likely to have a current or future material effect on our financial condition, results of operations, or liquidity.

25

Critical Accounting Policies and Estimates

The preparation of our unaudited condensed consolidated financial statements in conformity with GAAP requires management to exercise judgment. We exercise considerable judgment with respect to establishing sound accounting policies and in making estimates and assumptions that affect the reported amounts of our assets and liabilities, our recognition of revenues and expenses, and disclosure of commitments and contingencies at the date of the financial statements. We evaluate our estimates and judgments on an on-going basis. We base our estimates and judgments on a variety of factors, including our historical experience, knowledge of our business and industry, and current and expected economic conditions that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. We periodically re-evaluate our estimates and assumptions with respect to these judgments and modify our approach when circumstances indicate that modifications are necessary. While we believe that the factors we evaluate provide us with a meaningful basis for establishing and applying sound accounting policies, we cannot guarantee that the results will always be accurate. Because the determination of these estimates requires the exercise of judgment, actual results could differ from such estimates.

Please refer to our Annual Report on Form 10-K for the year ended December 31, 2022, filed with the SEC on April 17, 2023, for a discussion of our critical accounting policies and estimates.

Effective January 1, 2023, we adopted the provisions of Accounting Standards Update No. 2016-13, "Financial Instruments – Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments" (as amended). Although the adoption of this new guidance did not have a significant impact on the Company’s results of operations, cash flows, or financial condition, it represented a change in our accounting policy with respect to the estimation of allowance for uncollectible accounts. Refer to Part I, Item 1, Note 5 of this Quarterly Report on Form 10-Q for additional information. During the three months ended March 31, 2023, there were no other material changes to our accounting policies.

ITEM 3.    QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

Not applicable to smaller reporting companies.

ITEM 4.    CONTROLS AND PROCEDURES

A. EVALUATION OF DISCLOSURE CONTROLS AND PROCEDURES:

Our management, under the supervision and with the participation of our Chief Executive Officer and Chief Financial Officer, evaluated the effectiveness of the design and operation of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)) as of March 31, 2023, the end of the period covered by this report. Based on, and as of the date of such evaluation, the Chief Executive Officer and the Chief Financial Officer have concluded that our disclosure controls and procedures were effective as of March 31, 2023 such that the information required to be disclosed in our SEC reports is recorded, processed, summarized, and reported within the time periods specified in SEC rules and forms, and is accumulated and communicated to our management, including our principal executive officer and principal financial officer, as appropriate, to allow timely decisions regarding required disclosure.

B. CHANGES IN INTERNAL CONTROL OVER FINANCIAL REPORTING:

There have not been any changes in our internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) during the fiscal quarter ended March 31, 2023 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

26

PART II. OTHER INFORMATION

ITEM 1.    LEGAL PROCEEDINGS

In the ordinary course of business, from time to time we become involved in legal claims and litigation. In the opinion of management, based on consultations with legal counsel, the disposition of litigation currently pending against us is unlikely to have, individually or in the aggregate, a materially adverse effect on our business, financial position, or results of operations.

ITEM 1A.    RISK FACTORS

We operate in a highly competitive industry that involves numerous known and unknown risks and uncertainties that could impact our operations. The risks described in Part I, Item 1A, “Risk Factors” of our Annual Report on Form 10-K for the year ended December 31, 2022 are not the only risks we face. Additional risks and uncertainties not currently known to us or that we currently deem to be immaterial also may materially adversely affect our financial condition and/or operating results.

ITEM 2.    UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

There were no sales of unregistered or registered securities during the three months ended March 31, 2023.

ITEM 3.    DEFAULTS UPON SENIOR SECURITIES

None.

ITEM 4.    MINE SAFETY DISCLOSURES

Not applicable.

ITEM 5.    OTHER INFORMATION

On May 15, 2023, the Company, through its subsidiaries, H Halston, LLC and H Heritage Licensing, LLC (collectively, the “Licensor”), entered into a master license agreement relating to the Halston Brand (the “Halston Master License”) with an industry-leading wholesale apparel company, for men’s and women’s apparel, men’s and women’s fashion accessories, children’s apparel and accessories, home, airline amenity and amenity kits, and such other product categories as mutually agreed upon. The Halston Master License provides for an upfront cash payment and royalties payable to the Company, including certain guaranteed minimum royalties, includes significant annual minimum net sales requirements, and has a twenty-five-year term (consisting of an initial five-year period, followed by a twenty-year period), subject to the licensee’s right to terminate with at least 120 days’ notice prior to the end of each five-year period during the term. The licensee has an option to purchase the Halston Brand for $5.0 million at the end of the twenty-five-year term, which right may be accelerated under certain conditions associated with an uncured material breach of the Halston Master License in accordance with the terms of the Halston Master License. The Licensor granted to the licensee a security interest in the Halston trademarks to secure the Licensor’s obligations under the Halston Master License, including to honor the obligations under the purchase option. In connection with the Halston Master License, the Company issued to the licensee a ten-year warrant to purchase up to 1,000,000 shares of the Company’s common stock at an exercise price of $1.50 per share, which vest based upon certain annual royalty targets being satisfied.

27

ITEM 6.    EXHIBITS

The following exhibits are filed herewith:

31.1 Rule 13a-14(a)/15d-14(a) Certification (CEO)

31.2 Rule 13a-14(a)/15d-14(a) Certification (CFO)

32.1 Section 1350 Certification (CEO) *

32.2 Section 1350 Certification (CFO) *

101.INS Inline XBRL Instance Document

101.SCH Inline XBRL Taxonomy Extension Schema Document

101.CAL Inline XBRL Taxonomy Extension Calculation Linkbase Document

101.DEF Inline XBRL Taxonomy Extension Definitions Linkbase Document

101.LAB Inline XBRL Taxonomy Extension Label Linkbase Document

101.PRE Inline XBRL Taxonomy Extension Presentation Linkbase Document

104 Cover Page Interactive Data File (formatted as inline XBRL and contained in Exhibit 101)

* Furnished herewith.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

Date: May 18, 2023

By:

/s/ Robert W. D’Loren

 

 

Name: Robert W. D’Loren

 

 

Title: Chairman and Chief Executive Officer

 

 

 

 

By:

/s/ James Haran

 

 

Name: James Haran

 

 

Title: Chief Financial Officer and Vice President

28

EX-31.1 2 xelb-20230331xex31d1.htm EX-31.1

EXHIBIT 31.1

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO

SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Robert W. D’Loren, certify that:

1. I have reviewed this Quarterly Report on Form 10-Q for the quarter ended March 31, 2023 of Xcel Brands, Inc. (the “Company”).

2. Based on my knowledge, this quarterly report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this quarterly report;

3. Based on my knowledge, the financial statements, and other financial information included in this quarterly report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this quarterly report;

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

a) All significant deficiencies and material weaknesses in the design or operation of internal controls over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

May 18, 2023

By:

/s/ Robert W. D’Loren

 

 

Name: Robert W. D’Loren

 

 

Title: Chairman and Chief Executive Officer


EX-31.2 3 xelb-20230331xex31d2.htm EX-31.2

EXHIBIT 31.2

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO

SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, James Haran, certify that:

1. I have reviewed this Quarterly Report on Form 10-Q for the quarter ended March 31, 2023 of Xcel Brands, Inc. (the “Company”).

2. Based on my knowledge, this quarterly report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this quarterly report;

3. Based on my knowledge, the financial statements, and other financial information included in this quarterly report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this quarterly report;

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the Company’s board of directors (or persons performing the equivalent functions):

a) All significant deficiencies and material weaknesses in the design or operation of internal controls over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

May 18, 2023

By:

/s/ James Haran

 

 

Name: James Haran

Title: Chief Financial Officer and Vice President

 

 


EX-32.1 4 xelb-20230331xex32d1.htm EX-32.1

EXHIBIT 32.1

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Xcel Brands, Inc. (the “Company”) on Form 10-Q for the period ended March 31, 2023 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Robert W. D’Loren, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to my knowledge:

(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

May 18, 2023

By:

/s/ Robert W. D’Loren

 

 

Name: Robert W. D’Loren

 

 

Title: Chairman and Chief Executive Officer


EX-32.2 5 xelb-20230331xex32d2.htm EX-32.2

EXHIBIT 32.2

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Xcel Brands, Inc. (the “Company”) on Form 10-Q for the period ended March 31, 2023 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, James Haran, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to my knowledge:

(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

May 18, 2023

By:

/s/ James Haran

 

 

Name: James Haran

 

 

Title: Chief Financial Officer and Vice President


EX-101.SCH 6 xelb-20230331.xsd EX-101.SCH 99900 - Disclosure - Standard And Custom Axis Domain Defaults link:presentationLink link:calculationLink link:definitionLink 00100 - Statement - Consolidated Balance Sheets link:presentationLink link:calculationLink link:definitionLink 00200 - Statement - Consolidated Statements of Operations link:presentationLink link:calculationLink link:definitionLink 00400 - Statement - Consolidated Statements of Cash Flows link:presentationLink link:calculationLink link:definitionLink 40302 - Disclosure - Trademarks and Other Intangibles - Schedule of Trademarks and Other Intangibles (Details) link:presentationLink link:calculationLink link:definitionLink 40502 - Disclosure - Leases - Maturities of Lease Liabilities (Details) (Calc2) link:presentationLink link:calculationLink link:definitionLink 40602 - Disclosure - Leases - Maturities of Lease Liabilities (Details) link:presentationLink link:calculationLink link:definitionLink 40901 - Disclosure - Earnings (Loss) Per Share - Basic and Diluted Earnings Per Share (Details) link:presentationLink link:calculationLink link:definitionLink 00300 - Statement - Consolidated Statements of Stockholders' Equity link:presentationLink link:calculationLink link:definitionLink 30803 - Disclosure - Stockholders' Equity (Tables) link:presentationLink link:calculationLink link:definitionLink 40101 - Disclosure - Nature of Operations, Background, and Basis of Presentation (Details) link:presentationLink link:calculationLink link:definitionLink 40102 - Disclosure - Nature of Operations, Background, and Basis of Presentation - Liquidity (Details) link:presentationLink link:calculationLink link:definitionLink 40201 - Disclosure - Equity Method Investment - IM Topco, LLC (Details) link:presentationLink link:calculationLink link:definitionLink 40202 - Disclosure - Equity Method Investment - Summarized financial information (Details) link:presentationLink link:calculationLink link:definitionLink 40301 - Disclosure - Trademarks and Other Intangibles - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 40401 - Disclosure - Significant Contracts and Concentrations - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 40501 - Disclosure - Accounts Receivable (Details) link:presentationLink link:calculationLink link:definitionLink 40601 - Disclosure - Leases - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 40701 - Disclosure - Debt - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 40801 - Disclosure - Stockholders' Equity - Equity Incentive Plans (Details) link:presentationLink link:calculationLink link:definitionLink 40802 - Disclosure - Stockholders' Equity - Stock-based Compensation (Details) link:presentationLink link:calculationLink link:definitionLink 40803 - Disclosure - Stockholders' Equity - Stock Options (Details) link:presentationLink link:calculationLink link:definitionLink 40806 - Disclosure - Stockholders' Equity - Non-Vested Options (Details) link:presentationLink link:calculationLink link:definitionLink 40807 - Disclosure - Stockholders' Equity - Warrants (Details) link:presentationLink link:calculationLink link:definitionLink 40808 - Disclosure - Stockholders' Equity - Stock Awards (Details) link:presentationLink link:calculationLink link:definitionLink 40809 - Disclosure - Stockholders' Equity - Restricted Stock (Details) link:presentationLink link:calculationLink link:definitionLink 40902 - Disclosure - Earnings (Loss) Per Share - Anti-dilutive Securities Excluded (Details) link:presentationLink link:calculationLink link:definitionLink 41003 - Disclosure - Income Taxes (Details) link:presentationLink link:calculationLink link:definitionLink 41101 - Disclosure - Related Party Transactions - Isaac Mizrahi (Details) link:presentationLink link:calculationLink link:definitionLink 41201 - Disclosure - Commitments and Contingencies - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 41301 - Disclosure - Subsequent Events - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 9940202 - Disclosure - Summary of Significant Accounting Policies - Accounts Receivable (Details) 10K link:presentationLink link:calculationLink link:definitionLink 00090 - Document - Document and Entity Information link:presentationLink link:calculationLink link:definitionLink 00105 - Statement - Consolidated Balance Sheets (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 10101 - Disclosure - Nature of Operations, Background, and Basis of Presentation link:presentationLink link:calculationLink link:definitionLink 10201 - Disclosure - Equity Method Investment link:presentationLink link:calculationLink link:definitionLink 10301 - Disclosure - Trademarks and Other Intangibles link:presentationLink link:calculationLink link:definitionLink 10401 - Disclosure - Significant Contracts link:presentationLink link:calculationLink link:definitionLink 10501 - Disclosure - Accounts Receivable link:presentationLink link:calculationLink link:definitionLink 10601 - Disclosure - Leases link:presentationLink link:calculationLink link:definitionLink 10701 - Disclosure - Debt link:presentationLink link:calculationLink link:definitionLink 10801 - Disclosure - Stockholders' Equity link:presentationLink link:calculationLink link:definitionLink 10901 - Disclosure - Earnings (Loss) Per Share link:presentationLink link:calculationLink link:definitionLink 11001 - Disclosure - Income Taxes link:presentationLink link:calculationLink link:definitionLink 11101 - Disclosure - Related Party Transactions link:presentationLink link:calculationLink link:definitionLink 11201 - Disclosure - Commitments and Contingencies link:presentationLink link:calculationLink link:definitionLink 11301 - Disclosure - Subsequent Events link:presentationLink link:calculationLink link:definitionLink 30203 - Disclosure - Equity Method Investment (Tables) link:presentationLink link:calculationLink link:definitionLink 30303 - Disclosure - Trademarks and Other Intangibles (Tables) link:presentationLink link:calculationLink link:definitionLink 30603 - Disclosure - Leases (Tables) link:presentationLink link:calculationLink link:definitionLink 30903 - Disclosure - Earnings (Loss) Per Share (Tables) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 7 xelb-20230331_cal.xml EX-101.CAL EX-101.DEF 8 xelb-20230331_def.xml EX-101.DEF EX-101.LAB 9 xelb-20230331_lab.xml EX-101.LAB EX-101.PRE 10 xelb-20230331_pre.xml EX-101.PRE XML 11 R1.htm IDEA: XBRL DOCUMENT v3.23.1
Document and Entity Information - shares
3 Months Ended
Mar. 31, 2023
May 15, 2023
Document And Entity Information [Abstract]    
Document Type 10-Q  
Document Quarterly Report true  
Document Period End Date Mar. 31, 2023  
Current Fiscal Year End Date --12-31  
Document Transition Report false  
Entity File Number 001-37527  
Entity Registrant Name XCEL BRANDS, INC.  
Entity Incorporation, State or Country Code DE  
Entity Tax Identification Number 76-0307819  
Entity Address, Address Line One 1333 Broadway, 10th Floor  
Entity Address, City or Town New York  
Entity Address, State or Province NY  
Entity Address, Postal Zip Code 10018  
City Area Code 347  
Local Phone Number 727-2474  
Title of 12(b) Security Common Stock, $0.001 par value per share  
Trading Symbol XELB  
Security Exchange Name NASDAQ  
Entity Current Reporting Status Yes  
Entity Interactive Data Current Yes  
Entity Filer Category Non-accelerated Filer  
Entity Small Business true  
Entity Emerging Growth Company false  
Entity Shell Company false  
Entity Common Stock, Shares Outstanding   19,683,194
Entity Central Index Key 0001083220  
Document Fiscal Year Focus 2023  
Document Fiscal Period Focus Q1  
Amendment Flag false  
XML 12 R2.htm IDEA: XBRL DOCUMENT v3.23.1
Consolidated Balance Sheets - USD ($)
$ in Thousands
Mar. 31, 2023
Dec. 31, 2022
Current Assets:    
Cash and cash equivalents $ 1,612 $ 4,608
Accounts receivable, net 5,969 5,110
Inventory 3,099 2,845
Prepaid expenses and other current assets 1,032 1,457
Total current assets 11,712 14,020
Non-current Assets:    
Property and equipment, net 1,237 1,418
Operating lease right-of-use assets 5,185 5,420
Trademarks and other intangibles, net 46,130 47,665
Equity method investment 18,680 19,195
Deferred tax assets, net 1,107 1,107
Other assets 110 110
Total non-current assets 72,449 74,915
Total Assets 84,161 88,935
Current Liabilities:    
Accounts payable, accrued expenses and other current liabilities 5,549 3,958
Accrued income taxes payable 555 568
Accrued payroll 477 416
Current portion of operating lease obligations 1,395 1,376
Current portion of contingent obligations   243
Total current liabilities 7,976 6,561
Long-Term Liabilities:    
Long-term portion of operating lease obligations 5,531 5,839
Long-term portion of contingent obligations 6,396 6,396
Total long-term liabilities 11,927 12,235
Total Liabilities 19,903 18,796
Commitments and Contingencies
Stockholders' Equity:    
Preferred stock, $.001 par value, 1,000,000 shares authorized, none issued and outstanding
Common stock, $.001 par value, 50,000,000 shares authorized, and 19,633,194 and 19,624,860 shares issued and outstanding at March 31, 2023 and December 31, 2022, respectively 20 20
Paid-in capital 103,649 103,592
Accumulated deficit (38,440) (32,797)
Total Xcel Brands, Inc. stockholders' equity 65,229 70,815
Noncontrolling interest (971) (676)
Total Stockholders' Equity 64,258 70,139
Total Liabilities and Stockholders' Equity $ 84,161 $ 88,935
XML 13 R3.htm IDEA: XBRL DOCUMENT v3.23.1
Consolidated Balance Sheets (Parenthetical) - $ / shares
Mar. 31, 2023
Dec. 31, 2022
Statement of Financial Position [Abstract]    
Preferred stock, par value (in dollars per share) $ 0.001 $ 0.001
Preferred stock, shares authorized (in shares) 1,000,000 1,000,000
Preferred stock, shares issued (in shares) 0 0
Preferred stock, shares outstanding (in shares) 0 0
Common stock, par value (in dollars per share) $ 0.001 $ 0.001
Common stock, shares authorized (in shares) 50,000,000 50,000,000
Common stock, shares issued (in shares) 19,633,194 19,624,860
Common stock, shares outstanding (in shares) 19,633,194 19,624,860
XML 14 R4.htm IDEA: XBRL DOCUMENT v3.23.1
Consolidated Statements of Operations - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Revenues    
Net revenue $ 6,050 $ 8,747
Cost of goods sold 2,693 1,680
Gross profit 3,357 7,067
Operating costs and expenses    
Salaries, benefits and employment taxes 3,465 4,861
Other selling, general and administrative expenses 3,493 3,416
Total operating costs and expenses 6,958 8,277
Operating loss before other expense (income), including non-cash expenses (3,601) (1,210)
Other expense (income), including non-cash expenses    
Depreciation and amortization expense 1,797 1,820
Loss from equity method investment 515  
Total other expense (income), including non-cash expenses 2,312 1,820
Operating loss (5,913) (3,030)
Interest and finance expense    
Interest expense - term loan debt   708
Other interest and finance charges, net 25 1
Total interest and finance expense 25 709
Loss before income taxes (5,938) (3,739)
Net loss (5,938) (3,739)
Net loss attributable to noncontrolling interest (295) (252)
Net loss attributable to Xcel Brands, Inc. stockholders $ (5,643) $ (3,487)
Loss per common share attributable to Xcel Brands, Inc. stockholders:    
Basic net loss per share $ (0.29) $ (0.18)
Diluted net loss per share $ (0.29) $ (0.18)
Weighted average number of common shares outstanding:    
Basic weighted average number of shares outstanding 19,633,194 19,571,119
Diluted weighted average common shares outstanding 19,633,194 19,571,119
Net licensing revenue    
Revenues    
Net revenue $ 2,222 $ 5,961
Net sales    
Revenues    
Net revenue $ 3,828 $ 2,786
XML 15 R5.htm IDEA: XBRL DOCUMENT v3.23.1
Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Common Stock
Paid-In Capital [Member]
Retained Earnings (Accumulated Deficit) [Member]
Noncontrolling Interest [Member]
Total
Balances at Dec. 31, 2021 $ 20 $ 103,039 $ (28,779) $ 662 $ 74,942
Balances (in shares) at Dec. 31, 2021 19,571,119        
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Compensation expense related to stock options and restricted stock   30     30
Net loss     (3,487) (252) (3,739)
Balances at Mar. 31, 2022 $ 20 103,069 (32,266) 410 71,233
Balances (in shares) at Mar. 31, 2022 19,571,119        
Balances at Dec. 31, 2022 $ 20 103,592 (32,797) (676) 70,139
Balances (in shares) at Dec. 31, 2022 19,624,860        
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Compensation expense related to stock options and restricted stock   51     51
Shares issued to consultant in connection with stock grant   6     6
Shares issued to consultant in connection with stock grant (in shares) 8,334        
Net loss     (5,643) (295) (5,938)
Balances at Mar. 31, 2023 $ 20 $ 103,649 $ (38,440) $ (971) $ 64,258
Balances (in shares) at Mar. 31, 2023 19,633,194        
XML 16 R6.htm IDEA: XBRL DOCUMENT v3.23.1
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Cash flows from operating activities    
Net loss $ (5,938) $ (3,739)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization expense 1,797 1,820
Amortization of deferred finance costs included in interest expense   91
Stock-based compensation 57 32
Undistributed proportional share of net loss of equity method investee 515  
Changes in operating assets and liabilities:    
Accounts receivable (859) (1,036)
Inventory (254) (566)
Prepaid expenses and other current and non-current assets 425 15
Accounts payable, accrued expenses, accrued payroll, accrued income taxes payable, and other current liabilities 1,396 2,620
Lease-related assets and liabilities (54) (128)
Net cash used in operating activities (2,915) (891)
Cash flows from investing activities    
Purchase of property and equipment (81) (35)
Net cash provided by (used in) investing activities (81) (35)
Cash flows from financing activities    
Payment of long-term debt   (625)
Net cash (used in) provided by financing activities   (625)
Net decrease in cash, cash equivalents, and restricted cash (2,996) (1,551)
Cash, cash equivalents, and restricted cash at beginning of period 4,608 5,222
Cash, cash equivalents, and restricted cash at end of period 1,612 3,671
Reconciliation to amounts on consolidated balance sheets:    
Cash and cash equivalents 1,612 3,063
Restricted cash   608
Total cash, cash equivalents, and restricted cash 1,612 3,671
Supplemental disclosure of cash flow information:    
Cash paid during the period for interest   $ 623
Cash paid during the period for income taxes $ 16  
XML 17 R7.htm IDEA: XBRL DOCUMENT v3.23.1
Nature of Operations, Background, and Basis of Presentation
3 Months Ended
Mar. 31, 2023
Nature of Operations, Background, and Basis of Presentation [Abstract]  
Nature of Operations, Background, and Basis of Presentation

1. Nature of Operations, Background, and Basis of Presentation

The accompanying condensed consolidated balance sheet as of December 31, 2022 (which has been derived from audited financial statements) and the unaudited interim condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States (“GAAP”) for interim financial information and pursuant to the instructions to Form 10-Q and Article 8 of Regulation S-X promulgated by the United States Securities and Exchange Commission (“SEC”). Certain information or footnote disclosures normally included in financial statements prepared in accordance with GAAP have been condensed or omitted, pursuant to the rules and regulations of the SEC for interim financial reporting. Accordingly, they do not include all the information and footnotes necessary for a comprehensive presentation of financial position, results of operations, or cash flows.

In the opinion of management, the accompanying unaudited condensed consolidated financial statements were prepared following the same policies and procedures used in the preparation of the audited consolidated financial statements and reflect all adjustments (consisting of normal recurring adjustments) necessary to present fairly the results of operations, financial position, and cash flows of Xcel Brands, Inc. and its subsidiaries (the “Company” or "Xcel"). The results of operations for the interim periods presented herein are not necessarily indicative of the results for the entire fiscal year or for any future interim periods. These unaudited condensed consolidated financial statements should be read in conjunction with the Company’s Annual Report on Form 10-K for the year ended December 31, 2022, as filed with the SEC on April 17, 2023.

The Company is a media and consumer products company engaged in the design, production, marketing, live streaming, wholesale distribution, and direct-to-consumer sales of branded apparel, footwear, accessories, fine jewelry, home goods and other consumer products, and the acquisition of dynamic consumer lifestyle brands.

Currently, the Company’s brand portfolio consists of the LOGO by Lori Goldstein brand (the “Lori Goldstein Brand”), the Halston brands (the "Halston Brand"), the Judith Ripka brands (the "Ripka Brand"), the C Wonder brands (the "C Wonder Brand"), the Longaberger brand (the “Longaberger Brand”), the Isaac Mizrahi brands (the "Isaac Mizrahi Brand"), and other proprietary brands.

The Lori Goldstein Brand, Halston Brand, Ripka Brand, and C Wonder Brand are wholly owned by the Company.
The Company manages the Longaberger Brand through its 50% ownership interest in Longaberger Licensing, LLC; the Company consolidates Longaberger Licensing, LLC and recognizes noncontrolling interest for the remaining ownership interest held by a third party.
The Company manages the Q Optix business through its 50% ownership interest in Q Optix, LLC; the Company consolidates Q Optix, LLC and recognizes noncontrolling interest for the remaining ownership interest held by a third party.
The Company wholly owned and managed the Isaac Mizrahi Brand through May 31, 2022. On May 31, 2022, the Company sold to a third party a majority interest in a newly-created subsidiary that was formed to hold the Isaac Mizrahi Brand trademarks, but retained a noncontrolling interest in the brand through a 30% ownership interest in IM Topco, LLC, and continues to contribute to the operations of the brand through a service agreement (see Note 2 and Note 11 for additional details). The Company accounts for its interest in IM Topco, LLC using the equity method of accounting.

The Company designs, produces, markets, and distributes products, licenses its brands to third parties, and generates licensing revenues through contractual arrangements with manufacturers and retailers. The Company and its licensees distribute through an omni-channel retail sales strategy, which includes distribution through interactive television, digital live-stream shopping, brick-and-mortar retail, wholesale, and e-commerce channels to be everywhere its customers shop.

The Company’s wholesale and direct-to-consumer operations are presented as "Net sales" and "Cost of goods sold" in the Condensed Consolidated Statements of Operations, separately from the Company’s net licensing revenue.

Liquidity and Management’s Plans  

The Company incurred a net loss of approximately $5.6 million during the three months ended March 31, 2023 (which included non-cash expenses of approximately $2.4 million), and had an accumulated deficit of approximately $38.4 million as of March 31, 2023. Net cash used in operating activities was approximately $2.9 million for the three months ended March 31, 2023. The Company had working capital (current assets less current liabilities, excluding the current portion of lease obligations and any contingent obligations payable in common stock) of approximately $5.1 million as of March 31, 2023. The Company’s cash and cash equivalents were approximately $1.6 million as of March 31, 2023. The aforementioned factors raise uncertainties about the Company’s ability to continue as a going concern.

Management plans to mitigate an expected shortfall of capital and to support future operations by shifting the business from a wholesale/licensing hybrid model into a “licensing-plus” business model. In the first quarter of 2023, the Company began to restructure its business operations by entering into new licensing agreements and joint venture arrangements with best-in-class business partners. The Company entered into a new interactive television licensing agreement with America’s Collectibles Network, Inc. d/b/a Jewelry Television (“JTV”) for the Ripka Brand, and a separate license with JTV for the Ripka Brand’s e-commerce business. For apparel, similar transactions have recently been executed. In conjunction with the launch of the C Wonder Brand on HSN, the Company licensed the wholesale operations related to the brand to One Jeanswear Group, LLC (“OJG”); this new license with OJG also includes certain other new celebrity brands that the Company plans to launch in 2023 and beyond. For the Halston Brand, on May 15, 2023 the Company entered into a new master license agreement for men’s, women’s, and children’s apparel, fashion accessories, and other product categories with an industry-leading wholesale apparel company for distribution through department stores, e-commerce, and other retailers (see Note 13). This new master license for the Halston Brand provides for an upfront cash payment and royalties, including certain guaranteed minimum royalties to the Company, includes significant annual minimum net sales requirements, and has a twenty-five-year term (consisting of an initial five-year period, followed by a twenty-year period), subject to the licensee’s right to terminate with at least 120 days’ notice prior to the end of each five-year period during the term.

Management expects the transition of these operating businesses to be completed by the end of the second quarter of 2023. Management believes that this evolution of the Company’s operating model will provide the Company with significant cost savings and allow the Company to reduce and better manage its exposure to operating risks. As of March 31, 2023, the Company took steps that will reduce payroll costs by $6 million and operating expenses by $7 million over the next twelve months.

Based on these recent events and changes in the Company’s business model, management expects to generate adequate cash flows to meet the Company’s operating and capital expenditure needs, for at least the twelve months subsequent to the filing date of this Quarterly Report on Form 10-Q, and therefore, such conditions and uncertainties with respect to the Company’s ability to continue as a going concern as of March 31, 2023, have subsequently been alleviated.

Recently Adopted Accounting Pronouncements

The Company adopted the provisions of Accounting Standards Update (“ASU”) No. 2016-13, "Financial Instruments – Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments" (as amended by ASU No. 2018-19 in November 2018, ASU No. 2019-05 in May 2019, ASU No. 2019-10 and 2019-11 in November 2019, ASU No. 2020-02 in February 2020, and ASU No. 2022-02 in March 2022) effective January 1, 2023. This ASU requires entities to estimate lifetime expected credit losses for financial instruments, including trade and other receivables, which will result in earlier recognition of credit losses. The adoption of this new guidance did not have a significant impact on the Company’s results of operations, cash flows, or financial condition.

XML 18 R8.htm IDEA: XBRL DOCUMENT v3.23.1
Equity Method Investment
3 Months Ended
Mar. 31, 2023
Equity Method Investment, Summarized Financial Information [Abstract]  
Equity Method Investment

2.      Equity Method Investment

IM Topco, LLC

On May 27, 2022, Xcel (along with IM Topco, LLC (“IM Topco”) and IM Brands, LLC (“IMB”), both wholly owned subsidiaries of the Company) and IM WHP, LLC (“WHP”), a subsidiary of WHP Global, a private equity-backed brand management and licensing company, entered into a membership purchase agreement. Pursuant to this agreement, on May 31, 2022, (i) the Company contributed assets owned by IMB, including the Isaac Mizrahi Brand trademarks and other intellectual property rights relating thereto into IM Topco, and (ii) the Company sold 70% of the membership interests of IM Topco to WHP. The Company accounts for its 30% interest in the ongoing operations of IM Topco as other expense (income) under the equity method of accounting.

Pursuant to the business venture agreement between the Company and WHP governing the operation of IM Topco, IM Topco’s net cash flow (as defined in the agreement) shall be distributed to the members during each fiscal year no less than once per fiscal quarter, as follows:

(i)first, 100% to WHP, until WHP has received an aggregate amount during such fiscal year equal to $8,852,000 (subject to adjustment in certain circumstances as set forth in the agreement);
(ii)second, 100% to Xcel, until Xcel has received an aggregate amount during such fiscal year equal to $1,316,200 (subject to adjustment in certain circumstances as set forth in the agreement); and
(iii)thereafter, in proportion to the members’ respective percentage interests.

The Company recognized an equity method loss of $0.52 million related to its investment for the three months ended March 31, 2023, based on the distribution provisions described above.

Summarized financial information for IM Topco for the three months ended March 31, 2023 is as follows:

($ in thousands)

Revenues

$

3,346

Gross profit

3,346

Loss from continuing operations

(143)

Net loss

(143)

XML 19 R9.htm IDEA: XBRL DOCUMENT v3.23.1
Trademarks and Other Intangibles
3 Months Ended
Mar. 31, 2023
Goodwill and Intangible Assets Disclosure [Abstract]  
Trademarks and Other Intangibles

3.      Trademarks and Other Intangibles  

Trademarks and other intangibles, net consist of the following:

    

Weighted

    

    

    

 

Average

 

March 31, 2023

 

Amortization

Gross Carrying

Accumulated

Net Carrying

($ in thousands)

Period

Amount

Amortization

Amount

Trademarks (finite-lived)

 

15 years

 

68,880

 

22,866

 

46,014

Copyrights and other intellectual property

 

8 years

 

429

 

313

 

116

Total

$

69,309

$

23,179

$

46,130

    

Weighted

    

    

    

 

Average

 

December 31, 2022

 

Amortization

 

Gross Carrying

Accumulated

Net Carrying

($ in thousands)

Period

Amount

Amortization

Amount

Trademarks (finite-lived)

 

15 years

 

68,880

 

21,346

 

47,534

Copyrights and other intellectual property

 

8 years

 

429

 

298

 

131

Total

 

  

$

69,309

$

21,644

$

47,665

Amortization expense for intangible assets was approximately $1.54 million for the three-month period ended March 31, 2023 (the "current quarter") and was approximately $1.53 million for the three-month period ended March 31, 2022 (the "prior year quarter").

XML 20 R10.htm IDEA: XBRL DOCUMENT v3.23.1
Significant Contracts
3 Months Ended
Mar. 31, 2023
Risks and Uncertainties [Abstract]  
Significant Contracts and Concentrations

4.      Significant Contracts and Concentrations

Qurate Agreements

Under the Company’s agreements with Qurate Retail Group (“Qurate”), collectively referred to as the Qurate Agreements, Qurate is obligated to make payments to the Company on a quarterly basis, based primarily upon a percentage of net retail sales of certain specified branded merchandise. Net retail sales are defined as the aggregate amount of all revenue generated through the sale of the specified branded products by Qurate and its subsidiaries under the Qurate Agreements, net of customer returns, and excluding freight, shipping and handling charges, and sales, use, or other taxes. Net licensing revenue from the Qurate Agreements represents a significant portion of the Company’s total net revenue.

Net licensing revenue from the Qurate Agreements totaled $1.52 million and $5.01 million for the current quarter and prior year quarter, respectively, representing approximately 25% and 57% of the Company’s total net revenue for the current quarter and prior year quarter, respectively. The prior year quarter included revenues from Qurate Agreement related to the Isaac Mizrahi Brand; such agreement was assigned to IM Topco on May 31, 2022.
As of March 31, 2023 and December 31, 2022, the Company had receivables from Qurate of $1.5 million and $0.9 million, respectively, representing approximately 25% and 17% of the Company’s total net accounts receivable, respectively.
XML 21 R11.htm IDEA: XBRL DOCUMENT v3.23.1
Accounts Receivable
3 Months Ended
Mar. 31, 2023
Accounts Receivable [Abstract]  
Accounts Receivable

5. Accounts Receivable

Accounts receivable are presented on the Company’s condensed consolidated balance sheets net of allowances for credit losses. Such allowances were approximately $0.0 million as of both March 31, 2023 and December 31, 2022. The

Company did not recognize any credit loss expense in the current quarter or prior year quarter. For the current quarter, there were no significant write-offs or recoveries.

The allowance for credit losses is determined based upon a variety of judgments and factors. Factors considered in determining the allowance include historical collection, write-off experience, and management's assessment of collectibility from customers, including current conditions, reasonable forecasts, and expectations of future collectibility and collection efforts. Management continuously assesses the collectibility of receivables and adjusts estimates based on actual experience and future expectations based on economic indicators. Management also monitors the aging analysis of receivables to determine if there are changes in the collections of accounts receivable. Receivable balances are written-off against the allowance for credit losses when such balances are deemed to be uncollectible.

Also, as of March 31, 2023 and December 31, 2022, approximately $1.86 million and $1.65 million, respectively, of the Company's outstanding receivables were assigned to a third-party agent pursuant to a services agreement entered into during the third quarter of 2022, under which the Company assigned, for purposes of collection only, the right to collect certain specified receivables on the Company's behalf and solely for the Company's benefit. Under such agreement, the Company retains ownership of such assigned receivables, and receives payment from the agent (less certain fees charged by the agent) upon the agent's collection of the receivables from customers. During the current quarter, the Company paid approximately $0.05 million in fees to the agent under the aforementioned services agreement.

XML 22 R12.htm IDEA: XBRL DOCUMENT v3.23.1
Leases
3 Months Ended
Mar. 31, 2023
Leases [Abstract]  
Leases

6. Leases

The Company has an operating lease for its corporate offices and operations facility, as well as certain equipment with a term of 12 months or less. The Company also has an operating lease for its former retail store location, which was closed in 2022; the Company is currently in the process of negotiating the termination of this lease.

As of March 31, 2023, the Company’s real estate leases have remaining lease terms of 4 – 6 years, with a weighted average remaining lease term of approximately 4.7 years and a weighted average discount rate of 6.25%.

Lease expense included in selling, general and administrative expenses on the Company’s unaudited condensed consolidated statements of operations was approximately $0.4 million for both the current quarter and prior year quarter.

Cash paid for amounts included in the measurement of operating lease liabilities was $0.4 million and $0.6 million in the current quarter and prior year quarter, respectively.

As of March 31, 2023, the maturities of lease obligations were as follows:

($ in thousands)

    

2023 (April 1 through December 31)

$

1,290

2024

1,711

2025

 

1,711

2026

 

1,711

2027

 

1,452

Thereafter (through 2028)

 

158

Total lease payments

8,033

Less: Discount

1,107

Present value of lease liabilities

6,926

Current portion of lease liabilities

1,395

Non-current portion of lease liabilities

$

5,531

XML 23 R13.htm IDEA: XBRL DOCUMENT v3.23.1
Debt
3 Months Ended
Mar. 31, 2023
Debt Disclosure [Abstract]  
Debt

7. Debt

The Company did not have any debt obligations as of March 31, 2023 or December 31, 2022.

From December 30, 2021 through May 31, 2022, the Company had term loan debt outstanding pursuant to an agreement with First Eagle Alternative Credit Agent, LLC (“FEAC”); this debt was repaid in full and extinguished on May 31, 2022. For the prior year quarter, the Company incurred interest expense (including both interest paid in cash and the amortization of deferred finance costs) related to term loan debt of approximately $0.71 million, and the effective interest rate related to term loan debt was approximately 9.8%.

XML 24 R14.htm IDEA: XBRL DOCUMENT v3.23.1
Stockholders' Equity
3 Months Ended
Mar. 31, 2023
Stockholders' Equity Note [Abstract]  
Stockholders' Equity

8. Stockholders’ Equity

Equity Incentive Plans

A total of 4,000,000 shares of common stock are eligible for issuance under the Company’s 2021 Equity Incentive Plan (the “2021 Plan”). The 2021 Plan provides for the grant of any or all of the following types of awards: stock options (incentive or non-qualified), restricted stock, restricted stock units, performance awards, or cash awards. The 2021 Plan is administered by the Company’s Board of Directors, or, at the Board’s discretion, a committee of the Board.

In addition, stock-based awards (including options, warrants, and restricted stock) previously granted under the Company’s 2011 Equity Incentive Plan (the “2011 Plan”) remain outstanding and shares of common stock may be issued to satisfy options or warrants previously granted under the 2011 Plan, although no new awards may be granted under the 2011 Plan.

Stock-based Compensation

The Company accounts for stock-based compensation in accordance with Accounting Standards Codification (“ASC”) Topic 718, “Compensation - Stock Compensation,” by recognizing the fair value of stock-based compensation as an operating expense over the service period of the award or term of the corresponding contract, as applicable. Forfeitures are accounted for as a reduction of compensation cost in the period when such forfeitures occur. For stock option awards for which vesting is contingent upon the achievement of certain performance targets, the timing and amount of compensation expense recognized is based upon the Company’s projections and estimates of the relevant performance metric(s) until the time the performance obligation is satisfied. Expense for such awards is recognized only to the extent that the achievement of the specified performance target(s) has been met or is considered probable.

Total expense recognized in the current quarter and prior year quarter for all forms of stock-based compensation was approximately $0.06 million and $0.03 million, respectively. Of the current quarter expense amount, substantially all of the expense related to directors and consultants, and was recorded within other selling, general and administrative expenses in the accompanying condensed consolidated statements of operations. Of the prior year quarter expense amount, approximately $0.01 million related to employees and was recorded within salaries, benefits and expenses, while approximately $0.02 million related to directors and consultants and was recorded within other selling, general and administrative expenses.

Stock Options

A summary of the Company’s stock options activity for the current quarter is as follows:

Weighted

Average

Weighted

Remaining

Average

Contractual

Aggregate

Number of

Exercise

Life

Intrinsic

    

Options

    

Price

    

(in Years)

    

Value

Outstanding at January 1, 2023

 

5,614,310

$

2.12

 

4.76

$

Granted

 

 

 

  

 

  

Canceled

 

 

 

  

 

  

Exercised

 

 

 

  

 

  

Expired/Forfeited

 

(245,530)

 

3.84

 

  

 

  

Outstanding at March 31, 2023, and expected to vest

 

5,368,780

$

2.04

 

4.69

$

Exercisable at March 31, 2023

 

1,671,280

$

2.76

 

2.22

$

Compensation expense related to stock options for the current quarter and the prior year quarter was approximately $0.03 million and $0.02 million, respectively. Total unrecognized compensation expense related to unvested stock options at March 31, 2023 was approximately $0.06 million and is expected to be recognized over a weighted average period of approximately 1.01 years.

A summary of the Company’s non-vested stock options activity for the current quarter is as follows:

    

    

Weighted

 Average 

Number of

Grant Date 

    

Options

    

Fair Value

Balance at January 1, 2023

 

3,697,500

$

0.05

Granted

 

 

Vested

 

Forfeited or Canceled

 

 

Balance at March 31, 2023

 

3,697,500

$

0.05

Warrants

A summary of the Company’s warrants activity for the current quarter is as follows:

Weighted

Average

Weighted

Remaining

 

Average

 

Contractual

Aggregate

Number of

Exercise

 

Life

Intrinsic

    

Warrants

    

Price

    

(in Years)

    

Value

Outstanding and exercisable at January 1, 2023

 

116,065

$

3.15

 

1.57

$

Granted

 

 

 

 

  

Canceled

 

 

 

 

  

Exercised

 

 

 

 

  

Expired/Forfeited

 

 

 

 

  

Outstanding and exercisable at March 31, 2023

 

116,065

$

3.15

 

1.32

$

No compensation expense related to warrants was recognized in the current quarter or prior year quarter.

Stock Awards

A summary of the Company’s restricted stock activity for the current quarter is as follows:  

Weighted

Number of

Average

Restricted

Grant Date

    

Shares

    

Fair Value

Outstanding at January 1, 2023

 

333,333

$

3.71

Granted

 

8,334

 

0.75

Canceled

 

 

Vested

 

(8,334)

 

0.75

Expired/Forfeited

 

 

Outstanding at March 31, 2023

 

333,333

$

3.71

On January 1, 2023, the Company issued 8,334 shares of common stock to a consultant, which vested immediately.

Compensation expense related to stock awards was approximately $0.03 million for the current quarter and approximately $0.01 million for the prior year quarter. Total unrecognized compensation expense related to unvested restricted stock grants at March 31, 2023 was approximately $0.04 million and is expected to be recognized over a weighted average period of approximately 1.04 years.

Restricted Stock Units

There were no restricted stock units outstanding as of March 31, 2023 and December 31, 2022, and no restricted stock units have been issued since the inception of the 2021 Plan.

Shares Available Under the Company’s Equity Incentive Plans

As of March 31, 2023, there were 3,321,075 shares of common stock available for award grants under the 2021 Plan.

Shares Reserved for Issuance

As of March 31, 2023, there were 8,805,920 shares of common stock reserved for issuance, including 5,484,845 shares reserved pursuant to unexercised warrants and stock options previously granted under the 2011 Plan, 376,850 shares reserved pursuant to unexercised stock options granted under the 2021 Plan, and 3,321,075 shares available for issuance under the 2021 Plan.

XML 25 R15.htm IDEA: XBRL DOCUMENT v3.23.1
Earnings (Loss) Per Share
3 Months Ended
Mar. 31, 2023
Earnings (Loss) Per Share [Abstract]  
Earnings (Loss) Per Share

9.    Earnings (Loss) Per Share

Basic earnings (loss) per share (“EPS”) is computed by dividing net income (loss) available to common stockholders by the weighted average number of common shares outstanding during the period. Diluted EPS gives effect to all potentially dilutive common shares outstanding during the period, including stock options and warrants, using the treasury stock method. Diluted EPS excludes all potentially dilutive shares of common stock if their effect is anti-dilutive. The following

table is a reconciliation of the numerator and denominator of the basic and diluted net (loss) income per share computations for the three months ended March 31, 2023 and 2022:

Three Months Ended

March 31, 

    

2023

    

2022

Numerator:

Net loss attributable to Xcel Brands, Inc. stockholders (in thousands)

$

(5,643)

$

(3,487)

Denominator:

Basic weighted average number of shares outstanding

19,633,194

 

19,571,119

 

Add: Effect of warrants

 

 

Add: Effect of stock options

Diluted weighted average number of shares outstanding

19,633,194

 

19,571,119

Basic net loss per share

$

(0.29)

$

(0.18)

Diluted net loss per share

$

(0.29)

$

(0.18)

As a result of the net loss for the current quarter and prior year quarter, the Company calculated diluted EPS using basic weighted average shares outstanding for such periods, as utilizing diluted shares would be anti-dilutive to loss per share.

The computation of diluted EPS excludes the following potentially dilutive securities because their inclusion would be anti-dilutive:  

Three Months Ended

March 31, 

    

2023

    

2022

Stock options

5,368,780

5,266,660

Warrants

116,065

116,065

Total

5,484,845

 

5,382,725

 

XML 26 R16.htm IDEA: XBRL DOCUMENT v3.23.1
Income Taxes
3 Months Ended
Mar. 31, 2023
Income Taxes  
Income Taxes

10.    Income Taxes

The estimated annual effective income tax rate for the current quarter and the prior year quarter was approximately 0% for both periods, resulting in an income tax benefit of $0 for both periods.

For both the current quarter and the prior year quarter, the federal statutory rate differed from the effective tax rate due to the recording of a valuation allowance against the benefit that would have otherwise been recognized, as it was considered not more likely than not that the net operating losses generated during each period will be utilized in future periods.

XML 27 R17.htm IDEA: XBRL DOCUMENT v3.23.1
Related Party Transactions
3 Months Ended
Mar. 31, 2023
Related Party Transactions [Abstract]  
Related Party Transactions

11.    Related Party Transactions

IM Topco, LLC

The Company holds a noncontrolling interest in IM Topco, which is accounted for under the equity method of accounting.

On May 31, 2022, the Company entered into a services agreement with IM Topco, pursuant to which the Company provides certain design and support services (including assistance with the operations of the interactive television business

and related talent support) to IM Topco in exchange for payments of $300,000 per year. For the three months ended March 31, 2023, the Company recognized service fee income related to this agreement of $75,000.

On May 31, 2022, the Company entered into a license agreement with IM Topco, pursuant to which IM Topco granted the Company a license to use certain Isaac Mizrahi trademarks on and in connection with the design, manufacture, distribution, sale, and promotion of women’s sportswear products in the United States and Canada during the term of the agreement, in exchange for the payment of royalties in connection therewith. The initial term of this agreement was set to end on December 31, 2026, and provided guaranteed royalties to IM Topco of $400,000 per year. Effective December 16, 2022, the license agreement between IM Topco and Xcel was terminated in favor of a new similar license agreement between IM Topco and an unrelated third party. However, as part of the termination of the May 31, 2022 license agreement, Xcel provided a guarantee to IM Topco for the payment of any difference between (i) the royalties received by IM Topco from the unrelated third party under the new agreement and (ii) the amount of guaranteed royalties that IM Topco would have received from Xcel under the May 31, 2022 agreement. For the three months ended March 31, 2023, the estimated amount of such shortfall was approximately $60,000, which the Company recognized as royalty expense in the condensed consolidated statements of operations.

XML 28 R18.htm IDEA: XBRL DOCUMENT v3.23.1
Commitments and Contingencies
3 Months Ended
Mar. 31, 2023
Commitments and Contingencies Disclosure [Abstract]  
Commitments and Contingencies

12.    Commitments and Contingencies

Contingent Obligation – Lori Goldstein Earn-Out

In connection with the April 1, 2021 purchase of the Lori Goldstein trademarks, the Company agreed to pay the seller additional cash consideration (the “Lori Goldstein Earn-Out”) of up to $12.5 million, based on royalties earned during the six calendar year period commencing in 2021. The Lori Goldstein Earn-Out was initially recorded as a liability of $6.6 million, based on the difference between the fair value of the acquired assets of the Lori Goldstein brand and the total consideration paid, in accordance with the guidance in Accounting Standards Codification Subtopic 805-50. Based on the performance of the Lori Goldstein brand through December 31, 2022, approximately $0.2 million of additional consideration has been earned by the seller to date, and this amount was paid to the seller in the current quarter. At December 31, 2022, $0.2 million of the balance was recorded as a current liability and $6.4 million was recorded as a long-term liability; at March 31, 2023, the entire remaining balance of $6.4 million is recorded as a long-term liability.

Contingent Obligation – Isaac Mizrahi Transaction

In connection with the May 31, 2022 transaction related to the sale of a majority interest in the Isaac Mizrahi Brand (see Note 2), the Company agreed with WHP that, in the event that IM Topco receives less than $13.3 million in aggregate royalties for any four consecutive calendar quarters over a three-year period ending on May 31, 2025, WHP will be entitled to receive from the Company up to $16 million, less all amounts of net cash flow distributed to WHP on an accumulated basis, as an adjustment to the purchase price previously paid by WHP. Such amount would be payable by the Company in either cash or equity interests in IM Topco held by the Company. No amount has been recorded in the accompanying condensed consolidated balance sheets related to this contingent obligation, and management believes the likelihood of any such payment is remote. Based on IM Topco’s earnings from May 31, 2022 through March 31, 2023 and the applicable distribution provisions, WHP earned $5.89 million in cash flow, which reduces the maximum potential purchase price adjustment to $10.11 million.

Legal Proceedings

From time to time, the Company becomes involved in legal claims and litigation in the ordinary course of business. In the opinion of management, based on consultations with legal counsel, the disposition of litigation currently pending against the Company is unlikely to have, individually or in the aggregate, a materially adverse effect on the Company’s business, financial position, results of operations, or cash flows. The Company routinely assesses all its litigation and threatened litigation as to the probability of ultimately incurring a liability, and records its best estimate of the ultimate loss in situations where it assesses the likelihood of loss as probable.

Other Matters

On November 22, 2022, the Company received a letter from the Listing Qualifications Department of The Nasdaq Stock Market (“Nasdaq”) notifying the Company that the minimum bid price per share for its common stock fell below $1.00 for a period of 30 consecutive business days. Therefore, the Company did not meet the minimum bid price requirement set forth in the Nasdaq Listing Rules.

The letter also states that pursuant to Nasdaq Listing Rules 5810(c)(3)(A), the Company will be provided 180 calendar days to regain compliance with the minimum bid price requirement, or until May 22, 2022.

In accordance with Nasdaq Listing Rule 5810(c)(3)(A), the Company can regain compliance if, at any time during the Tolling Period or such 180-day period, the closing bid price of the Company’s common stock is at least $1.00 for a minimum period of 10 consecutive business days. If by May 22, 2023, the Company does not regain compliance with the Nasdaq Listing Rules, the Company may be eligible for additional time to regain compliance pursuant to Nasdaq Listing Rule 5810(c)(3)(A)(ii). To qualify, the Company would need to submit a transfer application and a $5,000 application fee. The Company would also need to provide written notice to Nasdaq of its intention to cure the minimum bid price deficiency during the second compliance period by effecting a reverse stock split, if necessary. As part of its review process, the Nasdaq staff will make a determination of whether it believes the Company will be able to cure this deficiency. Should the Nasdaq staff conclude that the Company will not be able to cure the deficiency, or should the Company determine not to submit a transfer application or make the required representation, Nasdaq will provide notice that the Company’s shares of common stock will be subject to delisting.

If the Company does not regain compliance within the allotted compliance period, including any extensions that may be granted by Nasdaq, Nasdaq will provide notice that the Company’s shares of common stock will be subject to delisting from the Nasdaq Global Market. At such time, the Company may appeal the delisting determination to a hearings panel.

The Company intends to monitor its closing bid price and the market value of its publicly held common stock between now and May 22, 2023, and will consider available options to resolve the Company’s noncompliance with the minimum bid price requirement, as may be necessary. There can be no assurance that the Company will be able to regain compliance with the minimum bid price requirement or will otherwise be in compliance with other Nasdaq listing criteria.

XML 29 R19.htm IDEA: XBRL DOCUMENT v3.23.1
Subsequent Events
3 Months Ended
Mar. 31, 2023
Subsequent Events.  
Subsequent Events

13.    Subsequent Events

On May 15, 2023, the Company, through its subsidiaries, H Halston, LLC and H Heritage Licensing, LLC (collectively, the “Licensor”), entered into a master license agreement relating to the Halston Brand (the “Halston Master License”) with an industry-leading wholesale apparel company, for men’s and women’s apparel, men’s and women’s fashion accessories, children’s apparel and accessories, home, airline amenity and amenity kits, and such other product categories as mutually agreed upon. The Halston Master License provides for an upfront cash payment and royalties payable to the Company, including certain guaranteed minimum royalties, includes significant annual minimum net sales requirements, and has a twenty-five-year term (consisting of an initial five-year period, followed by a twenty-year period), subject to the licensee’s right to terminate with at least 120 days’ notice prior to the end of each five-year period during the term. The licensee has an option to purchase the Halston Brand for $5.0 million at the end of the twenty-five-year term, which right may be accelerated under certain conditions associated with an uncured material breach of the Halston Master License in accordance with the terms of the Halston Master License. The Licensor granted to the licensee a security interest in the Halston trademarks to secure the Licensor’s obligations under the Halston Master License, including to honor the obligations under the purchase option. In connection with the Halston Master License, the Company issued to the licensee a ten-year warrant to purchase up to 1,000,000 shares of the Company’s common stock at an exercise price of $1.50 per share, which vest based upon certain annual royalty targets being satisfied.

XML 30 R20.htm IDEA: XBRL DOCUMENT v3.23.1
Equity Method Investment (Tables)
3 Months Ended
Mar. 31, 2023
Acquisitions, Divestitures and Variable Interest Entities[Abstract]  
Summarized financial information for IM Topco

($ in thousands)

Revenues

$

3,346

Gross profit

3,346

Loss from continuing operations

(143)

Net loss

(143)

XML 31 R21.htm IDEA: XBRL DOCUMENT v3.23.1
Trademarks and Other Intangibles (Tables)
3 Months Ended
Mar. 31, 2023
Goodwill and Intangible Assets Disclosure [Abstract]  
Schedule of Trademarks and Other Intangibles

    

Weighted

    

    

    

 

Average

 

March 31, 2023

 

Amortization

Gross Carrying

Accumulated

Net Carrying

($ in thousands)

Period

Amount

Amortization

Amount

Trademarks (finite-lived)

 

15 years

 

68,880

 

22,866

 

46,014

Copyrights and other intellectual property

 

8 years

 

429

 

313

 

116

Total

$

69,309

$

23,179

$

46,130

    

Weighted

    

    

    

 

Average

 

December 31, 2022

 

Amortization

 

Gross Carrying

Accumulated

Net Carrying

($ in thousands)

Period

Amount

Amortization

Amount

Trademarks (finite-lived)

 

15 years

 

68,880

 

21,346

 

47,534

Copyrights and other intellectual property

 

8 years

 

429

 

298

 

131

Total

 

  

$

69,309

$

21,644

$

47,665

XML 32 R22.htm IDEA: XBRL DOCUMENT v3.23.1
Leases (Tables)
3 Months Ended
Mar. 31, 2023
Leases [Abstract]  
Maturities of Lease Liabilities

($ in thousands)

    

2023 (April 1 through December 31)

$

1,290

2024

1,711

2025

 

1,711

2026

 

1,711

2027

 

1,452

Thereafter (through 2028)

 

158

Total lease payments

8,033

Less: Discount

1,107

Present value of lease liabilities

6,926

Current portion of lease liabilities

1,395

Non-current portion of lease liabilities

$

5,531

XML 33 R23.htm IDEA: XBRL DOCUMENT v3.23.1
Stockholders' Equity (Tables)
3 Months Ended
Mar. 31, 2023
Stockholders' Equity Note [Abstract]  
Summary of Stock Option Activity

Weighted

Average

Weighted

Remaining

Average

Contractual

Aggregate

Number of

Exercise

Life

Intrinsic

    

Options

    

Price

    

(in Years)

    

Value

Outstanding at January 1, 2023

 

5,614,310

$

2.12

 

4.76

$

Granted

 

 

 

  

 

  

Canceled

 

 

 

  

 

  

Exercised

 

 

 

  

 

  

Expired/Forfeited

 

(245,530)

 

3.84

 

  

 

  

Outstanding at March 31, 2023, and expected to vest

 

5,368,780

$

2.04

 

4.69

$

Exercisable at March 31, 2023

 

1,671,280

$

2.76

 

2.22

$

Summary of Stock Option Activity for Non-Vested Options

    

    

Weighted

 Average 

Number of

Grant Date 

    

Options

    

Fair Value

Balance at January 1, 2023

 

3,697,500

$

0.05

Granted

 

 

Vested

 

Forfeited or Canceled

 

 

Balance at March 31, 2023

 

3,697,500

$

0.05

Summary of Warrant Activity

Weighted

Average

Weighted

Remaining

 

Average

 

Contractual

Aggregate

Number of

Exercise

 

Life

Intrinsic

    

Warrants

    

Price

    

(in Years)

    

Value

Outstanding and exercisable at January 1, 2023

 

116,065

$

3.15

 

1.57

$

Granted

 

 

 

 

  

Canceled

 

 

 

 

  

Exercised

 

 

 

 

  

Expired/Forfeited

 

 

 

 

  

Outstanding and exercisable at March 31, 2023

 

116,065

$

3.15

 

1.32

$

Summary of Restricted Stock Activity

Weighted

Number of

Average

Restricted

Grant Date

    

Shares

    

Fair Value

Outstanding at January 1, 2023

 

333,333

$

3.71

Granted

 

8,334

 

0.75

Canceled

 

 

Vested

 

(8,334)

 

0.75

Expired/Forfeited

 

 

Outstanding at March 31, 2023

 

333,333

$

3.71

XML 34 R24.htm IDEA: XBRL DOCUMENT v3.23.1
Earnings (Loss) Per Share (Tables)
3 Months Ended
Mar. 31, 2023
Earnings (Loss) Per Share [Abstract]  
Schedule of the basic and diluted net loss per share

Three Months Ended

March 31, 

    

2023

    

2022

Numerator:

Net loss attributable to Xcel Brands, Inc. stockholders (in thousands)

$

(5,643)

$

(3,487)

Denominator:

Basic weighted average number of shares outstanding

19,633,194

 

19,571,119

 

Add: Effect of warrants

 

 

Add: Effect of stock options

Diluted weighted average number of shares outstanding

19,633,194

 

19,571,119

Basic net loss per share

$

(0.29)

$

(0.18)

Diluted net loss per share

$

(0.29)

$

(0.18)

Anti-dilutive Securities Excluded from Computation of Earnings (Loss) Per Share

Three Months Ended

March 31, 

    

2023

    

2022

Stock options

5,368,780

5,266,660

Warrants

116,065

116,065

Total

5,484,845

 

5,382,725

 

XML 35 R25.htm IDEA: XBRL DOCUMENT v3.23.1
Nature of Operations, Background, and Basis of Presentation (Details)
3 Months Ended
Mar. 31, 2023
May 31, 2022
Longaberger Licensing, LLC | Variable Interest Entity, Primary Beneficiary    
New Accounting Pronouncements or Change in Accounting Principle [Line Items]    
Variable Interest Entity, Qualitative or Quantitative Information, Ownership Percentage 50.00%  
Q Optix, LLC | Variable Interest Entity, Primary Beneficiary    
New Accounting Pronouncements or Change in Accounting Principle [Line Items]    
Variable Interest Entity, Qualitative or Quantitative Information, Ownership Percentage 50.00%  
IM Topco, LLC    
New Accounting Pronouncements or Change in Accounting Principle [Line Items]    
Ownership interest   30.00%
XML 36 R26.htm IDEA: XBRL DOCUMENT v3.23.1
Nature of Operations, Background, and Basis of Presentation - Liquidity (Details) - USD ($)
$ in Thousands
3 Months Ended
May 15, 2023
Mar. 31, 2023
Mar. 31, 2022
Dec. 31, 2022
New Accounting Pronouncements or Change in Accounting Principle [Line Items]        
Net (loss) income   $ (5,643) $ (3,487)  
Net loss   5,938 3,739  
Accumulated deficit   (38,440)   $ (32,797)
Other Noncash Expense   2,400    
Net cash used in operating activities   2,915 891  
Working capital, Net   5,100    
Cash and cash equivalents   1,612 3,063  
Reduction in payroll costs   6,000    
Reduction in operating expenses   $ 7,000    
Payment of long-term debt     $ 625  
Halston License | Subsequent Events        
New Accounting Pronouncements or Change in Accounting Principle [Line Items]        
Additional royalty payable term 20 years      
Halston License | Minimum | Subsequent Events        
New Accounting Pronouncements or Change in Accounting Principle [Line Items]        
Royalty payable term 5 years      
Halston License | Maximum | Subsequent Events        
New Accounting Pronouncements or Change in Accounting Principle [Line Items]        
Royalty payable term 25 years      
XML 37 R27.htm IDEA: XBRL DOCUMENT v3.23.1
Equity Method Investment - IM Topco, LLC (Details) - USD ($)
3 Months Ended
May 31, 2022
Mar. 31, 2023
May 27, 2022
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]      
Loss from equity method investment   $ (515,000)  
IM Topco, LLC      
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]      
Ownership interest 30.00%    
IM Topco, LLC      
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]      
Loss from equity method investment   $ (520,000)  
Business Venture Agreement      
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]      
Net cash flow distributable to members (in percent) 100.00%    
Net cash flow distributable to members $ 1,316,200    
Business Venture Agreement | WHP      
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]      
Net cash flow distributable to members (in percent) 100.00%    
Net cash flow distributable to members $ 8,852,000    
IM Brand trademarks and other intellectual property rights | Disposed of by Sale | IM Topco, LLC      
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]      
Ownership interest     70.00%
XML 38 R28.htm IDEA: XBRL DOCUMENT v3.23.1
Equity Method Investment - Summarized financial information (Details) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]    
Gross Profit $ 3,357 $ 7,067
Net loss (5,938) $ (3,739)
IM Topco, LLC    
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]    
Revenues 3,346  
Gross Profit 3,346  
Loss from continuing operations (143)  
Net loss $ (143)  
XML 39 R29.htm IDEA: XBRL DOCUMENT v3.23.1
Trademarks and Other Intangibles - Narrative (Details) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Goodwill and Intangible Assets Disclosure [Abstract]    
Amortization expense for intangible assets $ 1,540 $ 1,530
XML 40 R30.htm IDEA: XBRL DOCUMENT v3.23.1
Trademarks and Other Intangibles - Schedule of Trademarks and Other Intangibles (Details) - USD ($)
$ in Thousands
3 Months Ended 12 Months Ended
Mar. 31, 2023
Dec. 31, 2022
Trademarks and Other Intangibles    
Gross Carrying Amount (definite-lived) $ 69,309  
Gross Carrying Amount, Total   $ 69,309
Accumulated Amortization 23,179 21,644
Net Carrying Amount 46,130  
Net Carrying Amount, Total $ 46,130 $ 47,665
Trademarks    
Trademarks and Other Intangibles    
Weighted Average Amortization Period 15 years 15 years
Gross Carrying Amount (definite-lived) $ 68,880 $ 68,880
Accumulated Amortization 22,866 21,346
Net Carrying Amount $ 46,014 $ 47,534
Copyrights and other intellectual property    
Trademarks and Other Intangibles    
Weighted Average Amortization Period 8 years 8 years
Gross Carrying Amount (definite-lived) $ 429 $ 429
Accumulated Amortization 313 298
Net Carrying Amount $ 116 $ 131
XML 41 R31.htm IDEA: XBRL DOCUMENT v3.23.1
Significant Contracts and Concentrations - Narrative (Details) - USD ($)
$ in Thousands
3 Months Ended 12 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Dec. 31, 2022
Product Information [Line Items]      
Net revenue $ 6,050 $ 8,747  
Accounts receivable 5,969   $ 5,110
Net licensing revenue      
Product Information [Line Items]      
Net revenue $ 2,222 $ 5,961  
Sales [Member] | Customer Concentration Risk [Member] | Qurate      
Product Information [Line Items]      
Concentration Risk, Percentage 25.00% 57.00%  
Sales [Member] | Customer Concentration Risk [Member] | Qurate | Net licensing revenue      
Product Information [Line Items]      
Net revenue $ 1,520 $ 5,010  
Accounts Receivable [Member] | Customer Concentration Risk [Member] | Qurate      
Product Information [Line Items]      
Concentration Risk, Percentage 25.00%   17.00%
Accounts receivable $ 1,500   $ 900
XML 42 R32.htm IDEA: XBRL DOCUMENT v3.23.1
Accounts Receivable (Details) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2023
Dec. 31, 2022
Accounts Receivable [Abstract]    
Allowance for doubtful accounts receivable $ 0  
Accounts receivable, assigned to third party agent for collection 1,860 $ 1,650
Accounts receivable, collection agent fees $ 50  
XML 43 R33.htm IDEA: XBRL DOCUMENT v3.23.1
Leases - Narrative (Details) - USD ($)
$ in Millions
3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Lessee, Lease, Description [Line Items]    
Weighted average remaining lease term for operating leases 4 years 8 months 12 days  
Weighted average discount rate 6.25%  
Cash payments for operating lease expense $ 0.4 $ 0.6
Selling, general and administrative expenses    
Lessee, Lease, Description [Line Items]    
Operating lease expense $ 0.4 $ 0.4
Minimum    
Lessee, Lease, Description [Line Items]    
Remaining lease term 4 years  
Maximum    
Lessee, Lease, Description [Line Items]    
Remaining lease term 6 years  
XML 44 R34.htm IDEA: XBRL DOCUMENT v3.23.1
Leases - Maturities of Lease Liabilities (Details) - USD ($)
$ in Thousands
Mar. 31, 2023
Dec. 31, 2022
Leases [Abstract]    
2023 (April 1 through December 31) $ 1,290  
2024 1,711  
2025 1,711  
2026 1,711  
2027 1,452  
Thereafter (through 2028) 158  
Total lease payments 8,033  
Less: Discount 1,107  
Present value of lease liabilities 6,926  
Current portion of lease liabilities 1,395 $ 1,376
Non-current portion of lease liabilities $ 5,531 $ 5,839
XML 45 R35.htm IDEA: XBRL DOCUMENT v3.23.1
Debt - Narrative (Details)
$ in Thousands
3 Months Ended
Mar. 31, 2022
USD ($)
Debt Disclosure [Abstract]  
Effective interest rate (as percentage) 9.80%
Repayment of principal $ 625
XML 46 R36.htm IDEA: XBRL DOCUMENT v3.23.1
Stockholders' Equity - Equity Incentive Plans (Details)
Mar. 31, 2023
shares
Stockholders' Equity  
Shares of common stock reserved for issuance (in shares) 8,805,920
2011 Equity Incentive Plan | Unexercised Stock Options  
Stockholders' Equity  
Shares are granted available for issuance (in shares) 5,484,845
2021 Equity Incentive Plan  
Stockholders' Equity  
Number of common stock eligible for issuance 4,000,000
Shares are granted available for issuance (in shares) 3,321,075
Shares of common stock reserved for issuance (in shares) 3,321,075
2021 Equity Incentive Plan | Stock options  
Stockholders' Equity  
Shares of common stock reserved for issuance (in shares) 376,850
XML 47 R37.htm IDEA: XBRL DOCUMENT v3.23.1
Stockholders' Equity - Stock-based Compensation (Details) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Stockholders' Equity    
Compensation expense $ 60 $ 30
Operating cost $ 57 32
Non Management Directors    
Stockholders' Equity    
Compensation expense   20
Employee    
Stockholders' Equity    
Compensation expense   $ 10
XML 48 R38.htm IDEA: XBRL DOCUMENT v3.23.1
Stockholders' Equity - Stock Options (Details) - USD ($)
3 Months Ended 12 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Dec. 31, 2022
Other disclosures      
Compensation expense $ 60,000.00 $ 30,000.00  
Employee      
Other disclosures      
Compensation expense   10,000.00  
Non Management Directors      
Other disclosures      
Compensation expense   20,000.00  
Stock options      
Number of Options      
Outstanding, beginning balance (in shares) 5,614,310    
Granted (in shares) 0    
Canceled (in shares) 0    
Exercised (in shares) 0    
Expired/Forfeited (in shares) (245,530)    
Outstanding, ending balance (in shares) 5,368,780   5,614,310
Exercisable (in shares) 1,671,280    
Weighted Average Exercise Price      
Outstanding, beginning balance (in dollars per share) $ 2.12    
Granted (in dollars per share) 0    
Canceled (in dollars per share) 0    
Exercised (in dollars per share) 0    
Expired/Forfeited (in dollars per share) 3.84    
Outstanding, ending balance (in dollars per share) 2.04   $ 2.12
Exercisable (in dollars per share) $ 2.76    
Other disclosures      
Outstanding Weighted Average Remaining Contractual Life (in Years) 4 years 8 months 8 days   4 years 9 months 3 days
Exercisable Weighted Average Remaining Contractual Life (in Years) 2 years 2 months 19 days    
Aggregate Intrinsic Value, Outstanding $ 0   $ 0
Aggregate Intrinsic Value, Exercisable 0    
Compensation expense 30,000.00 $ 20,000.00  
Unrecognized compensation expense $ 60,000.00    
Weighted average period of recognition 1 year 3 days    
XML 49 R39.htm IDEA: XBRL DOCUMENT v3.23.1
Stockholders' Equity - Non-Vested Options (Details)
3 Months Ended
Mar. 31, 2023
$ / shares
shares
Stock options  
Number of Options  
Beginning Balance (in shares) 3,697,500
Ending Balance (in shares) 3,697,500
Weighted Average Grant Date Fair Value  
Beginning Balance (in dollars per share) | $ / shares $ 0.05
Ending Balance (in dollars per share) | $ / shares $ 0.05
Stock options  
Number of Options  
Granted (in shares) 0
XML 50 R40.htm IDEA: XBRL DOCUMENT v3.23.1
Stockholders' Equity - Warrants (Details) - USD ($)
3 Months Ended 12 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Dec. 31, 2022
Other disclosures      
Compensation expense $ 60,000.00 $ 30,000.00  
Warrants      
Number of Other than Options      
Outstanding and exercisable, beginning balance (in shares) 116,065    
Granted (in shares) 0    
Canceled (in shares) 0    
Exercised (in shares) 0    
Expired/Forfeited (in shares) 0    
Outstanding and exercisable, ending balance (in shares) 116,065   116,065
Weighted Average Exercise Price      
Outstanding and exercisable, beginning balance (in dollars per share) $ 3.15    
Granted (in dollars per share) 0    
Canceled (in dollars per share) 0    
Exercised (in dollars per share) 0    
Expired/Forfeited (in dollars per share) 0    
Outstanding and exercisable, ending balance (in dollars per share) $ 3.15   $ 3.15
Weighted Average Remaining Contractual Life (in Years), Outstanding and exercisable 1 year 3 months 25 days   1 year 6 months 25 days
Aggregate Intrinsic Value, Outstanding and exercisable $ 0   $ 0
Other disclosures      
Compensation expense $ 0   $ 0
XML 51 R41.htm IDEA: XBRL DOCUMENT v3.23.1
Stockholders' Equity - Stock Awards (Details) - USD ($)
$ / shares in Units, $ in Thousands
3 Months Ended
Apr. 20, 2022
Mar. 31, 2023
Mar. 31, 2022
Other disclosures      
Compensation expense   $ 60 $ 30
Non Management Directors      
Other disclosures      
Compensation expense     20
Employee      
Other disclosures      
Compensation expense     10
Restricted Stock      
Number of Other than Options      
Outstanding, beginning balance (in shares)   333,333  
Granted (in shares)   8,334  
Canceled (in shares)   0  
Vested (in shares)   (8,334)  
Expired/Forfeited (in shares)   0  
Outstanding, ending balance (in shares)   333,333  
Weighted Average Exercise Price      
Outstanding, beginning balance (in dollars per share)   $ 3.71  
Granted (in dollars per share)   0.75  
Canceled (in dollars per share)   0  
Vested (in dollars per share)   0.75  
Expired/Forfeited (in dollars per share)   0  
Outstanding, ending balance (in dollars per share)   $ 3.71  
Other disclosures      
Compensation expense   $ 30 $ 10
Unrecognized compensation expense   $ 40  
Weighted average period of recognition   1 year 14 days  
Restricted Stock | Consultant      
Number of Other than Options      
Granted (in shares) 8,334    
XML 52 R42.htm IDEA: XBRL DOCUMENT v3.23.1
Stockholders' Equity - Restricted Stock (Details) - shares
Mar. 31, 2023
Dec. 31, 2022
Stockholders' Equity    
Common stock, shares outstanding (in shares) 19,633,194 19,624,860
Common stock, shares issued (in shares) 19,633,194 19,624,860
Restricted Stock    
Stockholders' Equity    
Common stock, shares outstanding (in shares) 0  
Common stock, shares issued (in shares) 0  
XML 53 R43.htm IDEA: XBRL DOCUMENT v3.23.1
Earnings (Loss) Per Share - Basic and Diluted Earnings Per Share (Details) - USD ($)
$ / shares in Units, $ in Thousands
3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Earnings (Loss) Per Share [Abstract]    
Net loss attributable to Xcel Brands, Inc. stockholders $ (5,643) $ (3,487)
Basic weighted average number of shares outstanding 19,633,194 19,571,119
Diluted weighted average number of shares outstanding 19,633,194 19,571,119
Basic net loss per share $ (0.29) $ (0.18)
Diluted net loss per share $ (0.29) $ (0.18)
XML 54 R44.htm IDEA: XBRL DOCUMENT v3.23.1
Earnings (Loss) Per Share - Anti-dilutive Securities Excluded (Details) - shares
3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Dilutive securities 5,484,845 5,382,725
Stock options    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Dilutive securities 5,368,780 5,266,660
Warrants    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Dilutive securities 116,065 116,065
XML 55 R45.htm IDEA: XBRL DOCUMENT v3.23.1
Income Taxes (Details)
$ in Thousands
15 Months Ended
Mar. 31, 2023
USD ($)
Income Taxes  
Effective income tax rate 0.00%
Income tax benefit $ 0
XML 56 R46.htm IDEA: XBRL DOCUMENT v3.23.1
Related Party Transactions - Isaac Mizrahi (Details) - USD ($)
3 Months Ended
Mar. 31, 2023
May 31, 2022
Restricted Stock    
Asset Purchase Agreement    
Number of shares vested 8,334  
IM Topco [Member] | Services Agreement    
Asset Purchase Agreement    
Due from related party   $ 300,000
Revenue from services provided $ 75,000  
IM Topco [Member] | License Agreement    
Asset Purchase Agreement    
Royalty guarantees 400,000  
Recognized royalty expense $ 60,000  
XML 57 R47.htm IDEA: XBRL DOCUMENT v3.23.1
Commitments and Contingencies - Narrative (Details)
$ in Thousands
3 Months Ended 12 Months Ended
May 31, 2022
USD ($)
item
Apr. 01, 2021
USD ($)
Mar. 31, 2023
USD ($)
Mar. 31, 2022
USD ($)
Dec. 31, 2022
USD ($)
Commitments and Contingencies          
Weighted average remaining lease term for operating leases     4 years 8 months 12 days    
Weighted average discount rate     6.25%    
Cash payments for operating lease expense     $ 400 $ 600  
Contingent obligation     $ 6,396   $ 6,396
Earn-out balance before settlement         243
Additional consideration is payable to the seller         200
Minimum          
Commitments and Contingencies          
Remaining lease term     4 years    
Maximum          
Commitments and Contingencies          
Remaining lease term     6 years    
Isaac Mizrahi sale transaction with IM Topco | Disposed of by Sale          
Commitments and Contingencies          
Number of consecutive quarters for royalty payable term | item 4        
Royalty payable term 3 years        
Contingent obligation $ 0        
Isaac Mizrahi sale transaction with IM Topco | Disposed of by Sale | WHP          
Commitments and Contingencies          
WHP earned in cashflow         5,890
Adjustments to purchase price payable         10,110
Isaac Mizrahi sale transaction with IM Topco | Disposed of by Sale | Maximum          
Commitments and Contingencies          
Royalty guarantees 13,300        
Adjustments to purchase price payable $ 16,000        
Lori Goldstein Brand          
Commitments and Contingencies          
Contingent consideration   $ 12,500      
Contingent obligation     $ 6,400   6,400
Earn-out balance before settlement         200
Royalties earned     6 years    
Contingent obligation (Lori Goldstein Earn-Out)         $ 6,600
XML 58 R48.htm IDEA: XBRL DOCUMENT v3.23.1
Subsequent Events - Narrative (Details) - USD ($)
$ / shares in Units, $ in Millions
May 15, 2023
Mar. 31, 2023
Dec. 31, 2022
May 27, 2022
Subsequent Event [Line Items]        
Purchaseable stock   19,633,194 19,624,860  
IM Intellectual Property | Disposed of by Sale | IM Topco, LLC        
Subsequent Event [Line Items]        
Ownership interest       70.00%
Subsequent Events | Halston License        
Subsequent Event [Line Items]        
Additional royalty payable term 20 years      
Total purchase price $ 5.0      
Warrant term 10 years      
Subsequent Events | Halston License | Minimum        
Subsequent Event [Line Items]        
Royalty payable term 5 years      
Subsequent Events | Halston License | Maximum        
Subsequent Event [Line Items]        
Royalty payable term 25 years      
Subsequent Events | Halston License | Warrants        
Subsequent Event [Line Items]        
Purchaseable stock 1,000,000      
Warrants outstanding, exercise price (in dollars per share) $ 1.50      
XML 59 R49.htm IDEA: XBRL DOCUMENT v3.23.1
Summary of Significant Accounting Policies - Accounts Receivable (Details) 10K - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2023
Dec. 31, 2022
Summary of Significant Accounting Policies [Abstract]    
Accounts receivable $ 5,969 $ 5,110
Allowance for doubtful accounts 0  
Accounts receivable, assigned to third party agent for collection 1,860 $ 1,650
Accounts receivable, collection agent fees $ 50  
XML 60 xelb-20230331x10q_htm.xml IDEA: XBRL DOCUMENT 0001083220 xelb:BusinessVentureAgreementMember xelb:ImWhpLlcMember 2022-05-31 0001083220 xelb:BusinessVentureAgreementMember 2022-05-31 0001083220 xelb:HalstonBrandMember srt:MinimumMember us-gaap:SubsequentEventMember 2023-05-15 2023-05-15 0001083220 xelb:HalstonBrandMember srt:MaximumMember us-gaap:SubsequentEventMember 2023-05-15 2023-05-15 0001083220 us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember xelb:IsaacMizrahiSaleTransactionWithImTopcoMember 2022-05-31 2022-05-31 0001083220 us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember xelb:IsaacMizrahiSaleTransactionWithImTopcoMember xelb:ImWhpLlcMember 2022-01-01 2022-12-31 0001083220 xelb:BusinessVentureAgreementMember xelb:ImWhpLlcMember 2022-05-31 2022-05-31 0001083220 xelb:BusinessVentureAgreementMember 2022-05-31 2022-05-31 0001083220 xelb:LoriGoldsteinBrandMember 2021-04-01 2021-04-01 0001083220 xelb:LoriGoldsteinBrandMember 2023-01-01 2023-03-31 0001083220 xelb:LoriGoldsteinBrandMember 2022-01-01 2022-12-31 0001083220 2022-01-01 2022-12-31 0001083220 us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember xelb:IsaacMizrahiSaleTransactionWithImTopcoMember xelb:ImWhpLlcMember 2022-12-31 0001083220 xelb:HalstonBrandMember us-gaap:SubsequentEventMember 2023-05-15 2023-05-15 0001083220 xelb:HalstonBrandMember us-gaap:SubsequentEventMember 2023-05-15 0001083220 us-gaap:VariableInterestEntityPrimaryBeneficiaryMember xelb:QOptixLlcMember 2023-01-01 2023-03-31 0001083220 us-gaap:VariableInterestEntityPrimaryBeneficiaryMember xelb:LongabergerLicensingLLCMember 2023-01-01 2023-03-31 0001083220 us-gaap:CommonStockMember 2023-01-01 2023-03-31 0001083220 us-gaap:RetainedEarningsMember 2023-03-31 0001083220 us-gaap:NoncontrollingInterestMember 2023-03-31 0001083220 us-gaap:AdditionalPaidInCapitalMember 2023-03-31 0001083220 us-gaap:RetainedEarningsMember 2022-12-31 0001083220 us-gaap:NoncontrollingInterestMember 2022-12-31 0001083220 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0001083220 us-gaap:RetainedEarningsMember 2022-03-31 0001083220 us-gaap:NoncontrollingInterestMember 2022-03-31 0001083220 us-gaap:AdditionalPaidInCapitalMember 2022-03-31 0001083220 us-gaap:RetainedEarningsMember 2021-12-31 0001083220 us-gaap:NoncontrollingInterestMember 2021-12-31 0001083220 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0001083220 us-gaap:CommonStockMember 2023-03-31 0001083220 us-gaap:CommonStockMember 2022-12-31 0001083220 us-gaap:CommonStockMember 2022-03-31 0001083220 us-gaap:CommonStockMember 2021-12-31 0001083220 us-gaap:EmployeeStockOptionMember 2022-01-01 2022-12-31 0001083220 us-gaap:EmployeeStockOptionMember 2022-12-31 0001083220 us-gaap:EmployeeStockOptionMember 2023-03-31 0001083220 us-gaap:EmployeeStockOptionMember 2022-12-31 0001083220 xelb:UnexercisedStockOptionsMember xelb:EquityIncentivePlan2011Member 2023-03-31 0001083220 us-gaap:RestrictedStockMember 2022-12-31 0001083220 xelb:ConsultantMember us-gaap:RestrictedStockMember 2022-04-20 2022-04-20 0001083220 xelb:ImTopcoMember xelb:LicenseAgreementMember 2023-03-31 0001083220 srt:MaximumMember us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember xelb:IsaacMizrahiSaleTransactionWithImTopcoMember 2022-05-31 0001083220 xelb:ImTopcoMember xelb:LicenseAgreementMember 2023-01-01 2023-03-31 0001083220 xelb:ImTopcoMember xelb:ServicesAgreementMember 2023-01-01 2023-03-31 0001083220 xelb:QurateRetailGroupMember us-gaap:LicenseMember us-gaap:SalesMember us-gaap:CustomerConcentrationRiskMember 2023-01-01 2023-03-31 0001083220 us-gaap:ProductMember 2023-01-01 2023-03-31 0001083220 us-gaap:LicenseMember 2023-01-01 2023-03-31 0001083220 xelb:QurateRetailGroupMember us-gaap:LicenseMember us-gaap:SalesMember us-gaap:CustomerConcentrationRiskMember 2022-01-01 2022-03-31 0001083220 us-gaap:ProductMember 2022-01-01 2022-03-31 0001083220 us-gaap:LicenseMember 2022-01-01 2022-03-31 0001083220 us-gaap:RetainedEarningsMember 2023-01-01 2023-03-31 0001083220 us-gaap:NoncontrollingInterestMember 2023-01-01 2023-03-31 0001083220 us-gaap:RetainedEarningsMember 2022-01-01 2022-03-31 0001083220 us-gaap:NoncontrollingInterestMember 2022-01-01 2022-03-31 0001083220 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2023-01-01 2023-03-31 0001083220 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2022-01-01 2022-03-31 0001083220 xelb:IMTopcoLLCMember 2022-05-31 0001083220 srt:MinimumMember 2023-03-31 0001083220 srt:MaximumMember 2023-03-31 0001083220 xelb:IMTopcoLLCMember 2023-01-01 2023-03-31 0001083220 xelb:IMTopcoLLCMember 2023-01-01 2023-03-31 0001083220 us-gaap:TrademarksMember 2023-01-01 2023-03-31 0001083220 us-gaap:IntellectualPropertyMember 2023-01-01 2023-03-31 0001083220 us-gaap:TrademarksMember 2022-01-01 2022-12-31 0001083220 us-gaap:IntellectualPropertyMember 2022-01-01 2022-12-31 0001083220 us-gaap:TrademarksMember 2023-03-31 0001083220 us-gaap:IntellectualPropertyMember 2023-03-31 0001083220 us-gaap:TrademarksMember 2022-12-31 0001083220 us-gaap:IntellectualPropertyMember 2022-12-31 0001083220 xelb:IMTopcoLLCMember us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember xelb:IsaacMizrahiBrandTrademarksAndOtherIntellectualPropertyMember 2022-05-27 0001083220 us-gaap:EmployeeStockOptionMember 2023-03-31 0001083220 2022-01-01 2023-03-31 0001083220 xelb:ImTopcoMember xelb:ServicesAgreementMember 2022-05-31 0001083220 us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember xelb:IsaacMizrahiSaleTransactionWithImTopcoMember 2022-05-31 0001083220 xelb:QurateRetailGroupMember us-gaap:SalesMember us-gaap:CustomerConcentrationRiskMember 2023-01-01 2023-03-31 0001083220 xelb:QurateRetailGroupMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2023-01-01 2023-03-31 0001083220 xelb:QurateRetailGroupMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2022-01-01 2022-12-31 0001083220 xelb:QurateRetailGroupMember us-gaap:SalesMember us-gaap:CustomerConcentrationRiskMember 2022-01-01 2022-03-31 0001083220 us-gaap:RestrictedStockMember 2023-03-31 0001083220 us-gaap:EmployeeStockOptionMember xelb:EquityIncentivePlan2021Member 2023-03-31 0001083220 xelb:EquityIncentivePlan2021Member 2023-03-31 0001083220 us-gaap:WarrantMember 2023-03-31 0001083220 us-gaap:WarrantMember 2022-12-31 0001083220 xelb:HalstonBrandMember us-gaap:WarrantMember us-gaap:SubsequentEventMember 2023-05-15 0001083220 2021-12-31 0001083220 2022-03-31 0001083220 xelb:LoriGoldsteinBrandMember 2023-03-31 0001083220 xelb:LoriGoldsteinBrandMember 2022-12-31 0001083220 us-gaap:WarrantMember 2023-01-01 2023-03-31 0001083220 us-gaap:EmployeeStockOptionMember 2023-01-01 2023-03-31 0001083220 us-gaap:WarrantMember 2022-01-01 2022-03-31 0001083220 us-gaap:EmployeeStockOptionMember 2022-01-01 2022-03-31 0001083220 us-gaap:WarrantMember 2023-01-01 2023-03-31 0001083220 us-gaap:RestrictedStockMember 2023-01-01 2023-03-31 0001083220 us-gaap:EmployeeStockOptionMember 2023-01-01 2023-03-31 0001083220 us-gaap:WarrantMember 2022-01-01 2022-12-31 0001083220 xelb:NonManagementDirectorsMember 2022-01-01 2022-03-31 0001083220 xelb:EmployeeMember 2022-01-01 2022-03-31 0001083220 us-gaap:RestrictedStockMember 2022-01-01 2022-03-31 0001083220 us-gaap:EmployeeStockOptionMember 2022-01-01 2022-03-31 0001083220 us-gaap:AdditionalPaidInCapitalMember 2023-01-01 2023-03-31 0001083220 us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-03-31 0001083220 2022-01-01 2022-03-31 0001083220 xelb:QurateRetailGroupMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2023-03-31 0001083220 xelb:QurateRetailGroupMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2022-12-31 0001083220 2023-03-31 0001083220 2022-12-31 0001083220 2023-05-15 0001083220 2023-01-01 2023-03-31 shares iso4217:USD iso4217:USD shares pure xelb:item -0.29 -0.18 19633194 19571119 0001083220 --12-31 2023 Q1 false 0 0 19633194 19624860 P6Y P25Y P20Y P10Y P25Y P20Y P25Y P5Y P5Y P5Y P5Y 10-Q true 2023-03-31 false 001-37527 XCEL BRANDS, INC. DE 76-0307819 1333 Broadway, 10th Floor New York NY 10018 347 727-2474 Common Stock, $0.001 par value per share XELB NASDAQ Yes Yes Non-accelerated Filer true false false 19683194 1612000 4608000 5969000 5110000 3099000 2845000 1032000 1457000 11712000 14020000 1237000 1418000 5185000 5420000 46130000 47665000 18680000 19195000 1107000 1107000 110000 110000 72449000 74915000 84161000 88935000 5549000 3958000 555000 568000 477000 416000 1395000 1376000 243000 7976000 6561000 5531000 5839000 6396000 6396000 11927000 12235000 19903000 18796000 0.001 0.001 1000000 1000000 0 0 0.001 0.001 50000000 50000000 19633194 19624860 20000 20000 103649000 103592000 -38440000 -32797000 65229000 70815000 -971000 -676000 64258000 70139000 84161000 88935000 2222000 5961000 3828000 2786000 6050000 8747000 2693000 1680000 3357000 7067000 3465000 4861000 3493000 3416000 6958000 8277000 -3601000 -1210000 1797000 1820000 515000 -2312000 -1820000 -5913000 -3030000 708000 25000 1000 -25000 -709000 -5938000 -3739000 -5938000 -3739000 -295000 -252000 -5643000 -3487000 -0.29 -0.18 19633194 19571119 19571119 20000 103039000 -28779000 662000 74942000 30000 30000 -3487000 -252000 -3739000 19571119 20000 103069000 -32266000 410000 71233000 19624860 20000 103592000 -32797000 -676000 70139000 51000 51000 8334 6000 6000 -5643000 -295000 -5938000 19633194 20000 103649000 -38440000 -971000 64258000 -5938000 -3739000 1797000 1820000 91000 57000 32000 -515000 859000 1036000 254000 566000 -425000 -15000 1396000 2620000 -54000 -128000 -2915000 -891000 81000 35000 -81000 -35000 625000 -625000 -2996000 -1551000 4608000 5222000 1612000 3671000 1612000 3063000 608000 1612000 3671000 623000 16000 <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;">1. Nature of Operations, Background, and Basis of Presentation</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">The accompanying condensed consolidated balance sheet as of December 31, 2022 (which has been derived from audited financial statements) and the unaudited interim condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States (“GAAP”) for interim financial information and pursuant to the instructions to Form 10-Q and Article 8 of Regulation S-X promulgated by the United States Securities and Exchange Commission (“SEC”). Certain information or footnote disclosures normally included in financial statements prepared in accordance with GAAP have been condensed or omitted, pursuant to the rules and regulations of the SEC for interim financial reporting. Accordingly, they do not include all the information and footnotes necessary for a comprehensive presentation of financial position, results of operations, or cash flows.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">In the opinion of management, the accompanying unaudited condensed consolidated financial statements were prepared following the same policies and procedures used in the preparation of the audited consolidated financial statements and reflect all adjustments (consisting of normal recurring adjustments) necessary to present fairly the results of operations, financial position, and cash flows of Xcel Brands, Inc. and its subsidiaries (the “Company” or "Xcel"). The results of operations for the interim periods presented herein are not necessarily indicative of the results for the entire fiscal year or for any future interim periods. These unaudited condensed consolidated financial statements should be read in conjunction with the Company’s Annual Report on Form 10-K for the year ended December 31, 2022, as filed with the SEC on April 17, 2023.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">The Company is a media and consumer products company engaged in the design, production, marketing, live streaming, wholesale distribution, and direct-to-consumer sales of branded apparel, footwear, accessories, fine jewelry, home goods and other consumer products, and the acquisition of dynamic consumer lifestyle brands. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">Currently, the Company’s brand portfolio consists of the LOGO by Lori Goldstein brand (the “Lori Goldstein Brand”), the Halston brands (the "Halston Brand"), the Judith Ripka brands (the "Ripka Brand"), the C Wonder brands (the "C Wonder Brand"), the Longaberger brand (the “Longaberger Brand”), the Isaac Mizrahi brands (the "Isaac Mizrahi Brand"), and other proprietary brands. </p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">●</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">The Lori Goldstein Brand, Halston Brand, Ripka Brand, and C Wonder Brand are wholly owned by the Company.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">●</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">The Company manages the Longaberger Brand through its </span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">50%</span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> ownership interest in Longaberger Licensing, LLC; the Company consolidates Longaberger Licensing, LLC and recognizes noncontrolling interest for the remaining ownership interest held by a third party. </span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">●</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">The Company manages the Q Optix business through its </span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">50%</span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> ownership interest in Q Optix, LLC; the Company consolidates Q Optix, LLC and recognizes noncontrolling interest for the remaining ownership interest held by a third party.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">●</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">The Company wholly owned and managed the Isaac Mizrahi Brand through May 31, 2022. On May 31, 2022, the Company sold to a third party a majority interest in a newly-created subsidiary that was formed to hold the Isaac Mizrahi Brand trademarks, but retained a noncontrolling interest in the brand through a </span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">30%</span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> ownership interest in IM Topco, LLC, and continues to contribute to the operations of the brand through a service agreement (see Note 2 and Note 11 for additional details). The Company accounts for its interest in IM Topco, LLC using the equity method of accounting.</span></td></tr></table><div style="margin-top:12pt;"/><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">The Company designs, produces, markets, and distributes products, licenses its brands to third parties, and generates licensing revenues through contractual arrangements with manufacturers and retailers. The Company and its licensees distribute through an omni-channel retail sales strategy, which includes distribution through interactive television, digital live-stream shopping, brick-and-mortar retail, wholesale, and e-commerce channels to be everywhere its customers shop.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">The Company’s wholesale and direct-to-consumer operations are presented as "Net sales" and "Cost of goods sold" in the Condensed Consolidated Statements of Operations, separately from the Company’s net licensing revenue.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Liquidity and Management’s Plans  </span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;">The Company incurred a net loss of approximately $5.6 million during the three months ended March 31, 2023 (which included non-cash expenses of approximately $2.4 million), and had an accumulated deficit of approximately $38.4 million as of March 31, 2023. Net cash used in operating activities was approximately $2.9 million for the three months ended March 31, 2023. The Company had working capital (current assets less current liabilities, excluding the current portion of lease obligations and any contingent obligations payable in common stock) of approximately $5.1 million as of March 31, 2023. The Company’s cash and cash equivalents were approximately $1.6 million as of March 31, 2023. The aforementioned factors raise uncertainties about the Company’s ability to continue as a going concern.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;">Management plans to mitigate an expected shortfall of capital and to support future operations by shifting the business from a wholesale/licensing hybrid model into a “licensing-plus” business model. In the first quarter of 2023, the Company began to restructure its business operations by entering into new licensing agreements and joint venture arrangements with best-in-class business partners. The Company entered into a new interactive television licensing agreement with America’s Collectibles Network, Inc. d/b/a Jewelry Television (“JTV”) for the Ripka Brand, and a separate license with JTV for the Ripka Brand’s e-commerce business. For apparel, similar transactions have recently been executed. In conjunction with the launch of the C Wonder Brand on HSN, the Company licensed the wholesale operations related to the brand to One Jeanswear Group, LLC (“OJG”); this new license with OJG also includes certain other new celebrity brands that the Company plans to launch in 2023 and beyond. For the Halston Brand, on May 15, 2023 the Company entered into a new master license agreement for men’s, women’s, and children’s apparel, fashion accessories, and other product categories with an industry-leading wholesale apparel company for distribution through department stores, e-commerce, and other retailers (see Note 13). This new master license for the Halston Brand provides for an upfront cash payment and royalties, including certain guaranteed minimum royalties to the Company, includes significant annual minimum net sales requirements, and has a <span style="-sec-ix-hidden:Hidden_lm4ifpvDpUCljzU8qqmc1A;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">twenty-five</span></span>-year term (consisting of an initial <span style="-sec-ix-hidden:Hidden_fzANZa6p80eCdLBqUVhbzA;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">five</span></span>-year period, followed by a <span style="-sec-ix-hidden:Hidden_vks2rimjWUuCC8hxX-BkHA;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">twenty</span></span>-year period), subject to the licensee’s right to terminate with at least 120 days’ notice prior to the end of each <span style="-sec-ix-hidden:Hidden_726D_9hpjEq9IgrOQ2G_ZA;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">five</span></span>-year period during the term. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;">Management expects the transition of these operating businesses to be completed by the end of the second quarter of 2023. Management believes that this evolution of the Company’s operating model will provide the Company with significant cost savings and allow the Company to reduce and better manage its exposure to operating risks. As of March 31, 2023, the Company took steps that will reduce payroll costs by $6 million and operating expenses by $7 million over the next twelve months.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;">Based on these recent events and changes in the Company’s business model, management expects to generate adequate cash flows to meet the Company’s operating and capital expenditure needs, for at least the twelve months subsequent to the filing date of this Quarterly Report on Form 10-Q, and therefore, such conditions and uncertainties with respect to the Company’s ability to continue as a going concern as of March 31, 2023, have subsequently been alleviated.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-style:italic;font-weight:bold;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"><span style="font-style:italic;font-weight:bold;">Recently Adopted Accounting Pronouncements</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;">The Company adopted the provisions of Accounting Standards Update (“ASU”) No. 2016-13, "Financial Instruments – Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments" (as amended by ASU No. 2018-19 in November 2018, ASU No. 2019-05 in May 2019, ASU No. 2019-10 and 2019-11 in November 2019, ASU No. 2020-02 in February 2020, and ASU No. 2022-02 in March 2022) effective January 1, 2023. This ASU requires entities to estimate lifetime expected credit losses for financial instruments, including trade and other receivables, which will result in earlier recognition of credit losses. The adoption of this new guidance did not have a significant impact on the Company’s results of operations, cash flows, or financial condition.</p> 0.50 0.50 0.30 -5600000 2400000 -38400000 -2900000 5100000 1600000 6000000 7000000 <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;text-align:justify;margin:0pt 0pt 12pt 0pt;">2.      Equity Method Investment</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;text-align:justify;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;">IM Topco, LLC</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;text-align:justify;margin:0pt 0pt 12pt 0pt;"><span style="font-weight:normal;">On May 27, 2022, Xcel (along with IM Topco, LLC (“IM Topco”) and IM Brands, LLC (“IMB”), both wholly owned subsidiaries of the Company) and IM WHP, LLC (“WHP”), a subsidiary of WHP Global, a private equity-backed brand management and licensing company, entered into a membership purchase agreement. Pursuant to this agreement, on May 31, 2022, (i) the Company contributed assets owned by IMB, including the Isaac Mizrahi Brand trademarks and other intellectual property rights relating thereto into IM Topco, and (ii) the Company sold </span><span style="font-weight:normal;">70%</span><span style="font-weight:normal;"> of the membership interests of IM Topco to WHP. The Company accounts for its </span><span style="font-weight:normal;">30%</span><span style="font-weight:normal;"> interest in the ongoing operations of IM Topco as other expense (income) under the equity method of accounting.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">Pursuant to the business venture agreement between the Company and WHP governing the operation of IM Topco, IM Topco’s net cash flow (as defined in the agreement) shall be distributed to the members during each fiscal year no less than once per fiscal quarter, as follows:</p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:36pt;padding:0pt;">(i)</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">first, </span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">100%</span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> to WHP, until WHP has received an aggregate amount during such fiscal year equal to </span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">$8,852,000 </span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(subject to adjustment in certain circumstances as set forth in the agreement); </span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:36pt;padding:0pt;">(ii)</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">second, </span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">100%</span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> to Xcel, until Xcel has received an aggregate amount during such fiscal year equal to </span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">$1,316,200</span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> (subject to adjustment in certain circumstances as set forth in the agreement); and </span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:36pt;padding:0pt;">(iii)</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">thereafter, in proportion to the members’ respective percentage interests.</span></td></tr></table><div style="margin-top:12pt;"/><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">The Company recognized an equity method loss of $0.52 million related to its investment for the three months ended March 31, 2023, based on the distribution provisions described above.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">Summarized financial information for IM Topco for the three months ended March 31, 2023 is as follows:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"><span style="font-size:0pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:76.57%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;width:2.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;width:18.46%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:76.57%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">($ in thousands)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;width:2.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;width:18.46%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:76.57%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Revenues</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 3,346</p></td></tr><tr><td style="vertical-align:bottom;width:76.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Gross profit</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 3,346</p></td></tr><tr><td style="vertical-align:bottom;width:76.57%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Loss from continuing operations</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (143)</p></td></tr><tr><td style="vertical-align:bottom;width:76.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Net loss</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (143)</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt;"><span style="font-size:1pt;margin-bottom:12pt;visibility:hidden;">​</span></p> 0.70 0.30 1 8852000 1 1316200 -520000 <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"><span style="font-size:0pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:76.57%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;width:2.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;width:18.46%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:76.57%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">($ in thousands)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;width:2.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;width:18.46%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:76.57%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Revenues</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 3,346</p></td></tr><tr><td style="vertical-align:bottom;width:76.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Gross profit</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 3,346</p></td></tr><tr><td style="vertical-align:bottom;width:76.57%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Loss from continuing operations</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (143)</p></td></tr><tr><td style="vertical-align:bottom;width:76.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Net loss</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (143)</p></td></tr></table> 3346000 3346000 -143000 -143000 <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;text-align:justify;margin:0pt 0pt 12pt 0pt;">3.      Trademarks and Other Intangibles   </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;">Trademarks and other intangibles, net consist of the following:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:52.6%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.32%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.71%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.73%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.67%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:52.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Weighted</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.71%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:52.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Average</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> </b></p></td><td colspan="8" style="vertical-align:bottom;white-space:nowrap;width:34.32%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">March 31, 2023</b></p></td></tr><tr><td style="vertical-align:bottom;width:52.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Amortization</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Gross Carrying</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Accumulated</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Net Carrying</b></p></td></tr><tr><td style="vertical-align:bottom;width:52.6%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">($ in thousands)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Period</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.04%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Amount</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.88%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Amortization</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.79%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Amount</b></p></td></tr><tr><td style="vertical-align:bottom;width:52.6%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Trademarks (finite-lived)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">15 years</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.32%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.71%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 68,880</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.73%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 22,866</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 46,014</p></td></tr><tr><td style="vertical-align:bottom;width:52.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Copyrights and other intellectual property</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">8 years</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.32%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.71%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 429</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.73%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 313</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.67%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 116</p></td></tr><tr><td style="vertical-align:bottom;width:52.6%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.32%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">$</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.71%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 69,309</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">$</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.73%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 23,179</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">$</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.67%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 46,130</b></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;white-space:nowrap;width:52.63%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.31%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.69%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.73%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.67%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:52.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Weighted</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:52.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Average</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> </b></p></td><td colspan="8" style="vertical-align:bottom;white-space:nowrap;width:34.29%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December 31, 2022</b></p></td></tr><tr><td style="vertical-align:bottom;width:52.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Amortization</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Gross</b><b style="font-family:'Calibri','Helvetica','sans-serif';font-weight:bold;"> </b><b style="font-weight:bold;">Carrying</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Accumulated</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Net Carrying</b></p></td></tr><tr><td style="vertical-align:bottom;width:52.63%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">($ in thousands)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Period</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.01%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Amount</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.88%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Amortization</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.79%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Amount</b></p></td></tr><tr><td style="vertical-align:bottom;width:52.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Trademarks (finite-lived)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">15 years</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.31%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.69%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 68,880</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.73%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 21,346</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 47,534</p></td></tr><tr><td style="vertical-align:bottom;width:52.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Copyrights and other intellectual property</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">8 years</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.31%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.69%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 429</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.73%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 298</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.67%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 131</p></td></tr><tr><td style="vertical-align:bottom;width:52.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">  </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.31%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">$</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.69%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 69,309</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">$</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.73%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 21,644</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">$</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.67%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 47,665</b></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;">Amortization expense for intangible assets was approximately $1.54 million for the three-month period ended March 31, 2023 (the "current quarter") and was approximately $1.53 million for the three-month period ended March 31, 2022 (the "prior year quarter").</p> <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:52.6%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.32%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.71%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.73%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.67%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:52.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Weighted</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.71%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:52.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Average</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> </b></p></td><td colspan="8" style="vertical-align:bottom;white-space:nowrap;width:34.32%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">March 31, 2023</b></p></td></tr><tr><td style="vertical-align:bottom;width:52.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Amortization</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Gross Carrying</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Accumulated</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Net Carrying</b></p></td></tr><tr><td style="vertical-align:bottom;width:52.6%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">($ in thousands)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Period</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.04%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Amount</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.88%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Amortization</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.79%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Amount</b></p></td></tr><tr><td style="vertical-align:bottom;width:52.6%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Trademarks (finite-lived)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">15 years</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.32%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.71%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 68,880</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.73%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 22,866</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 46,014</p></td></tr><tr><td style="vertical-align:bottom;width:52.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Copyrights and other intellectual property</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">8 years</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.32%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.71%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 429</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.73%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 313</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.67%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 116</p></td></tr><tr><td style="vertical-align:bottom;width:52.6%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.32%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">$</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.71%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 69,309</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">$</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.73%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 23,179</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">$</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.67%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 46,130</b></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;white-space:nowrap;width:52.63%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.31%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.69%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.73%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.67%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:52.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Weighted</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:52.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Average</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> </b></p></td><td colspan="8" style="vertical-align:bottom;white-space:nowrap;width:34.29%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December 31, 2022</b></p></td></tr><tr><td style="vertical-align:bottom;width:52.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Amortization</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Gross</b><b style="font-family:'Calibri','Helvetica','sans-serif';font-weight:bold;"> </b><b style="font-weight:bold;">Carrying</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Accumulated</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Net Carrying</b></p></td></tr><tr><td style="vertical-align:bottom;width:52.63%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">($ in thousands)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Period</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.01%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Amount</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.88%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Amortization</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.79%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Amount</b></p></td></tr><tr><td style="vertical-align:bottom;width:52.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Trademarks (finite-lived)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">15 years</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.31%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.69%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 68,880</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.73%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 21,346</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 47,534</p></td></tr><tr><td style="vertical-align:bottom;width:52.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Copyrights and other intellectual property</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">8 years</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.31%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.69%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 429</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.73%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 298</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.67%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 131</p></td></tr><tr><td style="vertical-align:bottom;width:52.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">  </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.31%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">$</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.69%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 69,309</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">$</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.73%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 21,644</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">$</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.67%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><b style="font-weight:bold;"> 47,665</b></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p> P15Y 68880000 22866000 46014000 P8Y 429000 313000 116000 69309000 23179000 46130000 P15Y 68880000 21346000 47534000 P8Y 429000 298000 131000 69309000 21644000 47665000 1540000 1530000 <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;text-align:justify;margin:0pt 0pt 12pt 0pt;">4.      Significant Contracts and Concentrations</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;text-align:justify;margin:0pt 0pt 12pt 0pt;">Qurate Agreements</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">Under the Company’s agreements with Qurate Retail Group (“Qurate”), collectively referred to as the Qurate Agreements, Qurate is obligated to make payments to the Company on a quarterly basis, based primarily upon a percentage of net retail sales of certain specified branded merchandise. Net retail sales are defined as the aggregate amount of all revenue generated through the sale of the specified branded products by Qurate and its subsidiaries under the Qurate Agreements, net of customer returns, and excluding freight, shipping and handling charges, and sales, use, or other taxes. Net licensing revenue from the Qurate Agreements represents a significant portion of the Company’s total net revenue.</p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">●</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Net licensing revenue from the Qurate Agreements totaled </span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">$1.52</span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> million and </span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">$5.01</span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> million for the current quarter and prior year quarter, respectively, representing approximately </span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">25%</span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> and </span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">57%</span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> of the Company’s total net revenue for the current quarter and prior year quarter, respectively. The prior year quarter included revenues from Qurate Agreement related to the Isaac Mizrahi Brand; such agreement was assigned to IM Topco on May 31, 2022.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">●</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">As of March 31, 2023 and December 31, 2022, the Company had receivables from Qurate of </span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">$1.5</span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> million and </span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">$0.9</span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> million, respectively, representing approximately </span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">25%</span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> and </span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">17%</span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> of the Company’s total net accounts receivable, respectively.</span></td></tr></table> 1520000 5010000.00 0.25 0.57 1500000 900000 0.25 0.17 <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;">5. Accounts Receivable </b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;">Accounts receivable are presented on the Company’s condensed consolidated balance sheets net of allowances for credit losses. Such allowances were approximately $0.0 million as of both March 31, 2023 and December 31, 2022. The </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">Company did not recognize any credit loss expense in the current quarter or prior year quarter. For the current quarter, there were no significant write-offs or recoveries.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">The allowance for credit losses is determined based upon a variety of judgments and factors. Factors considered in determining the allowance include historical collection, write-off experience, and management's assessment of collectibility from customers, including current conditions, reasonable forecasts, and expectations of future collectibility and collection efforts. Management continuously assesses the collectibility of receivables and adjusts estimates based on actual experience and future expectations based on economic indicators. Management also monitors the aging analysis of receivables to determine if there are changes in the collections of accounts receivable. Receivable balances are written-off against the allowance for credit losses when such balances are deemed to be uncollectible.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">Also, as of March 31, 2023 and December 31, 2022, approximately $1.86 million and $1.65 million, respectively, of the Company's outstanding receivables were assigned to a third-party agent pursuant to a services agreement entered into during the third quarter of 2022, under which the Company assigned, for purposes of collection only, the right to collect certain specified receivables on the Company's behalf and solely for the Company's benefit. Under such agreement, the Company retains ownership of such assigned receivables, and receives payment from the agent (less certain fees charged by the agent) upon the agent's collection of the receivables from customers. During the current quarter, the Company paid approximately $0.05 million in fees to the agent under the aforementioned services agreement. </p> 0.0 1860000 1650000 50000.00 <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;">6. Leases </b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">The Company has an operating lease for its corporate offices and operations facility, as well as certain equipment with a term of 12 months or less. The Company also has an operating lease for its former retail store location, which was closed in 2022; the Company is currently in the process of negotiating the termination of this lease.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">As of March 31, 2023, the Company’s real estate leases have remaining lease terms of 4 – 6 years, with a weighted average remaining lease term of approximately 4.7 years and a weighted average discount rate of 6.25%. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">Lease expense included in selling, general and administrative expenses on the Company’s unaudited condensed consolidated statements of operations was approximately $0.4 million for both the current quarter and prior year quarter.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">Cash paid for amounts included in the measurement of operating lease liabilities was $0.4 million and $0.6 million in the current quarter and prior year quarter, respectively.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;">As of March 31, 2023, the maturities of lease obligations were as follows:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:84.97%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.69%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.69%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.62%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:84.97%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">($ in thousands)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">    </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:84.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">2023 (April 1 through December 31)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.69%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.69%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:middle;width:10.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">1,290</p></td></tr><tr><td style="vertical-align:bottom;width:84.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">2024</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:middle;width:10.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">1,711</p></td></tr><tr><td style="vertical-align:bottom;width:84.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">2025</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.69%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.69%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:middle;width:10.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">1,711</p></td></tr><tr><td style="vertical-align:bottom;width:84.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">2026</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:middle;width:10.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">1,711</p></td></tr><tr><td style="vertical-align:bottom;width:84.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">2027</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.69%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.69%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:middle;width:10.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">1,452</p></td></tr><tr><td style="vertical-align:bottom;width:84.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Thereafter (through 2028)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.69%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:middle;width:10.62%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">158</p></td></tr><tr><td style="vertical-align:bottom;width:84.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Total lease payments</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.69%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.69%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:middle;width:10.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">8,033</p></td></tr><tr><td style="vertical-align:bottom;width:84.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Less: Discount</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.69%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:middle;width:10.62%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">1,107</p></td></tr><tr><td style="vertical-align:bottom;width:84.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Present value of lease liabilities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.69%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.69%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:middle;width:10.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">6,926</p></td></tr><tr><td style="vertical-align:bottom;width:84.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Current portion of lease liabilities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.69%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:middle;width:10.62%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">1,395</p></td></tr><tr><td style="vertical-align:bottom;width:84.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Non-current portion of lease liabilities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.69%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.69%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:middle;width:10.62%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">5,531</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt;"><span style="font-size:1pt;margin-bottom:12pt;visibility:hidden;">​</span></p> P4Y P6Y P4Y8M12D 0.0625 400000 400000 400000 600000 <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:84.97%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.69%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.69%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.62%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:84.97%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">($ in thousands)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">    </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:84.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">2023 (April 1 through December 31)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.69%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.69%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:middle;width:10.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">1,290</p></td></tr><tr><td style="vertical-align:bottom;width:84.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">2024</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:middle;width:10.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">1,711</p></td></tr><tr><td style="vertical-align:bottom;width:84.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">2025</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.69%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.69%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:middle;width:10.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">1,711</p></td></tr><tr><td style="vertical-align:bottom;width:84.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">2026</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:middle;width:10.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">1,711</p></td></tr><tr><td style="vertical-align:bottom;width:84.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">2027</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.69%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.69%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:middle;width:10.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">1,452</p></td></tr><tr><td style="vertical-align:bottom;width:84.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Thereafter (through 2028)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.69%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:middle;width:10.62%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">158</p></td></tr><tr><td style="vertical-align:bottom;width:84.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Total lease payments</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.69%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.69%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:middle;width:10.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">8,033</p></td></tr><tr><td style="vertical-align:bottom;width:84.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Less: Discount</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.69%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:middle;width:10.62%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">1,107</p></td></tr><tr><td style="vertical-align:bottom;width:84.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Present value of lease liabilities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.69%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.69%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:middle;width:10.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">6,926</p></td></tr><tr><td style="vertical-align:bottom;width:84.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Current portion of lease liabilities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.69%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:middle;width:10.62%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">1,395</p></td></tr><tr><td style="vertical-align:bottom;width:84.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Non-current portion of lease liabilities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.69%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.69%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:middle;width:10.62%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">5,531</p></td></tr></table> 1290000 1711000 1711000 1711000 1452000 158000 8033000 1107000 6926000 1395000 5531000 <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;">7. Debt</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;">The Company did not have any debt obligations as of March 31, 2023 or December 31, 2022.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;">From December 30, 2021 through May 31, 2022, the Company had term loan debt outstanding pursuant to an agreement with First Eagle Alternative Credit Agent, LLC (“FEAC”); this debt was repaid in full and extinguished on May 31, 2022. For the prior year quarter, the Company incurred interest expense (including both interest paid in cash and the amortization of deferred finance costs) related to term loan debt of approximately $0.71 million, and the effective interest rate related to term loan debt was approximately 9.8%.</p> 710000 0.098 <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:9.35pt;text-indent:-9.35pt;margin:0pt 0pt 12pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:9.25pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">8.</b></span><b style="font-weight:bold;white-space:pre-wrap;"> Stockholders’ Equity </b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Equity Incentive Plans</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">A total of 4,000,000 shares of common stock are eligible for issuance under the Company’s 2021 Equity Incentive Plan (the “2021 Plan”). The 2021 Plan provides for the grant of any or all of the following types of awards: stock options (incentive or non-qualified), restricted stock, restricted stock units, performance awards, or cash awards. The 2021 Plan is administered by the Company’s Board of Directors, or, at the Board’s discretion, a committee of the Board. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">In addition, stock-based awards (including options, warrants, and restricted stock) previously granted under the Company’s 2011 Equity Incentive Plan (the “2011 Plan”) remain outstanding and shares of common stock may be issued to satisfy options or warrants previously granted under the 2011 Plan, although no new awards may be granted under the 2011 Plan.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Stock-based Compensation </span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">The Company accounts for stock-based compensation in accordance with Accounting Standards Codification (“ASC”) Topic 718, “Compensation - Stock Compensation,” by recognizing the fair value of stock-based compensation as an operating expense over the service period of the award or term of the corresponding contract, as applicable. Forfeitures are accounted for as a reduction of compensation cost in the period when such forfeitures occur. For stock option awards for which vesting is contingent upon the achievement of certain performance targets, the timing and amount of compensation expense recognized is based upon the Company’s projections and estimates of the relevant performance metric(s) until the time the performance obligation is satisfied. Expense for such awards is recognized only to the extent that the achievement of the specified performance target(s) has been met or is considered probable.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">Total expense recognized in the current quarter and prior year quarter for all forms of stock-based compensation was approximately $0.06 million and $0.03 million, respectively. Of the current quarter expense amount, substantially all of the expense related to directors and consultants, and was recorded within other selling, general and administrative expenses in the accompanying condensed consolidated statements of operations. Of the prior year quarter expense amount, approximately $0.01 million related to employees and was recorded within salaries, benefits and expenses, while approximately $0.02 million related to directors and consultants and was recorded within other selling, general and administrative expenses. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Stock Options</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;">A summary of the Company’s stock options activity for the current quarter is as follows: </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:58.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:58.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Weighted</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:58.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Average</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:58.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Weighted</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Remaining</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:58.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Average</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Contractual</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Aggregate</b></p></td></tr><tr><td style="vertical-align:bottom;width:58.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Number of</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Exercise</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Life</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Intrinsic</b></p></td></tr><tr><td style="vertical-align:bottom;width:58.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';">    </span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Options</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';">    </span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.2%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Price</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';">    </span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.52%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">(in Years)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';">    </span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.2%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Value</b></p></td></tr><tr><td style="vertical-align:top;width:58.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Outstanding at January 1, 2023</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 5,614,310</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 2.12</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.52%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 4.76</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td></tr><tr><td style="vertical-align:top;width:58.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Granted</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">  </p></td></tr><tr><td style="vertical-align:top;width:58.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Canceled</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.52%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">  </p></td></tr><tr><td style="vertical-align:top;width:58.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Exercised</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">  </p></td></tr><tr><td style="vertical-align:top;width:58.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Expired/Forfeited</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (245,530)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.16%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 3.84</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.52%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.16%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">  </p></td></tr><tr><td style="vertical-align:top;width:58.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Outstanding at March 31, 2023, and expected to vest</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 5,368,780</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.16%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 2.04</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.52%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 4.69</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.16%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td></tr><tr><td style="vertical-align:top;width:58.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Exercisable at March 31, 2023</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,671,280</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.16%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 2.76</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.52%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 2.22</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.16%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">Compensation expense related to stock options for the current quarter and the prior year quarter was approximately $0.03 million and $0.02 million, respectively. Total unrecognized compensation expense related to unvested stock options at March 31, 2023 was approximately $0.06 million and is expected to be recognized over a weighted average period of approximately 1.01 years.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;">A summary of the Company’s non-vested stock options activity for the current quarter is as follows: </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:74.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.3%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:74.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Weighted</b></p></td></tr><tr><td style="vertical-align:bottom;width:74.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> Average </b></p></td></tr><tr><td style="vertical-align:bottom;width:74.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Number of</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Grant Date </b></p></td></tr><tr><td style="vertical-align:bottom;width:74.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';">    </span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Options</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';">    </span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.78%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Fair Value</b></p></td></tr><tr><td style="vertical-align:bottom;width:74.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Balance at January 1, 2023</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 3,697,500</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 0.05</p></td></tr><tr><td style="vertical-align:bottom;width:74.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Granted</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td></tr><tr><td style="vertical-align:bottom;width:74.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Vested</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td></tr><tr><td style="vertical-align:bottom;width:74.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Forfeited or Canceled</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.3%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td></tr><tr><td style="vertical-align:bottom;width:74.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Balance at March 31, 2023</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.15%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 3,697,500</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.3%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 0.05</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Warrants</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;">A summary of the Company’s warrants activity for the current quarter is as follows: </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:59.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:59.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Weighted</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:59.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Average</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:59.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Weighted</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Remaining</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:59.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;"> </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Average</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;"> </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Contractual</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Aggregate</b></p></td></tr><tr><td style="vertical-align:bottom;width:59.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Number of</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Exercise</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;"> </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Life</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Intrinsic</b></p></td></tr><tr><td style="vertical-align:bottom;width:59.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">    </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.03%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Warrants</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">    </p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Price</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">    </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.52%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">(in Years)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">    </p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.45%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Value</b></p></td></tr><tr><td style="vertical-align:bottom;width:59.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Outstanding and exercisable at January 1, 2023</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 116,065</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 3.15</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.52%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 1.57</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.31%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> —</p></td></tr><tr><td style="vertical-align:bottom;width:59.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Granted</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> <span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">  </p></td></tr><tr><td style="vertical-align:bottom;width:59.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Canceled</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.52%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> <span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.31%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">  </p></td></tr><tr><td style="vertical-align:bottom;width:59.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Exercised</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> <span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">  </p></td></tr><tr><td style="vertical-align:bottom;width:59.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Expired/Forfeited</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.03%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.35%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.52%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> <span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.31%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">  </p></td></tr><tr><td style="vertical-align:bottom;width:59.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Outstanding and exercisable at March 31, 2023</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.03%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 116,065</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.35%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 3.15</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.52%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 1.32</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.31%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> —</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">No compensation expense related to warrants was recognized in the current quarter or prior year quarter.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Stock Awards</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;">A summary of the Company’s restricted stock activity for the current quarter is as follows:  </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:74.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.3%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:74.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Weighted</b></p></td></tr><tr><td style="vertical-align:bottom;width:74.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Number of</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Average</b></p></td></tr><tr><td style="vertical-align:bottom;width:74.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Restricted</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Grant Date</b></p></td></tr><tr><td style="vertical-align:bottom;width:74.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';">    </span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Shares</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';">    </span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.78%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Fair Value</b></p></td></tr><tr><td style="vertical-align:bottom;width:74.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Outstanding at January 1, 2023</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 333,333</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 3.71</p></td></tr><tr><td style="vertical-align:bottom;width:74.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Granted</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 8,334</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 0.75</p></td></tr><tr><td style="vertical-align:bottom;width:74.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Canceled</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> —</p></td></tr><tr><td style="vertical-align:bottom;width:74.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Vested</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (8,334)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 0.75</p></td></tr><tr><td style="vertical-align:bottom;width:74.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Expired/Forfeited</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.15%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.3%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> —</p></td></tr><tr><td style="vertical-align:bottom;width:74.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Outstanding at March 31, 2023</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.15%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 333,333</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.3%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 3.71</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">On January 1, 2023, the Company issued 8,334 shares of common stock to a consultant, which vested immediately.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">Compensation expense related to stock awards was approximately $0.03 million for the current quarter and approximately $0.01 million for the prior year quarter. Total unrecognized compensation expense related to unvested restricted stock grants at March 31, 2023 was approximately $0.04 million and is expected to be recognized over a weighted average period of approximately 1.04 years.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Restricted Stock Units</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">There were no restricted stock units outstanding as of March 31, 2023 and December 31, 2022, and no restricted stock units have been issued since the inception of the 2021 Plan.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Shares Available Under the Company’s Equity Incentive Plans</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">As of March 31, 2023, there were 3,321,075 shares of common stock available for award grants under the 2021 Plan.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Shares Reserved for Issuance</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;">As of March 31, 2023, there were 8,805,920 shares of common stock reserved for issuance, including 5,484,845 shares reserved pursuant to unexercised warrants and stock options previously granted under the 2011 Plan, 376,850 shares reserved pursuant to unexercised stock options granted under the 2021 Plan, and 3,321,075 shares available for issuance under the 2021 Plan.</p> 4000000 60000.00 30000.00 10000.00 20000.00 <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:58.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:58.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Weighted</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:58.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Average</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:58.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Weighted</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Remaining</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:58.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Average</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Contractual</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Aggregate</b></p></td></tr><tr><td style="vertical-align:bottom;width:58.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Number of</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Exercise</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Life</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Intrinsic</b></p></td></tr><tr><td style="vertical-align:bottom;width:58.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';">    </span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Options</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';">    </span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.2%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Price</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';">    </span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.52%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">(in Years)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';">    </span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.2%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Value</b></p></td></tr><tr><td style="vertical-align:top;width:58.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Outstanding at January 1, 2023</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 5,614,310</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 2.12</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.52%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 4.76</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td></tr><tr><td style="vertical-align:top;width:58.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Granted</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">  </p></td></tr><tr><td style="vertical-align:top;width:58.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Canceled</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.52%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">  </p></td></tr><tr><td style="vertical-align:top;width:58.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Exercised</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">  </p></td></tr><tr><td style="vertical-align:top;width:58.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Expired/Forfeited</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (245,530)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.16%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 3.84</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.52%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.16%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">  </p></td></tr><tr><td style="vertical-align:top;width:58.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Outstanding at March 31, 2023, and expected to vest</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 5,368,780</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.16%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 2.04</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.52%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 4.69</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.16%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td></tr><tr><td style="vertical-align:top;width:58.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Exercisable at March 31, 2023</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,671,280</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.16%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 2.76</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.52%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 2.22</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.16%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p> 5614310 2.12 P4Y9M3D 0 0 0 0 0 0 0 245530 3.84 5368780 2.04 P4Y8M8D 0 1671280 2.76 P2Y2M19D 0 30000.00 20000.00 60000.00 P1Y3D <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:74.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.3%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:74.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Weighted</b></p></td></tr><tr><td style="vertical-align:bottom;width:74.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> Average </b></p></td></tr><tr><td style="vertical-align:bottom;width:74.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Number of</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Grant Date </b></p></td></tr><tr><td style="vertical-align:bottom;width:74.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';">    </span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Options</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';">    </span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.78%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Fair Value</b></p></td></tr><tr><td style="vertical-align:bottom;width:74.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Balance at January 1, 2023</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 3,697,500</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 0.05</p></td></tr><tr><td style="vertical-align:bottom;width:74.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Granted</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td></tr><tr><td style="vertical-align:bottom;width:74.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Vested</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td></tr><tr><td style="vertical-align:bottom;width:74.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Forfeited or Canceled</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.3%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td></tr><tr><td style="vertical-align:bottom;width:74.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Balance at March 31, 2023</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.15%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 3,697,500</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.3%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 0.05</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p> 3697500 0.05 3697500 0.05 <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:59.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:59.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Weighted</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:59.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Average</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:59.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Weighted</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Remaining</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:59.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;"> </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Average</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;"> </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Contractual</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Aggregate</b></p></td></tr><tr><td style="vertical-align:bottom;width:59.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Number of</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Exercise</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;"> </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Life</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Intrinsic</b></p></td></tr><tr><td style="vertical-align:bottom;width:59.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">    </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.03%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Warrants</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">    </p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Price</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">    </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.52%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">(in Years)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">    </p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.45%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Value</b></p></td></tr><tr><td style="vertical-align:bottom;width:59.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Outstanding and exercisable at January 1, 2023</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 116,065</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 3.15</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.52%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 1.57</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.31%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> —</p></td></tr><tr><td style="vertical-align:bottom;width:59.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Granted</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> <span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">  </p></td></tr><tr><td style="vertical-align:bottom;width:59.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Canceled</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.52%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> <span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.31%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">  </p></td></tr><tr><td style="vertical-align:bottom;width:59.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Exercised</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> <span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">  </p></td></tr><tr><td style="vertical-align:bottom;width:59.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Expired/Forfeited</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.03%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.35%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.52%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> <span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.31%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">  </p></td></tr><tr><td style="vertical-align:bottom;width:59.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Outstanding and exercisable at March 31, 2023</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.03%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 116,065</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.35%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 3.15</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.52%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 1.32</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.14%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.31%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> —</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p> 116065 3.15 P1Y6M25D 0 0 0 0 0 0 0 0 0 116065 3.15 P1Y3M25D 0 0 0 <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:74.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.3%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:74.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Weighted</b></p></td></tr><tr><td style="vertical-align:bottom;width:74.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Number of</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Average</b></p></td></tr><tr><td style="vertical-align:bottom;width:74.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Restricted</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Grant Date</b></p></td></tr><tr><td style="vertical-align:bottom;width:74.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';">    </span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Shares</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';">    </span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.78%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Fair Value</b></p></td></tr><tr><td style="vertical-align:bottom;width:74.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Outstanding at January 1, 2023</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 333,333</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 3.71</p></td></tr><tr><td style="vertical-align:bottom;width:74.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Granted</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 8,334</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 0.75</p></td></tr><tr><td style="vertical-align:bottom;width:74.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Canceled</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> —</p></td></tr><tr><td style="vertical-align:bottom;width:74.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Vested</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (8,334)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 0.75</p></td></tr><tr><td style="vertical-align:bottom;width:74.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Expired/Forfeited</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.15%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.3%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> —</p></td></tr><tr><td style="vertical-align:bottom;width:74.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Outstanding at March 31, 2023</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.15%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 333,333</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.3%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 3.71</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p> 333333 3.71 8334 0.75 0 0 8334 0.75 0 0 333333 3.71 8334 30000.00 10000.00 40000.00 P1Y14D 0 0 3321075 8805920 5484845 376850 3321075 <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:10.1pt;text-indent:-10.1pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">9.    </b><b style="font-weight:bold;white-space:pre-wrap;">Earnings (Loss) Per Share </b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;">Basic earnings (loss) per share (“EPS”) is computed by dividing net income (loss) available to common stockholders by the weighted average number of common shares outstanding during the period. Diluted EPS gives effect to all potentially dilutive common shares outstanding during the period, including stock options and warrants, using the treasury stock method. Diluted EPS excludes all potentially dilutive shares of common stock if their effect is anti-dilutive. The following </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">table is a reconciliation of the numerator and denominator of the basic and diluted net (loss) income per share computations for the three months ended March 31, 2023 and 2022:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:60.13%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.93%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.74%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.93%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.77%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.74%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:60.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;width:2.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td colspan="4" style="vertical-align:bottom;white-space:nowrap;width:32.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Three Months Ended </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:60.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;width:2.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:34.18%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">March 31, </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:60.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">    </p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:15.6%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2023</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">    </p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:15.63%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:60.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Numerator:</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.93%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.93%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:60.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Net loss attributable to Xcel Brands, Inc. stockholders (in thousands)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (5,643)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (3,487)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:60.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.93%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.93%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:60.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Denominator:</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:60.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Basic weighted average number of shares outstanding</p></td><td style="vertical-align:bottom;width:2.93%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 19,633,194</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.93%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 19,571,119</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td></tr><tr><td style="vertical-align:bottom;width:60.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> Add: Effect of warrants</span></p></td><td style="vertical-align:bottom;width:2.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td></tr><tr><td style="vertical-align:bottom;width:60.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> Add: Effect of stock options</span></p></td><td style="vertical-align:bottom;width:2.93%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.74%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.93%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.77%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:60.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Diluted weighted average number of shares outstanding</p></td><td style="vertical-align:bottom;width:2.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.74%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 19,633,194</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.77%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 19,571,119</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:60.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;width:2.93%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.93%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:60.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Basic net loss per share</p></td><td style="vertical-align:bottom;width:2.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.74%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (0.29)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.77%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (0.18)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:60.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Diluted net loss per share</p></td><td style="vertical-align:bottom;width:2.93%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.74%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (0.29)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.93%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.77%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (0.18)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;">As a result of the net loss for the current quarter and prior year quarter, the Company calculated diluted EPS using basic weighted average shares outstanding for such periods, as utilizing diluted shares would be anti-dilutive to loss per share.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;">The computation of diluted EPS excludes the following potentially dilutive securities because their inclusion would be anti-dilutive:  </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:63.09%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:3.08%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:14.4%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:3.08%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:14.4%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:63.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:31.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Three Months Ended </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:63.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:31.88%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">March 31, </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:63.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';">    </span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.4%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2023</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';">    </span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.4%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:63.09%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Stock options</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.08%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.4%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 5,368,780</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.08%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.4%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 5,266,660</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:63.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Warrants</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.4%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 116,065</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.4%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 116,065</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:63.09%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Total</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.08%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.4%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 5,484,845</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.08%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.4%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 5,382,725</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt;"><span style="font-size:1pt;margin-bottom:12pt;visibility:hidden;">​</span></p> <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:60.13%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.93%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.74%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.93%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.77%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.74%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:60.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;width:2.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td colspan="4" style="vertical-align:bottom;white-space:nowrap;width:32.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Three Months Ended </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:60.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;width:2.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:34.18%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">March 31, </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:60.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">    </p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:15.6%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2023</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">    </p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:15.63%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:60.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Numerator:</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.93%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.93%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:60.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Net loss attributable to Xcel Brands, Inc. stockholders (in thousands)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (5,643)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (3,487)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:60.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.93%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.93%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:60.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Denominator:</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:60.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Basic weighted average number of shares outstanding</p></td><td style="vertical-align:bottom;width:2.93%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 19,633,194</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.93%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 19,571,119</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td></tr><tr><td style="vertical-align:bottom;width:60.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> Add: Effect of warrants</span></p></td><td style="vertical-align:bottom;width:2.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td></tr><tr><td style="vertical-align:bottom;width:60.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> Add: Effect of stock options</span></p></td><td style="vertical-align:bottom;width:2.93%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.74%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.93%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.77%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:60.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Diluted weighted average number of shares outstanding</p></td><td style="vertical-align:bottom;width:2.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.74%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 19,633,194</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.77%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 19,571,119</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:60.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;width:2.93%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.93%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:60.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Basic net loss per share</p></td><td style="vertical-align:bottom;width:2.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.74%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (0.29)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.77%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (0.18)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:60.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Diluted net loss per share</p></td><td style="vertical-align:bottom;width:2.93%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.74%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (0.29)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.93%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.77%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (0.18)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p> -5643000 -3487000 19633194 19571119 19633194 19571119 -0.29 -0.18 -0.29 -0.18 <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:63.09%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:3.08%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:14.4%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:3.08%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:14.4%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:63.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:31.88%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Three Months Ended </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:63.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:31.88%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">March 31, </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:63.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';">    </span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.4%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2023</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';">    </span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.4%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:63.09%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Stock options</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.08%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.4%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 5,368,780</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.08%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.4%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 5,266,660</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:63.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Warrants</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.4%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 116,065</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.4%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 116,065</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:63.09%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Total</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.08%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.4%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 5,484,845</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.08%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.4%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 5,382,725</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td></tr></table> 5368780 5266660 116065 116065 5484845 5382725 <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">10.    Income Taxes</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">The estimated annual effective income tax rate for the current quarter and the prior year quarter was approximately 0% for both periods, resulting in an income tax benefit of $0 for both periods. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">For both the current quarter and the prior year quarter, the federal statutory rate differed from the effective tax rate due to the recording of a valuation allowance against the benefit that would have otherwise been recognized, as it was considered not more likely than not that the net operating losses generated during each period will be utilized in future periods.</p> 0 0 <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">11.    Related Party Transactions</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">IM Topco, LLC</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">The Company holds a noncontrolling interest in IM Topco, which is accounted for under the equity method of accounting. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;">On May 31, 2022, the Company entered into a services agreement with IM Topco, pursuant to which the Company provides certain design and support services (including assistance with the operations of the interactive television business </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">and related talent support) to IM Topco in exchange for payments of $300,000 per year. For the three months ended March 31, 2023, the Company recognized service fee income related to this agreement of $75,000.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;">On May 31, 2022, the Company entered into a license agreement with IM Topco, pursuant to which IM Topco granted the Company a license to use certain Isaac Mizrahi trademarks on and in connection with the design, manufacture, distribution, sale, and promotion of women’s sportswear products in the United States and Canada during the term of the agreement, in exchange for the payment of royalties in connection therewith. The initial term of this agreement was set to end on December 31, 2026, and provided guaranteed royalties to IM Topco of $400,000 per year. Effective December 16, 2022, the license agreement between IM Topco and Xcel was terminated in favor of a new similar license agreement between IM Topco and an unrelated third party. However, as part of the termination of the May 31, 2022 license agreement, Xcel provided a guarantee to IM Topco for the payment of any difference between (i) the royalties received by IM Topco from the unrelated third party under the new agreement and (ii) the amount of guaranteed royalties that IM Topco would have received from Xcel under the May 31, 2022 agreement. For the three months ended March 31, 2023, the estimated amount of such shortfall was approximately $60,000, which the Company recognized as royalty expense in the condensed consolidated statements of operations.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p> 300000 75000 400000 60000 <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">12.    Commitments and Contingencies</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Contingent Obligation – Lori Goldstein Earn-Out</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">In connection with the April 1, 2021 purchase of the Lori Goldstein trademarks, the Company agreed to pay the seller additional cash consideration (the “Lori Goldstein Earn-Out”) of up to $12.5 million, based on royalties earned during the <span style="-sec-ix-hidden:Hidden_0gEQZzzl_k64K5RfZ0fwgQ;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">six</span></span> calendar year period commencing in 2021. The Lori Goldstein Earn-Out was initially recorded as a liability of $6.6 million, based on the difference between the fair value of the acquired assets of the Lori Goldstein brand and the total consideration paid, in accordance with the guidance in Accounting Standards Codification Subtopic 805-50. Based on the performance of the Lori Goldstein brand through December 31, 2022, approximately $0.2 million of additional consideration has been earned by the seller to date, and this amount was paid to the seller in the current quarter. At December 31, 2022, $0.2 million of the balance was recorded as a current liability and $6.4 million was recorded as a long-term liability; at March 31, 2023, the entire remaining balance of $6.4 million is recorded as a long-term liability.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Contingent Obligation – Isaac Mizrahi Transaction</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">In connection with the May 31, 2022 transaction related to the sale of a majority interest in the Isaac Mizrahi Brand (see Note 2), the Company agreed with WHP that, in the event that IM Topco receives less than $13.3 million in aggregate royalties for any four consecutive calendar quarters over a three-year period ending on May 31, 2025, WHP will be entitled to receive from the Company up to $16 million, less all amounts of net cash flow distributed to WHP on an accumulated basis, as an adjustment to the purchase price previously paid by WHP. Such amount would be payable by the Company in either cash or equity interests in IM Topco held by the Company. No amount has been recorded in the accompanying condensed consolidated balance sheets related to this contingent obligation, and management believes the likelihood of any such payment is remote. Based on IM Topco’s earnings from May 31, 2022 through March 31, 2023 and the applicable distribution provisions, WHP earned $5.89 million in cash flow, which reduces the maximum potential purchase price adjustment to $10.11 million.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-style:italic;font-weight:bold;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Legal Proceedings</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">From time to time, the Company becomes involved in legal claims and litigation in the ordinary course of business. In the opinion of management, based on consultations with legal counsel, the disposition of litigation currently pending against the Company is unlikely to have, individually or in the aggregate, a materially adverse effect on the Company’s business, financial position, results of operations, or cash flows. The Company routinely assesses all its litigation and threatened litigation as to the probability of ultimately incurring a liability, and records its best estimate of the ultimate loss in situations where it assesses the likelihood of loss as probable.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Other Matters</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">On November 22, 2022, the Company received a letter from the Listing Qualifications Department of The Nasdaq Stock Market (“Nasdaq”) notifying the Company that the minimum bid price per share for its common stock fell below $1.00 for a period of 30 consecutive business days. Therefore, the Company did not meet the minimum bid price requirement set forth in the Nasdaq Listing Rules.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The letter also states that pursuant to Nasdaq Listing Rules 5810(c)(3)(A), the Company will be provided 180 calendar days to regain compliance with the minimum bid price requirement, or until May 22, 2022.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">In accordance with Nasdaq Listing Rule 5810(c)(3)(A), the Company can regain compliance if, at any time during the Tolling Period or such 180-day period, the closing bid price of the Company’s common stock is at least $1.00 for a minimum period of 10 consecutive business days. If by May 22, 2023, the Company does not regain compliance with the Nasdaq Listing Rules, the Company may be eligible for additional time to regain compliance pursuant to Nasdaq Listing Rule 5810(c)(3)(A)(ii). To qualify, the Company would need to submit a transfer application and a $5,000 application fee. The Company would also need to provide written notice to Nasdaq of its intention to cure the minimum bid price deficiency during the second compliance period by effecting a reverse stock split, if necessary. As part of its review process, the Nasdaq staff will make a determination of whether it believes the Company will be able to cure this deficiency. Should the Nasdaq staff conclude that the Company will not be able to cure the deficiency, or should the Company determine not to submit a transfer application or make the required representation, Nasdaq will provide notice that the Company’s shares of common stock will be subject to delisting.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">If the Company does not regain compliance within the allotted compliance period, including any extensions that may be granted by Nasdaq, Nasdaq will provide notice that the Company’s shares of common stock will be subject to delisting from the Nasdaq Global Market. At such time, the Company may appeal the delisting determination to a hearings panel.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">The Company intends to monitor its closing bid price and the market value of its publicly held common stock between now and May 22, 2023, and will consider available options to resolve the Company’s noncompliance with the minimum bid price requirement, as may be necessary. There can be no assurance that the Company will be able to regain compliance with the minimum bid price requirement or will otherwise be in compliance with other Nasdaq listing criteria.</p> 12500000 6600000 200000 200000 6400000 6400000 13300000 4 P3Y 16000000 0 5890000 10110000 <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">13.    Subsequent Events</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">On May 15, 2023, the Company, through its subsidiaries, H Halston, LLC and H Heritage Licensing, LLC (collectively, the “Licensor”), entered into a master license agreement relating to the Halston Brand (the “Halston Master License”) with an industry-leading wholesale apparel company, for men’s and women’s apparel, men’s and women’s fashion accessories, children’s apparel and accessories, home, airline amenity and amenity kits, and such other product categories as mutually agreed upon. The Halston Master License provides for an upfront cash payment and royalties payable to the Company, including certain guaranteed minimum royalties, includes significant annual minimum net sales requirements, and has a <span style="-sec-ix-hidden:Hidden_BXKa_UXAsEKkThIsjXjkIg;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">twenty-five</span></span>-year term (consisting of an initial <span style="-sec-ix-hidden:Hidden_aemNv13NfEyaSCLoO7eV_g;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">five</span></span>-year period, followed by a <span style="-sec-ix-hidden:Hidden_1ARMNIDhjkCifhlQOAz7hA;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">twenty</span></span>-year period), subject to the licensee’s right to terminate with at least 120 days’ notice prior to the end of each <span style="-sec-ix-hidden:Hidden_Tl_5VilOoU6j-0RCls1ksg;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">five</span></span>-year period during the term. The licensee has an option to purchase the Halston Brand for $5.0 million at the end of the <span style="-sec-ix-hidden:Hidden_Yc1zKIKSukeAURzxWmMmcw;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">twenty-five</span></span>-year term, which right may be accelerated under certain conditions associated with an uncured material breach of the Halston Master License in accordance with the terms of the Halston Master License. The Licensor granted to the licensee a security interest in the Halston trademarks to secure the Licensor’s obligations under the Halston Master License, including to honor the obligations under the purchase option. In connection with the Halston Master License, the Company issued to the licensee a <span style="-sec-ix-hidden:Hidden_8gE87REHLEm2Wj2Lq_q2jA;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">ten</span></span>-year warrant to purchase up to 1,000,000 shares of the Company’s common stock at an exercise price of $1.50 per share, which vest based upon certain annual royalty targets being satisfied.</p> 5000000.0 1000000 1.50 EXCEL 61 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx M4$L#!!0 ( ">%LE8'04UB@0 +$ 0 9&]C4')O<',O87!P+GAM M;$V./0L",1!$_\IQO;=!P4)B0-!2L+(/>QLOD&1#LD)^OCG!CVX>;QA&WPIG M*N*I#BV&5(_C(I(/ !47BK9.7:=N')=HI6-Y #OGDK7A.YNJQ<&4GPZ4A!0W_J=0U[R;UEA_6\#MI7E!+ P04 M " GA;)69IT[ .\ K @ $0 &1O8U!R;W!S+V-O&ULS9)1 M2\,P$,>_BN2]O:15D=#E9<,G!<&!XEM(;EM8TX;DI-VW-ZU;A^@'\#%W__SN M=W"-"=+T$5]B'S"2PW0S^K9+TH05.Q %"9#, ;U.94YTN;GKH]>4GW$/09NC MWB-4G-^#1])6DX8)6(2%R%1CC301-?7QC+=FP8?/V,XP:P!;]-A1 E$*8&J: M&$YCV\ 5,,$(HT_?!;0+<:[^B9T[P,[),;DE-0Q#.=1S+N\@X/WYZ75>MW!= M(MT9S+^2DW0*N&*7R6_U>K-]9*KB55WPNT(\;"LN;X7D_&-R_>%W%?:]=3OW MCXTO@JJ!7W>AO@!02P,$% @ )X6R5IE&UL[5I;<]HX%'[OK]!X9_9M"\8V@;:T$W-I=MNTF83M M3A^%$5B-;'EDD81_OTV23;J;/ 0LZ?O.14?GZ#AY\^XN8NB&B)3R M> +]O6N[!3+ MUES@6QHO(];JM-O=5H1I;*$81V1@?5XL:$#05%%:;U\@M.4?,_@5RU2-9:,! M$U=!)KF(M/+Y;,7\VMX^9<_I.ATR@6XP&U@@?\YOI^1.6HCA5,+$P&IG/U9K MQ]'22(""R7V4!;I)]J/3%0@R#3LZG5C.=GSVQ.V?C,K:=#1M&N#C\7@XMLO2 MBW A(5M>5 TR M6'!VULS2 Y9>*?IUE!K9';O=05SP6.XYB1'^QL4$UFG2&98T1G*=D 4. #?$ MT4Q0?*]!MHK@PI+27)#6SRFU4!H(FLB!]4>"(<7K;YH] M5Z%82=J$^!!&&N*<<^9ST6S[!Z5&T?95O-RCEU@5 9<8WS2J-2S%UGB5P/&M MG#P=$Q+-E L&08:7)"82J3E^34@3_BNEVOZKR2.FJW"$2M"/F(9 M-AIRM1:!MG&IA&!:$L;1>$[2M!'\6:PUDSY@R.S-D77.UI$.$9)>-T(^8LZ+ MD!&_'H8X2IKMHG%8!/V>7L-)P>B"RV;]N'Z&U3-L+([W1]072N0/)J<_Z3(T M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+ M.7\N?<^E[[GT/:'2MSAD6R4)RU3393>* M$IY"&V[I4_5*E=?EK[DHN#Q;Y.FOH70^+,_Y/%_GM,T+,T.WF)&Y M"M-2D&_#^>G%>!KB.=D$N7V85VWGV-'1^^?!4;"C[SR6'<>(\J(A[J&&F,_# M0X=Y>U^89Y7&4#04;6RL)"Q&MV"XU_$L%.!D8"V@!X.O40+R4E5@,5O& RN0 MHGQ,C$7H<.>77%_CT9+CVZ9EM6ZO*7<9;2)2.<)IF!-GJ\K>9;'!51W/55OR ML+YJ/;053L_^6:W(GPP13A8+$DACE!>F2J+S&5.^YRM)Q%4XOT4SMA*7&+SC MYL=Q3E.X$G:V#P(RN;LYJ7IE,6>F\M\M# DL6XA9$N)-7>W5YYNTB42%(JP# 4A M%W+C[^^3:G>,U_HL@6V$5#)DU1?*0XG!/3-R0]A4)?.NVB8+A=OB5,V[&KXF M8$O#>FZ=+2?_VU[4/;07/4;SHYG@'K.' MYA,L0Z1^P7V*BH 1JV*^NJ]/^26<.[1[\8$@F_S6VZ3VW> ,?-2K6J5D*Q$_ M2P=\'Y(&8XQ;]#1?CQ1BK::QK<;:,0QY@%CS#*%F.-^'19H:,]6+K#F-"F]! MU4#E/]O4#6CV#30,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04 M" GA;)64 D2TMP% 'P & 'AL+W=OG M!C(D2BZO6 MD'X8N?69&)2YE%_-Q=B_:CFF1"(4GC86'/X]BY$(0^,$Y?AW M9]HJ?M,(7W_>N]]E\ SYXD8R?#/P->KJU:_17RQX&FH'^3F5[$#.C-^G@R3 M["_9Y,]VNRWBI8F6T4X,)8B"./_/7W85\5I *P1L)V#O!-2M$+@[@9N!YB7+ ML&ZXYH-+)3=$F:?!S7S(ZB93 TT0FV:<:07?!J#3@QOII= JFO#8)[>Q#O26 MC..\>YAJ;I-DQ95(+CL:?LUH.M[.^3IW9A7.+ODH8[U*P-47_EM]!TI9%)7M MBWK-4,./7)T2EYX0YC#74IY1G7Q+Z)E-_:8T;E%Q;F;GUE7%66J6V2AFA MJH9XYP7>^6%X4Z$":?JN3V#JL#8>[E0,R,H1B>H;Q#,QJ M 0TYX9&U>]88?1G=WI/KA^'D9G:2EV\\&9W:@'&CIL2O\@8]A'@<>U)!/\T6 MRQ,RTS JB51D)--8JRW\]^W5@+O?W%J145%39%8BLT.0'_D+&?LP6(-%X.4A MH;I'UUCVSMN.Z_3Z],+*BXJ;\I;)B**)8\\[]'UP3T[V'\@]/$<^Q?9VQ2VI MZ[KD6DGN;_CVA%!'K\A=**6M[D:X5U/\,A%1/-.\QQ^9*^C:CW(36]%QNPF\ M"CW!JY"5]!@YB99!B>+QYCUI,8JG2CX'L6=O:=QS\F0%/49BHF5DHGC2>0\Z ME8F&3/%7L*Z>J'!'"HM2WTIZC,Q$R]!$:U)3QJD$KP;##=RN=9G%54VQRIA$ M\6QS+TT&G*YDC,6(&I,>Z[59M]>U\ATC)-$R)5$\XCP&&@*27!#*?IS_1&;" M2Q6TI!42=QK)*(*5:::E]_6$?.^<0D\(6"OA&&&*E6&* MX1D(,K ?Q$LRVT9S&=K8:PR^W-Y?6S<6CA&96!F9&!YJ]JU);E^\%8^7HC(D MUAA-AK.;H?5]&QU?V?(WF*PI845)K9M/-8Y/UBVK$:YJREDF M(W90,AK'6JA\ ].\CO(]N)43=ZSB/$8$8F4$8@=%(//6!I$>0L%2*NMD5.,S MD7&;>YX &S#Q:YOM%^&RIGAE_&$' MQ9_;2*BE&96_@ ,$<%@JUCRVMRMN6+G5@.N:@I;IA^'A9=^.*P'MB.'A-M5X MQTA!K$Q!# \P^VGVS1(_R_;WR:=40Z:-S0)J)?Y&^697#[G;6>9F3IJ>!_3B MO._2"PA7SS;&,@FQ@S:,1C"=*HA\X]@7+^0W86_&NGTCASI]ES''RG",L..6 M8XP.]3LE(_G9\,?N5E&$A**!4B=TQ[, RH_;LTOM%QG)Y9SJ;6,LH\KP7VA MS /P_4)*O;\P/U <>@_^ U!+ P04 " GA;)65<%8HMT& !7'P & M 'AL+W=O,\=>?7( MQ;=R3:D$3WE6E->CM92;R^FT3-8T)^4%W]!"_;+D(B=2/8K5M-P(2M)**<^F MR//":4Y8,9I?5=_=B?D5W\J,%?1.@'*;YT0\OZ49?[P>P='AB\]LM9;ZB^G\ M:D-6])[*KYL[H9ZFC964Y;0H&2^ H,OKT0V\7.!(*U02?S/Z6!Y]!MJ5!\Z_ MZ8=WZ?7(TXAH1A.I31#U9T<7-,NT)87C^][HJ'FG5CS^?+#^9^6\/>UEO!))M*7F^5U8(L MT,MX+X7ZE2D].5_PHN092XFD*7A+,E(D%-QK6GSIS;@VPWHO759;DA"KT=J\Y14[.AH_O-/ M,/1^MWEW)F,=7W'C*W99GR](N09JU4"B/]#O6[8CF7+>NHJUJ; RI0O ;@Y# MJ"*^._;&%/)#+VJ$.BC]!J7O1'F3)'RK0*G*D%"%\"&C8U!0:0-96PJ.WA_$ M8=P#:1&"T+.##!J0@1/DNV*G L?%LPU58+P0>W$?E2F$(C^PHPH;5*$3U9V@ M&\)20)]4:2]I62TVEVLJ5/VH\YQ4>6Y#'1J H(?["VX1\H.9'?6L03USHO[" M) '!FOAO.C)2T2/D>&ECNJ($8.:O$1UY,DM.5(CIGI3B3L8Z_<>-O?"*1 M5',@Y'.50+I0;!1=R\%M&)LQ1WC66QB+D \':@7T6L[RG$@_*9Q$LF(%,JHH M' C-U1.^G&S5PW N[:UVBT(4]"#;I/RA7()'/ O="2](JCHPU9T=;5!62%*L MF*IVY6"<]W:#3KV%V.O#MHC-PG"@N,"6*J&3G>9_J$10.9%3N>:I KRCI=1Y M886*S.6.PLB :A&+83P$M64ZZ*:Z6[JD:KNF0)*G?1H,1Q5;"HO73]]34EV@ M+=E!-]M]JA;?D:@F>QV3UQZ;6Z@+K:4XZ.:XNBX71Z7/ =.DLQGR_3[IV<3\ M& XM=\M[T$U\-=2;87@F;T6^ZF?Z\"QB48R'X+4$!V4"9T,U?9Q&_)<-W$D2<26.MN3K(V0-4"169 #,\M,*1P' M0U338!,AH,X M[L?6*C4;@G\T,;IIT (_X84&K[\]A?R\TZ1)G\C' PZVY(GJ"D5!D?UMXNT94_D.POK>UZL)E^HR$^65N2DX5?'_4S6NFZWS(S< MS%RY+;7;/["%3"H. MQG1)M4A..!=6OY&KGYVNK *S:1R=,ACHV<.R'5Q=Z2 M.7K)N)HU'IS:'[:Q-49&I;6((334>J"6A9&;A6NT[T]@- D3QK&'^Q@M8M%L M,*(ML2(WL2YXGK-JDJA;@L4A$9(AO$Y[]NT'K/OXQPUU3^):AL:>LW+=2YY\ M6_,LI:+\!=23E;5P82?3O[9PG_$82XKM?]C\.;"\Z!J4P38 MD6RK>D0X]CQ/_P/EF@C=(V[5M"G8?S0=ZUF$ E:6NK6I>L>M+-74G*IDL8;. M">85:7(&0]V M;T&/M%KJ*VAJN-0M +/%2X=(AB/0XS',/:;1^2/H[!1L(<3 M$ D^$)&LFZ/Z2N*6)C1_4/WZX01^#)2-#:TN8#+K82BVM"C]^=4MTPW=T6&W MNXNY(RR=L (D9,-4#;1BL\ST'@Z-@<(N%\1H &/;O^"39]W;?)M5-RXI7;*$ M64\HL#G?3W#D^T8<;7)(M6,#.-N& [_D*.#?A&;@K=#W/F/PKD@NZKQLJABM MJIC5 ;.-" .$C#A;C@>\:.AX +?M!G:W&Q]YH9L+/0KIW&:%(FY:VD-M-@V3 M>-9OBVQ2X=!D@=O6 K^DM;!1@Q6JV3*$/CJ:<_=83;&9!X=Z.-QV%OB5G455 M(5X,/C*NCFPG,C8QRXG,].C64U\YJ]*U8D6I.N&ETO,N9LI[4=_BU@^2;ZJ+ MT %LE8003\L M] ( %,* 8 >&PO=V]R:W-H965T&ULK59;;],P%/XK M5D!HDT9SZW6TD;9.$SP@5:N !\2#EYPVUAP[V&X[^/4<)UEHMO0VZ$/CR_D^ M?Y]S')_Q1JH'G0(8\IAQH2=.:DQ^Z;HZ3B&CNB-S$#BSD"JC!KMJZ>I< 4T* M4,;=P//Z;D:9<*)Q,393T5BN#&<"9HKH5991]>L:N-Q,'-]Y&KACR]38 3<: MYW0)Q-@48W3-C7.#<*9QGB3#25 M0DO.$FH@(=>44Q$#F5LZ3%#PA3OXY@8M8SX: M(A?DE@DTSB@G,ZE9D5_?K^ZU49AE/]JLEMS==FY[]"YU3F.8.'BV-*@U.-&[ M-W[?^]!F_#^1-;8AK+S?#4@%+X\C'5XH<+DE-%UI2O@)PQ01+).56: MY*#*%W_>MAOE$H-B"?O=6$=>Q_/\L;O>MGDHJJ&_6^OOGJ:_3$]"5R:5BOW& M">NC'&T57_+WMF3Y7O%[)O]P7,- KS;0>Y4!IO7JL/C>"U'/9>^+: CNUX+[ MKQ*,=X0V5"1,+ ^I[A]4O2^BH7I0JQ[L53V568:G^A^2?'!4DA^*:H@?UN*' M)X@_.<.'+S:SY[6F^!&!#?VC6O_H=/W')?CHY:D;]&BPIBF:*51\H&X#S"RG-4\?6%74=&?T!4$L#!!0 ( ">%LE:TU9(4 M6@8 .X> 8 >&PO=V]R:W-H965T&ULM5EK;]LV%/TK MA%<,+1#'(FD]G#D&FF2/ NU:-.VZK[1$VT(ETB5I.]FO'RG)DBU13#)H7V); MN;PZ]Z%[CLCY@8OO\BUE^C\K+G*B]$^Q MGLBMH"0I%N79!'E>,,E)RD:+>7'MDUC,^4YE*:.?!)"[/"?B\89F_' ]@J/C MA<_I>J/,AD_5U^TGH7]-:B])FE,F4\Z H*OKT5MX=8L#LZ"P^"NE M!WGR'9A0EIQ_-S_>)=TBPSGC2.'Y7347U/L_#T^]'[ M;T7P.I@ED?269]_21&VN1]$()'1%=IGZS ]_T"H@W_B+>2:+O^!0VH;3$8AW M4O&\6JP1Y"DK/\E#E8B3!=J/?0&J%J#V@KX[X&H!+@(MD15AW1%%%G/!#T 8 M:^W-?"ER4ZS6T:3,E/%>"?W?5*]3BUO.),_2A"B:@'NE/W2-E 1\!3YNJ2 F MUQ*,P=?[._#ZU1OP"J0,?-GPG20LD?.)TAB,ITE^FO!_JN1\&'SA3&PE^ M90E-SM=/-/8Z '0,X 8Y'7X@XA)@> &0A[ %S^WSER,''%SG$Q?^<(^_SW1/ MV8Y:,U.NG-I7FN?U2FY)3*]'^H&45.SI:/'S3S#P?K&%-9"SLR"G=9!3E_?% MGWJ\B#)06YSEXJ!8;,;(?A%XOC>?[$_Q=XVBX_!J7[\1URZ4RG;OF M/)% ]W5B@U?Z\$_NC((9;L'K&L$@\NSP@AI>X(3WN^!2@JW@JU39@ 6=>V+L MARU@7:/0"WKR%M; 0F?35D\Z6X-89U "_6@#^J"90MH;.1RRD0=R=A9X5 <> M.2MR3S(B4BHOP)(RJLM2Q9YO,_YH!B%0Y,&>@ZA;K&G@MXK5-9I& ;07:U9C MGCDQ?U0;JGE8$Y\NV 58:^""9 5NDFB&2*4RQ=Q39PEG%OB=A\!F! ,[?.@U MC.,Y _C"E<;+7]ASE=-3,,',CUJ(+581"GL>#WA"DM"=\QIL9A[A)=7ZB0)> M5*("#5ZG+.8Y?7.A&3+.=HFQ9IR-8R(W[LA@!_,8!QYLAV8Q@PCVS"2(FMB0 M^^$?* HTY% 8RMMY3AH2AT[Z7-Q1[39.2:DTS9.5G,E> [HCUVJ'D%.U88GNI)[*I499U;(TPX8'[8' MF?O._[4>#:]#-[%7(V.@3K4( Q1.V*+ NBO42,!H%L#G$\2*[PNPX_]&6S/ M9IL9]G ?P$8*0+<6>,<4U2541=NO4D983)T=/Z@8&,K;>?"-'(!N/5 '?VRR M,= 7E%/51O- )\C&E);;>,-$6LC@1BUA]=5 M :@S'KHV/2H'-3(!/4!N-@-P:X?V),BA'4[]X M1!8N]V>XK69L9CC$?5 ;RD=.^BS>W_K&3[7T26@6,P>TAGF1FWF/T !12J3+ MG2++3">2F]$> M=MNA/S?=I%AS8N'K68 QG$W;Y;59^B&$L&?4XX;@L9O@C^W8B::WOM9-U2Z9 M]X1BM72&TG _=G-_,?33V)QN:&YR;(VZ_;QX#W@@;^=1-S("NW<.G'O=@VX' M#.7M/-"3/?VG18FKJ+A#P BA]@NEQFVO(O@_ M-@%PHT>P6X\XVVU023&4M_- &TF!W9+BJ78+.HV$(]06Z!8K%$;MS=O)RW99'KXV;\B3X@WZ]3)D$&5UI ME]YEJ),KRL/5\H?BV^)\%LE;6L.I<.04 #X> 8 >&PO=V]R:W-H965T&ULO5EM;]LV$/XKA%9L"3!'HEZMS#'0V!*6#RV"I-T^%/O R+0M5!)= MD8[3?S]25F1+HAB[Y?;%ULO=<^0]1]X=-=F1\BM=8\S 2YX5],98,[:Y-DV: MK'&.Z!79X(*_69(R1XS?EBN3;DJ,%I52GIFV9?EFCM+"F$ZJ9_?E=$*V+$L+ M?%\"NLUS5'Z_Q1G9W1C0>'WPD*[63#PPIY,-6N%'S#YO[DM^9S8HBS3'!4U) M 4J\O#'>P^L8!D*ADO@KQ3MZ= W$5)X(^2IN[A8WAB5&A#.<, &!^-\SGN$L M$TA\'-]J4*.Q*12/KU_1XVKR?#)/B.(9R?Y.%VQ]8XP-L,!+M,W8 ]G]B>L) M>0(O(1FM?L%N+QLX!DBVE)&\5N8CR--B_X]>:D<<*< A!;M6L#L*MC>@X-0* M3D?!#0<4W%K![2@X0T/R:@7OU#GXM8)?^7[OK,K3<\30=%*2'2B%-$<3%Q5= ME39W<%J(R'ID)7^; &=JD#&7@RP>X*ADM,F0HQ5B-^(GS.;363 M$]^P;S?LVQ6..X!SBS)4))@"Q/A$DRO@P-^!;=E01N<>RJ^@Q(;U/+6MB?E\ MS%E?!%J.Y81ML7E?;&2/@Z C%O7%?-]NR\1]F< -W8-4RRU.XQ;G-+=<\!"G M:\39NCS)17M8[WC^H1= "#M3FRGMBVQR33@V)+H5NC- XEV1\%1+,;C@M%57EV+'DNYJ7Q[XV@0\5>U0 MN9"MQUM7HUMF.L'F.L$BG6"Q)K 6^U[#OJ=ZW>=8'._YX>1XXZ#3B:32-E>-Y7)H(*CW-GR M:M!X-3@YPW] 99.^;)F;@[J5REQX=NQ M'%^.Q'83=-2\1\X/. HC[0H$%A]8\M Y-G?73!:S42S5N.[Y] MVQW[76>I1W!N@&M%B[2BQ;K0VEP>->CP?ZQC:V.:4JE6M+E6M$@K6JP+K1T$ MASX=JAOU_Z:<51L].QCLWM[AP<[>J=5BI!4M5H^_3=SA) &JCQ(>J\T7I)1N M]TPEG*!MQE#!Q"KF=T5]QKI+V;KF<57RUU+"=';G,]@_KO"[?&D]6]"*%BN' MWZ;K<&8 E4WI3]!UG&JEU+F]T8X=Q^UF5:U' UK1(JUHL2ZT-M&'XP&H/A]0 M=9MJU;-7F4ZT.>PWWB//=YU.\2D3LT.O4WU*P4)G/+"*#IT\5+?R0TVG(_6V M_W9E+I'AI;GO=MM.B=S(&;NNU76/1"X,8-<]?2G?M;TA]QQ:\X,.SM(\H1G!UT.M$BK6BQ+K0]E^;1ES3Q9953LDIY197A)8>WK@+N M^W+_L7)_P\BF^KCV1!@C>76YQH@7Y4* OU\2PEYOQ/>ZYI/Q]%]02P,$% M @ )X6R5E8@T.U^!@ 71T !@ !X;"]W;W)KK#3>G\U&JEH1U.BWHD] MY?"?C9 IT7 KMR.UEY3$^:(T&>'Q.!REA/'!_)*GTA&-!:#'O@"7"W![P:1G@5\N\'.@A64YK/=$ MD^5"BDY;_+5@(9Q$\8'+>&_#-;IY4IP)1(6$TUC]*#A!V*D%1(; MM")JASY G!4:HF\/[]'K5V_0*\0X^KH3F2(\5HN1!AN,IE%4ON^V>!_N>9^/ M/@NN=PK]SF,:'Z\?@>T5 /P"X!8[%7XF\AWRO;<(C[%OL6=U^G+L,,>O_.GG M^OP^?QJG;7*G;:1($=2;))KQ;9&P3#-J]5JA=6+7:FKY2NU)1*\'4*R*R@,= M+'_]Q0O'O]D@7TC9D0,FE0,F+NW++]!Z$J&L((N58;[2])?#:IN8Y, #,%U0") M;HO>E0U9<,GP74C9D9_"RD^A,WSO*2B-&"EZ+(\12874[)_B 7V"\:&HS0.% MVJ 1-6\ZG[9":Q&:X;$]LM/*XJG3XINF@="VH(=3*2%^&\8)CRB*A(*@,QXE M65R$E7%-P77:ABKT)D^ D06I')#6AJFH/KNF/ MC.EGE%*]$R9(!X@/M49FWH7C!2T\3MO^8PEYXWJFCMU#8$?XEJI6!U&*0AZ: MFDH86;.DOYN4ZB^4?)?2=NR,!L'PW/4912(S;1?Z"F4'LDZL42VU-,,ZG 7S M5EQM4M[8#^VYZN':2.PT\A/D&]="/EM-P]V7XF#2-LTB%81]EM5\PG-.Z^6= MI'O"XI=65220T#LJ@1Y"G^,Z?\(%'U;W>:99D?@=&R>X73L6H49]'<.H68'G MI@55%NS)LTF!MS!1(YG1&EC]!$2D2)+Z ?1ND5*DR1-M*N@XHE%75O23+C!_ M'K;A=Z5PV#>DO)I_>,ZQO?R#0J\>2IKD3-O>#*Q&!Y:TZN2>16].#V*7'E@06(3Z$.!Z[..?C/U6WA4$].ZQ>]S?D6>37";M$L&W0V#:*7#RM37=W+K.1FXA!R'N"VO-#;";&U2) M62=C,T5/CK+S+6=CM;"-?JPUV\!NMF&PQC229EB9AF]PORW0F[YQ((GY@BYF MK_F"DBPRX\P(6#%WJ03,@<[(M8EY0= S"'!-.K";=*Q.MQX1C=9TRS@WD30] MDTHF8BNH+D&8A./V+H9%*L"XYZ,*US0"NVG$F9"HX4A.,%WFX(4>;H/I2OGA MM"\^-;_ H;-AWI>[,.5V@Q9FMR%GB7 7-7)B6D[TE;DW>T%6PR[4OXX]'MB6/,,[.89]R=T :>&LR/3 M91_-ZCN&4;,/[&8?7X4FR?]N=UU:80M$5ZJ_F/R:??AN]O&0[?=)OGL/0&*F MHD2HK-AGB5Z(";3TXN0'RLU:1/Y%J\F)C_'5W\V6S'BCE5>>S2[33@W MA*/&055*Y38_OU,HWQHHCGRJI]49X4U^,M9Z?NM=K8J3OEI-R.,LK;K38Y\=A:Z&U2//+'24QE48 _K\10K_YN M=DBV9>77[ZLBV8Y+= /O%[H,LUEVOJO5T:^RY*Y3RXK(J:_=L4GC?/#X\ M=%FA*NGFIE$UWJR-K:3'K=TO!);PI/#PZ?/VWD1ITI_W/SP>+NL*.2ZTK5 M3IM:6+5^-CE9/'YQE];S@E^TVKK!M2!)5L:Z0YZ8ZDC>^>#9Y.!&Y6LNV])_,]B<5 MY;E']#)3.OXKMF'M YR8M1CT,-CP\NF'#,FY8,M_A(.;R M>^GE\Z?6;(6EU:!&%RPJ[P9SNB:CG'F+MQK[_/-WTK=6";,6[QME)6G*3<4+ MF9UOK&GK?"IDG>/>:4>+/ECE5.UYW=-##P:(S&$6#WL1#EO><-BQ>&MJ7SCQ M0YVK?+S_$(QWW"\3]R^6MQ)\*^U<'"^F8GFT/+Z%WG&GC6.F=_SW:T/\ZV3E MO(67_7N?8L*Y=_>?2Y'WV#4R4\\F#=&T%VKR_+MO%O>/GMPBU=U.JKNW4?^[ M;7S[88NY^%^T^+E0B-3,5(VL=[K>B,S 5VJG]4$%IBGGVMFZ(S.<>+@NV\>+I='3UZ>G'S@R\63.P+I MNF.XYTS7(8US/H2 36M=*VLOO&'"NH8+MYPO'3VCQ"<61[./O/K$>IV52CPD M97]2F[8,E,YFOX%O4[7E)MAFMX?+,Y6U5GN-2Z+UPV56R'JCQ*FI*NTXQR=! MSGXX37+,Q:FR'K5EQ#ID6QOC:^.5R+7+2N/@<$[4M((4!AV6;1X4MM@F!;C (V#"6##\7)\P&+LO=E';M M1&X@D4_""$@6C30V8E(%Y$< .(?:RJ=)06%D54$E%-(TPS@#9ST7C7&:GD[! MCT,Y8\;-('9!+9.N$&O4<#<7KX(;FD;7D58E:Y1PTBWS/@[A/H3^2NALE56] MG=:FQ-E$C<@[6>$=]F?)G^!_FT73N.61 .GH?5<')+SP9K[PSL F^)9A!KJ6T9(N4&K>\S$/'4FX)V M_):I4KRP>($MK^ILSFLTR+EVY72NI24E'=!!,62I_]+!7&':$MF*>)'L,=CSI:T#7.140(P-E+5X M\,2)D[IN0>@31Z[ RI0D_]G)PMPKPCC7:]*4BM5:EWC7'4'Y 81.D/Q+L7@0 MX$RP13Q=H%1*42E8,[@ I&LKD(7?YTC83L1XP[$;1&(7 +ER>@._B>O8AX"^ MSQ5Y[E249!'D?"4KOM\6!GE,EIQ7O=6KMG>['/;)_,R;67U5:5%EBL,PGACR(OH .&[771IETMEMGO MK0Z10(?FNQIL9_V.4J^5\SMPS_S /TX1CC!V3*G7;,G+!!D2^44;$8.Z2]QO MWK]\3^7L#=@7+TV9.T\>'K8-(^K* @['5,/"T3_)$F ^[HWA.$D/>?TDKGQ- MOER(3[HYE^/EX=%H\:GXE5S>CA=V3T=KWQCX!GQQDY9?$:%_NX?_5T[*3+S5 M?UA9Z/%IXU?=D;U)84FXMO*4 9-EOOOFT?T'CYZPD^_3WE2,E#,5 ^$#[;&0 MG';(?9%MS+;N84BT^?C$%%:A;KEKZ@DD?0&\NBDXF=X[^@?3M:[034A$\#4* ML^&^-SJC:DNA].;-Z9,A \.,Y&[9%,M.9C:U_H-!38V=WD(R*BS=R2G96$6] M-]>AZ^P5JF1%2"S5%JXNK?\3JO@(Y.[UI5BU8 O1^R7Q_[PENYZW+Y7+RO1P]&649 XIPJ_H@=2N/R"QS>[T:ZDZB7VW(W MRY"+J61UQ9N\6'JQE5PK*\4D"R9]$ZM6YHJ2/%(G$CAT1@B:Y+Q1O;%:K$:B M2G%\HZE?O16?39,9-N(TU204E59QY\"G4/E0"2$/H$3,KE=/H[X7H2#DQBJN MT>+ *27>$;3PBOF(R M93TE/^%J2?M#%TB[RY0F8- +%10==SNA]E:UGE'_5JLRTHI0@"8@7FUVA"2H\XZ]BQO! MB3Z;D$'"7$YX5:H+[1AMY'JC/40A=#(+Z(306M-PCEQ9G9W/P.NL0N$&T@H< M#,!+T)P"3JD "^!1D5?6,? >U&=W6X*K+&X8LY%NZ)"12CJDT .C&Z#0P+VE M50-4C+B=O%,^*&C"VR>G!EX(YPK8A_+$)(7@:8=@3X<(]JS'K5?F*BYT. K9 MC,<:^W!.C?.ON<\GI._$U=ONQZNV_>AE)!GA$-KZG!"+B&BQC%#P'W6 M7.HJ\/'MO?E]46GD&!@;35D*+M@=\5R%&6# QV^EA9ND$5X:V'3]._+5C-L= M==F$@+E^V')^-QT644(@E*LUFD6_9_OQPWY_'"2-F9H+,A]S MD5K+:&SJ\\A[PUB#,O0UUAYUI%,%^ZH2QC%)LM!@FV=ALN&X.,@"K 6[3E&\ M4HE.STHM5[K4(8.H2U)DTG]:PC.'@*%+)=% F56I-\E["4N%DDT2TOKAZT;N MY*I4H5VJ( 9BWF3G=_9ZP>(KBMT7::SHKLVE?'R!R.DF E?.6 P\[>8S))3/ MGHUEU [":@;A;J7F[C$+,Z8PG%H9E,Q]0134NDO5C4H='2D1Q7%0"3IU7R7Z M>!(-QQ$V5K +#0+KF%S1,)"Q283_W:)94[8NC08ZHKREF_RLM44" M^[U%H:+4MV95C\'/2FT@(TZ@BDLSQ39FVX[D6!;%K7W )(:PT"!A=8 @>.<7 MZ-L+Y#"F>;W>K7#B3"-QE(B/_CPJJ_6UFL?GANFN"2#LAK*TCY]PW@GRO\YD MYRBG0%?TT6E%%1&Y@\(WCF;RP]6A%*]# RP^]\33[//UYU]&,UQ2Z;7.1W9) M/Y7JP @V[]O4,3:HB$DK?R""@C?#0 X6B: M%1BF@8-X"6S1!%B7E/K^]T)L!,R',G1Q'J7'=BYKQ.A*[:""H._A0"#:U81.8G$O5D)_NX]6TGF>> 09 M>H\D^^,BV1RHR(QN.;,6NLQM_W0PMD'.#1]+!T.;42-/ !9)"B"/W\8/? MSP&C[&Z&BL(%9X"8 O5N1$4L[L6#.7DU#TVIJ%@N8)W+#OGH\.N@0U@<,_Z/ MQKVBG_4^I9,X%YIL'<:,HFV0.^M8ZU'HF!/&RV8GRU!1@W]PPH\.LD$:E+ 0 M#%2A-:W:JE^??#5:[ MV9HR%/\)#\+UGOH32DWH[3FT]6 B[M0 SZ2\H!)6)J.5:O!91]5YBFJG:-YZ MM0[,AR>O5*D!-[M8@7G4A2G;X43^:J'MN0F%:HOZGFPUB@OVO:$B,\+53EY@ M;P0R]-5@M(#.77/.^'6 7TFIW7(=V:=&#;I%!W\*GU>K2D\W+BX0D>]CQ M0O*WJCJ:-N1M:GE2^0P?WES?<%R9B8Y*_G3P::=W(].UI6C#X:-T,?@J04"' M/LO>;MR \0+:88'1B9#B:T02C8HI)CT#U$!I)"_/1W"RZC_!K37/-*A?"IX% M7_L87!-EZ_J\_F,W6+:*\"&J7YMQ+QT&"T%;8W3('H?$1'JX$MM_$2?N1:O3 M4&M[V5*]A1\#*4BNN,G0Z?^G5)E/AJ1'7(Q7DOWV$9Z( ])Q%1HJ MA T82PP]G"T>D;>_0_SPMQAZ-AVN>#0[NDIC%N2NVCLV,?1K[69?Y8JC>M#E_?\F[$)_O^W7-X>#75!5-Z.DW8_2!#;$0?EC5/>U^EG82 M?HW5+P^_:8-Y-U SDM@:6X_F#^Y-4$KX=V+AQIN&?YNU,MZ;BB\+X"=E:0'> MTV>T=$,'=#_6>_X?4$L#!!0 ( ">%LE8@^JG<:04 .H, 8 >&PO M=V]R:W-H965T&ULM5=K;]LV%/TK%UY6)(!FRW)>R MHLCX" M-%O0=NN 81]HB;;84J1+4G'=7[]SJ8?M-,E68/MBB=3EX;GOZ[.E=9]\*66@ M+Y4V_GQ0AK X&8U\7LI*^*%=2(,O,^LJ$;!T\Y%?."F*>*C2HRQ-#T>54&9P M<1;W;MW%F:V#5D;>.O)U50FWNI3:+L\'XT&W\5;-R\ ;HXNSA9C+=S+\MKAU M6(UZE$)5TGAE#3DY.Q\\'Y]<[K-\%/A=R:7?>"?69&KM)UY<%^>#E E)+?/ M" */.WDEM68@T/C<8@[Z*_G@YGN'_C+J#EVFPLLKJS^H(I3G@^,!%7(F:AW> MVN5KV>ISP'BYU3[^TK*1/4H'E-<^V*H]# :5,LU3?&GML''@^+$#67L@B[R; MBR++GT40%V?.+LFQ--#X):H:3X.<,NR4=\'AJ\*Y/;#^# ]?4*I_5ZI_:?0O\M_3R-E M0WH,C*YOZ+U=Y#:A-V^NZ%=#-V)%V5%T39;0'[G4M"NT-7.$;RCOR>\^^^$X MR]+3;CWR$D6$Q-S) MB#&DV]KY6@ -PJ%4?OTM(=N8NLT"F'I7[6TJBSM-<&I:!UPGO)?!MQ::KF"# MRP0<_D07=G!L#G@ ME"&]WP 1>6YK T'D)BD\)P#LCN,E(B,,+;-CTC%_MW&%;W647]#:X(M=V,A6 M[N"SVFTXEZ8R+*4T6X9@ZW"T MS>V==*;S3$]VDVM"FSDS/CKU9-"H<^%+FJ&?(ND\]R!E8K1%H/[R/?*ET!H< MJ%"^CY*6=&M^*FK'%*3( :E\#G>OI'!D+&G6*90"E$PN"00[B<^U<+!YPK:< M(2WMTI_$T)PIYQ&VXQ1N:?R7$)M-1XT1^8B=7*(/(UK1DN?@.N<\$Q5;MR/C MZWMDX Z\ G#G.#D^R)(T36D7^?L1 MF>D/!:&*/DU:M.POG,?,))=2@JID@)$\0*'RHE?T D,3AJ^"* MR/)]1#,\U+M3/B9Z(7V.?:8V17X--WO[K._M:J.W,X.^-OQK.J3\5O"S(=/) MZ3\^=W<:Q]G:<]/;>U3PK40UJ>'T;F.')LED_Y!>.38Q5)ZI\,VI1N0-2\R< MK6)[4*:^5PV_(37>G^S1+PBMZ+Z'/[>KAV:6T<;\64DWCU.VIU@QFU&TW^T' M^>?-_+H6;_X%P,IS!8I:SG T'1X=#)JNTRV"7<1I%C,!9N/X6N+/B'0L@.\S M:T.WX OZOS<7?P-02P,$% @ )X6R5D5M#M&3 P XPH !@ !X;"]W M;W)KM# MMZ#MUH=A#[1T;!&E1)6DXGB_?H>4+6N&XP'!, Q[L4GJ.]^Y\O!,UU)]TR6B M@:=*U'KFE<8TUT&@\Q(KID>RP9J^+*6JF*&M6@6Z4<@*)U2)( [#+*@8K[WY MU)T]J/E4MD;P&A\4Z+:JF-KQ#,IPU;X6 7[EN-:#-5A/%E)^LYL/Q6@='? M(]ZA$):(S/B^Y?1ZE59PN-ZQOW.^DR\+IO%.BJ^\,.7,FWA0X)*UPGR2ZQ]Q MZ\_8\N52:/<+ZPX[3CS(6VUDM14F"RI>=__L:1N'@< D?$8@W@K$SNY.D;/R MGADVGRJY!F71Q&87SE4G3<;QVB;ELU'TE9.\"'M?4A/L;\H;:<9 MDQ'\'>DA0#H WP-\J*F-Y)*NK#8@ET 6$I!-Y_7JVMX_6H2A\G;?^W_J[N3 M6+R8X.81%;4FH!+,R[X&]Y\KJ0S_@[G^LCM\KZ36<,>4VI#3>VR>MU4KV-"< MGRA:/?#\C$))$9.MIN#JBQ[U@(K+8JBTK>2DVV90(:1<^%,AN8 M'/"G\56_3J)]"*,H@R_2D.AS.3B#[,I/PJO!09SXT>7P@.R+DO#%:?[/U-D] MYE@M**C;4HN/I_G_46*1GZ2#$KOTQ\D_5F+QU61?8DET4&+'2BKRLS0=EM2E MGV7CXS' )YJ)M&UMP_8'K'M UHQL;\C,)TY3 XH-G$6C<4JOMQ!6VDK9QFA* MA?BFLH\E-%T"T#Z9A]WFW(*]O%4**>#?6Z8,*N_"Q>>XKN2%NN*MKH8 RD5W MKVYT[-4*!H-'A6KEQBM-+P"51C>#]*?]!'?3#2Y[>#?^D2$K7FL0N"31<'0Y M]D!U(U6W,;)Q8\Q"&AJ*W+*D*125!=#WI91FM[$*^KEV_B=02P,$% @ M)X6R5N//1%Y.! A0H !D !X;"]W;W)K&UL MI5;;;N,V$/V5@;(;M(!AV;*=FR] DNVV>7"1)IOVH>@#+8TE(I2H)2D[[M=W MAI)L)W&"M'VQR>',X9RYB9.U-H\V0W3PE*O"3H/,N?(B#&V<82YL5Y=8T,E2 MFUPXVIHTM*5!D7BC7(51KW<2YD(6P6SB9;=F-M&54[+ 6P.VRG-A-E>H]'H: M](-6<"?3S+$@G$U*D>(]NH?RUM NW*(D,L?"2EV P>4TN.Q?7 U9WRO\+G%M M]]; 3!9:/_+F)ID&/78(%<:.$03]K? :E6(@GU[]@PV?$>+%6UO_"NM8=THUQ99W.&V/:Y[*H M_\53$X<]@[/>&P918Q!YO^N+O)=?A!.SB=%K,*Q-:+SP5+TU.2<+3LJ],W0J MR<[-[F5:R*6,1>'@6A?.4)CL)'0$S0IAW,!?"=&'0[T#4BP;OX VV/ <>;_ &WIVTCQ9$D;CT>OH=^ M.#.> >UB9 '7]<%DO8\\[,)'P>&WBE8(EZE!I%XDI0?*L &7(:GFI2@VQT=G M4?]T3.8[I;5T66M[AQ1M!3\;797P VM'O7%]YC?]\8\=H#KVC;I"M>%F1V,P M :=!6'_7*S\ZK4A:T LE4UI[@UP\(I1B4SM"@CU7@>< ?*^$<6CH(NIG24C< MU@F41M)!+(S@#H"< M;#-:2HM=^/6EJ3#(HX/RDK0$14K4F 2(7%>4%H(72I'="HL*(<4"34#!,BHV5#T('*HL=T 8TW4S7 MBR>T=:R4C'GLDUG+?FET?MA!4O'-QTL!=J^N2VW\X&_"\[):G79"-5GUEW3A M^.C\Y/1\_.]]\%@4\$_][BBB,:V4_^(0U4^C;J^_E=!'U"/$%94WN=A4HM>D M\J/3#0K3BCMT-2>U[HK.CJF/;DG9?:**==PQT>BS!QF=?OXPW__E31>^D>5K M+9 %5P3%HKG%UG%[&3,Z5FW'L@\W5H@8YO)O(S()5US 8RK2.-M-%5A3JPC+ M*:[M;N;P39>QYJZ>BTW[N8AVB;ST74K?$L)I/R:>WA>,,5^0NZU-Y]F8R 3[ M'Z-"_Y"U_D>R)N*8YX+=<^Q%2@Y]=,*]IP%U;^H? M0!8\5/U*V$JW;ZS+^FFQ4Z\?:!3&5-(G0>&23'O=TU$ IG[TU!NG2__06&A' MH\(O,WHGHF$%.E]J[=H-7[!]><[^ 5!+ P04 " GA;)6[-I$_C8% "E M# &0 'AL+W=O'80^T="6QI4B5I.)XOW[GDOIRX@9]243J?IQ[ M[N41?;FS[JNOB(*XK[7Q5[,JA.;5%=;4,6+IRZ1M',H]. MM5ZN5ZOS92V5F5U?QKT/[OK2MD$K0Q^<\&U=2[>_)6UW5[.36;_Q4955X(WE M]64C2_I$X7/SP6&U'*+DJB;CE37"47$UNSEY=7O*]M'@+T4[/WD67,G6VJ^\ M^"._FJT8$&G* D>0^'=';TAK#@08W[J8LR$E.TZ?^^CO8NVH92L]O;'Z;Y6' MZFIV,1,Y%;+5X:/=_4Y=/6<<+[/:Q[]BEVPWR)BU/MBZ<\:Z5B;]E_<=#Q.' MB]5W'-:=PSKB3HDBRK)7BGYNM#PY3\>^Q@E.\T^/Q^*2\ M\HW,Z&J&H^#)W='L^ME/)^>KUT^@/1W0GCX5_4=[\F20XQ#/%N(8%<.>&_>D M(Q$=3:!?G:B\RBX<;# $_>:I5+MMY*+4U&(HZE M%P;:8@LA-12 ][V F(C,4:Z"T-9[\@OQJ/]%[\O%JL M< :TCL?9<\RM#97 M,"W'QHI!Z2Z[?72_$GR-^D:M<&!NX7EL:]1\R M87>"2-!]PX4)E0K/6N? A/C62A<0%O@;I_!W3]+UNPL!H3AF/N=-E!-K,E9X MA:2%RB1,=DX%>F&+PG-0!G1'3C$C#'@@Y#%E0GG(#Z)#%2+GW(:V86K$G42( ML&>&OK1Y"1%%&YB7 O-N'8*_2P^Q;RH'KIQ+[>,I4\8ZQO3*9+K-250*DN0 M7<-5=]HZ'ZN(Q"$Y?.8Q8RT-Q)T1/ <$!NYYP=#Z %NE%< 6SM:=Y)'S\RXE M0^GIY'%3G!!O\07RUL11!36421]\RL@(LB"C':+G-0:$>E?"P4BZF0= ??QU \$X%,G I9XG[@PX.A>CS3NXH, M+@@XS@>ADFC-0#^GOT'M\TX.?D0)Y@]5Y61Q<3[*"ERP>X)+@]Z/^L=?W)C*%&.2JZTEKHL0.+"C1,8 XXYI%S9&TL MTSTYA*C=&BZ0W1S?91A3]U9DY (Z*)@)*!< 34L]_#J DRU54A>13'P5F.6B M4\:IC:%"A87X'#''I@]USP_0.^+DR+,S4(9*-0P\.?3\3N D%4@; -?(?60R MRDLZ&KS\!99^J*L@6&+V7!R^DKNDJ8#K:O'R;)8&J5\$V\2+*#[:8"<^5O@= M08X-\+ZP-O0+3C#\,KG^'U!+ P04 " GA;)67(LN;F8$ "."@ &0 M 'AL+W=O)WVQ9+(.6?.#&?&G&^U M^6H+1 =/I:KL(BB@4@V3*)H, M2R&K8#GW:_=F.=>-4[+">P.V*4MA=C>H]'81Q$&_\$EN"L<+P^6\%AO\C.Z/ M^M[0UW#/DLL2*RMU!0;7B^ ZOKP9L;TW^%/BUAZ\ T>RTOHK?_R:+X*(!:'" MS#&#H,2X%HUR MG_3V%^SB&3-?II7UO[!M;6,RSAKK=-F!24$IJ_8IGKH\' !FT7< 20=(O.[6 MD5=Y)YQ8SHW>@F%K8N,7'ZI'DSA9\:%\=H9V)>'<\C>DD.Q\Z(B+5X99A[MI M<D82\DZ87<)"<)/PHS@#0.(8F2] 1?N@\L]7SI MR<#@[^N5=8;._I]C,;84H^,4W ^7MA89+@(J>(OF$8/E^W?Q)+HZ(7"T%S@Z MQ7XB\Z=QDP%TL7TI$&YU68MJ!X6P("J@9C7"R6H#BFV NA:DLY!I4VO:0=#K MM6E<6UB*32KI="$2TI2;A9X;&45\#/C2RIDYT5)RN $.34E,$"=0 MMF5 ?A1:.W@A2BBKWU+&9 :JA MDBMP!WXD;3?&D$"U8PO>JXVF,"VKK'"CG6R=\Q:KEY7WP-NN(+P7-8!K#Z!: M)*]],8:'OMZ_FR7Q],J28*$ K>.)9-!C1U"-1Y(PK9J4I8^RU M.V]X:(2A]'BAM9%DPBGIEP=P*VP!M9"YAXN2\V%?Q,QL)66D,5[4@:9]_I44 M*^X.B:W(%[+8,RU,]@L=YW]3&-)AVQK]?Y/:G2I 2DEC6@UDT0K3*R4W??:0 M.D=P0RGZI[67OMRB].K-Y_E9*UDWEC3:'U\9L 8XOR;Q"F(R-+K9%'"'&98K M"BR-GR%G$(?)1<20T2N>.)S&,6^-7R]-7B]-#Y9&XX0G"S7=FG-YWHL@L]FS M]W@\@R_:4=VVZ:G%KJVS;Y7,PBA-J0\LI>FN[Y+7%LE9MJ"AL M. , /$& 9 >&PO=V]R:W-H965TU*UH@L&PY;;+$-N X"3:@!8*VVSX,^T!+)XDH1:K'4VSOU^](V8HS)/YB MD\=[C^\=R=-LX^B'KQ$9MHVQ?I[4S.U5FOJ\QD;YD6O1RDKIJ%$L4ZI2WQ*J M(H(:DV;C\:>T4=HFBUF,/=!BYCHVVN(#@>^:1M'N!HW;S)-)<@A\U57-(9 N M9JVJ\!OR'^T#R2P=6 K=H/7:62 LY\ER[2"#O/+MF#Q8%C;;]O]KNZW $N!R_ M LCV@"SJ[C>**F\5J\6,W 8H9 M;&$2K$2WBM V'\HU)5K7@>'&+:YZE+$QA MGN9[U$V/REY!3>&+LUQ[N+,%%L_QJ2@89&0'&3?92<(OBD8PG9Q!-LZF)_BF M@ZUIY)N>L 6WVN?&^8X0_EZN/9-<@7]>,MMSG;_,%9[%E6]5CO-$[KU'>L1D M\>[-Y-/X^H32\T'I^2GV5P_@-.IB!-'B]QIAY9I6V1T4N@#K&&KUB! #(<.M MC:Y4> $>E =7@M0ZKX=B@R.ARK%9(QV"V0C>O;G,QM-KN"?7'*V/X_H$N";7 M5;5P[0;0F42?U-2J $9JP#AE]U(Z]JQLH6T%;4>^4Y:!G6@%51&BO'66Z\\U MW&OR#'>J,@A+(S16A<<+*\)",RPKR3R#SY]7\#X(S<;7]W?+51Q.KC]80P&?4_\ZNOQE]-+-3X_:4(-4Q6;K17QGN>](0W3HY\N^ MC3VE]Q\#N:.5EAMKL!2H>/F8 /4-MI^P:V-3D^I*BXS#6KY)2"%!UDOG^# ) M&PQ?N<5_4$L#!!0 ( ">%LE;DSCF.:@D $(B 9 >&PO=V]R:W-H M965T@7[8M461PYF',\\,25^OA/RB M%HQI\I1GA;KI++0N7_9Z*EFPG*JN*%D!;V9"YE3#HYSW5"D93WEZ+2F>\8.\E456>4[F^9YE8W72BCF_XP.<+C0V]V^N2SMDC MTY_*]Q*>>K64E.>L4%P41++93>GD_P/ZFPV?.5JKQG: E4R&^X,.;]*83 MHD(L8XE&"10^ENR!91D* C6^.IF=>DHX8H+Q&9,O_)RO;MCSLDJ906N1L,&N2\L)_TR>'0&# ) M6P;$;D!L]+83&2U?44UOKZ58$8F]01I^,:::T: <+W!1'K6$MQS&Z=M'+9(O M"Y&E3*J_D-=?*Z[7UST-DO%]+W%2[JV4N$5*G_PJ"KU0Y'61LG1[? \TJM6* MO5KW\5&!OU+9)?TH('$8]X_(Z]=F]HV\_C>82=X*S<@_[J9*2W".?QXRVTH= M'):* ?-2E31A-QV(",7DDG5N?_PA&H571W0>U#H/CDD_>VF.2YET25/0CS], MXFA\Y2%P'V^*A!48'N1]1@M%[H@6FF9$S,@@",,0_XA:4# 2VQ*1YQ!1"N42 M:"0LXW,^S1@!EB!%LWDU**)4]!*9P7!\XE+32J"+,1:*.9,0)?S40&#,2+.='K MTMI!5U2FZJ4S1)3($XI<\%HCD%"(XOG7BF9\QEEZ&0 1@;OP1+/4#MMO ;NY M5@$IF32DB5#8F0(4F%"U<,^[YG!%: I!SI5F$L1-UP?1NQ(Y1X1;7L$S(NIAT"^41KT M0 U1G19GS>F:3)EQ45!'"Z*HYFJVKAWERD#L[ M$#%Y1'",6@\B!5].[* +A^O=XT.-Z$=1\H2,HTG@4=_2[+E5>DO=P U&CP67 M%/."_VXB#>..^V"@ M.=JU9X*'V*\8& YSV[6II]T-5*#]*(E5XX7MP!T/A4R1)#[ =@1&47X 13!JL*^A.3VG!I%*0 8FH]Z:/) MEH?PM"""!TB<%A*)!$S@XIY$ZS'0"JHIDBKFH-:ZV8VW=B: M46VI-/79R,R..$%EO$D0J#(B(Z%"-/2$K VB8#FA)@=7#0@X/(1_9GW6)4*D M@V4]G_*(8JP:QW01GN);.ZO(>$IM'H(/7&Z#I:,6Z%!;?V )=@'8!SFJ06[8 MSO(R$VO&5*NIBF94<@9@3,'*&50(-GR<70&2 !10^_/%A^9KQ?H[0NVR$WGG M4N.=W[EY']BEANTRRNRW,)W[VFS7U[#:4:XL@R(,Q83]JS_=YV]F8P= ?F_! M=Y#98-_[_13[8$HA#(COI=*#2YU0_V[ZS.>2 47O*_ZVRJ>PKN =ON7U$Y,) M5YNNO_#9YN$-".? IDG=XEWMO<1,#T4G^3L$)Q#Q9U,_O&L6>9K\C185NJ/; M)I)A,(H&03\*:WG/2-R-8C+HCD>--N.P\17YV55F_KEI3_/Y ;-"=D9';^XY M/4N(X+3G2A 8<1$/AL&P'U[6??K=R6"#S+;IL#^&%.@WR$%-)8GC!ZPE (_^ M:!*,)]MXA / 8_3B !Y.?4QI^W, RJ-Q%,0[T@#8N!O'!Z1M?.A@R5%3V39K MM)$%&MA"V8=S87\O%\9MN=!F[ZIHY.V6.JE6NBH0X7K'5W/>'FKG)&H@PN;: M3;](OZBWP_Y/X_TX2]ZI\MZ1](EG7[G1.MC;Y:2N] M[(99%(V"<+3QUF>0 *,A\-EP_ =R]S?G\&_/Y>TY_=R1)Y#:3<1M0/6/I>&W MXF12JZ/>[Q^.;V*!$?:SL=\TW-G=^4FFV3L\_;,P3BMC[ =,&P=\V-AV)!D] MVI/*1BXZ4>;V^_T _K;6?QS5$3&!EYNZ,>R.AZ>=WV6J"S/V696Z,Z93%>:Q MHO78 8(?=RB,_DA1NA=4"L$;XI?0GP;IY M;=/U(7RWI#PSI/VI]9ZC[<+M@ G&_ST2$#MQ%(00CVW7 M/.SJ_,%>6]HC[S?^YNZD.I-@$@Z#%W'KK:!LRO4W@@'97",-@\%D$$P&M4'U MB+*2V%U;EV9U'MX4I<7N=N7!1,AN'94V[/XU\^9G)M?+^ 1=%5H>\5?M]8_D+BSOPO8=+>_KH"UG$/Y1C(V M@Z%([!TB[2\6[(,6I?F5P%1H+7+S=<$HZ(D=X/U,".T?<(+Z9R.W_P902P,$ M% @ )X6R5KO<[[*N! .PX !D !X;"]W;W)K&ULM5?;;N,V$/V5@;98Q(!JZ^);$MM G$W1!;J+8)-V"Q1]H"7:(D*1 M6I**DWY]A]3%=E8QFFWR8O,R6=[7Q,YUY@"5%.$V,1"/[=TTO*N05"&M]J3*]= MTCKNMQOT7USL&,N*:'HI^5>6FFSN33U(Z9J4W'R1VU]I'<_(XB62:_<+V\HV MGGB0E-K(O'9&!CD3U3]YJ/.PYS -GG&(:H?(\:X67%,%-QE1=#8P"&^-!DD-M:R@ MHF>@8O@DAJP&]56S9DN2$+G'I:%INJ>>HOW[\)Q<'Z$\[#E/#R& M_K+].0YUVH?G,[ DFB5 VWGNY@N :4AD7I2& MIK!ZA)3=LQ2]0:"6,(%3M,$A]X1QLN(4C+0^.=8C'NWD+I,\I4I;=Y-1V+HB M0CAR3Q5J H@R7R$'N6Z]+!L-*"_:$.&62TME_ZP_\F4R[<,'QATK9 L;K'H- M=+U&';#+$\ZAD(8*P[!I::,MVKQD!=_&QTLWZ>( 65B1T8 >L"5*$6&T#Z5N M_ PJIB[58VV>4Y,])4H?+"0N_2S#AMKZ((? UG8)IIH@F:5AV,^-7Q]ND<%: M^MW9J0X)J1*$]TB5D$Q1"GFE&-0J!F"])UE;\ X>&]$9V!,7Q.=O]G_K MN.RKU[.F.XY/9QQGR[<=^=RD\<,P^ MBJ1_6$\G3&"&9:FM0:^%^PE.1OYX&!^,Q/YP.NF]6C(_[([+C\==R=$1.>BH MTJ<8X:D_CF,_/!WN#XTFH1^&IW"1IF=P514,XC4UV\DHC+[O/_$_5('_ M(U MWLC!6P;^6OM<;9%H#NBNW/>.5M"/3GN' ^&T]UVX_PND^;^H]$SCYUBK8PUN M(SI)J13**GPKB3*TDK<"!5W!(UY]S;#O;"]1M8AXA(3PI.3$\DSWU+J2]E7W M.>W8)$M!EZ@=U0V"54LTH#QS]H^[8FKHVG,K2XZ7*CT46*&H?6*)J34M+Y?W*7G/L>[^;V>4K^1(M]T5NG(C\=3 M?S(-]D:B\=@?CWK9_*PWA>X##Z="?#D=VL6GD3Z+6LNLC M<;#W08]WR,8]6^S75BE,]6W?CK8OHXOJ0; SKYY5F)X-PV Y7:-KT)^,/%#5 M4Z7J&%FXY\%*&GQLN&:&KSNJK '.KR6>D;IC%VC?BXM_ 5!+ P04 " G MA;)6(^TKS/4" "Y!@ &0 'AL+W=OU8LVA8J2QY%-^F^?I2$HOB.3RDK./%QM-=:! 9MJUU89DUS-UYGH>RP5:%B>_0R4[EJ54L2ZKS MT!$JG4"MS6=%<9:WRKALM4BQ*UHM?,_6.+PB"'W;*GJX0.LWRVR:[0/7IFXX M!O+5HE,UWB!_[JY(5OG(HDV++ACO@+!:9F^FYQ>G,3\E?#&X"0?/$#M9>W\7 M%Y_T,BNB(+18/;]':2"0RONTXL[%D!!X^[]D_I-ZEE[4*^-;;KT9S ML\Q>9:"Q4KWE:[_YB+M^7D2^TMN0?F$SY$[G&91]8-_NP**@-6[X5]O=' X MKXH_ &8[P"SI'@HEE>\4J]6"_ 8H9@M;?$BM)K2(,RX>R@V3[!K!\>J3*WV+ M<*NV&!8Y"V.,Y^4.?3&@9W] S^'2.VX"O'<:]<_X7)2,SHX27BB8P MGY[ K)C-C_#-Q_;FB6_^G^T-Z-/?H^.%. ^=*G&9R1L?D.XQ6SU_,CTK7A_1 M=CIJ.SW&_E=MQ]'38@*'#'#;(&!@(V\J:E#.]"T.%$ MKFJ0*V%<+36%[K#R&AU6AL%7\+3X!3J!#_O(ORD[2?$*-9+T'%AQSYX>AD:U MD1F0C*0BWZ;$QZ&,T]"]+'S:)2P]Z2A?5"JX5[97@X%8<3#E2@15B]L%3NG[ MEKA1+ [46PV-$FKI FEC0LQ EUAK9[ZC/@$9HP#B-$LO[J:3.N<96D\(UMS% MT0J?2\%$'"LYL6@Q8]$;Q5D?@IQZ+>4IG;CN*<91E?N!BI58*^6A9V-CZ7@@ M5<^]5-F/_'?O<7Y@)RU2G4PSBNT=#\XR1D=??C/8T6/Z8.IRGVL9%5BL!%I, M7K[(@ :C'!;LNV1.FQD6\+4DR0_%LE8V:B7 ^ 0 $4, 9 >&PO=V]R:W-H965T:^="155"KR^3))3N>%U&:R/HMG-VY]9JN0:T,W3OBJ**0[7%!N MZ_/)8M(=?-:[+/#!?'U6RAU]H?"MO''8S7LK2A=DO+9&.-J>3]XMWER_4%BV"LN(NW$44;Z70:[/G*V%8VE8XT4,-6H#G#:< ME"_!X:N&7EA_IEP&4N)&NG 07YTT7D:^_-D\P#Y+S=/6UD5C:_D+6RMQ;4W( MO/A@%*F[^G/@ZL$M.W 7RP<-7DLW$ZO%5"R3Y>H!>ZL^V%6TMWITL.+O=QL? M'';_'(N[,7MRW"SWS1M?RI3.)V@,3VY/D_6S)XO3Y.T#H$]ZT"YUBG!T\X1858$M$_(1EC*ROE*XASR#:ZQN=+9O5;0 M3\D%3##TL]<[S JC,*;*TKHP^'BN39I7BN.6WFL?I$FI\<=;'A$1'P2 MV6G&C@B80WL=1]FF\DB+]]&+:[,19,[H6Z MRE1/7F]7+QZZX7GA/H:J6$I5:5('%RRBV]&Q MO34 :)F/G-Q);2T!GV("4#_,UWM*J=B@U-H4G_;A M-LA[&N5 Y!WVCF2:2U]I\.>(QU$7P7/](DH.64!_$QA68G,8&43=1KFC$8Y& M-O,V\,2T/->M"UGP[&8LQ[.?R3 XK&V5*Y')/0V (HA(P.#O#E^]XT>9MK%1%X;O-^< _7Q4SPK$A61Q\+\]'3KB"WBP]8W%<<3//*ZT_[ M-_*[YFDXB#CD1KGFT-IM@R_A0W-B 9V=<9GCGDV,! M?-]:&[H-.^C__%JI(+X4IO17@W4(U:OQV&=K54@_LI4J<6=I72$#?KK5V%=.R9PW%68\ MFTQ>C@NIR\'U)5^[=]>7M@Y&E^K>"5\7A72[6V7L]FHP':0+[_5J'>C"^/JR MDBOU085_5?<.O\:ME5P7JO3:EL*IY=7@9OKJ]@6MYP7_UFKK.]\%1;*P]H%^ MO,VO!A-R2!F5!;(@\;%1KY4Q9 AN?&YL#MHC:6/W>[+^"\>.6!;2J]?6_*GS ML+X:G ]$KI:R-N&]W?ZFFGC.R%YFC>>_8AO7GLT&(JM]L$6S&1X4NHR?\DN3 MA\Z&\\E7-LR:#3/V.Q[$7KZ105Y?.KL5CE;#&GWA4'DWG-,E%>5#<+BKL2]< MO[9%H0.R'+R092Y>VS+HY MROO[QW"M]6^6_+N=/6GP3KJ1F$^'8C:9S9^P-V_CG;.]^=^)5[S1/C/6UTZ) M_]PL?' S7^/92$>\N+X(42D5[Z2F;H:@"E>N8T:7/_XP_3EY.*)$%ZT(;QX MROKWE^QI<]/92#R=E?97$.\61J\D\^G''\YGT^F%^-TZ+7ZU)O=!Z5+\+%WY M_%T=Q-M29+8L&_9M=5B+L%;BIG+:B%C0J:AJEZU!*F&7?/? & J00X0@4$.^ M#3\K6>Z$7#FE=*(3/HU>>!UKEQT^816DM^SR<57 MW.:[TXM37,MKARQ%;_27;V3M MK9;M#H T/9I27=KU31H:8##Y:&LZFA$I\0HQA M)W09%& 8!&442_IGWSJJ^(E72OQA@Q*STZ.Y9D?^_.T>]V08)E-J0_'1)?'V M3GRT56;A4*:@M%X8Y3W=*Y'#^6B><[Y%]4RFF;"ZRC&N"03K[.ANSX%L>+!7Q& M78*)&6M\%4MGBU[4J?8O]Y7G<"1LR,+6Q!1DN43;9* MT=U$KB$9>E$WY:!# MJ?%0[\GJHHYU H TX"P]W\@_0>,+3F*L7\L(\"2COVJC;>W-#E#7V+TCLR/Q MH<[6C2/H>[7)*3*002Y0_L6N%PORK5 ]I(Q=19K5Y[H+#$]+VOJME53UA D'$U50#UR]&Z<9EM\@GCE[$;3X.(C M]AJ)>'8V.O]'EPB@OO("S3M !Q]]#R;3D;3 M:;(^8JF9S"'0()H1]\YFX#&'^0NC';,5)QZ??<8O4-A"$2@VUFQB@0T;R8S4 M16P1!CK;:%I3?X!!EQCL4,7:14E?U![=QOL1J1JOJ71)6W!O7]".J!)8,$^Q M71\UISD9V(/&1T>1ZLIZ%GJRU'$EJYV#16)+(P5RA@K;1KS>J0EMA%L$#RO8?TN?RL_@0 M;/9 S'^ RI\T0[D;0X9%?2V2"^ATE M$F0K4!K/IRT5-RGJ)L^FH\DD=L74WN#??-+KC0E@(I>[B!4\U5AWP.@G) MZ)A?:&280DGI$XI8HJB%N7QO[(CG3SF>R?*(6WH)\@1N3:RYG3GQHX56X_M] M4UX7FQ?B?8XPFZK',^BYA);N8VHH=R@Y/3A!Z7"T41)<[>(I96B/J^F3N'J[ MI(F@DZ_Y < L2DH(>Z(JQV#0MU+('0]HZ/R:6BK[NI_H4\=Z?,8WT-:OV8G6 MIP"OI7$2.K [ !\/4V7S>.'K14&*%2?N)2$]=OQ69R6:^G""Q'9O+)7JZW:T MRBQ)IAMTBRUF=.@T*TFF.A&@*)I',^[^U& L]3?U%8CG"I*F\KF*)45@,\R]6PT Q9V?3#.'6H CU;[P('G?9R8@M>UN"EDD_-YZB_,F#L4VO@D0&.$$D(E&@JB)\DN!,C33 M;>,Y>Y9 DT@(;-*R2&1_]=$^G_+>)]YV\._-5@JC!-1P>@0Y3; MQQ,PN8XZ*A(=QD6RV,^9NSNT*+NN0.OXC+4_/$T4< M-C;2U"H1K:KQ*)1A,.,'LU[T"Q6VBK5CRR;Z DU7.#_I+8B0&ZD-P]Y6@DB?7^#Q0#7%+\C'SR:<(NDZY:FP-JQV>,D[1#T[[9ZXA_;LJ0U M6PU]@]4CEOA^0DFJ=09AIFE_=.R=W;CSRK50;L4OECT_IH3X]K6]VKZ[OHFO M;/?+XXMOP'&%1Q1TZ26V3D8_G0V$BR^3XX]@*WZ!NP 1;<%? 3K4DQ;@_M+B M ;'Y00>T;_2O_P=02P,$% @ )X6R5@#*H9%S P P0< !D !X;"]W M;W)K&ULC55M;]LX#/XKA <,&Y#%L=-N79L$6'H[ M]( 65ZQWVV?%IFVALN3J)9[__5&2XZ58E]L76Z+(AP\IDEKU2C^:!M'"]U9( MLTX::[O+-#5%@RTS<]6AI)-*Z999VNHZ-9U&5@:C5J3Y8O$^;1F7R6859/=Z MLU+."B[Q7H-Q;[U[1+)Y22MR@- M5Q(T5NOD4W:Y/?/Z0>$KQ]X[Q&(3P0 MT7@:,9/)I3<\7A_0_PRQ4RP[9O!:B6^\M,TZN4B@Q(HY8;^H_@;'>,X]7J&$ M"5_HHV[V,8'"&:O:T9@8M%S&/_L^YN'(X&+Q"X-\-,@#[^@HL/R#6;99:=6# M]MJ$YA\G=C MG+\49,0X>QG#]\:EZ5B!ZX2*WZ#>8[)Y_2I[O[@ZP?!L8GAV"OWW;N$T1+:< MPT\P\+>$.S9 =AZ3.0/;(%RKMF-R\!NM7-T )TU#MKSD3',T,[B!&R:H^.0, M;F^O@/J&BC!TV1[%$%V\?G61YXNKJ*ATV&97;V= MK%!C"5Q:!8PJV= >1-!#8+5&;#U_C8)9\@"DY@%'.K#5GLN;(Q^'D[L(%5WB MP2.UDVV(/SDLJ9OT\$[0Z/+ ?:,$&B;(:](SLPY4)X??J MF22:S/Y'K6*FB;.G0$-Y"+DM&BY*_3-8L'^FV1#8#!C7_K*!$3*W0U0;UX]T M=;,@,:YH0%%>-'1:E:ZP4#"+=8 "9J!UUC$AAICD$ERGY!S^.H':TE,! MM6-TD]83H:G&6]?^@#GH$Z#AM>05+UAP)2F 25W2B^6OSU"M/#FN0]V,R6@H M7@:V)\GPKJ*ZA/")@N-U/+0H7VKB]&BLMJCK\'@8*A,G;9RPDW1ZGS[%L?Q# M/3YN--)J+@T(K,AT,?]PGH".#T;<6-6%(;U3ED9^6#94J*B] IU72MG#QCN8 M7NW-?U!+ P04 " GA;)6G3&G-I(" # !0 &0 'AL+W=O%_?J=G3;K1-N]Q/;YON_NN_ANN%3ZV92(%EXK(MN=3H>JL8)+O--@ MFJIB^FV"0BU'02]8&^[YO+3.$*;#FLWQ >WW^D[3*>Q8/2;.S!*9DI]>P.M_DHB%Q"*#"SCH'1LL K%,(141HO*\Z@"^F MF_LU^R>OG;3,F,$K)7[PW):CX#R ' O6"'NOEE]PI>?,\65*&/^%9>L[(.>L M,595*S!E4''9KNQU58<-P'FT Q"O +'/NPWDL[QFEJ5#K9:@G3>QN8V7ZM&4 M')?NISQ83;><<#:]>6FX?8,IVE+E<"L7:"S5W,+1(YL)-,?#T%(8YQQF*\I) M2QGOH$Q@JJ0M#=S('/-_\2&EU^48KW.H\"JTJR.B=<=EP.0>:4MHK->^3 MZO638_A& TXXY-;K;;\@W.BJ"O7]G6WT@N>< M4A-8$#0Z_7@6@&[G17NPJO8].E.6.MYO2QJQJ)T#W1=*V?7!!>B&=OH'4$L# M!!0 ( ">%LE9EB5RU,0, )$) 9 >&PO=V]R:W-H965TU*!) BUZM**EMP$G6KA_:!4VV?ACV@9;.%E&* MU$@JKO?K>Y1L62L<#RB&8=@7D3S=/;R7AT=.-TI_-A6BA2^UD&;F5=8VUT%@ MB@IK9BY4@Y+^K)2NF:6E7@>FT C7U?6"8+YM&%K?$#[2W.O:14,*"6O41JN)&AU^0EW\4P<7J&$Z;ZPZ74G MB0=%:ZRJ=\;D0,._K37P2\#W3%Y!$/L1A MG)S 2X;8DPXO>0;OK5+EA@O117Z(&1;&H#5PQTTAE&DUPF^+I;&:&/3[L33T MNZ3'=W&GZMHTK,"91\?&H'Y";_[J192%KT_$D XQI*?0YP]T2LN6G%8K^+M: M'O/]-/JK%WD<)J_AWQH_=8<(R^\&6#RAIEX"1)6B&KAR^%TK;?F?K&L(>^%; MK8R!6Z;UELOU0;:'40JWJMEJ ME]*>$:IC!)>6FB!UQ98):#3U=VVWD'^#G\97PSR)#BF,H@P>E273YVKP$K(K M/PFO1H(X\:/+L8#\BY+PN\O\G^'9'198+RFI.ZK%Q\O\_Z!8Y"?IB&*7_B3Y MQR@67^4'BB71-Q0[1JG(S])T3*E+/\LF>\&QUAJ,KLD:];I[#!@H7%[Z&W.0 M#N^-17_-'M3[QPKUES67!@2NR#2\N)QXH/L'0+^PJNDNW:6R=(5WTXK>3*B= M OU?*67W"[?!\ J;?P502P,$% @ )X6R5@28\A2X @ ?P8 !D !X M;"]W;W)K&ULE57O;]HP$/U73EE548DUOPA0"DC0 M;MJD=D)MMWV8]L&$@UAUXLQV2OO?[^Q R@1EVY?8OKOW_,Y.7H9KJ1YUAFC@ M.1>%'GF9,>7 ]W6:8<[TN2RQH,Q2JIP96JJ5KTN%;.% N?"C(.CZ.>.%-QZZ MV$R-A[(R@AZ&T#=WR5&1OPQ\.2K? >S==RIFCE-RP+ MGF.AN2Q X7+D3<+!M&/K7<$WCFN],P?;R5S*1[OXO!AY@16$ E-C&1@-3WB% M0E@BDO%KP^DU6UK@[GS+_M'U3KW,F<8K*;[SA-^>P ^@';P"B#2!RNNN-G,IK9MAX MJ.0:E*TF-CMQK3HTB>.%O91[HRC+"6?&-T@M:6@]L+E ?3;T#9':E)]N"*8U M0?0&00RWLC"9A@_% A=_XGT2TRB*MHJFT5'"6Z;.(0[;$ 51?(0O;CJ,'5]\ MO,,?D[DVBEZ"GX=ZK"DZARGLAS'0)4MQY-&;KU$]H3<^?1=V@\LC CN-P,XQ M=FK85(H;3B+E$IQH6<0-B.+@(+Z>SQA.U>&-I4LA_J[H=Z M.Z%.$L%#AN0W2T-;MK8BJ*S_NGN8].%!&B9 N.,KV0L9A]%[2OKM(([IC+4> MP#77J:P*S!^RV+ZB?JTHI"RRE%LE8$?3Q1+@0 %\1 9 >&PO=V]R:W-H965T_CP@M9 M(LI_LJID/5\C82$D2VME9)#&676E#[4?6@I]:X^"4RLX)>]JHY+E6RKI:,#9 MBG EC6CJIC2UU$9R<:8>RE1R7(U13XZFDH5W2Y9$P,6/Y/)+$<^Q]Y/3 +Y.-:8ER-V#:KBQ=GBQ2A=8.*H\"MHLI%9+#@LJ'Q*_%.1 MSH"KD%C/7#X #V.Q$?TUGF\&'Q \QE(:-C-5$ ERQ>,0R$F#\0Q[ =TC,"OS6G[FSGG+SG M-%O[3XW;]K3'%S0+L60?%ER;>XQD'G.(3*SB:YTV,J[1[VT\ MLVTZEJ!PV=0@G> *@8<Z"7_<#6G4=HZ%C'<)P=:/5,1ZWQFEKC?5.M(?@>@/4R^^D&K4;[ZRC:58*Z M-_KN)6-?"7B:266LDK?MM%LGRSL:\SI!)C11L;HK.5S=?Q/HGM5^?)9A>0>S MH';JKN6VV":2\6$=W MK_U=[%C- YYZW'KV.*!H]YT#+V:NZ^KXVWI^@=U$=!\7-V\ZEA%XAX.W[DHGI>[I MMO+Q8=GY5K6/=D=\F:U#;PI\41[M!0E9D2->?7I +@NL M/B2!.:HJNS3"J^-\-9 L+X_0,R;Q0%[>+H'B&5()X/J%LE8CC44@?@, /$* 9 >&PO=V]R:W-H965T*6!-&VX^R.VOL./C',PEU^Z7;'>Z MH4?R1AM9[8S1@XJ)]DD?=W'X&H-X9Q [O]N+G)?7U-#91,DM458;T>R+H^JL MT3DF;%*61N%7AG9F=D.58&*CR<5O4NL>N05%EB550"[NZ(J#[DT"@_=8[2#? M82Y:S/@$9D+>26%*36Y$ <53^P#]ZYR,]TXNXK. [ZCJDR3R21S&R1F\I".= M.+SD7Y/^:[[21F&I?#I&NT5-CZ/:]AGKFN8P]; _-*@'\&:O7T59^.:,SVGG M@L(28P'S(1EN%7@?W$[D8^%F: M/)$D?CH:]KY;,*]!2!P)W\9[X>IHZZ879H,^8" W0$13K;",L-A<)6F" UT; MY(A]\P(CNO2S)/&CR_10-!A&?A1=DGE1C,G->HUSV.)MJ<)@&GW4HRA^>7YF M[Z)/9&V'^M>!')-?[YKF1Q+_7GEN4_2RO0]+*^S'E[VG@FC4>T'WFT!VSS/# M;- -L\'9,3,7AOWLYA;^)9,EY(UBAF&P;QYSWMBIL%:R(E>RJK$1W=\W)N3D MV#XVY\XZ<&I6_Z^'W/)HX0_\)!OYPU%X((FSS,^R+Y*/SULNBC(_S 8GSW?2 M4'X F(Y2?Y0.[&6CV!_& W*L"(*#-03G\<8M6YKDLA&FW4@Z:;?/S=LUYHMZ MNPQB7#8,67)8HVG8'V(Z5;M@M0YNR=WR;F_%O).)0":W&",:2I84(_ M?I:D3F73 +?'&_:/-G@,9DX5C$7ZC44Z&3@G#HE@09>IOA;K3U &=&3X0I$J M^TO6Y5G/(>%2:9&58/0@8[SXI_>E$%L Y*D'^"7 _Q,0[ $$)2"P@1:>V;#> M4TV'?2G61)K3R&8&5AN+QF@8-X_Q1DO<98C3P\]4+R40L2"7.4AJI%4=,J+A M72S%DD<=0GF$<\64.323H(!K>XZ\>0^:LE2][;L:73&$;EB:'15F_3UF W(A MN$X4^< CB';Q+H90Q>%OXACYC8075!Z0H-LAON<'-?Z,_P9_V*#]!F^"2M7 MTAWNH9L*'M,YR!@DF;+09#V/.V0Z'9-?Y)9*1N$QG239)Q0'@-A?/<8XR'+4<#O4R0D$PV9 M^E$GU&&;0K5$MB/4427446,^[4^9JR5-F:G'%1C!<&HVBOF$%Z]YK-4.N5QS MD"IA.9F!#$T-QU"G6>'(J77$? -60^_@J.^NMJ5H=/:94O0J*7J-4ESABTJS M^]:*J=':4W.D);(=88XK88Y?M)B.VQ2J);(=H4XJH4[^EV(Z^8=B:G3VF5*< M5E*<-DHQN2!?1!X*6TUU 33"G_K06R+;B;3K/38ZWHO61VF^):W:8ML5:ZLK M[#8FQF."L[)(:D-N)'ERR-V::@FJ:BDB<;=:W+*PJVC#'CBJ2P0*AW<(R?-5ET_<5$B]PVSG.AL0VWPP1O2B#- =Q? M"*$W$V.@NGL-?P-02P,$% @ )X6R5L+$M&9Y!0 ", !D !X;"]W M;W)K&ULQ9K1;N(X%(9?Q6)'JX[4EC@A ;J U#89 MS4CM3-7N[%RL]L(D!JQ)8L9VH$C[\&LG-"$0#)&\Z@TDP>>W_1W[V"=XM*;L M)U]@+,!K$J=\W%D(L;SI=GFXP GBUW2)4_G+C+($"7G+YEV^9!A%N5$2=VW+ M\KH)(FEG,LJ?/;')B&8B)BE^8H!G28+8Y@['=#WNP,[;@VOK6BGK%,9[EZ_J7_*.R\[,T4EO6ZH PXX(F6V/9@H2DQ3=ZW8+8 M,8#.$0-[:V#O&[A'#)RM@;-OT#MBT-L:],XU<+<&>=>[1=]S<#X2:#)B= V8 M*BW5U$5./[>6O$BJ!LJ+8/)7(NW$Y"L2&<. SL"W)69(.8]?@CL4_IPSFJ71 M)4!I).\YX:K0$\,V M5O 1;0!T+X%MV4Y3Z ML*=3ERX4X"*F7$XZZ16:X"8_:"7:^J$0\W(QM02M)E>NUY.38;4+N*&4TQOT MZZ4"0PVKD7-+%G+XSW,-EJ%DU7%Z) MR]/BD@$@2[(8"1RI19B$1#21TXJT)><=0+ER!KV>MOV27E]+[YM88 :^TC1$? &"5[G'XXU352O3EE__@)_=L_;IF:PQ,"168SPH M&0].3N@<;\;E&)5K%BUV,W+)RK>B1!#<.-NULFV9#PZ9#Z&[Q_RPT& (]R:[ MH5;54 Y+E$,MRA]R8Z^XA6A)!(HO@63;1$ZKTI;<\#!.PH/1:K+&P)!8#3&T MJEVWI85\K\:JVEGG@Q;+7?0*Q6KGU41:K]46]59MES7TH+W'NJ&48WE[*WU@ MJF5UBCNY"]12?,915N2;X[?-Q5P$6%RM:,W.M8FOF]L$"W6]@;K+.P)1:G7F5I4%M!C%Y0AN5D:G< M.Z;I_$I@EL@]V+0Q).NU6M,VFG5MU79]Y]GN?CSY/](I6.534)]0?48Q%W)X M/Y!0C6CP+WC)IEQ&9^6!8'4T/AO-L8RJ^4;5 E-J=?]461MTW_6=!32:^QE5 M\XVJ!:;4ZHZL\DEX(J&,(J(6$A0#1CJ%IA2JWNJ2G#A MX'UCG]%,V*B:;U0M,*56=V257D-]?OU\;L#3R[B:>&'['@(!__Q?_@ MY=/R&,=M?GAA[_D]O/&+PQB53'$VY!&Q.4DYB/%,2EK7?9DJL.*X17$CZ#(_ M3S"E0M DOUQ@%&&F"LC?9Y2*MQM507GH9?(?4$L#!!0 ( ">%LE;%&%JD MPP0 #X> 9 >&PO=V]R:W-H965TZ3J0:<&>3 J_)#9&?BVL.9VZ+$M.,Y(*R''&RFCKG_ED85 ;5'5\H MV8BM8Z2FLF3L5IU+XUH ZK4]EN'W\@/Z^ MFCQ,9HD%6;#T*XUE,G7&#HK)"I>I_,0V'T@SH:'"BU@JJE^T:>[U'!250K*L M,88(,IK7__A[0\26@3_881 T!L%C@^$.@T%C,/A9#\>-P7'%3#V5BH<02SR; M<+9!7-T-:.J@(K.RANG37.7]1G*X2L%.SMY]*ZF\1U=$)BQ&%_D=$1+2*M%; M='&%_F%%Q [1Y>4"'81$8IJ*-W#E\TV(#GY_,W$E1*!PW*CQMJB]!3N\#= 5 MRV4BT+L\)K%N[T+D;?C!0_CSP AXA>_1P#]$@1<$?>$\9\V/'LP'/>;A\\Z# MDS[GVEP&;2H&%=Q@!]Q%'K&,H!N))5$I.$1SG.(\@J&J ^ \1N=Q3%6]X!2% M5$0I$R4G BWOU6G!!(S_Q5E9B$/(9926,%800CT[R5$ M@"[ F_BO9_;S.MSC_G!50SH3!8[(U(&.(PB_(\[LC]_\D?=G7R9L@H66P+0T M';=I.C:ASRZ9$&C%689(73M973NTK9T^+HV8^W)9@XTJ,-78[V9OA_[0\[R) M>[=-DR6G&DW#EJ:AD2:M>_0Q8C3?EQ&;8*$E,(VV44O;Z'4U@9'---D$"RV! M:6DZ:=-T8GRZ/VYRPD5""RA[20"_M^AKC-.M.O6.!GJ-+HQ^]J7$$IA&R;BE M9/QK!6\TW_=)L@D66@+3:#MM:3M]705_:C---L%"2V!:FGRO6RA[+_#>-X/N M2V>#IK_Y0>(]>?/;JXZ^>8;9E MQ,N4(,F@761+6#.@ YHCX#N";/8IZ'GC97O5X#]:,Y@#V9NVEU!3?B>G?+.> M^CG:>IEZJH/\@3\*'G?#A3F"O?EZ"5GE=[K*-PNKW;T5_4!?/USW,F55;%E% M"VVAZ71V>LM_98++MZJXK**%MM#T7'6BRS>K+EL=]JDN>])AK!/U;9%"65?< 9/&H@!KO87!'3@NB- R;.5:A W&$C^@9X5Q^:0]JYZ MJ[K+%IK^A;\37H'WNCIT8%73644+;:'IN>J$7V 6?C_W7!5@5?@Z9_ MM#MIVUW-B[NUX981OJXV+@6*6)G+>N^M'6TW1\^K+4&WN[W>6;W"?$WAH4O) M"DS!%2R'>+U969](5E3;=TLF)&ULU5==;YLP%/TK%INF36H+@7QV"5*3[B-2NU7-/AZF/;AP$ZR!S6R3 MK/OUNS:4)BEE6]>7O01L?([/N?=B;L8;(;^I!$"3'UG*U<1)M,Z/75=%"614 M'8D<.#Y9"IE1C4.YB/^87$D5NSQ"P#KIC@1,)RXIQTCF<= M"[ K/C'8J*U[8JQ<"?'-#.;QQ/&,(D@ATH:"XF4-,TA3PX0ZOE>D3KVG 6[? MW["_MN;1S!55,!/I9Q;K9.(,'1+#DA:IOA2;MU 9ZAF^2*3*_I)-M=9S2%0H M+;(*C HRQLLK_5$%8@N /,T OP+X^X#N/8"@ @36:*G,VCJEFH9C*39$FM7( M9FYL;"P:W3!NTKC0$I\RQ.GPU?>"Z6MR#CH1,9GS-2B-6=+DD"QL9ME/B,F2 M<%DZ)@7/3T%3EJH7N/CCXI0\?_J"/,45Y$,B"D5YK,:N1HUF)S>J M]$Q+/?X]>@)R+KA.%'G%8XAW\2YZJPWZ-P:G?BOA.95').@<$-_S@P8]LS^' M^RUR@CK>@>4+[N&;\TAD0!:::C!Q/B!3FF)L<#_^N=&SQF9!^);">RPSJRP]8:NH0UH/G&TA[>*>T@Z/;W*KN5 M_H'B1[7XT3\=&*,_,="ZQ0,-=+S;C[?7:N',.%A*D9&J#DU5BKH0&S^_WMTC MI],-]FRU[_M07UM-2>?!1V8%[?_&0.L&?VO W6JP,I KVW6WC=DM3-LS8:*P8GATI+)'2.QI@AF39@Y8#+7+;QET)C4VA MO4VP;P=I%N#SI1#Z9F VJ/\)A+\ 4$L#!!0 ( ">%LE;R_&"L@ ( .@% M 9 >&PO=V]R:W-H965TXY.O2ND"8I1NVQBNT M-YL+3;NP9REXA=)P)4'C:A),1Z?SLZF:S]CU<^SX#1UPZ7[%Z^LIE-..)M=:U;0NZ W M TP6\-66J.%,6B;7?"G0P!OXPK1F3FPX7*!E7)A7%+VY6L#AP2LX "[ANE2U M(;Q)0TM%.>HP[PJ8M07$3Q20P+F2MC3P0198/,2'U$S?4;SK:!8_2WC.]!$D MH]<01W$R4,_\W^'Q,^4DO<")YTN>X/ND5-%P(;R\]\+"U!BT!A;'>7&&9&BY3SRW1VFXW6]O M*"FY3VK+#O>&ID*]]EYB(%>UM.UKZZ.]74W]E#Z*S\C&6M>YIVD]D-[2FDL# M E=$&1V])1/0K:^T&ZLV?C27RM*@^V5)5HS:)=#Y2BF[V[@+>G//_@)02P,$ M% @ )X6R5D"7[Q46! Z1( !D !X;"]W;W)K&ULM5A=<]HX%/TK&F]G)YEI8TL&8[+ 3$*VNWUHFVG2[;-B"]#4EEA) MAK*_?B7;L;%1E,*R+^"/>X_.N9+NO=9DR\5WN2)$@1]YQN346RFUOO9]F:Q( MCN457Q.FWRRXR+'2MV+IR[4@."V=\LQ'01#Y.:;,FTW*9_=B-N&%RB@C]P+( M(L^QV-V2C&^G'O2>'WRARY4R#_S99(V7Y(&HK^M[H>_\!B6E.6&2<@8$64R] M&W@]1X%Q*"W^HF0K]ZZ!D?+$^7=S\R&=>H%A1#*2* .!]=^&S$F6&23-X^\: MU&O&-([[U\_H[TOQ6LP3EF3.LV\T5:NI%WL@)0M<9.H+W_Y):D%#@Y?P3):_ M8%O;!AY("JEX7CMK!CEEU3_^40=BST'CV!U0[8#Z#M$+#F'M$)9"*V:EK#NL M\&PB^!8(8ZW1S$49F]);JZ',3..#$OHMU7YJ]BAPJA>&7C0 LQ1\5BLBP >F M,%O2IXQ(\ X\Z*63%AD!? %>-;^X(PK33%YJQZ\/=^#BS25X R@#CRM>2.TC M)[[2O,WH?E)SO*TXHA\L):G%?^[VA\@!X.N -5%#SU&[14[$ MCUA<@1"^!2A H8V0V_V.)(T[, 4N]%:F MC"KR+M-I(KVTA:#"C4I&UOP2-7.+,I M0^=0)ZZ@N!$2'RO$L7[B@RFW MZ;%8C:)H:(_XN"$Z=A)M[*N(<^D_UQHW0#L M=1S0.=/?RM;*[/\-$;I5[.0!<$\$Y;8B?_L*+!R"'<'"%K_Y2:Y=>:B5A_ZG M>E0#=S)N',?][?>J69=XVT1 9YD^*C774)VLB^(HZE.UF,%P$+U M2WYT%WS M?S(]P\,*/X@"..BSM)B-AN$+)02VQ1NZJ_>+_H@I M< ;60G^/";6SDC]K,3\76C<4;=6'T?F3GK.3.#H 9T+K!J#M)Z"[H3@YZ;EA M8T?..\&S*Z[M,:"[R?@/*<_22Z!^A_>*49=TVV] =\-Q5+H;'^2Q$(9]FH=& M:!S;::*V74#.:ORSJ:Y&V8\1A/UT;#,*88^AOW>8D!.Q+,]8)$C,R-6Y0O.T M.<>Y*4\O_-:\.@32G\E+RB3(R$*[!E&ULM5A1C^(V$/XK5GJJ[J3K)@XD MP!:0=DE/7:E[HDNO?3C=@TD&L#:)J6W@*O7'UTZR"0DAA3W?"\2.O\\SG^/Q MC,<'QI_%!D"BKTFK!A/B%1-OK;%E@.),E 2 MVZ[C^'9":&I-QUG?G$_';"=CFL*<([%+$L+_N8>8'286MEXZGNAZ(W6'/1UO MR1H6(#]MYURU[)(EH@FD@K(4<5A-K#M\&^"A!F0C_J1P$$?/2+NR9.Q9-QZB MB>5HBR"&4&H*HO[V,(,XUDS*CK\+4JN<4P./GU_8/V3.*V>61,",Q7_12&XF MUM!"$:S(+I9/[/ K% YYFB]DL2J[=4X>1T0=O>=,K%[J7\?7.\,TYBW:A1 ]I'BSTIOO\FQJ$'B0DXDO;BN6,_79& M'9%NQ9:$,+%4R!' ]V!-?_P!^\[/;6J9) L,D=64[)=*]KO8IQ]5-.:PAW0' M;:+E8#\#ZZB[G_J.YXSM_;$8IX.&@_Z@/BCH-..53GJEDUZGDW=AR':I"@4< M0J![LHQ;GGDJ-/)!8E!H,^/D"R!?T'_HEF6Y@"OIQSHB8KG MXV&_[]2+5ETZY[OV8S))%A@BJ^F,G2JW[]$NU]BQK:.\9C;0;=QKG7&P^B<=&LWBC;($IMKJ<52*/ORF3QZ=9.O;<9BK? M,LISL-/?RG3>Z G R5 04'I_..7*:=;E]=%&IPLTZN_ 5*',JOY@K>\M+Y;OL*K71?X]O9_G5 M<$63WU0_$KZFJ4 QK!2EH]RO& MY$M#3U!>P4__ U!+ P04 " GA;)6_H;%S*0" !Q!P &0 'AL+W=O MV-LO7---H>V"GR85V> -ZMMJ*-/R^EU*2WP<+QG_^*T&RTKHG NV$^:ZV+JG7N0XYK43%^+W5=L]426+Q-, MN2?LFM@X]B"KE19E"S85E)0W;W+?]N$ 8'CZ 4$+")X#)J\ PA80.J%-94[6 M@FB2)E+L0-IHPV8'KC<.;=10;K_BC99FEQJ<3F=9)FJN%5QCAG1+5@SA>(&: M4*9.X /J\37)K=E\+,VSV63)W@E3PA7@NM"P6>> M8_X4[YN:N\*#?>&7P2#A%9%G$(Y/(1@%84\]\V'X K,.'@R4$W9]#!U?^(8^ M_IJME);F1_W=UZ^&;]+/9P_OA:I(AE//G$Z%^O[=.!Y]ZA/[G\B>2)]T MTB=#[.F,&2L@/$,PI@*YJ%=Z73-S0-N.R*XC?6UHN&/';2UGFXX2?WNH;3#[ M/VJ+.FW1L+:7(DZ!*$4W''/0 G1!90X5D?H!C.MQ[9I@3F7K4WV2FY31@>3Q M>?Q<=?2B+^,X>@QZHB;NU,1O5_-8ZUX 8N\!CU]4%#TO>C#]6S^5?^!J)1*Z&- MX[IA8>Y$E#; [*^%T/N)3=#=LNE?4$L#!!0 ( ">%LE8X0&PO=V]R:W-H965T;'%RQS. M.1R2,^.-D+_4$E'#0Y;F:N(MM2[.?%_-EI@Q=2P*S&ED+F3&-#7EPE>%1)98 MHRSUHR 8^AGCN1>/;=^UC,=BI5.>X[4$M8:ZXR$'B?.*=AV?3<& ,[(P?'#=J[QL,E7LA?IG& MYV3B!<8C3'&F#02COS5.,4T-$OGQ7P7JU6L:P_WO+?HG2Y[(W#.%4Y'>\40O M)][(@P3G;)7J&['Y!RM"UL&92)7]A4TY=W#JP6REM,@J8_(@XWGYSQXJ(?8, MHL$!@Z@RB)X8A/T#!KW*H&>)EIY96I=,LW@LQ0:DF4UHYL-J8ZV)#<_--MYJ M2:.<['3\!4D#!1_A*Y.2&4GA_25JQE/U@7J_WU["^WC *CVX$KE>*O@[3S!IVOOD<>UVM'7[(G("7C%Y#+WP"*(@ MZK7X,WV^>>1PIU>KV+-XO8,J*H5X!%;-([A$-9.\L''Z\PO-A<\:,_5OFW E M<+\=V!SB,U6P&4X\.J4*Y1J]^,\_PF'P5QOKCL :&O1K#?HN]/C.GAA,@*U1 MT@U A]Q<(SQ?0&ID 8TR [IX@.X@$VK;@=9XY5FT["OA SXQJ)5A"AV/\)N]9)PWI2P^N3VNL3 MI]>W]%20AT>PP)R\38'EM"\)W:EKJJ_QNC4@G^DL/:D=@#2%&M1"CM[JL M1EUJT!%80X/36H-39S!\>W[ GCXG8'\SJ>%C&.S>YL#IY17%9K;*6M];I^5+ MMZ(KM";/O1PD?*N(K)"[TJ$CM*8.T4Z'R+G?-RTO9BMI-TSU.K82=%J^EN N M30J=&0CE70\' [K31*@KM";/72H4]M\LH#O*5RH=WB+["7?I3^C.?YX=T&Z8 MH2.@.TV$_+U"*D.YL/6E INRE<5)W5O7L.>V:BC_[N:3Z'*690.-S(?2V81:H*_[X?U!+ M P04 " GA;)6A10D\TX# #(# &0 'AL+W=O65"60B&';&GRG"$X+X-28CJ6Y9LIQ)D1#W$ UXF0DV8T3"'2_2(Q',^97)DUBISG**,8YH!AA8CX]8> MC&U7!90K?F*TYGO70*',*'U1@^_SD6$I1XB@6"@)*+]6:(P(44K2Q]^-J%'O MJ0+WK[?J7TMX"3.#'(TI^87G(AD9H0'F: $+(A[H^AO: 'E*+Z:$EY]@7:T- M? /$!1R? V00XYP:XFX R8 M5).7$R0@)OQ*KGU^G(#+BRMP 7 &GA):<)C-^= 4TI"2->/-YE^JS9UW-K^' M[ :X]B?@6([;$C[6AT]07(<[A^&F3$.="Z?.A5/JN?I<_+Z=<<'D[^M/&U$E MT6N74(=NP',8HY$A3Q5';(6,Z.,'V[<^M_'])[$#6K>F=77JD;=P[9=QK,^Z=8UPKW=&X7QOW3QGWVXS[YQC72GX0YP,PP3RF129:ZZ%U_#1L*VA0Z+?IBK'7$MA:C*D2S01805(@U0U4#X?L MNH%6-/L(S>^K-\,AFG;KKFB["F]K2VHT+AA3:#EE91=Y-IQS_-S$E>H;7VE_D&SZ[BK\>."[7EN\RW7]!J=@.5#-;_WF)_@%0 M2P,$% @ )X6R5I2>=3E: @ ,@4 !D !X;"]W;W)K&UL?53O;],P$/U73F%"FP1-FOY@C#32NFZ"#T/3QN #XH.;7!IK MB1WL2[O]]YR=-A34]4OBL^^]>V?[.=EH\V1+1(+GNE)V%I1$S448VJS$6MB! M;E#Q2J%-+8A#LPIM8U#D'E1781Q%T[ 64@5IXN?N3)KHEBJI\,Z ;>M:F)KDIR$V&:-&*%#TB/S9WA*.Q90$8849.0;!OS5>854Y(I;Q>\L9]"4=<'^\8[_Q MO7,O2V'Q2E<_9$[E+#@/(,="M!7=Z\UGW/;C!6:ZLOX+FRYW' >0M99TO06S M@EJJ[B^>M_NP!XA? \1;0.QU=X6\RH4@D29&;\"X;&9S ]^J1[,XJ=RA/)#A M5X)'@/7X4QPNT/G"Z0A*SL&9R 5/"MU*T5*K=)2%S.@<)L2SWOJ.-7 MJ$=PJQ65%JY5COF_^)!E]EKCG=9Y?)3P5I@!C(;O(([B&!X?%G!Z6#-^77X>:[KC&A[FZ5G\:3_XJ' M>_>X1K/R;K60Z591=Z7[V?Y!N.Q\\#>]>TWXKJRDLE!AP=!H\('KF\ZA74"Z M\:Y8:F*/^6')CQH:E\#KA=:T"UR!_IE,_P!02P,$% @ )X6R5F[/M:_W M @ A L !D !X;"]W;W)K&ULO59A;]HP$/TK M5B9MG;0U<4(@=!!I;3>M'[:AHFZ?33B(52=.;0.MM!\_VPF!E9"UB!:DQ(Y] M[Y[/[^P;K+BXE2F 0O<9R^70294JSEQ7)BED1)[R G(],N,B(TIWQ=R5A0 R MM489X8 SOC%X65W&HCLY0)Y[>F M\2T>6Y251)!X(OD+"S-9HIF&7:JTU.9J;71DKH4>IME/Q6/'D M-N5L"D*^0U_N%E0]H(_KQE6>0&["AD:,Y!*=7((BE,GW U=IYP;"32I'YZ4C M?X^C[T2I]:. 8UQZ -/1[;Q2(^0PG/,BU%:4BCRM$4Z=Q"5,H% MT=%&)S2OHM,8Y-)3:#V9C%O&4>2%?=\;N,L&BIV:8J>5HN]AW+SIZ ^ZR>$> M1$*EYFKCC7X6)J5D$\%6/P<&.JQ7$1Y%#.$+<.S6'+M/$8-^H+D@N=(Q)4N= M4V3"X%E*Z.XH(>Q$^A\V*Z%7\^O]1PG^'B4TD6C%.C"249.QMCGWO=618^=FF& 0^]GI[ M=(BW;B;\:L=FY>KI+#?W#VZ].EKR19^ 'BA-O+B8<'"6%<.L% M=RC-S>6$VV^GHRJALZN$7C<*'V>4NU53F?I4UR]SJDL@!C-MZ)WV-((H2[ZR MHWAARZP)5[IHL\U4E\D@S 0]/N-%LE:R M.\R([P( )L+ 9 >&PO=V]R:W-H965TH7K(U$6]#VP(;HV)Y-LM\:\\K,$Q8P8\E?$LEX M8HTL%,$2YXE\8)OO4!KJ:[Z0)<+\HDT9ZU@HS(5D:0E6"E)"BR=^+1.Q U \ MS0"O!'C[@-X' +\$^,9HH81F)L2Z5+L]MAJ6%::/ ^T."C.T9E+- -C2"JXVWEIS+E M;4U-O5;".\POD.]^19[C^0UZ9O\/]UKD^%6.?M?&88C_'E(3UZ_$]5O%__>&>K"*DORO+:Y8U MJ&0-6F7]5*FZPU1=G>J2E&A.N+KH&&\LIU:F8P]*1V0UT\/*]+"3RAAV:;@C MLIKA465XU$EEM+(<:WAT<%B]#VKHLK)QV6KC)LT2]@:-TEN1QTKOB*QFTG7> MOXU.)\>SI.G(:7-2X"O3_0EUC>=4 M%LU!M5IUF->FK]I;G^K.T[1/[S1%VZH^_2M"!4I@J2B=BZ&J&EYT@L5$LLPT M4T],JM;,#&/5/0/7 >K]DC&YG>@-JGX\^ =02P,$% @ )X6R5GEX0\L_ M!@ 4BL !D !X;"]W;W)K&ULM9IK0'T.R)LN]\38@ STF<\LO!6HC-A>/P8$T2S,_HAJ3RFR5E"19R MEZT$7NB?BRN6-RSZE4PB@A*8]H"AA97@ZNX(7OCK. _(RO M$7GBC6V0E?) Z?=LYT-X.1AF+2(Q"40F@>7'(UF0.,Z49#M^E**#*F<6V-S> MJ;_+BY?%/&!.%C3^%H5B?3F8#D!(EG@;B\_TZ6]2%I0W,* QS_^#I^)<;S( MP98+FI3!L@5)E!:?^+DTHA& Q@<"4!F ]@+@Z$" 6P:X^QD.!8S*@%'N3%%* M[H./!9[/&'T"+#M;JF4;N9EYM"P_2K/K?B^8_#:2<6)^+VCP?4WCD##^)[CY ML8W$"W@+\L/@TR:[-AR\\HG 4^O9XZ0V3,-)R@S71>9T(%, M+KBEJ5AS<).&)-3$^^9XB P"CBR[JAWM:K]&1L5;S,Z "]\ -$2NID&+[N%( M5X\YW"?!H7"E&K>ZDFZNYQ[0^R36A($PXD%,^981KKM$A<1(+Y'-,1=\@P-R M.9"3""?LD0SF?_P&O>%?.GMLBOF6Q!3K1I5U(Y/Z?$$3.8]RG,]$Y#G;)CKW M"A4O5\DFU,>Y-Y1_,^>Q:4O[++=]EF]LT4_6.Z[J'1OKO4DV,7TAVAJ-D7U[ MB$TQWY*8XIA7.>;]^N#R;%IG4\RW)*98-ZFLFU@97$:5ONX58N/&&(2:,6@I MI6++M+)E:K3EHW3C%J>2K21%">!'3)(09=J.953J:XU-,=^2F.+@>>7@^:^/ MR7.;UMD4\RV)*=;!88U]0RNCTBS3U\!2K3DND69M- 8FCTIH!?6L"O MUA1C?&]3;*KYMM14[U#M'3(.RH_;Y$&.2KKEIAI3@SHTD_K-\T92 M:.B\HVQ)HBXCJHW9;]%H/'9;-MF$>]^6FFI3#>[03.[*%$WRS\[S\[0]/[O> M=#)M&6:5TG5I]WX65"]J!(=&3-V-)?P0'Z_]O'U/YDT@:M=N%;-MJ:E/&&O. M1D,C#WW+'SS+H73U2)B\V0.[V0?RBMQ6U7Q;:JJ;-9DC,YEWH*.0 MQC%F'&PDA>:]4=L9RSS3YHW(&41[/='G8+,44WFR$BN"B5U- D=_?TS MY^SMT"G8&]7LC MG8*[41R9>?P83W5TSFL[ MA\Z&+>>L GNI=O!G1'6D!G%T#,15JNKHP$33F(FW;X!5%+>EIAI5HSB:_OHC M8&3U\;E5-=^6FNI?C>_(C.^-H0=:I/J99.M&LJ\6-!4,!V*+8_!/M"PZY;]$ M=DE]1S0G'8&7+!1,05*\SY^"$+_H+MW"K-3;[&[M.M^UR]6T2WTU7]\&N.;' M[]MJ14V.HW%A@EAJWS1)I<=:9N*8NU==;1:&'J5+X?<.WX- M+Q;%\LY:IEAM>HO92DY;("9+*3D\F\@"6+& L]@1=),O:7R@0M DWUP3'!*6 MG2"_7U(J=CM9@FH9[?Q_4$L#!!0 ( ">%LE;4TRWEW@( (8) 9 M>&PO=V]R:W-H965T^LC82 MY67;!Q@"#3Z;Y-I$.':PG1:D_?C93AJRJ60JC"_QZW/WW%WNSM,U%WRQPMD^F3!14Z47HJE*PN!)+&@G+J!YPW=G&3,B:9V M[T)$4UXJFC&\$"#+/"?B<8Z4KV>.[VPV+K-EJLR&&TT+LL0K5#^+"Z%7;B,E MR7)D,N,,!"YFSJ%_,/<# [ WKC-S*FT7UA7=P=]!^)2*I[78,T@SU@UDH?:$2U &#P#"&J =81;*;(LCXDB MT53P-0AS6TLS$VNJ16MR&3-1N5)"GV8:IZ(KQ>.[E-,$A?P()_=EIAYA'\XY MV[]&J3"!'X5QGX1/QZA(1N7>U%5:L8&[<:UD7BD)GE$2PAEG*I5PPA),_L2[ MFG##.MBPG@>= L^(Z$'H?X; "T)X#R[(E B4]="A(6S\$EH-_2Z_ *]LWV9Q M)]SDTH$L2(PS1R>+1+%")_KPSA]Z7SK(]1MR?2L]?(;<>9G?H@"^V 1G&\'^ M&Q <- 0'G=Z;XS)C+&-+F!-*6(SP*6-U<+;^/Y6X@15G"LDJ"H>3T<#SINYJ M"X]APV/8R4/_;SN0&.Y&8M20&'5&Z\96!IU)ARL4NM+!5T&8 IVN"*((3CAO7X!2%,.*5$2"CT[V<]N0>_6OFWS8A*S;CE5:_G#;:[=-*0 MF^P:UQ>"JKWNLK1C7]A6/U6P?=?7SQJ&?^98_#$,>CTH%LE;Q(L0@V00 !8= 9 >&PO=V]R:W-H965T%OUQ"Q[<3!SN[" UVNI+[@3L=KLH1'D%_7]UR=N85*2&-(!&4)XK"8.%?X MTO?Z.B!]XAN%K=@[1KJ4.6//^N1+.'%ZND4002"U!%$?+S"#*-)*JAW?%ZQ* 0N?D4W MWS=4OJ'?T!/AG"12H",?)*&1.%87OS[ZZ.CGX[$K56(=[@9YDNLLB?=!DCZZ M98E<"723A!#6Q/OF>.P9!%Q5<5&VMRO[VC,JWA)^BOKX!'D]KU_3H%G[<*^N M'G.X#\%'X95J^L67V$_U^A_HW&R*^9;$*N@&!;J!27TZ8[&:0@5))R%XU<=01R]3 M&:4J>BY]F8YZZF_LONQC.7RJ?_B4;VS1)^L=%O4.C?7N!G9=C<;(KCW$IIAO M2:Q";%00&QD'US^;>*Y&%UN@;)C)%4G0W5IWF%J*(YL4;8KYEL0J%,\*BF?& M?G>WD4*2)*3)$JD/-=2 !U20>00G: Y+FB3ZUIQ$) D '=$$B151[:C]NT#LWTOM3CUD(F["<'V!Y/T$9TW0E8DFL M0N2B(')AGK=U-XF:D5PT(C'FZ8K$DE@%">Z57JYGA'*3#:IF*KF."8LY55]*BR MAA)N9X1D#%E9T"6U*J O!*0]_GI&;+K+>?F M/%/CY&QN46=^C5FK9$IKC^BE]5:SZMMMJ54)E8;F]UWO7MHR:K9DYNS=V;U(UPY+FTY-OOR MKD:B)<6+5K.[52O?E+.Z[EAZ=,_LT0_\Q /HY7G-9<82R4D@-R1"?]-%!NA? M4'B.3Y !;!VQAE9@]*9T41_%V;JJ-T0A>:M;SYB9E;I2;=>ND;%=5?+E2X!G M?@FX6BXY+(D$]$5QIHF@ ?I&H@UTAXL/UOG>#VIS6SI3,R6LXB@MO^?]_T5C MSZ9)GUE5\VVI5?F5+P:>T2JW7CG.98R=Q:K%-R;,BG7W-HQBX,MTXTV@@&T2 MF6VB%%>+S;VK=$OKW?5K?#G+MNA*F6S'\)9PY>8%BF"A)'NG9^HGD&>;<-F) M9.MT6VK.I&1Q>K@"$@+7#ZC["\;D[D0G*+9"I_\!4$L#!!0 ( ">%LE;T M3D)(L04 -XG 9 >&PO=V]R:W-H965T/[&4 MK\\][+UH2.6!\Q_%R=_QN3L12%JE"@NJ71S9E:5HHZ7[\-*)>W681 MV#Q^4?]<)J^3>:"237GZ/8G5XMP[]5#,9G25JEN^_HN9A(X+O8BGLOR+UN;> M@8>BE50\,\&Z!UF25Z_TR1C1",##'0'$!)#-@.,= 8$)"/JV,#0!P]*9*I72 MAY J.AD+OD:BN%NK%0>EF66T3C_)B\_]3@G];J+CU.1.\>C'@J8?>(!_)!15,HB1']WFBY'M] M41__L^ K2?-8CGVE.U@TXT>F,].J,V1'9P)TQ7.UD.@RCUG+$41X@,WNM?0KKZXPZ_HCH\P&5XT!$>]@\GCFR"^K,*2KU@A]ZU6C"! MXD1&*99/??\.CP9]=]D"*A4!B M+>N&M75#E_IDRC-=*24M:PU[*HY9EWM.E7W=J\1&I5A1?Q\GH\'8?VQZLGU+ M8&]I97I<9WKLS/2K3O"*YKIFZ^JL4)@(76&YZ!PK3J5]LX44"X'$6@Z.:@=' MOS[-1I#608J%0&(MZTYJZTY IIE395_W(,7"2NRX,2')C@EY6GMRZO3D,ENF M_)EU^N",W-<'2+$02*SEV,?:L8^_/@$_0EH'*18"B;6LPP/+B6V== M4+70J#5G(=XQ"W$#=+'3F%LFE4@BQ>**;CM-<4KL;0JD6@BEUK:/6/N(E;R&:JFIUK0'%TOBV'6.3^-')25D&HAE%K;2HOQV(FZD^N5DDH_(27Y M_#UZ8/,DS_6A?GQ-:1XQ]%8_1%6/5N\ZC04E?*/6G&I!^;,!JE"MMBVS^([= M_/Y%T+R8N:]Y \KO1JWIS6D0##>= 6JS[8S%?>SF_6DQ9M(>UH#"OE%K6K/Y M: /58-L7"_'8";J3;[K<]W %E..-6M.5#UTCYA"(CBVC8S>D7SXM]4-A['_F M8L:2/B:!XCK>1NRMH0/48-L@"^S83>RM^LS*U][%&93HC=KKQ?D0M(XMKF,W MKW\O%U?U.+IX9(+.&;I\8B)*)$,W&KBZZ1,4WT'50BBU]HJE!7CB!O@>=!#S M-*5"HJ7FL'(P=HY%=SO[>FS43IMC\>@$;XQ$J#;;WEG&)V[&;V)"3Y- B=^H M8=(L;DB-^BAIT&@ M5&[47AU'AX!R8J&KH&"O%& M[;62?@B.)Y;C"%"U$$JM[9^E?0*S).^6V=O"$]<76\:8[7MVK?(1 MR^[$S>[WN6 1G^?)O[H<17US!Z5VH];,:[B5^R&(G5AB)TZ&M<1.#;'KLI/P MN%C=,_85EG5:!0KNKW03HV=&!<)#%-/GKHD?0G6G_7V\9?7 S>J;:\KH/S3E MN5RENM2KSF_G09D<5"V$4FM[:=D]P* +S $HN8.JA5!J;2LMX =NP.^Y6AIL M8_CV:M74W=;>SH!RO=_8^)0Q,2\WD$E=]U>YJG8)U5?K36H7Y=:LC>M3?!96 M6\VL3+7S[8H*_0@N4]<"5XEEYN& T9J*X0;\_ MXUR]G!0-U%OZ)O\#4$L#!!0 ( ">%LE926[ ^A ( &H) 9 >&PO M=V]R:W-H965TBAI M)<9.(65][;HB*Z#$XI+54*F9%>,EEJK+UZZH.>#L95S[4N.2FA M$H15B,-J['SUKR3HL <1.)*M;YV<;-VK9MFK>"%M7YB?HE"_P(% M7A!VR"?]\BED5AX#3P B"Q =#P $6*CMNDKN4=O MS;TSL"?W@<]VY>]Z_\GWY=# ME0EO3O:F(UEM#L6NO5^E?4$L#!!0 ( M ">%LE:._QXF$P, /(( 9 >&PO=V]R:W-H965TG M#=T(51%\2?QR]_AY?/:=QVNE'TR!:.%[*:29!(6UR_,P-%F!)3,=M41),W.E M2V:IJQ>A66IDN7ATK"HKN,0;#:8J2Z9_3%&H]22( M@NW +5\4U@V$Z7C)%GB']GYYHZD7-B@Y+U$:KB1HG$^"B^C\>VV(2C +(<*-0_S4H?<'AV3CD'BA-3,OZXI9EHZU6H-VUH3F&GYOO#>I MX=)%\*>D+0R\DCGFC_U#4MU(C[?2I_%>P'=,=R")3B#NQDD+G\O# MW>,]=)(F$HG'2_XZ$E\N9L9J.O!?VW:M1NVUH[HD<&Z6+,-)0+?P1QO0:S:@MP\]?4\Y2Y!T8-9J/JLLFPD$J^!SA@*FVAV;$[B6 M60?H6F0/A1(YZM:35"\T\ NY/+9*3_N#'@5YM2NVQ2KIC8:-U2,5_49%?Z^* M^M*L??J@&\-6J"D;@JS*&054S;<7@S*JL22)0MZFH%ZDO\,M.ALD2736>R*B MS; _C*+HK%W'H-$QV*MC>^7_6G:TGD/?,VLC72 M:/=(=#OQV1.FK5;1J)WFJ*$Y.FC##R,Z.HAHJ]5O1,.=\E&B7OBJ:B!3E;1U M.FU&F\)]X>O5D_$I%?2Z_OZ"J5\#E"P77!H0."?(;F=(8=9UA:T[5BU]D9HI M2R7/-PMZE*!V!C0_5\IN.VZ!YIF3_@102P,$% @ )X6R5L-=:RSW @ M> L !D !X;"]W;W)K&ULS59=;YLP%/TK%I.F M3EH+@82D78+4I)U6J96B1EL?ICVXFD@!&Y_# M.<6C.=8JB%?N:+@@!,# MRC/7][S0S3&A3C0VC5DI,T)ASI$H\QSS/U/(V&;B])S=Q"-9I5)/N-&X MP"M8@/Q>S+D:N98E(3E001A%')83Y[IW->MY&F!6_""P$0?G2%MY9NQ%#^Z2 MB>-I19!!+#4%5HP]-?#P?,?^U9A79IZQ@!G+GD@BTXDS M)H! M?@WP3P']5P!!#0B,T4J9L76#)8[&G&T0UZL5FSXQV1BT6IGXK MX0/F%RCH?4:^YP<->F;_#_=;Y 0VX<#P!:_PZ11;0UQREJ,9RXM28E/:;(GL MMNSWX^>](D9W$G+QJRGE2D6_685^&ER) LC([(CIZ%U&KZ+ @Z[#*PCLJ/ AC:P81<% M/&PHS' T''DG!=RPS@_5QVLNX)%5.6I5^80YQU0V2FM%OG4K.B([,GEI35Z^ MB]J][#*PCLB. NMY^X; ZZ)Z:Y;#LNPI#>'IX_??ZRJ=[D$/DP-?F=9.H)B5 M5%;O?CMKV\=KTS2=S$]U6VEZHSU-U9.J-_N*4($R6"I*[V*H1/&JS:L&DA6F M4WIF4O5=YC15K3%PO4!=7S(F=P-] ]ML1W\!4$L#!!0 ( ">%LE90:$L; M*@( @% 9 >&PO=V]R:W-H965T\.U\EV/. M<=H)^:IJ (V.C'*5!;76S2(,55$#PVHB&N#FI!*286V6<@PX4&>NKV-S%/1:DHX;"12+6-8_ED"%5T63(/3QA/9U]INA'G:X#UL0;\T M&VE6XZ!4DMD;/SN.8-!T@+/YR?V[RYWD\L.*[@7]!O!Q@$CW(_XV-_#&2".WP'$/2!VOKV0<[G" M&N>I%!V2-MJPV8E+U:&-.<+M3]EJ:4Z)P>E\S0O! #WC(RATO0*-"54WZ H1 MCIYKT2K,2Y6&VDA90%CTM$M/&[]#.YVA1\%UK= #+Z'\ER T'@>C\MBMT?74SPIL,%Y XWN0_+N!2GAY]>QEM6V:A&EQ %IB> M4" /$.0?/TSGT;<1;[>#M]LQ]ORAJL!5K?D;SJ7&1R2QADM&/=571V5;\9!' M:7BXH#X;U&>CZNLWS1UPJ(B^).LYYB.RX5EU,I![UX,*%:+EVA?JL#NT^9VO M[K=P_T:8(M@3KA"%RD"CR6>C+GW?^846C:OUG="F<]RT-D\52!M@SBLA]&EA M!8;'+_\+4$L#!!0 ( ">%LE8R]T =9P, -X- 9 >&PO=V]R:W-H M965THC"6 M RM0*CFW;>D'$%%YPA.(\/XFXM:A4]MN'F]5O]JX!'F@4JXXN$O-E7!P#JUR!1F- W5+5]^@QRH MH_5\'DKSGRRSL5W/(GXJ%8]R8XP@8G'V2Y_R1&P8H$ZU@9L;N*\-=GGP<@.3 M.3N+S&!=4T6'?<&71.C1J*8O3&Z,-=*P6$_C1 E\R]!.#6\AI JF9$R%6I$[ M06-)38(E^41N)*4^&;%G00-&CJY!41;*8WQS/[DF1^^/^[;"&+22[>?^+C-_ M[@Y_'AGQ6 62?(FG,"W;VQA[ >"N 2[=6L$1%2?$:WTDKN-Z%?%<[3-?K:W= MFFB\(IV>D6OO3*=4@ODZHQ/%_<>J!-4JZ+(]EPGU86!A74H0"["&']ZUNL[G M*KJ&Q$JP[0*V;=2]'; 74N(^,TZ%'V AD8NY , *5U70[2:A&Q(K07<*Z$[M M#/](HP<0A,^(#"C*DP5.^>N5G#%G0ATCI+?3Q?#4\]I]>[')4NOMC2S=@J5; MRW(S(G<\\3GY/0)-]8?\(Q/TP7SDJIW.6MU#I[,AL5(*>D4*>HVMX5Z3T V) ME:!/"^C3VGF_3H',!(_P.YSM_HG>_:N0:W4.1<[$NAOUX#GZKZB($LQ9 7.V M9\M=0+P&DNO5FPB^8%M?F SJ;"N.7F](%N]; MI/6ZATY94VKE+&PT)ZW&JC.7:@J\(;4RN/L"[M8O:KZB(39D\Y1B2Z8 9"6R MN_6%:9I=?96F)>>J+6O*?+Y/&;/N-&(G N>$KV4*Z&\K?+L5C$UVOG8 M&QUT!&)N#A:2^#R-5=9,%T^+P\N%:=GME^'9R0<;TCG#]CF$&9HZ)SV<'I$= M)K(;Q1/3CS]PA=V]N0SP 9"#\#W,\[5^D8[*(YTP_]02P,$% @ )X6R M5JB=281C!P WT$ !D !X;"]W;W)K&ULK9QK M;]LV&(7_"N$50PNLL2793M(E!A)+7 LL79"TZV=:8FRMDNB)=)P,_?&C+K9, M6V:BXGQ);%GO0XI'O!V1NEB+_+M<<*[(4YID\K*W4&KYH=^7X8*G3)Z()<_T M+P\B3YG27_-Y7RYSSJ(R*$WZ[F P[JW.7 7SQ>J.-"?7"S9G-]S]75YF^MO_2TEBE.>R5AD).<;?,5_+G<^DN)29$-^++Y^BR]Z@R!%/>*@*!-/_'OF4)TE!TOGX MMX;VMFD6@;N?-W1:7KR^F!F3?"J2;W&D%I>]LQZ)^ -;)>I.K#_R^H+*#(8B MD>5?LJ[./3WMD7 EE4CK8)V#-,ZJ_^RI+HB= '=\),"M ]S] /=(@%<'>/L! MHR,!PSI@^-H41G7 Z+4!XSI@7)9]55AE2?M,L])7.1T'KAW6:?I6F>R1-C]SH5!:2!%G$HY9X:H]W M7 N@KPM@6PKNIA2N72OQACT3S_F-N /7)5_O??+VS3L2*YZV9&YJ1UTM\Q,R MJ%C.AM561B_E2&/J+'D63/!ZC&O!4#O&Y^%+&*/W=YY5<[V?NOI9L7E>X M83NN:(4_R"4+^65/-[.2YX^\-_GU%V<\^+U-2"3,1\(")(R"8(; PZW 0QM] M\JULV7E$V"//=4^E.Z.BN],:DX3K#H$HGJ=$=Y!$]Y5%0[/YH55]:UI=U4?" M?'LI#,DS9[DD9R2MVBW=@D7LN>T: V2V* AF2#_:2C_J)GT4RU"L,D6TSKQ- M7BNOJ[Q(F%_!G$%)*P9KCY/!R6#LCB[ZC[OB(1.E()@AWG@KWM@JWI3)!5FR MYZII;JF?A#_IP:ULU=&*[JHC$N97L/&.C,/!8$_#PW/&^^=04*8,:4ZWTIS: MI=GTD8J(61+/63%";Y/!BNDJ Q+FGQX6L7<^WM,!F2)](45#B+.M$&=6(0*6 M9^_U9$W/;!*6A9S,N*XHG$BN5,*+FM.FBI79514DS$?" B2,5K#1CGKNT&L7 M[WPKWKE5O*LHBHN*PQ(2"CU/CLK634]U8UFT>VR6Z+&)(&I1Z)DD/&_3TII$ M5RV1,!\)"Y P>GZHY4[S:FCI#)I)[,"JYHT>4J:KMMG:M3VRJTA0F@^E!5 : M1=%,17=L"0<[,ZQY*)V1-!]*"Z TBJ*9.KN-SJZUYMZUS =;Y;5B.LN+I/DO M7&(]^VN5$ID/BJ*94C9>CF-U$B8W[.EH(PSU;: T'TH+H#2*HIF*-N:-,P0W MPE"'!DKSH;0 2J,HFJESX]0X=JOFU8TPU*&!TOP7+G%L:82AK@V*9DK9^#:. MW;CY)!D+R4W\7\X6,9&LF,;D+).L>I"WCM6"?+HA7\0R%.0'\6.Y%))'1#R0 MV3.YU^>W"@^U=* T'TH+H#2*HIDW0^,4.:?@]AOJ&4%I/I060&D413-U;HPH MQ^Y$?5ZE,YX7=;CP,GBX*A_8_KMBN6[)*_LV%\\L4<^-MU$\=_EQ[!GGM7-H MN0Q-?VYJSU-G=:'N$Y1&4313W<:IT1YP:H_L+"74?(+2 M*(IFKC)H?"K7[E.]VKNO.;N&]=XSB*D]J:ZB06D!E$91-%.TQHIRK18(8$BE MCW[[>-NJ,]2U@M)\*"V TBB*9MX2C6OENMB!E0NUKZ T'TH+H#2*HIDZ-Y:6 M:[>T=*TENM/,=&V.,Q(RN7A(Q+I58*C#!:7Y4%H I=&:MCO0')V='WD@Y#;. ME6M?<7,5_;.2=055@BQ7>;@HG(UE'H=\,Y)JU1'J8$%I/I060&FTINWJZ P< MYYB0C37EVGT;2.=K<:;MR7?6&VII06D!E$91-/.V:&PN=PSN@*$.%I3F0VD! ME$91-%/GQL%R[8N=-G/?^8KI6J_X$7%/#QL?S]M?M36UI]59-:@?!:51%,U4 MK?&C7+L?]?.][]G!M%=GZE!(J/4$I050&D713"$;Z\FU>T9_BCPF?X@DDHKK M ?"UKH-M^S6N[9C.K2O4CH+2 BB-HFCFYHO&CO(&V%[4@RZF@M)\*"V TBB* M9NK<.%B>W<':L1V-Q8ZM$D,=J9IF-.CN:+]!]Z&)!E :1=%,[1JKR;.O'GJU M96SG=!8.:C'5-&/]]>'*>VB:M*:-CJ5IZK&S8\UN"?W7"7N,.>79WJ)I5%!M<*W.O53&H$02E^2]3MWJ"UK+!_K53;MM=K>PJ=58;:/U!: *71FF8TZ..#BMG?V9>> M\GQ>OD% DG(78+4Y>WMT^Y:"JW)O_MYQW_D05.\::##5JP]N6#Z/,TD2_J"1 M@Y-3G;&\>IM ]46)9;G[?2:4$FGY<<&9'@$5)^C?'X10FR]% MMW.DS^!U!+ M P04 " GA;)6HDH^/MD$ L(P &0 'AL+W=O,IEFJ5/]HBYP3'95&:V)[C#.P4T\R:3)D-;4^NU>A5Q:4>WRG9"OVEE%Q*DO&GHJ5ZWAJ.<6(2$(B62"P^O=,YB1) M"I(:QZ\::C7'+ KWE]_H?Y4GKTYFB069L^0'C>5Z:HTL%),5WB3RCFV_DOJ$ M^@4O8HDH7]&VWM>Q4+01DJ5UL1I!2K/J/WZIA=@KA7H#_0WYAP7_J&S@$A,$W&NMC[8XA7XOPC#4$_;]0> MZ%J25/S;I6R%ZW7CBCYS)7(]B?V\ M+W+GCEYO-'#T'4.@X6D"]AH!>T8!KV_1=2;5;*"FAPU.T(*KF8[+'7I% 14Y M$R1&;(66.W2/E<2O2!5\8WG$+M#-S;Q+;./Q3A4;$A9 PD(@F&9:OS&M#]N) M^I">0,("2%@(!-,\&32>#(Q?I'^V&>%B37,UWTJB^+++""/C5",@80$D+*Q@ MX[W6YUP.FZZGZ3ML]!T:]?W_Y= K^HH3U?,S=$,C=8%,N@0W0D\5'!(60,)" M()CFS*AQ9@3;C4:0GD#" DA8" 33/!DWGHR-WY;/<4R+N*=F=,YV.%$3>HYW MY562:DYIERMFH.>@'<&\*T',C96G6@ )"X%@F@6NTP8XQZC9-R:5_GE]B8IR MKMI49P*K,(.]=MG7+Q'GYB.=JC$H+82BZ2KOQ637J/*/(A.KKG/H<_U!N6OX M8)M+3U8=DA9"T735VRSL&F/=,=.QVG)+,YINNFT!3<>@M "4%D+1=*?:A.SZ ML-.S"QJ706D!*"V$HNG.M-';-6?ONR-GY@\P?4,# \W/H+00BJ:+WT9HUY@& MCVU@^.5@ P,-U:"T )060M%TI]I@[0Z &QAHR@:E!:"T$(JF.]-&B MZ4JW.=T[*J<+Q#922)S%-'N\0.2%\(B^_3J"SFB&8I8D:C9 .>'5[>SS3DNJ MHXWV+;E\_[.)>4@GVP$:X*%HE1WVWH,&Q7,DMY@_TDR@A*P4WKD5$DE:@PKF!IX7N06AW(G']=IV M"S=TE6N[X,;CDJQP@?JVG$LS$:IDDB*JXI7\%<,)I05/!^NZK@!A.D:[)D M",=7J EEZAWXWE<3<[NX@N.C=W $E,.W7%2*\%2-76W$VBW=I!5VV0@+7A 6 MPK7@.E?PD:>8/L6[QF3G--@ZO0P.$EX3>0JA?P*!%X0]>F:'X5>8=/#@@)RP M2WQ8\X7_GOB?TZ72TESX7WUI;+89]&]CB\"%*DF"$\=\Y0KE&IWX[1L_\C[T MY> _D3W)R*#+R. 0>]S=+MG=KCZ_#4E4D]@:M8Z'Y]'YV%WO^N@)\GVO"WJB M;]CI&Q[6QTS)(SQ!,,434E$M=58Q4X@:V7U:&\+AC@QO3^C!+?\RX5%G*'IM MPD^ *&6N(Z:@!>B,9=6Y&KW?SJ'5K +'WI$;/+\R^Z(/;O_:HW)V27:!T>L#1*\Z'5P80$P\.4Q\GS8F?;,M;8>?&R%'/,=H?0_-9%DSH8.1TX.F MLV$LXEBP,I)R?C2A7L0F$HN5:!- MM1DK78C4OQS<=3THQ$:G9$(JF]ME<-^39O@.L.J!0<9Y:[ 7NL!H4!&MJ1)W MIF,'V^ +*&C:C\O*."P4679[U^&:8&\FR42JC*HV33=J-)MN1GXJ4CW2A5Z5TR+'/?=.T//? M7>>""JH(WS1M:O^85_G5CN.;?V79_E;9->SUV+QZC]WD]2F83$[!Y$G49/\4 M3*;';S(^3H]1<\C8.,ELG6/:: #GQ6'X#4ZF?)TTF,P9UTPTO1G+,BI>'&>, MO"83\Z?,EKX9G]&AX['4PQM8M2>#'KX9Y P:6 M!S+]V5KCNXU7R/XZP/9T7X5@,\4K$9LIOM: ^-<-&&GJWVTL#S"P7<.>8!Q)4PR!6O37:)(@JY/ Q[\_V%,2QVGJ1P#S.XAC#(&G M$4%LE:7BKL

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how.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 63 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 64 FilingSummary.xml IDEA: XBRL DOCUMENT 3.23.1 html 110 237 1 false 43 0 false 5 false false R1.htm 00090 - Document - Document and Entity Information Sheet http://www.xcelbrands.com/role/DocumentDocumentAndEntityInformation Document and Entity Information Cover 1 false false R2.htm 00100 - Statement - Consolidated Balance Sheets Sheet http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheets Consolidated Balance Sheets Statements 2 false false R3.htm 00105 - Statement - Consolidated Balance Sheets (Parenthetical) Sheet http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheetsParenthetical Consolidated Balance Sheets (Parenthetical) Statements 3 false false R4.htm 00200 - Statement - Consolidated Statements of Operations Sheet http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfOperations Consolidated Statements of Operations Statements 4 false false R5.htm 00300 - Statement - Consolidated Statements of Stockholders' Equity Sheet http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfStockholdersEquity Consolidated Statements of Stockholders' Equity Statements 5 false false R6.htm 00400 - Statement - Consolidated Statements of Cash Flows Sheet http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfCashFlows Consolidated Statements of Cash Flows Statements 6 false false R7.htm 10101 - Disclosure - Nature of Operations, Background, and Basis of Presentation Sheet http://www.xcelbrands.com/role/DisclosureNatureOfOperationsBackgroundAndBasisOfPresentation Nature of Operations, Background, and Basis of Presentation Notes 7 false false R8.htm 10201 - Disclosure - Equity Method Investment Sheet http://www.xcelbrands.com/role/DisclosureEquityMethodInvestment Equity Method Investment Notes 8 false false R9.htm 10301 - Disclosure - Trademarks and Other Intangibles Sheet http://www.xcelbrands.com/role/DisclosureTrademarksAndOtherIntangibles Trademarks and Other Intangibles Notes 9 false false R10.htm 10401 - Disclosure - Significant Contracts Sheet http://www.xcelbrands.com/role/DisclosureSignificantContracts Significant Contracts Notes 10 false false R11.htm 10501 - Disclosure - Accounts Receivable Sheet http://www.xcelbrands.com/role/DisclosureAccountsReceivable Accounts Receivable Notes 11 false false R12.htm 10601 - Disclosure - Leases Sheet http://www.xcelbrands.com/role/DisclosureLeases Leases Notes 12 false false R13.htm 10701 - Disclosure - Debt Sheet http://www.xcelbrands.com/role/DisclosureDebt Debt Notes 13 false false R14.htm 10801 - Disclosure - Stockholders' Equity Sheet http://www.xcelbrands.com/role/DisclosureStockholdersEquity Stockholders' Equity Notes 14 false false R15.htm 10901 - Disclosure - Earnings (Loss) Per Share Sheet http://www.xcelbrands.com/role/DisclosureEarningsLossPerShare Earnings (Loss) Per Share Notes 15 false false R16.htm 11001 - Disclosure - Income Taxes Sheet http://www.xcelbrands.com/role/DisclosureIncomeTaxes Income Taxes Notes 16 false false R17.htm 11101 - Disclosure - Related Party Transactions Sheet http://www.xcelbrands.com/role/DisclosureRelatedPartyTransactions Related Party Transactions Notes 17 false false R18.htm 11201 - Disclosure - Commitments and Contingencies Sheet http://www.xcelbrands.com/role/DisclosureCommitmentsAndContingencies Commitments and Contingencies Notes 18 false false R19.htm 11301 - Disclosure - Subsequent Events Sheet http://www.xcelbrands.com/role/DisclosureSubsequentEvents Subsequent Events Notes 19 false false R20.htm 30203 - Disclosure - Equity Method Investment (Tables) Sheet http://www.xcelbrands.com/role/DisclosureEquityMethodInvestmentTables Equity Method Investment (Tables) Tables http://www.xcelbrands.com/role/DisclosureEquityMethodInvestment 20 false false R21.htm 30303 - Disclosure - Trademarks and Other Intangibles (Tables) Sheet http://www.xcelbrands.com/role/DisclosureTrademarksAndOtherIntangiblesTables Trademarks and Other Intangibles (Tables) Tables http://www.xcelbrands.com/role/DisclosureTrademarksAndOtherIntangibles 21 false false R22.htm 30603 - Disclosure - Leases (Tables) Sheet http://www.xcelbrands.com/role/DisclosureLeasesTables Leases (Tables) Tables http://www.xcelbrands.com/role/DisclosureLeases 22 false false R23.htm 30803 - Disclosure - Stockholders' Equity (Tables) Sheet http://www.xcelbrands.com/role/DisclosureStockholdersEquityTables Stockholders' Equity (Tables) Tables http://www.xcelbrands.com/role/DisclosureStockholdersEquity 23 false false R24.htm 30903 - Disclosure - Earnings (Loss) Per Share (Tables) Sheet http://www.xcelbrands.com/role/DisclosureEarningsLossPerShareTables Earnings (Loss) Per Share (Tables) Tables http://www.xcelbrands.com/role/DisclosureEarningsLossPerShare 24 false false R25.htm 40101 - Disclosure - Nature of Operations, Background, and Basis of Presentation (Details) Sheet http://www.xcelbrands.com/role/DisclosureNatureOfOperationsBackgroundAndBasisOfPresentationDetails Nature of Operations, Background, and Basis of Presentation (Details) Details http://www.xcelbrands.com/role/DisclosureNatureOfOperationsBackgroundAndBasisOfPresentation 25 false false R26.htm 40102 - Disclosure - Nature of Operations, Background, and Basis of Presentation - Liquidity (Details) Sheet http://www.xcelbrands.com/role/DisclosureNatureOfOperationsBackgroundAndBasisOfPresentationLiquidityDetails Nature of Operations, Background, and Basis of Presentation - Liquidity (Details) Details http://www.xcelbrands.com/role/DisclosureNatureOfOperationsBackgroundAndBasisOfPresentation 26 false false R27.htm 40201 - Disclosure - Equity Method Investment - IM Topco, LLC (Details) Sheet http://www.xcelbrands.com/role/DisclosureEquityMethodInvestmentImTopcoLlcDetails Equity Method Investment - IM Topco, LLC (Details) Details 27 false false R28.htm 40202 - Disclosure - Equity Method Investment - Summarized financial information (Details) Sheet http://www.xcelbrands.com/role/DisclosureEquityMethodInvestmentSummarizedFinancialInformationDetails Equity Method Investment - Summarized financial information (Details) Details 28 false false R29.htm 40301 - Disclosure - Trademarks and Other Intangibles - Narrative (Details) Sheet http://www.xcelbrands.com/role/DisclosureTrademarksAndOtherIntangiblesNarrativeDetails Trademarks and Other Intangibles - Narrative (Details) Details 29 false false R30.htm 40302 - Disclosure - Trademarks and Other Intangibles - Schedule of Trademarks and Other Intangibles (Details) Sheet http://www.xcelbrands.com/role/DisclosureTrademarksAndOtherIntangiblesScheduleOfTrademarksAndOtherIntangiblesDetails Trademarks and Other Intangibles - Schedule of Trademarks and Other Intangibles (Details) Details 30 false false R31.htm 40401 - Disclosure - Significant Contracts and Concentrations - Narrative (Details) Sheet http://www.xcelbrands.com/role/DisclosureSignificantContractsAndConcentrationsNarrativeDetails Significant Contracts and Concentrations - Narrative (Details) Details 31 false false R32.htm 40501 - Disclosure - Accounts Receivable (Details) Sheet http://www.xcelbrands.com/role/DisclosureAccountsReceivableDetails Accounts Receivable (Details) Details http://www.xcelbrands.com/role/DisclosureAccountsReceivable 32 false false R33.htm 40601 - Disclosure - Leases - Narrative (Details) Sheet http://www.xcelbrands.com/role/DisclosureLeasesNarrativeDetails Leases - Narrative (Details) Details 33 false false R34.htm 40602 - Disclosure - Leases - Maturities of Lease Liabilities (Details) Sheet http://www.xcelbrands.com/role/DisclosureLeasesMaturitiesOfLeaseLiabilitiesDetails Leases - Maturities of Lease Liabilities (Details) Details 34 false false R35.htm 40701 - Disclosure - Debt - Narrative (Details) Sheet http://www.xcelbrands.com/role/DisclosureDebtNarrativeDetails Debt - Narrative (Details) Details 35 false false R36.htm 40801 - Disclosure - Stockholders' Equity - Equity Incentive Plans (Details) Sheet http://www.xcelbrands.com/role/DisclosureStockholdersEquityEquityIncentivePlansDetails Stockholders' Equity - Equity Incentive Plans (Details) Details 36 false false R37.htm 40802 - Disclosure - Stockholders' Equity - Stock-based Compensation (Details) Sheet http://www.xcelbrands.com/role/DisclosureStockholdersEquityStockBasedCompensationDetails Stockholders' Equity - Stock-based Compensation (Details) Details 37 false false R38.htm 40803 - Disclosure - Stockholders' Equity - Stock Options (Details) Sheet http://www.xcelbrands.com/role/DisclosureStockholdersEquityStockOptionsDetails Stockholders' Equity - Stock Options (Details) Details 38 false false R39.htm 40806 - Disclosure - Stockholders' Equity - Non-Vested Options (Details) Sheet http://www.xcelbrands.com/role/DisclosureStockholdersEquityNonVestedOptionsDetails Stockholders' Equity - Non-Vested Options (Details) Details 39 false false R40.htm 40807 - Disclosure - Stockholders' Equity - Warrants (Details) Sheet http://www.xcelbrands.com/role/DisclosureStockholdersEquityWarrantsDetails Stockholders' Equity - Warrants (Details) Details 40 false false R41.htm 40808 - Disclosure - Stockholders' Equity - Stock Awards (Details) Sheet http://www.xcelbrands.com/role/DisclosureStockholdersEquityStockAwardsDetails Stockholders' Equity - Stock Awards (Details) Details 41 false false R42.htm 40809 - Disclosure - Stockholders' Equity - Restricted Stock (Details) Sheet http://www.xcelbrands.com/role/DisclosureStockholdersEquityRestrictedStockDetails Stockholders' Equity - Restricted Stock (Details) Details 42 false false R43.htm 40901 - Disclosure - Earnings (Loss) Per Share - Basic and Diluted Earnings Per Share (Details) Sheet http://www.xcelbrands.com/role/DisclosureEarningsLossPerShareBasicAndDilutedEarningsPerShareDetails Earnings (Loss) Per Share - Basic and Diluted Earnings Per Share (Details) Details http://www.xcelbrands.com/role/DisclosureEarningsLossPerShareTables 43 false false R44.htm 40902 - Disclosure - Earnings (Loss) Per Share - Anti-dilutive Securities Excluded (Details) Sheet http://www.xcelbrands.com/role/DisclosureEarningsLossPerShareAntiDilutiveSecuritiesExcludedDetails Earnings (Loss) Per Share - Anti-dilutive Securities Excluded (Details) Details http://www.xcelbrands.com/role/DisclosureEarningsLossPerShareTables 44 false false R45.htm 41003 - Disclosure - Income Taxes (Details) Sheet http://www.xcelbrands.com/role/DisclosureIncomeTaxesDetails Income Taxes (Details) Details http://www.xcelbrands.com/role/DisclosureIncomeTaxes 45 false false R46.htm 41101 - Disclosure - Related Party Transactions - Isaac Mizrahi (Details) Sheet http://www.xcelbrands.com/role/DisclosureRelatedPartyTransactionsIsaacMizrahiDetails Related Party Transactions - Isaac Mizrahi (Details) Details 46 false false R47.htm 41201 - Disclosure - Commitments and Contingencies - Narrative (Details) Sheet http://www.xcelbrands.com/role/DisclosureCommitmentsAndContingenciesNarrativeDetails Commitments and Contingencies - Narrative (Details) Details 47 false false R48.htm 41301 - Disclosure - Subsequent Events - Narrative (Details) Sheet http://www.xcelbrands.com/role/DisclosureSubsequentEventsNarrativeDetails Subsequent Events - Narrative (Details) Details 48 false false R49.htm 9940202 - Disclosure - Summary of Significant Accounting Policies - Accounts Receivable (Details) 10K Sheet http://www.xcelbrands.com/role/DisclosureSummaryOfSignificantAccountingPoliciesAccountsReceivableDetails10k Summary of Significant Accounting Policies - Accounts Receivable (Details) 10K Details 49 false false All Reports Book All Reports [dq-0542-Deprecated-Concept] Concept DueFromRelatedParties in us-gaap/2022 used in 1 facts was deprecated in us-gaap/2023 as of 2023 and should not be used. xelb-20230331x10q.htm 24 [dq-0542-Deprecated-Concept] Concept RevenueFromRelatedParties in us-gaap/2022 used in 1 facts was deprecated in us-gaap/2023 as of 2023 and should not be used. xelb-20230331x10q.htm 24 [ix-0514-Hidden-Fact-Eligible-For-Transform] WARN: 19 fact(s) appearing in ix:hidden were eligible for transformation: us-gaap:CommonStockSharesIssued, us-gaap:CommonStockSharesOutstanding, us-gaap:EarningsPerShareDiluted, us-gaap:PreferredStockSharesIssued, us-gaap:WarrantsAndRightsOutstandingTerm, us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding, xelb:AdditionalRoyaltyPayableTerm, xelb:AssetAcquisitionRoyaltiesTerm, xelb:RoyaltyPayableTerm - xelb-20230331x10q.htm 9 [ix-0514-Hidden-Fact-Not-Referenced] WARN: 2 fact(s) appearing in ix:hidden were not referenced by any -sec-ix-hidden style property: us-gaap:CommitmentsAndContingencies - xelb-20230331x10q.htm 9 xelb-20230331x10q.htm xelb-20230331.xsd xelb-20230331_cal.xml xelb-20230331_def.xml xelb-20230331_lab.xml xelb-20230331_pre.xml xelb-20230331xex31d1.htm xelb-20230331xex31d2.htm xelb-20230331xex32d1.htm xelb-20230331xex32d2.htm http://fasb.org/us-gaap/2022 http://xbrl.sec.gov/dei/2022 true true JSON 67 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "xelb-20230331x10q.htm": { "axisCustom": 0, "axisStandard": 25, "baseTaxonomies": { "http://fasb.org/us-gaap/2022": 372, "http://xbrl.sec.gov/dei/2022": 29 }, "contextCount": 110, "dts": { "calculationLink": { "local": [ "xelb-20230331_cal.xml" ] }, "definitionLink": { "local": [ "xelb-20230331_def.xml" ] }, "inline": { "local": [ "xelb-20230331x10q.htm" ] }, "labelLink": { "local": [ "xelb-20230331_lab.xml" ] }, "presentationLink": { "local": [ "xelb-20230331_pre.xml" ] }, "schema": { "local": [ "xelb-20230331.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/arcrole/esma-arcrole-2018-11-21.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd", "https://xbrl.sec.gov/country/2022/country-2022.xsd", "https://xbrl.sec.gov/dei/2022/dei-2022.xsd" ] } }, "elementCount": 397, "entityCount": 1, "hidden": { "http://fasb.org/us-gaap/2022": 13, "http://www.xcelbrands.com/20230331": 10, "http://xbrl.sec.gov/dei/2022": 5, "total": 28 }, "keyCustom": 37, "keyStandard": 200, "memberCustom": 19, "memberStandard": 20, "nsprefix": "xelb", "nsuri": "http://www.xcelbrands.com/20230331", "report": { "R1": { "firstAnchor": { "ancestors": [ "p", "div", "div", "body", "html" ], "baseRef": "xelb-20230331x10q.htm", "contextRef": "Duration_1_1_2023_To_3_31_2023_gEvb94xNAE2WJfB2T7RkIw", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "00090 - Document - Document and Entity Information", "menuCat": "Cover", "order": "1", "role": "http://www.xcelbrands.com/role/DocumentDocumentAndEntityInformation", "shortName": "Document and Entity Information", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "p", "div", "div", "body", "html" ], "baseRef": "xelb-20230331x10q.htm", "contextRef": "Duration_1_1_2023_To_3_31_2023_gEvb94xNAE2WJfB2T7RkIw", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R10": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "xelb-20230331x10q.htm", "contextRef": "Duration_1_1_2023_To_3_31_2023_gEvb94xNAE2WJfB2T7RkIw", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ConcentrationRiskDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "10401 - Disclosure - Significant Contracts", "menuCat": "Notes", "order": "10", "role": "http://www.xcelbrands.com/role/DisclosureSignificantContracts", "shortName": "Significant Contracts", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "xelb-20230331x10q.htm", "contextRef": "Duration_1_1_2023_To_3_31_2023_gEvb94xNAE2WJfB2T7RkIw", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ConcentrationRiskDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R11": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "xelb-20230331x10q.htm", "contextRef": "Duration_1_1_2023_To_3_31_2023_gEvb94xNAE2WJfB2T7RkIw", "decimals": null, "first": true, "lang": "en-US", "name": "xelb:AccountsReceivableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "10501 - Disclosure - Accounts Receivable", "menuCat": "Notes", "order": "11", "role": "http://www.xcelbrands.com/role/DisclosureAccountsReceivable", "shortName": "Accounts Receivable", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "xelb-20230331x10q.htm", "contextRef": "Duration_1_1_2023_To_3_31_2023_gEvb94xNAE2WJfB2T7RkIw", "decimals": null, "first": true, "lang": "en-US", "name": "xelb:AccountsReceivableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R12": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "xelb-20230331x10q.htm", "contextRef": "Duration_1_1_2023_To_3_31_2023_gEvb94xNAE2WJfB2T7RkIw", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LesseeOperatingLeasesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "10601 - Disclosure - Leases", "menuCat": "Notes", "order": "12", "role": "http://www.xcelbrands.com/role/DisclosureLeases", "shortName": "Leases", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "xelb-20230331x10q.htm", "contextRef": "Duration_1_1_2023_To_3_31_2023_gEvb94xNAE2WJfB2T7RkIw", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LesseeOperatingLeasesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R13": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "xelb-20230331x10q.htm", "contextRef": "Duration_1_1_2023_To_3_31_2023_gEvb94xNAE2WJfB2T7RkIw", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LongTermDebtTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "10701 - Disclosure - Debt", "menuCat": "Notes", "order": "13", "role": "http://www.xcelbrands.com/role/DisclosureDebt", "shortName": "Debt", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "xelb-20230331x10q.htm", "contextRef": "Duration_1_1_2023_To_3_31_2023_gEvb94xNAE2WJfB2T7RkIw", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LongTermDebtTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R14": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "xelb-20230331x10q.htm", "contextRef": "Duration_1_1_2023_To_3_31_2023_gEvb94xNAE2WJfB2T7RkIw", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "10801 - Disclosure - Stockholders' Equity", "menuCat": "Notes", "order": "14", "role": "http://www.xcelbrands.com/role/DisclosureStockholdersEquity", "shortName": "Stockholders' Equity", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "xelb-20230331x10q.htm", "contextRef": "Duration_1_1_2023_To_3_31_2023_gEvb94xNAE2WJfB2T7RkIw", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R15": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "xelb-20230331x10q.htm", "contextRef": "Duration_1_1_2023_To_3_31_2023_gEvb94xNAE2WJfB2T7RkIw", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:EarningsPerShareTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "10901 - Disclosure - Earnings (Loss) Per Share", "menuCat": "Notes", "order": "15", "role": "http://www.xcelbrands.com/role/DisclosureEarningsLossPerShare", "shortName": "Earnings (Loss) Per Share", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "xelb-20230331x10q.htm", "contextRef": "Duration_1_1_2023_To_3_31_2023_gEvb94xNAE2WJfB2T7RkIw", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:EarningsPerShareTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R16": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "xelb-20230331x10q.htm", "contextRef": "Duration_1_1_2023_To_3_31_2023_gEvb94xNAE2WJfB2T7RkIw", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "11001 - Disclosure - Income Taxes", "menuCat": "Notes", "order": "16", "role": "http://www.xcelbrands.com/role/DisclosureIncomeTaxes", "shortName": "Income Taxes", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "xelb-20230331x10q.htm", "contextRef": "Duration_1_1_2023_To_3_31_2023_gEvb94xNAE2WJfB2T7RkIw", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R17": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "xelb-20230331x10q.htm", "contextRef": "Duration_1_1_2023_To_3_31_2023_gEvb94xNAE2WJfB2T7RkIw", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "11101 - Disclosure - Related Party Transactions", "menuCat": "Notes", "order": "17", "role": "http://www.xcelbrands.com/role/DisclosureRelatedPartyTransactions", "shortName": "Related Party Transactions", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "xelb-20230331x10q.htm", "contextRef": "Duration_1_1_2023_To_3_31_2023_gEvb94xNAE2WJfB2T7RkIw", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R18": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "xelb-20230331x10q.htm", "contextRef": "Duration_1_1_2023_To_3_31_2023_gEvb94xNAE2WJfB2T7RkIw", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "11201 - Disclosure - Commitments and Contingencies", "menuCat": "Notes", "order": "18", "role": "http://www.xcelbrands.com/role/DisclosureCommitmentsAndContingencies", "shortName": "Commitments and Contingencies", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "xelb-20230331x10q.htm", "contextRef": "Duration_1_1_2023_To_3_31_2023_gEvb94xNAE2WJfB2T7RkIw", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R19": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "xelb-20230331x10q.htm", "contextRef": "Duration_1_1_2023_To_3_31_2023_gEvb94xNAE2WJfB2T7RkIw", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubsequentEventsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "11301 - Disclosure - Subsequent Events", "menuCat": "Notes", "order": "19", "role": "http://www.xcelbrands.com/role/DisclosureSubsequentEvents", "shortName": "Subsequent Events", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "xelb-20230331x10q.htm", "contextRef": "Duration_1_1_2023_To_3_31_2023_gEvb94xNAE2WJfB2T7RkIw", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubsequentEventsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R2": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "xelb-20230331x10q.htm", "contextRef": "As_Of_3_31_2023_VDBSL1P2q0qhICaSzA3qew", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "reportCount": 1, "unitRef": "Unit_Standard_USD_z_CXhzMrjkC9_PUwukjvAQ", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00100 - Statement - Consolidated Balance Sheets", "menuCat": "Statements", "order": "2", "role": "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheets", "shortName": "Consolidated Balance Sheets", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "xelb-20230331x10q.htm", "contextRef": "As_Of_12_31_2022_9wUGVqTt6UW3yIP_pgdoWw", "decimals": "-3", "lang": null, "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_z_CXhzMrjkC9_PUwukjvAQ", "xsiNil": "false" } }, "R20": { "firstAnchor": { "ancestors": [ "us-gaap:EquityMethodInvestmentsDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "xelb-20230331x10q.htm", "contextRef": "Duration_1_1_2023_To_3_31_2023_gEvb94xNAE2WJfB2T7RkIw", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:EquityMethodInvestmentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "30203 - Disclosure - Equity Method Investment (Tables)", "menuCat": "Tables", "order": "20", "role": "http://www.xcelbrands.com/role/DisclosureEquityMethodInvestmentTables", "shortName": "Equity Method Investment (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:EquityMethodInvestmentsDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "xelb-20230331x10q.htm", "contextRef": "Duration_1_1_2023_To_3_31_2023_gEvb94xNAE2WJfB2T7RkIw", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:EquityMethodInvestmentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R21": { "firstAnchor": { "ancestors": [ "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "xelb-20230331x10q.htm", "contextRef": "Duration_1_1_2023_To_3_31_2023_gEvb94xNAE2WJfB2T7RkIw", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "30303 - Disclosure - Trademarks and Other Intangibles (Tables)", "menuCat": "Tables", "order": "21", "role": "http://www.xcelbrands.com/role/DisclosureTrademarksAndOtherIntangiblesTables", "shortName": "Trademarks and Other Intangibles (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "xelb-20230331x10q.htm", "contextRef": "Duration_1_1_2023_To_3_31_2023_gEvb94xNAE2WJfB2T7RkIw", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R22": { "firstAnchor": { "ancestors": [ "us-gaap:LesseeOperatingLeasesTextBlock", "div", "div", "body", "html" ], "baseRef": "xelb-20230331x10q.htm", "contextRef": "Duration_1_1_2023_To_3_31_2023_gEvb94xNAE2WJfB2T7RkIw", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "30603 - Disclosure - Leases (Tables)", "menuCat": "Tables", "order": "22", "role": "http://www.xcelbrands.com/role/DisclosureLeasesTables", "shortName": "Leases (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:LesseeOperatingLeasesTextBlock", "div", "div", "body", "html" ], "baseRef": "xelb-20230331x10q.htm", "contextRef": "Duration_1_1_2023_To_3_31_2023_gEvb94xNAE2WJfB2T7RkIw", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R23": { "firstAnchor": { "ancestors": [ "ix:continuation", "div", "div", "body", "html" ], "baseRef": "xelb-20230331x10q.htm", "contextRef": "Duration_1_1_2023_To_3_31_2023_gEvb94xNAE2WJfB2T7RkIw", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "30803 - Disclosure - Stockholders' Equity (Tables)", "menuCat": "Tables", "order": "23", "role": "http://www.xcelbrands.com/role/DisclosureStockholdersEquityTables", "shortName": "Stockholders' Equity (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "div", "div", "body", "html" ], "baseRef": "xelb-20230331x10q.htm", "contextRef": "Duration_1_1_2023_To_3_31_2023_gEvb94xNAE2WJfB2T7RkIw", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R24": { "firstAnchor": { "ancestors": [ "ix:continuation", "div", "div", "body", "html" ], "baseRef": "xelb-20230331x10q.htm", "contextRef": "Duration_1_1_2023_To_3_31_2023_gEvb94xNAE2WJfB2T7RkIw", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "30903 - Disclosure - Earnings (Loss) Per Share (Tables)", "menuCat": "Tables", "order": "24", "role": "http://www.xcelbrands.com/role/DisclosureEarningsLossPerShareTables", "shortName": "Earnings (Loss) Per Share (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "div", "div", "body", "html" ], "baseRef": "xelb-20230331x10q.htm", "contextRef": "Duration_1_1_2023_To_3_31_2023_gEvb94xNAE2WJfB2T7RkIw", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R25": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "xelb-20230331x10q.htm", "contextRef": "Duration_1_1_2023_To_3_31_2023_srt_ConsolidatedEntitiesAxis_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember_srt_OwnershipAxis_xelb_LongabergerLicensingLLCMember_J-Azu8NQEEWINWysbcHO5Q", "decimals": "2", "first": true, "lang": null, "name": "us-gaap:VariableInterestEntityOwnershipPercentage", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_pure_ZB_L-admoE6jhTO9VkC0mQ", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "40101 - Disclosure - Nature of Operations, Background, and Basis of Presentation (Details)", "menuCat": "Details", "order": "25", "role": "http://www.xcelbrands.com/role/DisclosureNatureOfOperationsBackgroundAndBasisOfPresentationDetails", "shortName": "Nature of Operations, Background, and Basis of Presentation (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "xelb-20230331x10q.htm", "contextRef": "Duration_1_1_2023_To_3_31_2023_srt_ConsolidatedEntitiesAxis_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember_srt_OwnershipAxis_xelb_LongabergerLicensingLLCMember_J-Azu8NQEEWINWysbcHO5Q", "decimals": "2", "first": true, "lang": null, "name": "us-gaap:VariableInterestEntityOwnershipPercentage", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_pure_ZB_L-admoE6jhTO9VkC0mQ", "xsiNil": "false" } }, "R26": { "firstAnchor": { "ancestors": [ "b", "p", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "xelb-20230331x10q.htm", "contextRef": "Duration_1_1_2023_To_3_31_2023_gEvb94xNAE2WJfB2T7RkIw", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:NetIncomeLoss", "reportCount": 1, "unitRef": "Unit_Standard_USD_z_CXhzMrjkC9_PUwukjvAQ", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "40102 - Disclosure - Nature of Operations, Background, and Basis of Presentation - Liquidity (Details)", "menuCat": "Details", "order": "26", "role": "http://www.xcelbrands.com/role/DisclosureNatureOfOperationsBackgroundAndBasisOfPresentationLiquidityDetails", "shortName": "Nature of Operations, Background, and Basis of Presentation - Liquidity (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "xelb-20230331x10q.htm", "contextRef": "Duration_1_1_2023_To_3_31_2023_gEvb94xNAE2WJfB2T7RkIw", "decimals": "-5", "lang": null, "name": "us-gaap:OtherNoncashExpense", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_z_CXhzMrjkC9_PUwukjvAQ", "xsiNil": "false" } }, "R27": { "firstAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "xelb-20230331x10q.htm", "contextRef": "Duration_1_1_2023_To_3_31_2023_gEvb94xNAE2WJfB2T7RkIw", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:IncomeLossFromEquityMethodInvestments", "reportCount": 1, "unitRef": "Unit_Standard_USD_z_CXhzMrjkC9_PUwukjvAQ", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "40201 - Disclosure - Equity Method Investment - IM Topco, LLC (Details)", "menuCat": "Details", "order": "27", "role": "http://www.xcelbrands.com/role/DisclosureEquityMethodInvestmentImTopcoLlcDetails", "shortName": "Equity Method Investment - IM Topco, LLC (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "us-gaap:EquityMethodInvestmentsDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "xelb-20230331x10q.htm", "contextRef": "Duration_1_1_2023_To_3_31_2023_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_xelb_IMTopcoLLCMember_gkeUc-6pOU28TxJq4vdC3w", "decimals": "-4", "lang": null, "name": "us-gaap:IncomeLossFromEquityMethodInvestments", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_z_CXhzMrjkC9_PUwukjvAQ", "xsiNil": "false" } }, "R28": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "xelb-20230331x10q.htm", "contextRef": "Duration_1_1_2023_To_3_31_2023_gEvb94xNAE2WJfB2T7RkIw", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:GrossProfit", "reportCount": 1, "unitRef": "Unit_Standard_USD_z_CXhzMrjkC9_PUwukjvAQ", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "40202 - Disclosure - Equity Method Investment - Summarized financial information (Details)", "menuCat": "Details", "order": "28", "role": "http://www.xcelbrands.com/role/DisclosureEquityMethodInvestmentSummarizedFinancialInformationDetails", "shortName": "Equity Method Investment - Summarized financial information (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "us-gaap:EquityMethodInvestmentsTextBlock", "us-gaap:EquityMethodInvestmentsDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "xelb-20230331x10q.htm", "contextRef": "Duration_1_1_2023_To_3_31_2023_srt_OwnershipAxis_xelb_IMTopcoLLCMember_uA-k_kpu7EWk5tJ4oBdTYQ", "decimals": "-3", "lang": null, "name": "us-gaap:Revenues", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_z_CXhzMrjkC9_PUwukjvAQ", "xsiNil": "false" } }, "R29": { "firstAnchor": { "ancestors": [ "p", "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "xelb-20230331x10q.htm", "contextRef": "Duration_1_1_2023_To_3_31_2023_gEvb94xNAE2WJfB2T7RkIw", "decimals": "-4", "first": true, "lang": null, "name": "us-gaap:AmortizationOfIntangibleAssets", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_z_CXhzMrjkC9_PUwukjvAQ", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "40301 - Disclosure - Trademarks and Other Intangibles - Narrative (Details)", "menuCat": "Details", "order": "29", "role": "http://www.xcelbrands.com/role/DisclosureTrademarksAndOtherIntangiblesNarrativeDetails", "shortName": "Trademarks and Other Intangibles - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "xelb-20230331x10q.htm", "contextRef": "Duration_1_1_2023_To_3_31_2023_gEvb94xNAE2WJfB2T7RkIw", "decimals": "-4", "first": true, "lang": null, "name": "us-gaap:AmortizationOfIntangibleAssets", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_z_CXhzMrjkC9_PUwukjvAQ", "xsiNil": "false" } }, "R3": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "xelb-20230331x10q.htm", "contextRef": "As_Of_3_31_2023_VDBSL1P2q0qhICaSzA3qew", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:PreferredStockParOrStatedValuePerShare", "reportCount": 1, "unique": true, "unitRef": "Unit_Divide_USD_shares_SsYDDmtpD0CfipR2ERuG1g", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00105 - Statement - Consolidated Balance Sheets (Parenthetical)", "menuCat": "Statements", "order": "3", "role": "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheetsParenthetical", "shortName": "Consolidated Balance Sheets (Parenthetical)", "subGroupType": "parenthetical", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "xelb-20230331x10q.htm", "contextRef": "As_Of_3_31_2023_VDBSL1P2q0qhICaSzA3qew", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:PreferredStockParOrStatedValuePerShare", "reportCount": 1, "unique": true, "unitRef": "Unit_Divide_USD_shares_SsYDDmtpD0CfipR2ERuG1g", "xsiNil": "false" } }, "R30": { "firstAnchor": { "ancestors": [ "b", "p", "td", "tr", "table", "us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock", "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "xelb-20230331x10q.htm", "contextRef": "As_Of_3_31_2023_VDBSL1P2q0qhICaSzA3qew", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:FiniteLivedIntangibleAssetsGross", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_z_CXhzMrjkC9_PUwukjvAQ", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "40302 - Disclosure - Trademarks and Other Intangibles - Schedule of Trademarks and Other Intangibles (Details)", "menuCat": "Details", "order": "30", "role": "http://www.xcelbrands.com/role/DisclosureTrademarksAndOtherIntangiblesScheduleOfTrademarksAndOtherIntangiblesDetails", "shortName": "Trademarks and Other Intangibles - Schedule of Trademarks and Other Intangibles (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "b", "p", "td", "tr", "table", "us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock", "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "xelb-20230331x10q.htm", "contextRef": "As_Of_3_31_2023_VDBSL1P2q0qhICaSzA3qew", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:FiniteLivedIntangibleAssetsGross", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_z_CXhzMrjkC9_PUwukjvAQ", "xsiNil": "false" } }, "R31": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "xelb-20230331x10q.htm", "contextRef": "Duration_1_1_2023_To_3_31_2023_gEvb94xNAE2WJfB2T7RkIw", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax", "reportCount": 1, "unitRef": "Unit_Standard_USD_z_CXhzMrjkC9_PUwukjvAQ", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "40401 - Disclosure - Significant Contracts and Concentrations - Narrative (Details)", "menuCat": "Details", "order": "31", "role": "http://www.xcelbrands.com/role/DisclosureSignificantContractsAndConcentrationsNarrativeDetails", "shortName": "Significant Contracts and Concentrations - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ConcentrationRiskDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "xelb-20230331x10q.htm", "contextRef": "Duration_1_1_2023_To_3_31_2023_srt_MajorCustomersAxis_xelb_QurateRetailGroupMember_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_CustomerConcentrationRiskMember_p6xb0q6iTkCeTUNSXmQ1ew", "decimals": "2", "lang": null, "name": "us-gaap:ConcentrationRiskPercentage1", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_pure_ZB_L-admoE6jhTO9VkC0mQ", "xsiNil": "false" } }, "R32": { "firstAnchor": { "ancestors": [ "p", "xelb:AccountsReceivableTextBlock", "div", "div", "body", "html" ], "baseRef": "xelb-20230331x10q.htm", "contextRef": "As_Of_3_31_2023_VDBSL1P2q0qhICaSzA3qew", "decimals": "-4", "first": true, "lang": null, "name": "us-gaap:AllowanceForDoubtfulAccountsReceivable", "reportCount": 1, "unitRef": "Unit_Standard_USD_z_CXhzMrjkC9_PUwukjvAQ", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "40501 - Disclosure - Accounts Receivable (Details)", "menuCat": "Details", "order": "32", "role": "http://www.xcelbrands.com/role/DisclosureAccountsReceivableDetails", "shortName": "Accounts Receivable (Details)", "subGroupType": "details", "uniqueAnchor": null }, "R33": { "firstAnchor": { "ancestors": [ "p", "us-gaap:LesseeOperatingLeasesTextBlock", "div", "div", "body", "html" ], "baseRef": "xelb-20230331x10q.htm", "contextRef": "As_Of_3_31_2023_VDBSL1P2q0qhICaSzA3qew", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1", "reportCount": 1, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "40601 - Disclosure - Leases - Narrative (Details)", "menuCat": "Details", "order": "33", "role": "http://www.xcelbrands.com/role/DisclosureLeasesNarrativeDetails", "shortName": "Leases - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "us-gaap:OperatingLeaseExpense", "p", "us-gaap:LesseeOperatingLeasesTextBlock", "div", "div", "body", "html" ], "baseRef": "xelb-20230331x10q.htm", "contextRef": "Duration_1_1_2023_To_3_31_2023_us-gaap_IncomeStatementLocationAxis_us-gaap_SellingGeneralAndAdministrativeExpensesMember_2HZ04n9Yf0SUWWippfERJw", "decimals": "-5", "lang": null, "name": "us-gaap:OperatingLeaseExpense", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_z_CXhzMrjkC9_PUwukjvAQ", "xsiNil": "false" } }, "R34": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "us-gaap:LesseeOperatingLeasesTextBlock", "div", "div", "body", "html" ], "baseRef": "xelb-20230331x10q.htm", "contextRef": "As_Of_3_31_2023_VDBSL1P2q0qhICaSzA3qew", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_z_CXhzMrjkC9_PUwukjvAQ", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "40602 - Disclosure - Leases - Maturities of Lease Liabilities (Details)", "menuCat": "Details", "order": "34", "role": "http://www.xcelbrands.com/role/DisclosureLeasesMaturitiesOfLeaseLiabilitiesDetails", "shortName": "Leases - Maturities of Lease Liabilities (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "us-gaap:LesseeOperatingLeasesTextBlock", "div", "div", "body", "html" ], "baseRef": "xelb-20230331x10q.htm", "contextRef": "As_Of_3_31_2023_VDBSL1P2q0qhICaSzA3qew", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_z_CXhzMrjkC9_PUwukjvAQ", "xsiNil": "false" } }, "R35": { "firstAnchor": { "ancestors": [ "p", "us-gaap:LongTermDebtTextBlock", "div", "div", "body", "html" ], "baseRef": "xelb-20230331x10q.htm", "contextRef": "Duration_1_1_2022_To_3_31_2022_-zcZ1pMGiECMh2nlxhqFpA", "decimals": "3", "first": true, "lang": null, "name": "us-gaap:DebtInstrumentInterestRateDuringPeriod", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_pure_ZB_L-admoE6jhTO9VkC0mQ", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "40701 - Disclosure - Debt - Narrative (Details)", "menuCat": "Details", "order": "35", "role": "http://www.xcelbrands.com/role/DisclosureDebtNarrativeDetails", "shortName": "Debt - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "us-gaap:LongTermDebtTextBlock", "div", "div", "body", "html" ], "baseRef": "xelb-20230331x10q.htm", "contextRef": "Duration_1_1_2022_To_3_31_2022_-zcZ1pMGiECMh2nlxhqFpA", "decimals": "3", "first": true, "lang": null, "name": "us-gaap:DebtInstrumentInterestRateDuringPeriod", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_pure_ZB_L-admoE6jhTO9VkC0mQ", "xsiNil": "false" } }, "R36": { "firstAnchor": { "ancestors": [ "p", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "xelb-20230331x10q.htm", "contextRef": "As_Of_3_31_2023_VDBSL1P2q0qhICaSzA3qew", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:CommonStockCapitalSharesReservedForFutureIssuance", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_shares_YfHhYTyGz0OsnI0Wlr4lDA", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "40801 - Disclosure - Stockholders' Equity - Equity Incentive Plans (Details)", "menuCat": "Details", "order": "36", "role": "http://www.xcelbrands.com/role/DisclosureStockholdersEquityEquityIncentivePlansDetails", "shortName": "Stockholders' Equity - Equity Incentive Plans (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "xelb-20230331x10q.htm", "contextRef": "As_Of_3_31_2023_VDBSL1P2q0qhICaSzA3qew", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:CommonStockCapitalSharesReservedForFutureIssuance", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_shares_YfHhYTyGz0OsnI0Wlr4lDA", "xsiNil": "false" } }, "R37": { "firstAnchor": { "ancestors": [ "p", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "xelb-20230331x10q.htm", "contextRef": "Duration_1_1_2023_To_3_31_2023_gEvb94xNAE2WJfB2T7RkIw", "decimals": "-4", "first": true, "lang": null, "name": "us-gaap:AllocatedShareBasedCompensationExpense", "reportCount": 1, "unitRef": "Unit_Standard_USD_z_CXhzMrjkC9_PUwukjvAQ", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "40802 - Disclosure - Stockholders' Equity - Stock-based Compensation (Details)", "menuCat": "Details", "order": "37", "role": "http://www.xcelbrands.com/role/DisclosureStockholdersEquityStockBasedCompensationDetails", "shortName": "Stockholders' Equity - Stock-based Compensation (Details)", "subGroupType": "details", "uniqueAnchor": null }, "R38": { "firstAnchor": { "ancestors": [ "p", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "xelb-20230331x10q.htm", "contextRef": "Duration_1_1_2023_To_3_31_2023_gEvb94xNAE2WJfB2T7RkIw", "decimals": "-4", "first": true, "lang": null, "name": "us-gaap:AllocatedShareBasedCompensationExpense", "reportCount": 1, "unitRef": "Unit_Standard_USD_z_CXhzMrjkC9_PUwukjvAQ", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "40803 - Disclosure - Stockholders' Equity - Stock Options (Details)", "menuCat": "Details", "order": "38", "role": "http://www.xcelbrands.com/role/DisclosureStockholdersEquityStockOptionsDetails", "shortName": "Stockholders' Equity - Stock Options (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "xelb-20230331x10q.htm", "contextRef": "Duration_1_1_2023_To_3_31_2023_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember__NkTigduH0qYvAsRFZuiLg", "decimals": "INF", "lang": null, "name": "xelb:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsCancellationsInPeriod", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_shares_YfHhYTyGz0OsnI0Wlr4lDA", "xsiNil": "false" } }, "R39": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "us-gaap:ScheduleOfStockOptionsRollForwardTableTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "xelb-20230331x10q.htm", "contextRef": "As_Of_12_31_2022_us-gaap_DeferredCompensationArrangementWithIndividualShareBasedPaymentsByTypeOfDeferredCompensationAxis_us-gaap_EmployeeStockOptionMember_p4WSYl8jGUC8-6jR9H61_A", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_shares_YfHhYTyGz0OsnI0Wlr4lDA", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "40806 - Disclosure - Stockholders' Equity - Non-Vested Options (Details)", "menuCat": "Details", "order": "39", "role": "http://www.xcelbrands.com/role/DisclosureStockholdersEquityNonVestedOptionsDetails", "shortName": "Stockholders' Equity - Non-Vested Options (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "us-gaap:ScheduleOfStockOptionsRollForwardTableTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "xelb-20230331x10q.htm", "contextRef": "As_Of_12_31_2022_us-gaap_DeferredCompensationArrangementWithIndividualShareBasedPaymentsByTypeOfDeferredCompensationAxis_us-gaap_EmployeeStockOptionMember_p4WSYl8jGUC8-6jR9H61_A", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_shares_YfHhYTyGz0OsnI0Wlr4lDA", "xsiNil": "false" } }, "R4": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "xelb-20230331x10q.htm", "contextRef": "Duration_1_1_2023_To_3_31_2023_gEvb94xNAE2WJfB2T7RkIw", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax", "reportCount": 1, "unitRef": "Unit_Standard_USD_z_CXhzMrjkC9_PUwukjvAQ", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00200 - Statement - Consolidated Statements of Operations", "menuCat": "Statements", "order": "4", "role": "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfOperations", "shortName": "Consolidated Statements of Operations", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "xelb-20230331x10q.htm", "contextRef": "Duration_1_1_2023_To_3_31_2023_gEvb94xNAE2WJfB2T7RkIw", "decimals": "-3", "lang": null, "name": "us-gaap:CostOfGoodsAndServicesSold", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_z_CXhzMrjkC9_PUwukjvAQ", "xsiNil": "false" } }, "R40": { "firstAnchor": { "ancestors": [ "p", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "xelb-20230331x10q.htm", "contextRef": "Duration_1_1_2023_To_3_31_2023_gEvb94xNAE2WJfB2T7RkIw", "decimals": "-4", "first": true, "lang": null, "name": "us-gaap:AllocatedShareBasedCompensationExpense", "reportCount": 1, "unitRef": "Unit_Standard_USD_z_CXhzMrjkC9_PUwukjvAQ", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "40807 - Disclosure - Stockholders' Equity - Warrants (Details)", "menuCat": "Details", "order": "40", "role": "http://www.xcelbrands.com/role/DisclosureStockholdersEquityWarrantsDetails", "shortName": "Stockholders' Equity - Warrants (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "xelb-20230331x10q.htm", "contextRef": "Duration_1_1_2023_To_3_31_2023_us-gaap_AwardTypeAxis_us-gaap_WarrantMember_-SEYaMry-UyoTmFw4ck9qQ", "decimals": "INF", "lang": null, "name": "xelb:ClassOfWarrantOrRightGranted", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_shares_YfHhYTyGz0OsnI0Wlr4lDA", "xsiNil": "false" } }, "R41": { "firstAnchor": { "ancestors": [ "p", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "xelb-20230331x10q.htm", "contextRef": "Duration_1_1_2023_To_3_31_2023_gEvb94xNAE2WJfB2T7RkIw", "decimals": "-4", "first": true, "lang": null, "name": "us-gaap:AllocatedShareBasedCompensationExpense", "reportCount": 1, "unitRef": "Unit_Standard_USD_z_CXhzMrjkC9_PUwukjvAQ", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "40808 - Disclosure - Stockholders' Equity - Stock Awards (Details)", "menuCat": "Details", "order": "41", "role": "http://www.xcelbrands.com/role/DisclosureStockholdersEquityStockAwardsDetails", "shortName": "Stockholders' Equity - Stock Awards (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "us-gaap:ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "xelb-20230331x10q.htm", "contextRef": "As_Of_12_31_2022_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockMember_dzTFtJwgAkaqh-YY3ZXprg", "decimals": "INF", "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_shares_YfHhYTyGz0OsnI0Wlr4lDA", "xsiNil": "false" } }, "R42": { "firstAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "xelb-20230331x10q.htm", "contextRef": "As_Of_12_31_2022_9wUGVqTt6UW3yIP_pgdoWw", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:CommonStockSharesOutstanding", "reportCount": 1, "unitRef": "Unit_Standard_shares_YfHhYTyGz0OsnI0Wlr4lDA", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "40809 - Disclosure - Stockholders' Equity - Restricted Stock (Details)", "menuCat": "Details", "order": "42", "role": "http://www.xcelbrands.com/role/DisclosureStockholdersEquityRestrictedStockDetails", "shortName": "Stockholders' Equity - Restricted Stock (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "xelb-20230331x10q.htm", "contextRef": "As_Of_3_31_2023_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockMember_GyfC9frPg0ukq4_qiuHJZA", "decimals": "INF", "lang": null, "name": "us-gaap:CommonStockSharesOutstanding", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_shares_YfHhYTyGz0OsnI0Wlr4lDA", "xsiNil": "false" } }, "R43": { "firstAnchor": { "ancestors": [ "b", "p", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "xelb-20230331x10q.htm", "contextRef": "Duration_1_1_2023_To_3_31_2023_gEvb94xNAE2WJfB2T7RkIw", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:NetIncomeLoss", "reportCount": 1, "unitRef": "Unit_Standard_USD_z_CXhzMrjkC9_PUwukjvAQ", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "40901 - Disclosure - Earnings (Loss) Per Share - Basic and Diluted Earnings Per Share (Details)", "menuCat": "Details", "order": "43", "role": "http://www.xcelbrands.com/role/DisclosureEarningsLossPerShareBasicAndDilutedEarningsPerShareDetails", "shortName": "Earnings (Loss) Per Share - Basic and Diluted Earnings Per Share (Details)", "subGroupType": "details", "uniqueAnchor": null }, "R44": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "xelb-20230331x10q.htm", "contextRef": "Duration_1_1_2023_To_3_31_2023_gEvb94xNAE2WJfB2T7RkIw", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_shares_YfHhYTyGz0OsnI0Wlr4lDA", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "40902 - Disclosure - Earnings (Loss) Per Share - Anti-dilutive Securities Excluded (Details)", "menuCat": "Details", "order": "44", "role": "http://www.xcelbrands.com/role/DisclosureEarningsLossPerShareAntiDilutiveSecuritiesExcludedDetails", "shortName": "Earnings (Loss) Per Share - Anti-dilutive Securities Excluded (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "xelb-20230331x10q.htm", "contextRef": "Duration_1_1_2023_To_3_31_2023_gEvb94xNAE2WJfB2T7RkIw", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_shares_YfHhYTyGz0OsnI0Wlr4lDA", "xsiNil": "false" } }, "R45": { "firstAnchor": { "ancestors": [ "p", "us-gaap:IncomeTaxDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "xelb-20230331x10q.htm", "contextRef": "Duration_1_1_2022_To_3_31_2023_o9AEhRa1ckKYwE9-_ZW7bA", "decimals": "2", "first": true, "lang": null, "name": "us-gaap:EffectiveIncomeTaxRateContinuingOperations", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_pure_ZB_L-admoE6jhTO9VkC0mQ", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "41003 - Disclosure - Income Taxes (Details)", "menuCat": "Details", "order": "45", "role": "http://www.xcelbrands.com/role/DisclosureIncomeTaxesDetails", "shortName": "Income Taxes (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "us-gaap:IncomeTaxDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "xelb-20230331x10q.htm", "contextRef": "Duration_1_1_2022_To_3_31_2023_o9AEhRa1ckKYwE9-_ZW7bA", "decimals": "2", "first": true, "lang": null, "name": "us-gaap:EffectiveIncomeTaxRateContinuingOperations", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_pure_ZB_L-admoE6jhTO9VkC0mQ", "xsiNil": "false" } }, "R46": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "us-gaap:ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "xelb-20230331x10q.htm", "contextRef": "Duration_1_1_2023_To_3_31_2023_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockMember_uiE2NnK5KUetv7qIn1PYVA", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod", "reportCount": 1, "unitRef": "Unit_Standard_shares_YfHhYTyGz0OsnI0Wlr4lDA", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "41101 - Disclosure - Related Party Transactions - Isaac Mizrahi (Details)", "menuCat": "Details", "order": "46", "role": "http://www.xcelbrands.com/role/DisclosureRelatedPartyTransactionsIsaacMizrahiDetails", "shortName": "Related Party Transactions - Isaac Mizrahi (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "xelb-20230331x10q.htm", "contextRef": "As_Of_5_31_2022_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_xelb_ImTopcoMember_us-gaap_TypeOfArrangementAxis_xelb_ServicesAgreementMember_ncO9Z1q0FECqHCQbbS6JbA", "decimals": "INF", "lang": null, "name": "us-gaap:DueFromRelatedParties", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_z_CXhzMrjkC9_PUwukjvAQ", "xsiNil": "false" } }, "R47": { "firstAnchor": { "ancestors": [ "p", "us-gaap:LesseeOperatingLeasesTextBlock", "div", "div", "body", "html" ], "baseRef": "xelb-20230331x10q.htm", "contextRef": "As_Of_3_31_2023_VDBSL1P2q0qhICaSzA3qew", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1", "reportCount": 1, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "41201 - Disclosure - Commitments and Contingencies - Narrative (Details)", "menuCat": "Details", "order": "47", "role": "http://www.xcelbrands.com/role/DisclosureCommitmentsAndContingenciesNarrativeDetails", "shortName": "Commitments and Contingencies - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "xelb-20230331x10q.htm", "contextRef": "Duration_1_1_2022_To_12_31_2022_JQh73yKQjUmaMK8EMdlHLw", "decimals": "-5", "lang": null, "name": "xelb:AssetAcquisitionAdditionalConsiderationPayableToSeller", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_z_CXhzMrjkC9_PUwukjvAQ", "xsiNil": "false" } }, "R48": { "firstAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "xelb-20230331x10q.htm", "contextRef": "As_Of_12_31_2022_9wUGVqTt6UW3yIP_pgdoWw", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:CommonStockSharesOutstanding", "reportCount": 1, "unitRef": "Unit_Standard_shares_YfHhYTyGz0OsnI0Wlr4lDA", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "41301 - Disclosure - Subsequent Events - Narrative (Details)", "menuCat": "Details", "order": "48", "role": "http://www.xcelbrands.com/role/DisclosureSubsequentEventsNarrativeDetails", "shortName": "Subsequent Events - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "us-gaap:SubsequentEventsTextBlock", "div", "div", "body", "html" ], "baseRef": "xelb-20230331x10q.htm", "contextRef": "Duration_5_15_2023_To_5_15_2023_srt_CounterpartyNameAxis_xelb_HalstonBrandMember_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember_DeLf3-E2k02B471av9RYIA", "decimals": "-5", "lang": null, "name": "xelb:AssetAcquisitionPrice", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_z_CXhzMrjkC9_PUwukjvAQ", "xsiNil": "false" } }, "R49": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "xelb-20230331x10q.htm", "contextRef": "As_Of_3_31_2023_VDBSL1P2q0qhICaSzA3qew", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:AccountsReceivableNetCurrent", "reportCount": 1, "unitRef": "Unit_Standard_USD_z_CXhzMrjkC9_PUwukjvAQ", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "9940202 - Disclosure - Summary of Significant Accounting Policies - Accounts Receivable (Details) 10K", "menuCat": "Details", "order": "49", "role": "http://www.xcelbrands.com/role/DisclosureSummaryOfSignificantAccountingPoliciesAccountsReceivableDetails10k", "shortName": "Summary of Significant Accounting Policies - Accounts Receivable (Details) 10K", "subGroupType": "details", "uniqueAnchor": null }, "R5": { "firstAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "xelb-20230331x10q.htm", "contextRef": "As_Of_12_31_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_sHB16hjGj0atUb0WE4pJiw", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_z_CXhzMrjkC9_PUwukjvAQ", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00300 - Statement - Consolidated Statements of Stockholders' Equity", "menuCat": "Statements", "order": "5", "role": "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfStockholdersEquity", "shortName": "Consolidated Statements of Stockholders' Equity", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "xelb-20230331x10q.htm", "contextRef": "As_Of_12_31_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_sHB16hjGj0atUb0WE4pJiw", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_z_CXhzMrjkC9_PUwukjvAQ", "xsiNil": "false" } }, "R6": { "firstAnchor": { "ancestors": [ "b", "p", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "xelb-20230331x10q.htm", "contextRef": "Duration_1_1_2023_To_3_31_2023_gEvb94xNAE2WJfB2T7RkIw", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:ProfitLoss", "reportCount": 1, "unitRef": "Unit_Standard_USD_z_CXhzMrjkC9_PUwukjvAQ", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00400 - Statement - Consolidated Statements of Cash Flows", "menuCat": "Statements", "order": "6", "role": "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfCashFlows", "shortName": "Consolidated Statements of Cash Flows", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "xelb-20230331x10q.htm", "contextRef": "Duration_1_1_2022_To_3_31_2022_-zcZ1pMGiECMh2nlxhqFpA", "decimals": "-3", "lang": null, "name": "us-gaap:AmortizationOfFinancingCosts", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_z_CXhzMrjkC9_PUwukjvAQ", "xsiNil": "false" } }, "R7": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "xelb-20230331x10q.htm", "contextRef": "Duration_1_1_2023_To_3_31_2023_gEvb94xNAE2WJfB2T7RkIw", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "10101 - Disclosure - Nature of Operations, Background, and Basis of Presentation", "menuCat": "Notes", "order": "7", "role": "http://www.xcelbrands.com/role/DisclosureNatureOfOperationsBackgroundAndBasisOfPresentation", "shortName": "Nature of Operations, Background, and Basis of Presentation", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "xelb-20230331x10q.htm", "contextRef": "Duration_1_1_2023_To_3_31_2023_gEvb94xNAE2WJfB2T7RkIw", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R8": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "xelb-20230331x10q.htm", "contextRef": "Duration_1_1_2023_To_3_31_2023_gEvb94xNAE2WJfB2T7RkIw", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:EquityMethodInvestmentsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "10201 - Disclosure - Equity Method Investment", "menuCat": "Notes", "order": "8", "role": "http://www.xcelbrands.com/role/DisclosureEquityMethodInvestment", "shortName": "Equity Method Investment", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "xelb-20230331x10q.htm", "contextRef": "Duration_1_1_2023_To_3_31_2023_gEvb94xNAE2WJfB2T7RkIw", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:EquityMethodInvestmentsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R9": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "xelb-20230331x10q.htm", "contextRef": "Duration_1_1_2023_To_3_31_2023_gEvb94xNAE2WJfB2T7RkIw", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "10301 - Disclosure - Trademarks and Other Intangibles", "menuCat": "Notes", "order": "9", "role": "http://www.xcelbrands.com/role/DisclosureTrademarksAndOtherIntangibles", "shortName": "Trademarks and Other Intangibles", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "xelb-20230331x10q.htm", "contextRef": "Duration_1_1_2023_To_3_31_2023_gEvb94xNAE2WJfB2T7RkIw", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 43, "tag": { "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag", "terseLabel": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.xcelbrands.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.xcelbrands.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Document And Entity Information [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2022", "xbrltype": "stringItemType" }, "dei_CurrentFiscalYearEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "End date of current fiscal year in the format --MM-DD.", "label": "Current Fiscal Year End Date", "terseLabel": "Current Fiscal Year End Date" } } }, "localname": "CurrentFiscalYearEndDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.xcelbrands.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "gMonthDayItemType" }, "dei_DocumentFiscalPeriodFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.", "label": "Document Fiscal Period Focus", "terseLabel": "Document Fiscal Period Focus" } } }, "localname": "DocumentFiscalPeriodFocus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.xcelbrands.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "fiscalPeriodItemType" }, "dei_DocumentFiscalYearFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.", "label": "Document Fiscal Year Focus", "terseLabel": "Document Fiscal Year Focus" } } }, "localname": "DocumentFiscalYearFocus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.xcelbrands.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "gYearItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date", "terseLabel": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.xcelbrands.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "dateItemType" }, "dei_DocumentQuarterlyReport": { "auth_ref": [ "r531" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an quarterly report.", "label": "Document Quarterly Report" } } }, "localname": "DocumentQuarterlyReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.xcelbrands.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_DocumentTransitionReport": { "auth_ref": [ "r532" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a transition report.", "label": "Document Transition Report" } } }, "localname": "DocumentTransitionReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.xcelbrands.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type", "terseLabel": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.xcelbrands.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "submissionTypeItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.xcelbrands.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.xcelbrands.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.xcelbrands.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.xcelbrands.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r529" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key", "terseLabel": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.xcelbrands.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityCommonStockSharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.", "label": "Entity Common Stock, Shares Outstanding", "terseLabel": "Entity Common Stock, Shares Outstanding" } } }, "localname": "EntityCommonStockSharesOutstanding", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.xcelbrands.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "sharesItemType" }, "dei_EntityCurrentReportingStatus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Current Reporting Status", "terseLabel": "Entity Current Reporting Status" } } }, "localname": "EntityCurrentReportingStatus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.xcelbrands.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "yesNoItemType" }, "dei_EntityDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains.", "label": "Entity [Domain]" } } }, "localname": "EntityDomain", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.xcelbrands.com/role/DisclosureCommitmentsAndContingenciesNarrativeDetails", "http://www.xcelbrands.com/role/DisclosureEquityMethodInvestmentImTopcoLlcDetails" ], "xbrltype": "domainItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r529" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company", "terseLabel": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.xcelbrands.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.xcelbrands.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "fileNumberItemType" }, "dei_EntityFilerCategory": { "auth_ref": [ "r529" ], "lang": { "en-us": { "role": { "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Filer Category", "terseLabel": "Entity Filer Category" } } }, "localname": "EntityFilerCategory", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.xcelbrands.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "filerCategoryItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.xcelbrands.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityInteractiveDataCurrent": { "auth_ref": [ "r533" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).", "label": "Entity Interactive Data Current" } } }, "localname": "EntityInteractiveDataCurrent", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.xcelbrands.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "yesNoItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r529" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name", "terseLabel": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.xcelbrands.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityShellCompany": { "auth_ref": [ "r529" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.", "label": "Entity Shell Company", "terseLabel": "Entity Shell Company" } } }, "localname": "EntityShellCompany", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.xcelbrands.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntitySmallBusiness": { "auth_ref": [ "r529" ], "lang": { "en-us": { "role": { "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).", "label": "Entity Small Business", "terseLabel": "Entity Small Business" } } }, "localname": "EntitySmallBusiness", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.xcelbrands.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r529" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.xcelbrands.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "employerIdItemType" }, "dei_LegalEntityAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The set of legal entities associated with a report.", "label": "Legal Entity [Axis]" } } }, "localname": "LegalEntityAxis", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.xcelbrands.com/role/DisclosureCommitmentsAndContingenciesNarrativeDetails", "http://www.xcelbrands.com/role/DisclosureEquityMethodInvestmentImTopcoLlcDetails" ], "xbrltype": "stringItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.xcelbrands.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r528" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.xcelbrands.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r530" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.xcelbrands.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.xcelbrands.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "tradingSymbolItemType" }, "srt_ConsolidatedEntitiesAxis": { "auth_ref": [ "r176", "r359", "r360", "r363", "r364", "r426", "r501", "r555", "r558", "r559" ], "lang": { "en-us": { "role": { "label": "Consolidated Entities [Axis]" } } }, "localname": "ConsolidatedEntitiesAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.xcelbrands.com/role/DisclosureNatureOfOperationsBackgroundAndBasisOfPresentationDetails" ], "xbrltype": "stringItemType" }, "srt_ConsolidatedEntitiesDomain": { "auth_ref": [ "r176", "r359", "r360", "r363", "r364", "r426", "r501", "r555", "r558", "r559" ], "lang": { "en-us": { "role": { "label": "Consolidated Entities [Domain]" } } }, "localname": "ConsolidatedEntitiesDomain", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.xcelbrands.com/role/DisclosureNatureOfOperationsBackgroundAndBasisOfPresentationDetails" ], "xbrltype": "domainItemType" }, "srt_CounterpartyNameAxis": { "auth_ref": [ "r174", "r175", "r275", "r283", "r506", "r508" ], "lang": { "en-us": { "role": { "label": "Counterparty Name [Axis]" } } }, "localname": "CounterpartyNameAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.xcelbrands.com/role/DisclosureNatureOfOperationsBackgroundAndBasisOfPresentationLiquidityDetails", "http://www.xcelbrands.com/role/DisclosureSubsequentEventsNarrativeDetails" ], "xbrltype": "stringItemType" }, "srt_EquityMethodInvesteeNameDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Investment, Name [Domain]" } } }, "localname": "EquityMethodInvesteeNameDomain", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.xcelbrands.com/role/DisclosureEquityMethodInvestmentImTopcoLlcDetails", "http://www.xcelbrands.com/role/DisclosureSubsequentEventsNarrativeDetails" ], "xbrltype": "domainItemType" }, "srt_MajorCustomersAxis": { "auth_ref": [ "r224", "r517", "r561", "r609" ], "lang": { "en-us": { "role": { "label": "Customer [Axis]" } } }, "localname": "MajorCustomersAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.xcelbrands.com/role/DisclosureSignificantContractsAndConcentrationsNarrativeDetails" ], "xbrltype": "stringItemType" }, "srt_MaximumMember": { "auth_ref": [ "r260", "r261", "r262", "r263", "r302", "r460", "r485", "r502", "r503", "r515", "r520", "r527", "r560", "r602", "r603", "r604", "r605", "r606", "r607" ], "lang": { "en-us": { "role": { "label": "Maximum" } } }, "localname": "MaximumMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.xcelbrands.com/role/DisclosureCommitmentsAndContingenciesNarrativeDetails", "http://www.xcelbrands.com/role/DisclosureLeasesNarrativeDetails", "http://www.xcelbrands.com/role/DisclosureNatureOfOperationsBackgroundAndBasisOfPresentationLiquidityDetails", "http://www.xcelbrands.com/role/DisclosureSubsequentEventsNarrativeDetails" ], "xbrltype": "domainItemType" }, "srt_MinimumMember": { "auth_ref": [ "r260", "r261", "r262", "r263", "r302", "r460", "r485", "r502", "r503", "r515", "r520", "r527", "r560", "r602", "r603", "r604", "r605", "r606", "r607" ], "lang": { "en-us": { "role": { "label": "Minimum", "terseLabel": "Minimum" } } }, "localname": "MinimumMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.xcelbrands.com/role/DisclosureCommitmentsAndContingenciesNarrativeDetails", "http://www.xcelbrands.com/role/DisclosureLeasesNarrativeDetails", "http://www.xcelbrands.com/role/DisclosureNatureOfOperationsBackgroundAndBasisOfPresentationLiquidityDetails", "http://www.xcelbrands.com/role/DisclosureSubsequentEventsNarrativeDetails" ], "xbrltype": "domainItemType" }, "srt_NameOfMajorCustomerDomain": { "auth_ref": [ "r224", "r517", "r561", "r609" ], "lang": { "en-us": { "role": { "label": "Customer [Domain]" } } }, "localname": "NameOfMajorCustomerDomain", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.xcelbrands.com/role/DisclosureSignificantContractsAndConcentrationsNarrativeDetails" ], "xbrltype": "domainItemType" }, "srt_OwnershipAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Ownership [Axis]" } } }, "localname": "OwnershipAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.xcelbrands.com/role/DisclosureEquityMethodInvestmentImTopcoLlcDetails", "http://www.xcelbrands.com/role/DisclosureEquityMethodInvestmentSummarizedFinancialInformationDetails", "http://www.xcelbrands.com/role/DisclosureNatureOfOperationsBackgroundAndBasisOfPresentationDetails" ], "xbrltype": "stringItemType" }, "srt_OwnershipDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Ownership [Domain]" } } }, "localname": "OwnershipDomain", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.xcelbrands.com/role/DisclosureEquityMethodInvestmentImTopcoLlcDetails", "http://www.xcelbrands.com/role/DisclosureEquityMethodInvestmentSummarizedFinancialInformationDetails", "http://www.xcelbrands.com/role/DisclosureNatureOfOperationsBackgroundAndBasisOfPresentationDetails" ], "xbrltype": "domainItemType" }, "srt_ProductOrServiceAxis": { "auth_ref": [ "r222", "r461", "r516", "r526", "r552", "r553", "r561", "r608" ], "lang": { "en-us": { "role": { "label": "Product and Service [Axis]" } } }, "localname": "ProductOrServiceAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.xcelbrands.com/role/DisclosureSignificantContractsAndConcentrationsNarrativeDetails", "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfOperations" ], "xbrltype": "stringItemType" }, "srt_ProductsAndServicesDomain": { "auth_ref": [ "r222", "r461", "r516", "r526", "r552", "r553", "r561", "r608" ], "lang": { "en-us": { "role": { "label": "Product and Service [Domain]" } } }, "localname": "ProductsAndServicesDomain", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.xcelbrands.com/role/DisclosureSignificantContractsAndConcentrationsNarrativeDetails", "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfOperations" ], "xbrltype": "domainItemType" }, "srt_RangeAxis": { "auth_ref": [ "r260", "r261", "r262", "r263", "r300", "r302", "r328", "r329", "r330", "r436", "r460", "r485", "r502", "r503", "r515", "r520", "r527", "r551", "r560", "r603", "r604", "r605", "r606", "r607" ], "lang": { "en-us": { "role": { "label": "Range [Axis]" } } }, "localname": "RangeAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.xcelbrands.com/role/DisclosureCommitmentsAndContingenciesNarrativeDetails", "http://www.xcelbrands.com/role/DisclosureLeasesNarrativeDetails", "http://www.xcelbrands.com/role/DisclosureNatureOfOperationsBackgroundAndBasisOfPresentationLiquidityDetails", "http://www.xcelbrands.com/role/DisclosureSubsequentEventsNarrativeDetails" ], "xbrltype": "stringItemType" }, "srt_RangeMember": { "auth_ref": [ "r260", "r261", "r262", "r263", "r300", "r302", "r328", "r329", "r330", "r436", "r460", "r485", "r502", "r503", "r515", "r520", "r527", "r551", "r560", "r603", "r604", "r605", "r606", "r607" ], "lang": { "en-us": { "role": { "label": "Range [Domain]" } } }, "localname": "RangeMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.xcelbrands.com/role/DisclosureCommitmentsAndContingenciesNarrativeDetails", "http://www.xcelbrands.com/role/DisclosureLeasesNarrativeDetails", "http://www.xcelbrands.com/role/DisclosureNatureOfOperationsBackgroundAndBasisOfPresentationLiquidityDetails", "http://www.xcelbrands.com/role/DisclosureSubsequentEventsNarrativeDetails" ], "xbrltype": "domainItemType" }, "srt_RepurchaseAgreementCounterpartyNameDomain": { "auth_ref": [ "r174", "r175", "r275", "r283", "r507", "r508" ], "lang": { "en-us": { "role": { "label": "Counterparty Name [Domain]" } } }, "localname": "RepurchaseAgreementCounterpartyNameDomain", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.xcelbrands.com/role/DisclosureNatureOfOperationsBackgroundAndBasisOfPresentationLiquidityDetails", "http://www.xcelbrands.com/role/DisclosureSubsequentEventsNarrativeDetails" ], "xbrltype": "domainItemType" }, "srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis": { "auth_ref": [ "r232" ], "lang": { "en-us": { "role": { "label": "Investment, Name [Axis]" } } }, "localname": "ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.xcelbrands.com/role/DisclosureEquityMethodInvestmentImTopcoLlcDetails", "http://www.xcelbrands.com/role/DisclosureSubsequentEventsNarrativeDetails" ], "xbrltype": "stringItemType" }, "srt_TitleOfIndividualAxis": { "auth_ref": [ "r546", "r598" ], "lang": { "en-us": { "role": { "label": "Title of Individual [Axis]" } } }, "localname": "TitleOfIndividualAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.xcelbrands.com/role/DisclosureStockholdersEquityStockAwardsDetails", "http://www.xcelbrands.com/role/DisclosureStockholdersEquityStockBasedCompensationDetails", "http://www.xcelbrands.com/role/DisclosureStockholdersEquityStockOptionsDetails" ], "xbrltype": "stringItemType" }, "srt_TitleOfIndividualWithRelationshipToEntityDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Relationship to Entity [Domain]" } } }, "localname": "TitleOfIndividualWithRelationshipToEntityDomain", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.xcelbrands.com/role/DisclosureStockholdersEquityStockAwardsDetails", "http://www.xcelbrands.com/role/DisclosureStockholdersEquityStockBasedCompensationDetails", "http://www.xcelbrands.com/role/DisclosureStockholdersEquityStockOptionsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AccountingPoliciesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Summary of Significant Accounting Policies [Abstract]" } } }, "localname": "AccountingPoliciesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent": { "auth_ref": [ "r25" ], "calculation": { "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits.", "label": "Accounts Payable and Accrued Liabilities, Current", "terseLabel": "Accounts payable, accrued expenses and other current liabilities" } } }, "localname": "AccountsPayableAndAccruedLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccountsReceivableMember": { "auth_ref": [ "r499" ], "lang": { "en-us": { "role": { "documentation": "Due from customers or clients for goods or services that have been delivered or sold.", "label": "Accounts Receivable [Member]" } } }, "localname": "AccountsReceivableMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xcelbrands.com/role/DisclosureSignificantContractsAndConcentrationsNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AccountsReceivableNetCurrent": { "auth_ref": [ "r225", "r226" ], "calculation": { "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.", "label": "Accounts Receivable, Net, Current", "terseLabel": "Accounts receivable", "verboseLabel": "Accounts receivable, net" } } }, "localname": "AccountsReceivableNetCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xcelbrands.com/role/DisclosureSignificantContractsAndConcentrationsNarrativeDetails", "http://www.xcelbrands.com/role/DisclosureSummaryOfSignificantAccountingPoliciesAccountsReceivableDetails10k", "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccruedIncomeTaxesCurrent": { "auth_ref": [ "r15", "r118", "r128" ], "calculation": { "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all currently due domestic and foreign income tax obligations.", "label": "Accrued Income Taxes, Current", "terseLabel": "Accrued income taxes payable" } } }, "localname": "AccruedIncomeTaxesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdditionalPaidInCapital": { "auth_ref": [ "r20", "r525" ], "calculation": { "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.", "label": "Additional Paid in Capital, Common Stock", "verboseLabel": "Paid-in capital" } } }, "localname": "AdditionalPaidInCapital", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdditionalPaidInCapitalMember": { "auth_ref": [ "r334", "r335", "r336", "r542", "r543", "r544", "r591" ], "lang": { "en-us": { "role": { "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.", "label": "Paid-In Capital [Member]" } } }, "localname": "AdditionalPaidInCapitalMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfStockholdersEquity" ], "xbrltype": "domainItemType" }, "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": { "auth_ref": [ "r96", "r97", "r304" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.", "label": "Adjustments to Additional Paid in Capital, Share-based Compensation, Requisite Service Period Recognition", "terseLabel": "Compensation expense related to stock options and restricted stock" } } }, "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]", "verboseLabel": "Adjustments to reconcile net loss to net cash used in operating activities:" } } }, "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_AllocatedShareBasedCompensationExpense": { "auth_ref": [ "r332" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.", "label": "Allocated Share-based Compensation Expense", "terseLabel": "Compensation expense" } } }, "localname": "AllocatedShareBasedCompensationExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xcelbrands.com/role/DisclosureStockholdersEquityStockAwardsDetails", "http://www.xcelbrands.com/role/DisclosureStockholdersEquityStockBasedCompensationDetails", "http://www.xcelbrands.com/role/DisclosureStockholdersEquityStockOptionsDetails", "http://www.xcelbrands.com/role/DisclosureStockholdersEquityWarrantsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AllowanceForDoubtfulAccountsReceivable": { "auth_ref": [ "r155", "r227", "r241", "r243", "r244" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of allowance for credit loss on accounts receivable.", "label": "Allowance for Doubtful Accounts Receivable", "terseLabel": "Allowance for doubtful accounts receivable", "verboseLabel": "Allowance for doubtful accounts" } } }, "localname": "AllowanceForDoubtfulAccountsReceivable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xcelbrands.com/role/DisclosureAccountsReceivableDetails", "http://www.xcelbrands.com/role/DisclosureSummaryOfSignificantAccountingPoliciesAccountsReceivableDetails10k" ], "xbrltype": "monetaryItemType" }, "us-gaap_AmortizationOfFinancingCosts": { "auth_ref": [ "r37", "r278", "r400", "r539" ], "calculation": { "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfCashFlows": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization expense attributable to debt issuance costs.", "label": "Amortization of Debt Issuance Costs", "verboseLabel": "Amortization of deferred finance costs included in interest expense" } } }, "localname": "AmortizationOfFinancingCosts", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_AmortizationOfIntangibleAssets": { "auth_ref": [ "r51", "r70", "r75" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.", "label": "Amortization of Intangible Assets", "verboseLabel": "Amortization expense for intangible assets" } } }, "localname": "AmortizationOfIntangibleAssets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xcelbrands.com/role/DisclosureTrademarksAndOtherIntangiblesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": { "auth_ref": [ "r201" ], "lang": { "en-us": { "role": { "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.", "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount", "verboseLabel": "Dilutive securities" } } }, "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xcelbrands.com/role/DisclosureEarningsLossPerShareAntiDilutiveSecuritiesExcludedDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]", "terseLabel": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]" } } }, "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xcelbrands.com/role/DisclosureEarningsLossPerShareAntiDilutiveSecuritiesExcludedDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ArrangementsAndNonarrangementTransactionsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.", "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Domain]" } } }, "localname": "ArrangementsAndNonarrangementTransactionsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xcelbrands.com/role/DisclosureEquityMethodInvestmentImTopcoLlcDetails", "http://www.xcelbrands.com/role/DisclosureRelatedPartyTransactionsIsaacMizrahiDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AssetAcquisitionAxis": { "auth_ref": [ "r589" ], "lang": { "en-us": { "role": { "documentation": "Information by asset acquisition.", "label": "Asset Acquisition [Axis]" } } }, "localname": "AssetAcquisitionAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xcelbrands.com/role/DisclosureCommitmentsAndContingenciesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AssetAcquisitionContingentConsiderationLiabilityCurrent": { "auth_ref": [ "r589" ], "calculation": { "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheets": { "order": 5.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liability recognized from contingent consideration in asset acquisition, classified as current.", "label": "Business Combination, Contingent Consideration, Liability, Current", "terseLabel": "Earn-out balance before settlement", "verboseLabel": "Current portion of contingent obligations" } } }, "localname": "AssetAcquisitionContingentConsiderationLiabilityCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xcelbrands.com/role/DisclosureCommitmentsAndContingenciesNarrativeDetails", "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetAcquisitionContingentConsiderationLiabilityNoncurrent": { "auth_ref": [ "r589" ], "calculation": { "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesNoncurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liability recognized from contingent consideration in asset acquisition, classified as noncurrent.", "label": "Business Combination, Contingent Consideration, Liability, Noncurrent", "terseLabel": "Long-term portion of contingent obligations", "verboseLabel": "Contingent obligation" } } }, "localname": "AssetAcquisitionContingentConsiderationLiabilityNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xcelbrands.com/role/DisclosureCommitmentsAndContingenciesNarrativeDetails", "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetAcquisitionDomain": { "auth_ref": [ "r589" ], "lang": { "en-us": { "role": { "documentation": "Asset acquisition.", "label": "Asset Acquisition [Domain]" } } }, "localname": "AssetAcquisitionDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xcelbrands.com/role/DisclosureCommitmentsAndContingenciesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_Assets": { "auth_ref": [ "r117", "r127", "r153", "r171", "r212", "r216", "r220", "r233", "r264", "r265", "r267", "r268", "r269", "r270", "r271", "r273", "r274", "r359", "r363", "r382", "r525", "r556", "r557", "r600" ], "calculation": { "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheets": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets", "totalLabel": "Total Assets" } } }, "localname": "Assets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Assets [Abstract]", "verboseLabel": "Assets" } } }, "localname": "AssetsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsCurrent": { "auth_ref": [ "r147", "r157", "r171", "r233", "r264", "r265", "r267", "r268", "r269", "r270", "r271", "r273", "r274", "r359", "r363", "r382", "r525", "r556", "r557", "r600" ], "calculation": { "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets, Current", "totalLabel": "Total current assets" } } }, "localname": "AssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Assets, Current [Abstract]", "verboseLabel": "Current Assets:" } } }, "localname": "AssetsCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsNoncurrent": { "auth_ref": [ "r171", "r233", "r264", "r265", "r267", "r268", "r269", "r270", "r271", "r273", "r274", "r359", "r363", "r382", "r556", "r557", "r600" ], "calculation": { "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold or consumed after one year or beyond the normal operating cycle, if longer.", "label": "Other Assets", "totalLabel": "Total non-current assets" } } }, "localname": "AssetsNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsNoncurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Assets, Noncurrent [Abstract]", "terseLabel": "Non-current Assets:" } } }, "localname": "AssetsNoncurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_AwardTypeAxis": { "auth_ref": [ "r306", "r307", "r308", "r309", "r310", "r311", "r312", "r313", "r314", "r315", "r316", "r317", "r318", "r319", "r320", "r321", "r322", "r323", "r324", "r325", "r326", "r327", "r328", "r329", "r330", "r331" ], "lang": { "en-us": { "role": { "documentation": "Information by type of award under share-based payment arrangement.", "label": "Award Type [Axis]" } } }, "localname": "AwardTypeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xcelbrands.com/role/DisclosureRelatedPartyTransactionsIsaacMizrahiDetails", "http://www.xcelbrands.com/role/DisclosureStockholdersEquityEquityIncentivePlansDetails", "http://www.xcelbrands.com/role/DisclosureStockholdersEquityNonVestedOptionsDetails", "http://www.xcelbrands.com/role/DisclosureStockholdersEquityRestrictedStockDetails", "http://www.xcelbrands.com/role/DisclosureStockholdersEquityStockAwardsDetails", "http://www.xcelbrands.com/role/DisclosureStockholdersEquityStockOptionsDetails", "http://www.xcelbrands.com/role/DisclosureStockholdersEquityWarrantsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_CashAndCashEquivalentsAtCarryingValue": { "auth_ref": [ "r53", "r149", "r504" ], "calculation": { "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 }, "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.", "label": "Cash and Cash Equivalents, at Carrying Value", "periodEndLabel": "Cash and cash equivalents", "verboseLabel": "Cash and cash equivalents" } } }, "localname": "CashAndCashEquivalentsAtCarryingValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xcelbrands.com/role/DisclosureNatureOfOperationsBackgroundAndBasisOfPresentationLiquidityDetails", "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheets", "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": { "auth_ref": [ "r47", "r53", "r55" ], "calculation": { "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfCashFlows": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents", "periodEndLabel": "Cash, cash equivalents, and restricted cash at end of period", "periodStartLabel": "Cash, cash equivalents, and restricted cash at beginning of period", "totalLabel": "Total cash, cash equivalents, and restricted cash" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": { "auth_ref": [ "r47", "r113" ], "calculation": { "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfCashFlows": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect", "totalLabel": "Net decrease in cash, cash equivalents, and restricted cash" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1": { "auth_ref": [ "r296" ], "lang": { "en-us": { "role": { "documentation": "Exercise price per share or per unit of warrants or rights outstanding.", "label": "Class of Warrant or Right, Exercise Price of Warrants or Rights", "terseLabel": "Warrants outstanding, exercise price (in dollars per share)" } } }, "localname": "ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xcelbrands.com/role/DisclosureSubsequentEventsNarrativeDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ClassOfWarrantOrRightOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of warrants or rights outstanding.", "label": "Class of Warrant or Right, Outstanding", "periodEndLabel": "Outstanding and exercisable, ending balance (in shares)", "periodStartLabel": "Outstanding and exercisable, beginning balance (in shares)" } } }, "localname": "ClassOfWarrantOrRightOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xcelbrands.com/role/DisclosureStockholdersEquityWarrantsDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_CommitmentsAndContingencies": { "auth_ref": [ "r30", "r122", "r134" ], "calculation": { "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.", "label": "Commitments and Contingency", "verboseLabel": "Commitments and Contingencies" } } }, "localname": "CommitmentsAndContingencies", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Commitments and Contingencies Disclosure [Abstract]" } } }, "localname": "CommitmentsAndContingenciesDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": { "auth_ref": [ "r81", "r258", "r259", "r500", "r554" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for commitments and contingencies.", "label": "Commitments and Contingencies Disclosure [Text Block]", "verboseLabel": "Commitments and Contingencies" } } }, "localname": "CommitmentsAndContingenciesDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xcelbrands.com/role/DisclosureCommitmentsAndContingencies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CommonStockCapitalSharesReservedForFutureIssuance": { "auth_ref": [ "r31" ], "lang": { "en-us": { "role": { "documentation": "Aggregate number of common shares reserved for future issuance.", "label": "Common Stock, Capital Shares Reserved for Future Issuance", "verboseLabel": "Shares of common stock reserved for issuance (in shares)" } } }, "localname": "CommonStockCapitalSharesReservedForFutureIssuance", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xcelbrands.com/role/DisclosureStockholdersEquityEquityIncentivePlansDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockMember": { "auth_ref": [ "r542", "r543", "r591" ], "lang": { "en-us": { "role": { "documentation": "Stock that is subordinate to all other stock of the issuer.", "label": "Common Stock" } } }, "localname": "CommonStockMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfStockholdersEquity" ], "xbrltype": "domainItemType" }, "us-gaap_CommonStockParOrStatedValuePerShare": { "auth_ref": [ "r19" ], "lang": { "en-us": { "role": { "documentation": "Face amount or stated value per share of common stock.", "label": "Common Stock, Par or Stated Value Per Share", "verboseLabel": "Common stock, par value (in dollars per share)" } } }, "localname": "CommonStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "perShareItemType" }, "us-gaap_CommonStockSharesAuthorized": { "auth_ref": [ "r19" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.", "label": "Common Stock, Shares Authorized", "verboseLabel": "Common stock, shares authorized (in shares)" } } }, "localname": "CommonStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesIssued": { "auth_ref": [ "r19" ], "lang": { "en-us": { "role": { "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.", "label": "Common Stock, Shares, Issued", "verboseLabel": "Common stock, shares issued (in shares)" } } }, "localname": "CommonStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xcelbrands.com/role/DisclosureStockholdersEquityRestrictedStockDetails", "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesOutstanding": { "auth_ref": [ "r19", "r83" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.", "label": "Common Stock, Shares, Outstanding", "terseLabel": "Purchaseable stock", "verboseLabel": "Common stock, shares outstanding (in shares)" } } }, "localname": "CommonStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xcelbrands.com/role/DisclosureStockholdersEquityRestrictedStockDetails", "http://www.xcelbrands.com/role/DisclosureSubsequentEventsNarrativeDetails", "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockValue": { "auth_ref": [ "r19", "r525" ], "calculation": { "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Common Stock, Value, Issued", "terseLabel": "Common stock, $.001 par value, 50,000,000 shares authorized, and 19,633,194 and 19,624,860 shares issued and outstanding at March 31, 2023 and December 31, 2022, respectively" } } }, "localname": "CommonStockValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_ConcentrationRiskBenchmarkDomain": { "auth_ref": [ "r60", "r61", "r110", "r111", "r224", "r499" ], "lang": { "en-us": { "role": { "documentation": "The denominator in a calculation of a disclosed concentration risk percentage.", "label": "Concentration Risk Benchmark [Domain]" } } }, "localname": "ConcentrationRiskBenchmarkDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xcelbrands.com/role/DisclosureSignificantContractsAndConcentrationsNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ConcentrationRiskByBenchmarkAxis": { "auth_ref": [ "r60", "r61", "r110", "r111", "r224", "r498", "r499" ], "lang": { "en-us": { "role": { "documentation": "Information by benchmark of concentration risk.", "label": "Concentration Risk Benchmark [Axis]" } } }, "localname": "ConcentrationRiskByBenchmarkAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xcelbrands.com/role/DisclosureSignificantContractsAndConcentrationsNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ConcentrationRiskByTypeAxis": { "auth_ref": [ "r60", "r61", "r110", "r111", "r224", "r499", "r610" ], "lang": { "en-us": { "role": { "documentation": "Information by type of concentration risk, for example, but not limited to, asset, liability, net assets, geographic, customer, employees, supplier, lender.", "label": "Concentration Risk Type [Axis]" } } }, "localname": "ConcentrationRiskByTypeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xcelbrands.com/role/DisclosureSignificantContractsAndConcentrationsNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ConcentrationRiskDisclosureTextBlock": { "auth_ref": [ "r63" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for any concentrations existing at the date of the financial statements that make an entity vulnerable to a reasonably possible, near-term, severe impact. This disclosure informs financial statement users about the general nature of the risk associated with the concentration, and may indicate the percentage of concentration risk as of the balance sheet date.", "label": "Collaborative Arrangement Disclosure [Text Block]", "terseLabel": "Significant Contracts and Concentrations" } } }, "localname": "ConcentrationRiskDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xcelbrands.com/role/DisclosureSignificantContracts" ], "xbrltype": "textBlockItemType" }, "us-gaap_ConcentrationRiskPercentage1": { "auth_ref": [ "r60", "r61", "r110", "r111", "r224" ], "lang": { "en-us": { "role": { "documentation": "For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the \"benchmark\" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.", "label": "Concentration Risk, Percentage" } } }, "localname": "ConcentrationRiskPercentage1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xcelbrands.com/role/DisclosureSignificantContractsAndConcentrationsNarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_ConcentrationRiskTable": { "auth_ref": [ "r58", "r60", "r61", "r62", "r110", "r112", "r499" ], "lang": { "en-us": { "role": { "documentation": "Describes the nature of a concentration, a benchmark to which it is compared, and the percentage that the risk is to the benchmark.", "label": "Concentration Risk [Table]" } } }, "localname": "ConcentrationRiskTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xcelbrands.com/role/DisclosureSignificantContractsAndConcentrationsNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ConcentrationRiskTypeDomain": { "auth_ref": [ "r60", "r61", "r110", "r111", "r224", "r499" ], "lang": { "en-us": { "role": { "documentation": "For an entity that discloses a concentration risk as a percentage of some financial balance or benchmark, identifies the type (for example, asset, liability, net assets, geographic, customer, employees, supplier, lender) of the concentration.", "label": "Concentration Risk Type [Domain]" } } }, "localname": "ConcentrationRiskTypeDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xcelbrands.com/role/DisclosureSignificantContractsAndConcentrationsNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ContractualObligation": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of contractual obligation, including but not limited to, long-term debt, capital lease obligations, operating lease obligations, purchase obligations, and other commitments.", "label": "Contractual Obligation", "terseLabel": "Contingent obligation" } } }, "localname": "ContractualObligation", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xcelbrands.com/role/DisclosureCommitmentsAndContingenciesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CostOfGoodsAndServicesSold": { "auth_ref": [ "r41", "r461" ], "calculation": { "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfOperations": { "order": 2.0, "parentTag": "us-gaap_GrossProfit", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.", "label": "Cost of Goods and Services Sold", "terseLabel": "Cost of goods sold" } } }, "localname": "CostOfGoodsAndServicesSold", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_CostsAndExpenses": { "auth_ref": [ "r38" ], "calculation": { "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfOperations": { "order": 2.0, "parentTag": "xelb_OperatingIncomeLossBeforeOtherExpense", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Total costs of sales and operating expenses for the period.", "label": "Costs and Expenses", "totalLabel": "Total operating costs and expenses" } } }, "localname": "CostsAndExpenses", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_CostsAndExpensesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Costs and Expenses [Abstract]", "verboseLabel": "Operating costs and expenses" } } }, "localname": "CostsAndExpensesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfOperations" ], "xbrltype": "stringItemType" }, "us-gaap_CustomerConcentrationRiskMember": { "auth_ref": [ "r59", "r224" ], "lang": { "en-us": { "role": { "documentation": "Reflects the percentage that revenues in the period from one or more significant customers is to net revenues, as defined by the entity, such as total net revenues, product line revenues, segment revenues. The risk is the materially adverse effects of loss of a significant customer.", "label": "Customer Concentration Risk [Member]" } } }, "localname": "CustomerConcentrationRiskMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xcelbrands.com/role/DisclosureSignificantContractsAndConcentrationsNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DebtDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Debt Disclosure [Abstract]" } } }, "localname": "DebtDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentInterestRateDuringPeriod": { "auth_ref": [ "r29", "r114", "r276" ], "lang": { "en-us": { "role": { "documentation": "The average effective interest rate during the reporting period.", "label": "Debt Instrument, Interest Rate During Period", "terseLabel": "Effective interest rate (as percentage)" } } }, "localname": "DebtInstrumentInterestRateDuringPeriod", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xcelbrands.com/role/DisclosureDebtNarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DeferredCompensationArrangementWithIndividualShareBasedPaymentsByTypeOfDeferredCompensationAxis": { "auth_ref": [ "r95" ], "lang": { "en-us": { "role": { "documentation": "Information by type of deferred compensation related to equity-based payment arrangements. Includes, but is not limited to, employment contracts with one or more selected officers or key employees. Excludes broad group equity-based compensation plans, defined benefit pension plans, defined benefit other postretirement benefit plans and other deferred compensation that is not equivalent to a defined benefit pension plan or a defined benefit other postretirement benefit plan.", "label": "Equity-Based Arrangements, Individual Contracts, Type of Deferred Compensation [Axis]" } } }, "localname": "DeferredCompensationArrangementWithIndividualShareBasedPaymentsByTypeOfDeferredCompensationAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xcelbrands.com/role/DisclosureEarningsLossPerShareAntiDilutiveSecuritiesExcludedDetails", "http://www.xcelbrands.com/role/DisclosureStockholdersEquityNonVestedOptionsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DeferredIncomeTaxAssetsNet": { "auth_ref": [ "r337", "r338" ], "calculation": { "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheets": { "order": 7.0, "parentTag": "us-gaap_AssetsNoncurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.", "label": "Deferred Income Tax Assets, Net", "terseLabel": "Deferred tax assets, net" } } }, "localname": "DeferredIncomeTaxAssetsNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_DepreciationDepletionAndAmortization": { "auth_ref": [ "r51", "r209" ], "calculation": { "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 }, "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfOperations": { "order": 1.0, "parentTag": "us-gaap_OtherOperatingIncomeExpenseNet", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.", "label": "Depreciation, Depletion and Amortization", "terseLabel": "Depreciation and amortization expense" } } }, "localname": "DepreciationDepletionAndAmortization", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfCashFlows", "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_DisposalGroupClassificationAxis": { "auth_ref": [ "r145" ], "lang": { "en-us": { "role": { "documentation": "Information by disposal group classification.", "label": "Disposal Group Classification [Axis]" } } }, "localname": "DisposalGroupClassificationAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xcelbrands.com/role/DisclosureCommitmentsAndContingenciesNarrativeDetails", "http://www.xcelbrands.com/role/DisclosureEquityMethodInvestmentImTopcoLlcDetails", "http://www.xcelbrands.com/role/DisclosureSubsequentEventsNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DisposalGroupClassificationDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Component or group of components disposed of, including but not limited to, disposal group held-for-sale or disposed of by sale, disposed of by means other than sale, and discontinued operations.", "label": "Disposal Group Classification [Domain]" } } }, "localname": "DisposalGroupClassificationDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xcelbrands.com/role/DisclosureCommitmentsAndContingenciesNarrativeDetails", "http://www.xcelbrands.com/role/DisclosureEquityMethodInvestmentImTopcoLlcDetails", "http://www.xcelbrands.com/role/DisclosureSubsequentEventsNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember": { "auth_ref": [ "r77", "r79" ], "lang": { "en-us": { "role": { "documentation": "Disposal group that has been sold. Excludes disposals classified as discontinued operations.", "label": "Disposed of by Sale" } } }, "localname": "DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xcelbrands.com/role/DisclosureCommitmentsAndContingenciesNarrativeDetails", "http://www.xcelbrands.com/role/DisclosureEquityMethodInvestmentImTopcoLlcDetails", "http://www.xcelbrands.com/role/DisclosureSubsequentEventsNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain": { "auth_ref": [ "r518", "r519" ], "lang": { "en-us": { "role": { "documentation": "Name of disposal group.", "label": "Disposal Group Name [Domain]" } } }, "localname": "DisposalGroupsIncludingDiscontinuedOperationsNameDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xcelbrands.com/role/DisclosureEquityMethodInvestmentImTopcoLlcDetails", "http://www.xcelbrands.com/role/DisclosureSubsequentEventsNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DueFromRelatedParties": { "auth_ref": [ "r121", "r135", "r154", "r266", "r267", "r268", "r272", "r273", "r274", "r423", "r541" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "For an unclassified balance sheet, amounts due from related parties including affiliates, employees, joint ventures, officers and stockholders, immediate families thereof, and pension funds.", "label": "Due from Related Parties", "terseLabel": "Due from related party" } } }, "localname": "DueFromRelatedParties", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xcelbrands.com/role/DisclosureRelatedPartyTransactionsIsaacMizrahiDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_EarningsPerShareAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Earnings (Loss) Per Share [Abstract]" } } }, "localname": "EarningsPerShareAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_EarningsPerShareBasic": { "auth_ref": [ "r164", "r185", "r186", "r187", "r188", "r189", "r194", "r196", "r198", "r199", "r200", "r204", "r376", "r377", "r480", "r483", "r509" ], "lang": { "en-us": { "role": { "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.", "label": "Earnings Per Share, Basic", "terseLabel": "Basic net loss per share" } } }, "localname": "EarningsPerShareBasic", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xcelbrands.com/role/DisclosureEarningsLossPerShareBasicAndDilutedEarningsPerShareDetails", "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfOperations" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerShareBasicAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Earnings Per Share, Basic [Abstract]", "terseLabel": "Loss per common share attributable to Xcel Brands, Inc. stockholders:" } } }, "localname": "EarningsPerShareBasicAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfOperations" ], "xbrltype": "stringItemType" }, "us-gaap_EarningsPerShareDiluted": { "auth_ref": [ "r164", "r185", "r186", "r187", "r188", "r189", "r196", "r198", "r199", "r200", "r204", "r376", "r377", "r480", "r483", "r509" ], "lang": { "en-us": { "role": { "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.", "label": "Earnings Per Share, Diluted", "terseLabel": "Diluted net loss per share" } } }, "localname": "EarningsPerShareDiluted", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xcelbrands.com/role/DisclosureEarningsLossPerShareBasicAndDilutedEarningsPerShareDetails", "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfOperations" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerShareDilutedAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Earnings Per Share, Diluted [Abstract]", "terseLabel": "Weighted average number of common shares outstanding:" } } }, "localname": "EarningsPerShareDilutedAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfOperations" ], "xbrltype": "stringItemType" }, "us-gaap_EarningsPerShareTextBlock": { "auth_ref": [ "r201", "r202", "r203", "r205" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for earnings per share.", "label": "Earnings Per Share [Text Block]", "verboseLabel": "Earnings (Loss) Per Share" } } }, "localname": "EarningsPerShareTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xcelbrands.com/role/DisclosureEarningsLossPerShare" ], "xbrltype": "textBlockItemType" }, "us-gaap_EffectiveIncomeTaxRateContinuingOperations": { "auth_ref": [ "r340" ], "lang": { "en-us": { "role": { "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.", "label": "Effective Income Tax Rate Reconciliation, Percent", "verboseLabel": "Effective income tax rate" } } }, "localname": "EffectiveIncomeTaxRateContinuingOperations", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xcelbrands.com/role/DisclosureIncomeTaxesDetails" ], "xbrltype": "percentItemType" }, "us-gaap_EmployeeRelatedLiabilitiesCurrent": { "auth_ref": [ "r27" ], "calculation": { "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Employee-related Liabilities, Current", "verboseLabel": "Accrued payroll" } } }, "localname": "EmployeeRelatedLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized": { "auth_ref": [ "r333" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cost not yet recognized for nonvested award under share-based payment arrangement.", "label": "Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized", "terseLabel": "Unrecognized compensation expense" } } }, "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xcelbrands.com/role/DisclosureStockholdersEquityStockAwardsDetails", "http://www.xcelbrands.com/role/DisclosureStockholdersEquityStockOptionsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1": { "auth_ref": [ "r333" ], "lang": { "en-us": { "role": { "documentation": "Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized, Period for Recognition", "terseLabel": "Weighted average period of recognition" } } }, "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xcelbrands.com/role/DisclosureStockholdersEquityStockAwardsDetails", "http://www.xcelbrands.com/role/DisclosureStockholdersEquityStockOptionsDetails" ], "xbrltype": "durationItemType" }, "us-gaap_EmployeeStockOptionMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time.", "label": "Stock options" } } }, "localname": "EmployeeStockOptionMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xcelbrands.com/role/DisclosureEarningsLossPerShareAntiDilutiveSecuritiesExcludedDetails", "http://www.xcelbrands.com/role/DisclosureStockholdersEquityEquityIncentivePlansDetails", "http://www.xcelbrands.com/role/DisclosureStockholdersEquityNonVestedOptionsDetails", "http://www.xcelbrands.com/role/DisclosureStockholdersEquityStockOptionsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_EquityBasedArrangementsIndividualContractsTypeOfDeferredCompensationDomain": { "auth_ref": [ "r95" ], "lang": { "en-us": { "role": { "documentation": "Deferred compensation related to equity-based payment arrangements. Includes, but is not limited to, employment contracts with one or more selected officers or key employees. Excludes broad group equity-based compensation plans, defined benefit pension plans, defined benefit other postretirement benefit plans and other deferred compensation that is not equivalent to a defined benefit pension plan or a defined benefit other postretirement benefit plan.", "label": "Equity-Based Arrangements, Individual Contracts, Type of Deferred Compensation [Domain]" } } }, "localname": "EquityBasedArrangementsIndividualContractsTypeOfDeferredCompensationDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xcelbrands.com/role/DisclosureEarningsLossPerShareAntiDilutiveSecuritiesExcludedDetails", "http://www.xcelbrands.com/role/DisclosureStockholdersEquityNonVestedOptionsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_EquityComponentDomain": { "auth_ref": [ "r83", "r142", "r160", "r161", "r162", "r177", "r178", "r179", "r182", "r190", "r192", "r206", "r238", "r297", "r334", "r335", "r336", "r346", "r347", "r375", "r391", "r392", "r393", "r394", "r395", "r396", "r419", "r488", "r489", "r490" ], "lang": { "en-us": { "role": { "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.", "label": "Equity Component [Domain]" } } }, "localname": "EquityComponentDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfStockholdersEquity" ], "xbrltype": "domainItemType" }, "us-gaap_EquityMethodInvestmentOwnershipPercentage": { "auth_ref": [ "r66" ], "lang": { "en-us": { "role": { "documentation": "The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.", "label": "Equity Method Investment, Ownership Percentage", "terseLabel": "Ownership interest" } } }, "localname": "EquityMethodInvestmentOwnershipPercentage", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xcelbrands.com/role/DisclosureEquityMethodInvestmentImTopcoLlcDetails", "http://www.xcelbrands.com/role/DisclosureSubsequentEventsNarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_EquityMethodInvestmentSummarizedFinancialInformationAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Equity Method Investment, Summarized Financial Information [Abstract]" } } }, "localname": "EquityMethodInvestmentSummarizedFinancialInformationAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_EquityMethodInvestments": { "auth_ref": [ "r65", "r213", "r534" ], "calculation": { "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheets": { "order": 5.0, "parentTag": "us-gaap_AssetsNoncurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized.", "label": "Equity Method Investments", "terseLabel": "Equity method investment" } } }, "localname": "EquityMethodInvestments", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_EquityMethodInvestmentsDisclosureTextBlock": { "auth_ref": [ "r234" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for equity method investments and joint ventures. Equity method investments are investments that give the investor the ability to exercise significant influence over the operating and financial policies of an investee. Joint ventures are entities owned and operated by a small group of businesses as a separate and specific business or project for the mutual benefit of the members of the group.", "label": "Equity Method Investment" } } }, "localname": "EquityMethodInvestmentsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xcelbrands.com/role/DisclosureEquityMethodInvestment" ], "xbrltype": "textBlockItemType" }, "us-gaap_EquityMethodInvestmentsTextBlock": { "auth_ref": [ "r67" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of equity method investments including, but not limited to, name of each investee or group of investments, percentage ownership, difference between recorded amount of an investment and the value of the underlying equity in the net assets, and summarized financial information.", "label": "Equity Method Investments [Table Text Block]", "terseLabel": "Summarized financial information for IM Topco" } } }, "localname": "EquityMethodInvestmentsTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xcelbrands.com/role/DisclosureEquityMethodInvestmentTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]", "terseLabel": "Asset Purchase Agreement" } } }, "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xcelbrands.com/role/DisclosureRelatedPartyTransactionsIsaacMizrahiDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": { "auth_ref": [ "r379", "r380", "r381" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis.", "label": "Fair Value, Recurring and Nonrecurring [Table]" } } }, "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xcelbrands.com/role/DisclosureRelatedPartyTransactionsIsaacMizrahiDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FinancialInstrumentAxis": { "auth_ref": [ "r230", "r231", "r242", "r245", "r246", "r247", "r248", "r249", "r250", "r251", "r279", "r294", "r365", "r430", "r431", "r432", "r433", "r434", "r435", "r436", "r437", "r438", "r439", "r440", "r441", "r442", "r443", "r444", "r445", "r446", "r447", "r448", "r449", "r450", "r451", "r452", "r453", "r454", "r455", "r456", "r457", "r458", "r459", "r512", "r547", "r548", "r549", "r611", "r612", "r613", "r614", "r615", "r616", "r617" ], "lang": { "en-us": { "role": { "documentation": "Information by type of financial instrument.", "label": "Financial Instrument [Axis]" } } }, "localname": "FinancialInstrumentAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xcelbrands.com/role/DisclosureSubsequentEventsNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FiniteLivedIntangibleAssetUsefulLife": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Finite-Lived Intangible Asset, Useful Life", "presentationGuidance": "Weighted Average Amortization Period" } } }, "localname": "FiniteLivedIntangibleAssetUsefulLife", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xcelbrands.com/role/DisclosureTrademarksAndOtherIntangiblesScheduleOfTrademarksAndOtherIntangiblesDetails" ], "xbrltype": "durationItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": { "auth_ref": [ "r151", "r254" ], "calculation": { "http://www.xcelbrands.com/role/DisclosureTrademarksAndOtherIntangiblesScheduleOfTrademarksAndOtherIntangiblesDetails": { "order": 2.0, "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.", "label": "Finite-Lived Intangible Assets, Accumulated Amortization", "verboseLabel": "Accumulated Amortization" } } }, "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xcelbrands.com/role/DisclosureTrademarksAndOtherIntangiblesScheduleOfTrademarksAndOtherIntangiblesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": { "auth_ref": [ "r252", "r253", "r254", "r255", "r462", "r466" ], "lang": { "en-us": { "role": { "documentation": "Information by major type or class of finite-lived intangible assets.", "label": "Finite-Lived Intangible Assets by Major Class [Axis]" } } }, "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xcelbrands.com/role/DisclosureTrademarksAndOtherIntangiblesScheduleOfTrademarksAndOtherIntangiblesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FiniteLivedIntangibleAssetsGross": { "auth_ref": [ "r74", "r466" ], "calculation": { "http://www.xcelbrands.com/role/DisclosureTrademarksAndOtherIntangiblesScheduleOfTrademarksAndOtherIntangiblesDetails": { "order": 1.0, "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.", "label": "Finite-Lived Intangible Assets, Gross", "verboseLabel": "Gross Carrying Amount (definite-lived)" } } }, "localname": "FiniteLivedIntangibleAssetsGross", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xcelbrands.com/role/DisclosureTrademarksAndOtherIntangiblesScheduleOfTrademarksAndOtherIntangiblesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": { "auth_ref": [ "r71", "r73" ], "lang": { "en-us": { "role": { "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company.", "label": "Finite-Lived Intangible Assets, Major Class Name [Domain]" } } }, "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xcelbrands.com/role/DisclosureTrademarksAndOtherIntangiblesScheduleOfTrademarksAndOtherIntangiblesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FiniteLivedIntangibleAssetsNet": { "auth_ref": [ "r74", "r462" ], "calculation": { "http://www.xcelbrands.com/role/DisclosureTrademarksAndOtherIntangiblesScheduleOfTrademarksAndOtherIntangiblesDetails": { "order": 1.0, "parentTag": "us-gaap_IntangibleAssetsNetExcludingGoodwill", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.", "label": "Finite-Lived Intangible Assets, Net", "totalLabel": "Net Carrying Amount" } } }, "localname": "FiniteLivedIntangibleAssetsNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xcelbrands.com/role/DisclosureTrademarksAndOtherIntangiblesScheduleOfTrademarksAndOtherIntangiblesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Goodwill and Intangible Assets Disclosure [Abstract]" } } }, "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock": { "auth_ref": [ "r76" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for goodwill and intangible assets.", "label": "Goodwill and Intangible Assets Disclosure [Text Block]", "verboseLabel": "Trademarks and Other Intangibles" } } }, "localname": "GoodwillAndIntangibleAssetsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xcelbrands.com/role/DisclosureTrademarksAndOtherIntangibles" ], "xbrltype": "textBlockItemType" }, "us-gaap_GrossProfit": { "auth_ref": [ "r40", "r171", "r212", "r215", "r219", "r221", "r233", "r264", "r265", "r267", "r268", "r269", "r270", "r271", "r273", "r274", "r382", "r511", "r556" ], "calculation": { "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfOperations": { "order": 1.0, "parentTag": "xelb_OperatingIncomeLossBeforeOtherExpense", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.", "label": "Gross Profit", "terseLabel": "Gross Profit", "totalLabel": "Gross profit" } } }, "localname": "GrossProfit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xcelbrands.com/role/DisclosureEquityMethodInvestmentSummarizedFinancialInformationDetails", "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": { "auth_ref": [ "r34", "r115", "r124", "r138", "r212", "r215", "r219", "r221", "r481", "r511" ], "calculation": { "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfOperations": { "order": 1.0, "parentTag": "us-gaap_ProfitLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.", "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest", "totalLabel": "Loss before income taxes" } } }, "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest": { "auth_ref": [ "r102", "r171", "r181", "r212", "r215", "r219", "r221", "r233", "r264", "r265", "r267", "r268", "r269", "r270", "r271", "r273", "r274", "r377", "r382", "r511", "r556" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax of income (loss) from continuing operations including portion attributable to the noncontrolling interest.", "label": "Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest", "terseLabel": "Loss from continuing operations" } } }, "localname": "IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xcelbrands.com/role/DisclosureEquityMethodInvestmentSummarizedFinancialInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeLossFromEquityMethodInvestments": { "auth_ref": [ "r35", "r51", "r65", "r123", "r136", "r210" ], "calculation": { "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfCashFlows": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of income (loss) for proportionate share of equity method investee's income (loss).", "label": "Income (Loss) from Equity Method Investments", "negatedLabel": "Undistributed proportional share of net loss of equity method investee", "verboseLabel": "Loss from equity method investment" } } }, "localname": "IncomeLossFromEquityMethodInvestments", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xcelbrands.com/role/DisclosureEquityMethodInvestmentImTopcoLlcDetails", "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeStatementAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Income Statement [Abstract]" } } }, "localname": "IncomeStatementAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis": { "auth_ref": [ "r518", "r519" ], "lang": { "en-us": { "role": { "documentation": "Information by name of disposal group.", "label": "Disposal Group Name [Axis]" } } }, "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xcelbrands.com/role/DisclosureEquityMethodInvestmentImTopcoLlcDetails", "http://www.xcelbrands.com/role/DisclosureSubsequentEventsNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]" } } }, "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xcelbrands.com/role/DisclosureEquityMethodInvestmentImTopcoLlcDetails", "http://www.xcelbrands.com/role/DisclosureEquityMethodInvestmentSummarizedFinancialInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable": { "auth_ref": [ "r0", "r1", "r2", "r3", "r4", "r5", "r6", "r7", "r8", "r9", "r10", "r79", "r80" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.", "label": "Disposal Groups, Including Discontinued Operations [Table]" } } }, "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xcelbrands.com/role/DisclosureEquityMethodInvestmentImTopcoLlcDetails", "http://www.xcelbrands.com/role/DisclosureEquityMethodInvestmentSummarizedFinancialInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_IncomeStatementLocationAxis": { "auth_ref": [ "r256", "r257" ], "lang": { "en-us": { "role": { "documentation": "Information by location in the income statement.", "label": "Income Statement Location [Axis]" } } }, "localname": "IncomeStatementLocationAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xcelbrands.com/role/DisclosureLeasesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_IncomeStatementLocationDomain": { "auth_ref": [ "r257" ], "lang": { "en-us": { "role": { "documentation": "Location in the income statement.", "label": "Income Statement Location [Domain]" } } }, "localname": "IncomeStatementLocationDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xcelbrands.com/role/DisclosureLeasesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_IncomeTaxDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Income Taxes" } } }, "localname": "IncomeTaxDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxDisclosureTextBlock": { "auth_ref": [ "r172", "r341", "r342", "r343", "r348", "r350", "r352", "r353", "r354" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.", "label": "Income Tax Disclosure [Text Block]", "verboseLabel": "Income Taxes" } } }, "localname": "IncomeTaxDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xcelbrands.com/role/DisclosureIncomeTaxes" ], "xbrltype": "textBlockItemType" }, "us-gaap_IncomeTaxExpenseBenefit": { "auth_ref": [ "r173", "r191", "r192", "r211", "r339", "r349", "r351", "r484" ], "calculation": { "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfOperations": { "order": 2.0, "parentTag": "us-gaap_ProfitLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.", "label": "Income Tax Expense (Benefit)", "terseLabel": "Income tax benefit" } } }, "localname": "IncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xcelbrands.com/role/DisclosureIncomeTaxesDetails", "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxesPaid": { "auth_ref": [ "r48", "r54" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income.", "label": "Income Taxes Paid", "terseLabel": "Cash paid during the period for income taxes" } } }, "localname": "IncomeTaxesPaid", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccountsReceivable": { "auth_ref": [ "r50" ], "calculation": { "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfCashFlows": { "order": 6.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.", "label": "Increase (Decrease) in Accounts Receivable", "negatedLabel": "Accounts receivable" } } }, "localname": "IncreaseDecreaseInAccountsReceivable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInInventories": { "auth_ref": [ "r50" ], "calculation": { "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfCashFlows": { "order": 7.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.", "label": "Increase (Decrease) in Inventories", "negatedLabel": "Inventory" } } }, "localname": "IncreaseDecreaseInInventories", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Increase (Decrease) in Operating Capital [Abstract]", "verboseLabel": "Changes in operating assets and liabilities:" } } }, "localname": "IncreaseDecreaseInOperatingCapitalAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_IncreaseDecreaseInOperatingLeaseLiability": { "auth_ref": [ "r538", "r596" ], "calculation": { "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfCashFlows": { "order": 10.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in obligation for operating lease.", "label": "Increase (Decrease) in Operating Lease Liability", "terseLabel": "Lease-related assets and liabilities" } } }, "localname": "IncreaseDecreaseInOperatingLeaseLiability", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities": { "auth_ref": [ "r50" ], "calculation": { "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfCashFlows": { "order": 9.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in other obligations or expenses incurred but not yet paid.", "label": "Increase (Decrease) in Other Accounts Payable and Accrued Liabilities", "terseLabel": "Accounts payable, accrued expenses, accrued payroll, accrued income taxes payable, and other current liabilities" } } }, "localname": "IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInPrepaidExpensesOther": { "auth_ref": [ "r50" ], "calculation": { "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfCashFlows": { "order": 8.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) of consideration paid in advance for other costs that provide economic benefits in future periods.", "label": "Increase (Decrease) in Prepaid Expenses, Other", "negatedLabel": "Prepaid expenses and other current and non-current assets" } } }, "localname": "IncreaseDecreaseInPrepaidExpensesOther", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]", "terseLabel": "Increase (Decrease) in Stockholders' Equity [Roll Forward]" } } }, "localname": "IncreaseDecreaseInStockholdersEquityRollForward", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfStockholdersEquity" ], "xbrltype": "stringItemType" }, "us-gaap_IntangibleAssetsGrossExcludingGoodwill": { "auth_ref": [ "r150" ], "calculation": { "http://www.xcelbrands.com/role/DisclosureTrademarksAndOtherIntangiblesScheduleOfTrademarksAndOtherIntangiblesDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before accumulated amortization of intangible assets, excluding goodwill.", "label": "Intangible Assets, Gross (Excluding Goodwill)", "totalLabel": "Gross Carrying Amount, Total" } } }, "localname": "IntangibleAssetsGrossExcludingGoodwill", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xcelbrands.com/role/DisclosureTrademarksAndOtherIntangiblesScheduleOfTrademarksAndOtherIntangiblesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IntangibleAssetsNetExcludingGoodwill": { "auth_ref": [ "r69", "r72" ], "calculation": { "http://www.xcelbrands.com/role/DisclosureTrademarksAndOtherIntangiblesScheduleOfTrademarksAndOtherIntangiblesDetails": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_AssetsNoncurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.", "label": "Intangible Assets, Net (Excluding Goodwill)", "terseLabel": "Trademarks and other intangibles, net", "totalLabel": "Net Carrying Amount, Total" } } }, "localname": "IntangibleAssetsNetExcludingGoodwill", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xcelbrands.com/role/DisclosureTrademarksAndOtherIntangiblesScheduleOfTrademarksAndOtherIntangiblesDetails", "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_IntellectualPropertyMember": { "auth_ref": [ "r99" ], "lang": { "en-us": { "role": { "documentation": "Intangible asset arising from original creative thought. Include, but is not limited to, trademarks, patents, and copyrights.", "label": "Copyrights and other intellectual property" } } }, "localname": "IntellectualPropertyMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xcelbrands.com/role/DisclosureTrademarksAndOtherIntangiblesScheduleOfTrademarksAndOtherIntangiblesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_InterestAndDebtExpenseAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Interest and Debt Expense [Abstract]", "verboseLabel": "Interest and finance expense" } } }, "localname": "InterestAndDebtExpenseAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfOperations" ], "xbrltype": "stringItemType" }, "us-gaap_InterestExpenseDebt": { "auth_ref": [ "r44", "r277", "r280", "r513", "r514" ], "calculation": { "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfOperations": { "order": 1.0, "parentTag": "us-gaap_InterestIncomeExpenseNet", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of the cost of borrowed funds accounted for as interest expense for debt.", "label": "Interest Expense, Debt", "terseLabel": "Interest expense - term loan debt" } } }, "localname": "InterestExpenseDebt", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestIncomeExpenseNet": { "auth_ref": [ "r126" ], "calculation": { "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfOperations": { "order": 2.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The net amount of operating interest income (expense).", "label": "Interest Income (Expense), Net", "negatedTotalLabel": "Total interest and finance expense" } } }, "localname": "InterestIncomeExpenseNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestPaidNet": { "auth_ref": [ "r165", "r168", "r169" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.", "label": "Interest Paid, Excluding Capitalized Interest, Operating Activities", "terseLabel": "Cash paid during the period for interest" } } }, "localname": "InterestPaidNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryNet": { "auth_ref": [ "r156", "r505", "r525" ], "calculation": { "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheets": { "order": 4.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.", "label": "Inventory, Net", "verboseLabel": "Inventory" } } }, "localname": "InventoryNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LaborAndRelatedExpense": { "auth_ref": [ "r537" ], "calculation": { "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfOperations": { "order": 1.0, "parentTag": "us-gaap_CostsAndExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense for salary, wage, profit sharing; incentive and equity-based compensation; and other employee benefit.", "label": "Salaries Benefits And Employment Taxes", "verboseLabel": "Salaries, benefits and employment taxes" } } }, "localname": "LaborAndRelatedExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_LeasesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Leases [Abstract]" } } }, "localname": "LeasesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_LesseeLeaseDescriptionLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Lessee, Lease, Description [Line Items]", "terseLabel": "Lessee, Lease, Description [Line Items]" } } }, "localname": "LesseeLeaseDescriptionLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xcelbrands.com/role/DisclosureLeasesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LesseeLeaseDescriptionTable": { "auth_ref": [ "r408" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about lessee's leases.", "label": "Lessee, Lease, Description [Table]", "terseLabel": "Lessee, Lease, Description [Table]" } } }, "localname": "LesseeLeaseDescriptionTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xcelbrands.com/role/DisclosureLeasesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock": { "auth_ref": [ "r597" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.", "label": "Lessee, Operating Lease, Liability, Maturity [Table Text Block]", "terseLabel": "Maturities of Lease Liabilities" } } }, "localname": "LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xcelbrands.com/role/DisclosureLeasesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": { "auth_ref": [ "r412" ], "calculation": { "http://www.xcelbrands.com/role/DisclosureLeasesMaturitiesOfLeaseLiabilitiesDetails": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://www.xcelbrands.com/role/DisclosureLeasesMaturitiesOfLeaseLiabilitiesDetailsCalc2": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease.", "label": "Lessee, Operating Lease, Liability, Payments, Due", "totalLabel": "Total lease payments" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xcelbrands.com/role/DisclosureLeasesMaturitiesOfLeaseLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": { "auth_ref": [ "r412" ], "calculation": { "http://www.xcelbrands.com/role/DisclosureLeasesMaturitiesOfLeaseLiabilitiesDetailsCalc2": { "order": 5.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessee, Operating Lease, Liability, Payments, Due Next Twelve Months", "verboseLabel": "2024" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xcelbrands.com/role/DisclosureLeasesMaturitiesOfLeaseLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour": { "auth_ref": [ "r412" ], "calculation": { "http://www.xcelbrands.com/role/DisclosureLeasesMaturitiesOfLeaseLiabilitiesDetailsCalc2": { "order": 2.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessee, Operating Lease, Liability, Payments, Due Year Four", "verboseLabel": "2027" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFour", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xcelbrands.com/role/DisclosureLeasesMaturitiesOfLeaseLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree": { "auth_ref": [ "r412" ], "calculation": { "http://www.xcelbrands.com/role/DisclosureLeasesMaturitiesOfLeaseLiabilitiesDetailsCalc2": { "order": 3.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessee, Operating Lease, Liability, Payments, Due Year Three", "verboseLabel": "2026" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearThree", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xcelbrands.com/role/DisclosureLeasesMaturitiesOfLeaseLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": { "auth_ref": [ "r412" ], "calculation": { "http://www.xcelbrands.com/role/DisclosureLeasesMaturitiesOfLeaseLiabilitiesDetailsCalc2": { "order": 4.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessee, Operating Lease, Liability, Payments, Due Year Two", "verboseLabel": "2025" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xcelbrands.com/role/DisclosureLeasesMaturitiesOfLeaseLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear": { "auth_ref": [ "r597" ], "calculation": { "http://www.xcelbrands.com/role/DisclosureLeasesMaturitiesOfLeaseLiabilitiesDetailsCalc2": { "order": 6.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease having initial or remaining lease term in excess of one year to be paid in remainder of current fiscal year.", "label": "Lessee, Operating Lease, Liability, Payments, Remainder of Fiscal Year", "verboseLabel": "2023 (April 1 through December 31)" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xcelbrands.com/role/DisclosureLeasesMaturitiesOfLeaseLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount": { "auth_ref": [ "r412" ], "calculation": { "http://www.xcelbrands.com/role/DisclosureLeasesMaturitiesOfLeaseLiabilitiesDetails": { "order": 1.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.", "label": "Lessee, Operating Lease, Liability, Undiscounted Excess Amount", "terseLabel": "Less: Discount" } } }, "localname": "LesseeOperatingLeaseLiabilityUndiscountedExcessAmount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xcelbrands.com/role/DisclosureLeasesMaturitiesOfLeaseLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseRemainingLeaseTerm": { "auth_ref": [ "r595" ], "lang": { "en-us": { "role": { "documentation": "Remaining lease term of operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Lessee, Operating Lease, Remaining Lease Term", "terseLabel": "Remaining lease term" } } }, "localname": "LesseeOperatingLeaseRemainingLeaseTerm", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xcelbrands.com/role/DisclosureCommitmentsAndContingenciesNarrativeDetails", "http://www.xcelbrands.com/role/DisclosureLeasesNarrativeDetails" ], "xbrltype": "durationItemType" }, "us-gaap_LesseeOperatingLeasesTextBlock": { "auth_ref": [ "r413" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.", "label": "Lessee, Operating Leases [Text Block]", "terseLabel": "Leases" } } }, "localname": "LesseeOperatingLeasesTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xcelbrands.com/role/DisclosureLeases" ], "xbrltype": "textBlockItemType" }, "us-gaap_Liabilities": { "auth_ref": [ "r26", "r171", "r233", "r264", "r265", "r267", "r268", "r269", "r270", "r271", "r273", "r274", "r360", "r363", "r364", "r382", "r510", "r556", "r600", "r601" ], "calculation": { "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.", "label": "Liabilities", "totalLabel": "Total Liabilities" } } }, "localname": "Liabilities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Liabilities [Abstract]", "verboseLabel": "Current Liabilities:" } } }, "localname": "LiabilitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesAndStockholdersEquity": { "auth_ref": [ "r24", "r120", "r132", "r525", "r540", "r550", "r593" ], "calculation": { "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheets": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.", "label": "Liabilities and Equity", "totalLabel": "Total Liabilities and Stockholders' Equity" } } }, "localname": "LiabilitiesAndStockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Liabilities and Equity [Abstract]", "terseLabel": "Liabilities and Stockholders' Equity" } } }, "localname": "LiabilitiesAndStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesCurrent": { "auth_ref": [ "r28", "r148", "r171", "r233", "r264", "r265", "r267", "r268", "r269", "r270", "r271", "r273", "r274", "r360", "r363", "r364", "r382", "r525", "r556", "r600", "r601" ], "calculation": { "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.", "label": "Liabilities, Current", "totalLabel": "Total current liabilities" } } }, "localname": "LiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesNoncurrent": { "auth_ref": [ "r12", "r13", "r14", "r16", "r17", "r171", "r233", "r264", "r265", "r267", "r268", "r269", "r270", "r271", "r273", "r274", "r360", "r363", "r364", "r382", "r556", "r600", "r601" ], "calculation": { "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of obligation due after one year or beyond the normal operating cycle, if longer.", "label": "Liabilities, Noncurrent", "totalLabel": "Total long-term liabilities" } } }, "localname": "LiabilitiesNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesNoncurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Liabilities, Noncurrent [Abstract]", "verboseLabel": "Long-Term Liabilities:" } } }, "localname": "LiabilitiesNoncurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_LicenseMember": { "auth_ref": [ "r562" ], "lang": { "en-us": { "role": { "documentation": "Right to use intangible asset. Intangible asset includes, but is not limited to, patent, copyright, technology, manufacturing process, software or trademark.", "label": "Net licensing revenue" } } }, "localname": "LicenseMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xcelbrands.com/role/DisclosureSignificantContractsAndConcentrationsNarrativeDetails", "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfOperations" ], "xbrltype": "domainItemType" }, "us-gaap_LongTermDebtTextBlock": { "auth_ref": [ "r82" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for long-term debt.", "label": "Long-term Debt [Text Block]", "verboseLabel": "Debt" } } }, "localname": "LongTermDebtTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xcelbrands.com/role/DisclosureDebt" ], "xbrltype": "textBlockItemType" }, "us-gaap_MinorityInterest": { "auth_ref": [ "r33", "r119", "r131", "r171", "r233", "r264", "r267", "r268", "r269", "r273", "r274", "r382" ], "calculation": { "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).", "label": "Stockholders' Equity Attributable to Noncontrolling Interest", "terseLabel": "Noncontrolling interest" } } }, "localname": "MinorityInterest", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_MinorityInterestOwnershipPercentageByParent": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The parent entity's interest in net assets of the subsidiary, expressed as a percentage.", "label": "Noncontrolling Interest, Ownership Percentage by Parent", "terseLabel": "Ownership interest" } } }, "localname": "MinorityInterestOwnershipPercentageByParent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xcelbrands.com/role/DisclosureEquityMethodInvestmentImTopcoLlcDetails", "http://www.xcelbrands.com/role/DisclosureNatureOfOperationsBackgroundAndBasisOfPresentationDetails" ], "xbrltype": "percentItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivities": { "auth_ref": [ "r167" ], "calculation": { "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfCashFlows": { "order": 3.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.", "label": "Net Cash Provided by (Used in) Financing Activities", "totalLabel": "Net cash (used in) provided by financing activities" } } }, "localname": "NetCashProvidedByUsedInFinancingActivities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]", "verboseLabel": "Cash flows from financing activities" } } }, "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivities": { "auth_ref": [ "r167" ], "calculation": { "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.", "label": "Net Cash Provided by (Used in) Investing Activities", "totalLabel": "Net cash provided by (used in) investing activities" } } }, "localname": "NetCashProvidedByUsedInInvestingActivities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]", "verboseLabel": "Cash flows from investing activities" } } }, "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivities": { "auth_ref": [ "r47", "r49", "r52" ], "calculation": { "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.", "label": "Net Cash Provided by (Used in) Operating Activities", "negatedLabel": "Net cash used in operating activities", "totalLabel": "Net cash used in operating activities" } } }, "localname": "NetCashProvidedByUsedInOperatingActivities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xcelbrands.com/role/DisclosureNatureOfOperationsBackgroundAndBasisOfPresentationLiquidityDetails", "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]", "verboseLabel": "Cash flows from operating activities" } } }, "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetIncomeLoss": { "auth_ref": [ "r36", "r52", "r125", "r137", "r146", "r158", "r159", "r162", "r171", "r181", "r185", "r186", "r187", "r188", "r191", "r192", "r197", "r212", "r215", "r219", "r221", "r233", "r264", "r265", "r267", "r268", "r269", "r270", "r271", "r273", "r274", "r377", "r382", "r511", "r556" ], "calculation": { "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfOperations": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.", "label": "Net Income (Loss) Attributable to Parent", "totalLabel": "Net loss attributable to Xcel Brands, Inc. stockholders", "verboseLabel": "Net (loss) income" } } }, "localname": "NetIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xcelbrands.com/role/DisclosureEarningsLossPerShareBasicAndDilutedEarningsPerShareDetails", "http://www.xcelbrands.com/role/DisclosureNatureOfOperationsBackgroundAndBasisOfPresentationLiquidityDetails", "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetIncomeLossAttributableToNoncontrollingInterest": { "auth_ref": [ "r103", "r107", "r158", "r159", "r191", "r192", "r536" ], "calculation": { "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfOperations": { "order": 1.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of Net Income (Loss) attributable to noncontrolling interest.", "label": "Net Income (Loss) Attributable to Noncontrolling Interest", "terseLabel": "Net loss attributable to noncontrolling interest" } } }, "localname": "NetIncomeLossAttributableToNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "New Accounting Pronouncements or Change in Accounting Principle [Line Items]", "terseLabel": "New Accounting Pronouncements or Change in Accounting Principle [Line Items]" } } }, "localname": "NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xcelbrands.com/role/DisclosureNatureOfOperationsBackgroundAndBasisOfPresentationDetails", "http://www.xcelbrands.com/role/DisclosureNatureOfOperationsBackgroundAndBasisOfPresentationLiquidityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable": { "auth_ref": [ "r56", "r140", "r141", "r142", "r143", "r144", "r180", "r181", "r182", "r183", "r184", "r187", "r193", "r204", "r228", "r229", "r235", "r236", "r237", "r238", "r239", "r240", "r334", "r335", "r336", "r344", "r345", "r346", "r347", "r355", "r356", "r357", "r367", "r368", "r369", "r370", "r371", "r372", "r373", "r374", "r375", "r376", "r377", "r378", "r383", "r384", "r385", "r386", "r387", "r388", "r389", "r390", "r398", "r399", "r401", "r402", "r403", "r404", "r414", "r415", "r416", "r417", "r418", "r419", "r463", "r464", "r465", "r486", "r487", "r488", "r489", "r490", "r491", "r492", "r493", "r494", "r495", "r496", "r497" ], "lang": { "en-us": { "role": { "documentation": "Summarization of the changes in an accounting principle or a new accounting pronouncement, including the line items affected by the change and the financial effects of the change on those particular line items.", "label": "New Accounting Pronouncements or Change in Accounting Principle [Table]", "terseLabel": "New Accounting Pronouncements or Change in Accounting Principle [Table]" } } }, "localname": "NewAccountingPronouncementsOrChangeInAccountingPrincipleTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xcelbrands.com/role/DisclosureNatureOfOperationsBackgroundAndBasisOfPresentationDetails", "http://www.xcelbrands.com/role/DisclosureNatureOfOperationsBackgroundAndBasisOfPresentationLiquidityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_NoncontrollingInterestMember": { "auth_ref": [ "r100", "r297", "r542", "r543", "r544" ], "lang": { "en-us": { "role": { "documentation": "This element represents that portion of equity (net assets) in a subsidiary not attributable, directly or indirectly, to the parent. A noncontrolling interest is sometimes called a minority interest.", "label": "Noncontrolling Interest [Member]" } } }, "localname": "NoncontrollingInterestMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfStockholdersEquity" ], "xbrltype": "domainItemType" }, "us-gaap_OperatingIncomeLoss": { "auth_ref": [ "r212", "r215", "r219", "r221", "r511" ], "calculation": { "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfOperations": { "order": 1.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The net result for the period of deducting operating expenses from operating revenues.", "label": "Operating Income (Loss)", "totalLabel": "Operating loss" } } }, "localname": "OperatingIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingIncomeLossAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Nonoperating Income (Expense) [Abstract]", "terseLabel": "Other expense (income), including non-cash expenses" } } }, "localname": "OperatingIncomeLossAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfOperations" ], "xbrltype": "stringItemType" }, "us-gaap_OperatingLeaseExpense": { "auth_ref": [ "r594" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of operating lease expense. Excludes sublease income.", "label": "Operating Lease, Expense", "terseLabel": "Operating lease expense" } } }, "localname": "OperatingLeaseExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xcelbrands.com/role/DisclosureCommitmentsAndContingenciesNarrativeDetails", "http://www.xcelbrands.com/role/DisclosureLeasesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiability": { "auth_ref": [ "r406" ], "calculation": { "http://www.xcelbrands.com/role/DisclosureLeasesMaturitiesOfLeaseLiabilitiesDetails": { "order": 2.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease.", "label": "Operating Lease, Liability", "totalLabel": "Present value of lease liabilities" } } }, "localname": "OperatingLeaseLiability", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xcelbrands.com/role/DisclosureLeasesMaturitiesOfLeaseLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiabilityCurrent": { "auth_ref": [ "r406" ], "calculation": { "http://www.xcelbrands.com/role/DisclosureLeasesMaturitiesOfLeaseLiabilitiesDetails": { "order": 1.0, "parentTag": "us-gaap_OperatingLeaseLiability", "weight": 1.0 }, "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheets": { "order": 4.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.", "label": "Operating Lease, Liability, Current", "terseLabel": "Current portion of operating lease obligations", "verboseLabel": "Current portion of lease liabilities" } } }, "localname": "OperatingLeaseLiabilityCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xcelbrands.com/role/DisclosureLeasesMaturitiesOfLeaseLiabilitiesDetails", "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiabilityNoncurrent": { "auth_ref": [ "r406" ], "calculation": { "http://www.xcelbrands.com/role/DisclosureLeasesMaturitiesOfLeaseLiabilitiesDetails": { "order": 2.0, "parentTag": "us-gaap_OperatingLeaseLiability", "weight": 1.0 }, "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesNoncurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.", "label": "Operating Lease, Liability, Noncurrent", "terseLabel": "Non-current portion of lease liabilities", "verboseLabel": "Long-term portion of operating lease obligations" } } }, "localname": "OperatingLeaseLiabilityNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xcelbrands.com/role/DisclosureLeasesMaturitiesOfLeaseLiabilitiesDetails", "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeasePayments": { "auth_ref": [ "r407", "r409" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.", "label": "Operating Lease, Payments", "terseLabel": "Cash payments for operating lease expense" } } }, "localname": "OperatingLeasePayments", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xcelbrands.com/role/DisclosureCommitmentsAndContingenciesNarrativeDetails", "http://www.xcelbrands.com/role/DisclosureLeasesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseRightOfUseAsset": { "auth_ref": [ "r405" ], "calculation": { "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_AssetsNoncurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's right to use underlying asset under operating lease.", "label": "Operating Lease, Right-of-Use Asset", "terseLabel": "Operating lease right-of-use assets" } } }, "localname": "OperatingLeaseRightOfUseAsset", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent": { "auth_ref": [ "r411", "r524" ], "lang": { "en-us": { "role": { "documentation": "Weighted average discount rate for operating lease calculated at point in time.", "label": "Operating Lease, Weighted Average Discount Rate, Percent", "terseLabel": "Weighted average discount rate" } } }, "localname": "OperatingLeaseWeightedAverageDiscountRatePercent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xcelbrands.com/role/DisclosureCommitmentsAndContingenciesNarrativeDetails", "http://www.xcelbrands.com/role/DisclosureLeasesNarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": { "auth_ref": [ "r410", "r524" ], "lang": { "en-us": { "role": { "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Operating Lease, Weighted Average Remaining Lease Term", "terseLabel": "Weighted average remaining lease term for operating leases" } } }, "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xcelbrands.com/role/DisclosureCommitmentsAndContingenciesNarrativeDetails", "http://www.xcelbrands.com/role/DisclosureLeasesNarrativeDetails" ], "xbrltype": "durationItemType" }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Nature of Operations, Background, and Basis of Presentation [Abstract]" } } }, "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock": { "auth_ref": [ "r11", "r108" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.", "label": "Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]", "verboseLabel": "Nature of Operations, Background, and Basis of Presentation" } } }, "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xcelbrands.com/role/DisclosureNatureOfOperationsBackgroundAndBasisOfPresentation" ], "xbrltype": "textBlockItemType" }, "us-gaap_OtherAssetsNoncurrent": { "auth_ref": [ "r152" ], "calculation": { "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheets": { "order": 6.0, "parentTag": "us-gaap_AssetsNoncurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of noncurrent assets classified as other.", "label": "Other Assets, Noncurrent", "verboseLabel": "Other assets" } } }, "localname": "OtherAssetsNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherCommitmentsAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by type of other commitment.", "label": "Other Commitments [Axis]" } } }, "localname": "OtherCommitmentsAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xcelbrands.com/role/DisclosureCommitmentsAndContingenciesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_OtherCommitmentsDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Other future obligation.", "label": "Other Commitments [Domain]" } } }, "localname": "OtherCommitmentsDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xcelbrands.com/role/DisclosureCommitmentsAndContingenciesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_OtherNoncashExpense": { "auth_ref": [ "r52" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense or loss included in net income that result in no cash flow, classified as other.", "label": "Other Noncash Expense" } } }, "localname": "OtherNoncashExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xcelbrands.com/role/DisclosureNatureOfOperationsBackgroundAndBasisOfPresentationLiquidityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherOperatingIncomeExpenseNet": { "auth_ref": [], "calculation": { "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfOperations": { "order": 2.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The net amount of other operating income and expenses, the components of which are not separately disclosed on the income statement, from items that are associated with the entity's normal revenue producing operations.", "label": "Other income", "negatedTotalLabel": "Total other expense (income), including non-cash expenses" } } }, "localname": "OtherOperatingIncomeExpenseNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": { "auth_ref": [ "r45" ], "calculation": { "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.", "label": "Payments to Acquire Property, Plant, and Equipment", "negatedLabel": "Purchase of property and equipment" } } }, "localname": "PaymentsToAcquirePropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PlanNameAxis": { "auth_ref": [ "r563", "r564", "r565", "r566", "r567", "r568", "r569", "r570", "r571", "r572", "r573", "r574", "r575", "r576", "r577", "r578", "r579", "r580", "r581", "r582", "r583", "r584", "r585", "r586", "r587", "r588" ], "lang": { "en-us": { "role": { "documentation": "Information by plan name for share-based payment arrangement.", "label": "Plan Name [Axis]" } } }, "localname": "PlanNameAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xcelbrands.com/role/DisclosureStockholdersEquityEquityIncentivePlansDetails" ], "xbrltype": "stringItemType" }, "us-gaap_PlanNameDomain": { "auth_ref": [ "r563", "r564", "r565", "r566", "r567", "r568", "r569", "r570", "r571", "r572", "r573", "r574", "r575", "r576", "r577", "r578", "r579", "r580", "r581", "r582", "r583", "r584", "r585", "r586", "r587", "r588" ], "lang": { "en-us": { "role": { "documentation": "Plan name for share-based payment arrangement.", "label": "Plan Name [Domain]" } } }, "localname": "PlanNameDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xcelbrands.com/role/DisclosureStockholdersEquityEquityIncentivePlansDetails" ], "xbrltype": "domainItemType" }, "us-gaap_PreferredStockParOrStatedValuePerShare": { "auth_ref": [ "r18", "r281" ], "lang": { "en-us": { "role": { "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.", "label": "Preferred Stock, Par or Stated Value Per Share", "verboseLabel": "Preferred stock, par value (in dollars per share)" } } }, "localname": "PreferredStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "perShareItemType" }, "us-gaap_PreferredStockSharesAuthorized": { "auth_ref": [ "r18" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.", "label": "Preferred Stock, Shares Authorized", "verboseLabel": "Preferred stock, shares authorized (in shares)" } } }, "localname": "PreferredStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockSharesIssued": { "auth_ref": [ "r18", "r281" ], "lang": { "en-us": { "role": { "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.", "label": "Preferred Stock, Shares Issued", "verboseLabel": "Preferred stock, shares issued (in shares)" } } }, "localname": "PreferredStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockSharesOutstanding": { "auth_ref": [ "r18" ], "lang": { "en-us": { "role": { "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.", "label": "Preferred Stock, Shares Outstanding", "verboseLabel": "Preferred stock, shares outstanding (in shares)" } } }, "localname": "PreferredStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockValue": { "auth_ref": [ "r18", "r525" ], "calculation": { "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Preferred Stock, Value, Issued", "verboseLabel": "Preferred stock, $.001 par value, 1,000,000 shares authorized, none issued and outstanding" } } }, "localname": "PreferredStockValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": { "auth_ref": [ "r535" ], "calculation": { "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.", "label": "Prepaid Expense and Other Assets, Current", "verboseLabel": "Prepaid expenses and other current assets" } } }, "localname": "PrepaidExpenseAndOtherAssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProductInformationLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Product Information [Line Items]" } } }, "localname": "ProductInformationLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xcelbrands.com/role/DisclosureSignificantContractsAndConcentrationsNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ProductMember": { "auth_ref": [ "r516" ], "lang": { "en-us": { "role": { "documentation": "Article or substance produced by nature, labor or machinery.", "label": "Net sales" } } }, "localname": "ProductMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfOperations" ], "xbrltype": "domainItemType" }, "us-gaap_ProfitLoss": { "auth_ref": [ "r146", "r158", "r159", "r166", "r171", "r181", "r191", "r192", "r212", "r215", "r219", "r221", "r233", "r264", "r265", "r267", "r268", "r269", "r270", "r271", "r273", "r274", "r358", "r361", "r362", "r377", "r382", "r481", "r511", "r522", "r523", "r536", "r556" ], "calculation": { "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 }, "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfOperations": { "order": 2.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.", "label": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest", "negatedLabel": "Net loss", "terseLabel": "Net loss", "totalLabel": "Net loss", "verboseLabel": "Net loss" } } }, "localname": "ProfitLoss", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xcelbrands.com/role/DisclosureEquityMethodInvestmentSummarizedFinancialInformationDetails", "http://www.xcelbrands.com/role/DisclosureNatureOfOperationsBackgroundAndBasisOfPresentationLiquidityDetails", "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfCashFlows", "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfOperations", "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentNet": { "auth_ref": [ "r78", "r133", "r482", "r525" ], "calculation": { "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_AssetsNoncurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.", "label": "Property, Plant and Equipment, Net", "terseLabel": "Property and equipment, net" } } }, "localname": "PropertyPlantAndEquipmentNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_RelatedPartyDomain": { "auth_ref": [ "r301", "r422", "r423" ], "lang": { "en-us": { "role": { "documentation": "Related parties include affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.", "label": "Related Party [Domain]" } } }, "localname": "RelatedPartyDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xcelbrands.com/role/DisclosureRelatedPartyTransactionsIsaacMizrahiDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RelatedPartyTransactionsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Related Party Transactions [Abstract]" } } }, "localname": "RelatedPartyTransactionsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": { "auth_ref": [ "r301", "r422", "r468", "r469", "r470", "r471", "r472", "r473", "r474", "r475", "r476", "r477", "r478", "r479", "r599" ], "lang": { "en-us": { "role": { "documentation": "Information by type of related party. Related parties include, but not limited to, affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.", "label": "Related Party [Axis]" } } }, "localname": "RelatedPartyTransactionsByRelatedPartyAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xcelbrands.com/role/DisclosureRelatedPartyTransactionsIsaacMizrahiDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionsDisclosureTextBlock": { "auth_ref": [ "r420", "r421", "r423", "r424", "r425" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.", "label": "Related Party Transactions Disclosure [Text Block]", "verboseLabel": "Related Party Transactions" } } }, "localname": "RelatedPartyTransactionsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xcelbrands.com/role/DisclosureRelatedPartyTransactions" ], "xbrltype": "textBlockItemType" }, "us-gaap_RepaymentsOfLongTermDebt": { "auth_ref": [ "r46" ], "calculation": { "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer.", "label": "Repayments of Long-term Debt", "negatedLabel": "Payment of long-term debt", "terseLabel": "Repayment of principal", "verboseLabel": "Payment of long-term debt" } } }, "localname": "RepaymentsOfLongTermDebt", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xcelbrands.com/role/DisclosureDebtNarrativeDetails", "http://www.xcelbrands.com/role/DisclosureNatureOfOperationsBackgroundAndBasisOfPresentationLiquidityDetails", "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_RestrictedCashAndCashEquivalents": { "auth_ref": [ "r53", "r55", "r116", "r129", "r149" ], "calculation": { "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheets": { "order": 4.0, "parentTag": "us-gaap_AssetsNoncurrent", "weight": 1.0 }, "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash and cash equivalents restricted as to withdrawal or usage. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Restricted Cash and Cash Equivalents", "periodEndLabel": "Restricted cash", "verboseLabel": "Restricted cash" } } }, "localname": "RestrictedCashAndCashEquivalents", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheets", "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_RestrictedStockMember": { "auth_ref": [ "r57" ], "lang": { "en-us": { "role": { "documentation": "Stock including a provision that prohibits sale or substantive sale of an equity instrument for a specified period of time or until specified performance conditions are met.", "label": "Restricted Stock" } } }, "localname": "RestrictedStockMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xcelbrands.com/role/DisclosureRelatedPartyTransactionsIsaacMizrahiDetails", "http://www.xcelbrands.com/role/DisclosureStockholdersEquityRestrictedStockDetails", "http://www.xcelbrands.com/role/DisclosureStockholdersEquityStockAwardsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RetainedEarningsAccumulatedDeficit": { "auth_ref": [ "r21", "r84", "r130", "r492", "r497", "r525" ], "calculation": { "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheets": { "order": 4.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Retained Earnings (Accumulated Deficit)", "verboseLabel": "Accumulated deficit" } } }, "localname": "RetainedEarningsAccumulatedDeficit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xcelbrands.com/role/DisclosureNatureOfOperationsBackgroundAndBasisOfPresentationLiquidityDetails", "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_RetainedEarningsMember": { "auth_ref": [ "r142", "r177", "r178", "r179", "r182", "r190", "r192", "r238", "r334", "r335", "r336", "r346", "r347", "r375", "r488", "r490" ], "lang": { "en-us": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Retained Earnings (Accumulated Deficit) [Member]" } } }, "localname": "RetainedEarningsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfStockholdersEquity" ], "xbrltype": "domainItemType" }, "us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax": { "auth_ref": [ "r207", "r208", "r214", "r217", "r218", "r222", "r223", "r224", "r298", "r299", "r461" ], "calculation": { "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfOperations": { "order": 1.0, "parentTag": "us-gaap_GrossProfit", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, including tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value-added and excise.", "label": "Revenue from Contract with Customer, Including Assessed Tax", "terseLabel": "Net revenue" } } }, "localname": "RevenueFromContractWithCustomerIncludingAssessedTax", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xcelbrands.com/role/DisclosureSignificantContractsAndConcentrationsNarrativeDetails", "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_RevenueFromRelatedParties": { "auth_ref": [ "r39", "r139", "r266", "r267", "r268", "r272", "r273", "r274" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of revenue, fees and commissions earned from transactions between (a) a parent company and its subsidiaries; (b) subsidiaries of a common parent; (c) an entity and trusts for the benefit of employees, for example, but not limited to, pension and profit-sharing trusts that are managed by or under the trusteeship of the entity's management; (d) an entity and its principal, owners, management, or members of their immediate families; and (e) affiliates.", "label": "Revenue from Related Parties", "terseLabel": "Revenue from services provided" } } }, "localname": "RevenueFromRelatedParties", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xcelbrands.com/role/DisclosureRelatedPartyTransactionsIsaacMizrahiDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_Revenues": { "auth_ref": [ "r163", "r171", "r207", "r208", "r214", "r217", "r218", "r222", "r223", "r224", "r233", "r264", "r265", "r267", "r268", "r269", "r270", "r271", "r273", "r274", "r382", "r481", "r556" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).", "label": "Revenues", "terseLabel": "Revenues" } } }, "localname": "Revenues", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xcelbrands.com/role/DisclosureEquityMethodInvestmentSummarizedFinancialInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RevenuesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Revenues [Abstract]", "verboseLabel": "Revenues" } } }, "localname": "RevenuesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfOperations" ], "xbrltype": "stringItemType" }, "us-gaap_RisksAndUncertaintiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Risks and Uncertainties [Abstract]" } } }, "localname": "RisksAndUncertaintiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_RoyaltyExpense": { "auth_ref": [ "r42" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense related to royalty payments under a contractual arrangement such as payment for mineral and drilling rights and use of technology or intellectual property.", "label": "Royalty Expense", "terseLabel": "Recognized royalty expense" } } }, "localname": "RoyaltyExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xcelbrands.com/role/DisclosureRelatedPartyTransactionsIsaacMizrahiDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RoyaltyGuaranteesCommitmentsAmount": { "auth_ref": [ "r467" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount the entity has committed to make for future royalty guarantees.", "label": "Royalty Guarantees, Commitments, Amount", "terseLabel": "Royalty guarantees" } } }, "localname": "RoyaltyGuaranteesCommitmentsAmount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xcelbrands.com/role/DisclosureCommitmentsAndContingenciesNarrativeDetails", "http://www.xcelbrands.com/role/DisclosureRelatedPartyTransactionsIsaacMizrahiDetails", "http://www.xcelbrands.com/role/DisclosureSubsequentEventsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_SalesMember": { "auth_ref": [ "r109" ], "lang": { "en-us": { "role": { "documentation": "Primary financial statement caption encompassing revenue from sale of goods and services rendered in the normal course of business.", "label": "Sales [Member]" } } }, "localname": "SalesMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xcelbrands.com/role/DisclosureSignificantContractsAndConcentrationsNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock": { "auth_ref": [ "r57" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.", "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]", "terseLabel": "Anti-dilutive Securities Excluded from Computation of Earnings (Loss) Per Share" } } }, "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xcelbrands.com/role/DisclosureEarningsLossPerShareTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualShareBasedPaymentsTable": { "auth_ref": [ "r87", "r88", "r90", "r95" ], "lang": { "en-us": { "role": { "documentation": "Schedule, table or text reflecting equity-based arrangements (such as stock or unit options and stock or unit awards) with individual employees, which are generally based on employment contracts between the entity and one or more selected officers or key employees, and which contain a promise by the employer to pay certain equity-based awards at future dates, sometimes including a period after retirement, upon compliance with stipulated requirements. This type of arrangement is distinguished from broader based employee benefit plans as it is usually tailored to the employee. Disclosure also typically includes the amount of related compensation expense recognized during the reporting period, the number of shares or units issued during the period under such arrangements, and the carrying amount as of the balance sheet date of the related liability.", "label": "Schedule of Deferred Compensation Arrangement with Individual, Share-based Payments [Table]", "terseLabel": "Schedule of Deferred Compensation Arrangement with Individual, Share-based Payments [Table]" } } }, "localname": "ScheduleOfDeferredCompensationArrangementWithIndividualShareBasedPaymentsTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xcelbrands.com/role/DisclosureEarningsLossPerShareAntiDilutiveSecuritiesExcludedDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": { "auth_ref": [ "r545" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.", "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]", "terseLabel": "Schedule of the basic and diluted net loss per share" } } }, "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xcelbrands.com/role/DisclosureEarningsLossPerShareTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock": { "auth_ref": [ "r68" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of goodwill and intangible assets, which may be broken down by segment or major class.", "label": "Schedule of Intangible Assets and Goodwill [Table Text Block]", "verboseLabel": "Schedule of Trademarks and Other Intangibles" } } }, "localname": "ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xcelbrands.com/role/DisclosureTrademarksAndOtherIntangiblesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": { "auth_ref": [ "r303", "r305", "r306", "r307", "r308", "r309", "r310", "r311", "r312", "r313", "r314", "r315", "r316", "r317", "r318", "r319", "r320", "r321", "r322", "r323", "r324", "r325", "r326", "r327", "r328", "r329", "r330", "r331" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about share-based payment arrangement.", "label": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]", "terseLabel": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]" } } }, "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xcelbrands.com/role/DisclosureStockholdersEquityEquityIncentivePlansDetails", "http://www.xcelbrands.com/role/DisclosureStockholdersEquityNonVestedOptionsDetails", "http://www.xcelbrands.com/role/DisclosureStockholdersEquityRestrictedStockDetails", "http://www.xcelbrands.com/role/DisclosureStockholdersEquityStockAwardsDetails", "http://www.xcelbrands.com/role/DisclosureStockholdersEquityStockBasedCompensationDetails", "http://www.xcelbrands.com/role/DisclosureStockholdersEquityStockOptionsDetails", "http://www.xcelbrands.com/role/DisclosureStockholdersEquityWarrantsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": { "auth_ref": [ "r91", "r92", "r93" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.", "label": "Share-based Compensation, Stock Options, Activity [Table Text Block]", "verboseLabel": "Summary of Stock Option Activity" } } }, "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xcelbrands.com/role/DisclosureStockholdersEquityTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of the number and weighted-average grant date fair value for restricted stock and restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock and restricted stock units that were granted, vested, or forfeited during the year.", "label": "Schedule of Share-based Compensation, Restricted Stock and Restricted Stock Units Activity [Table Text Block]", "terseLabel": "Summary of Restricted Stock Activity" } } }, "localname": "ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xcelbrands.com/role/DisclosureStockholdersEquityTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfStockOptionsRollForwardTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the change in stock options.", "label": "Schedule of Stock Options Roll Forward [Table Text Block]", "terseLabel": "Summary of Stock Option Activity for Non-Vested Options" } } }, "localname": "ScheduleOfStockOptionsRollForwardTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xcelbrands.com/role/DisclosureStockholdersEquityTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock": { "auth_ref": [ "r85", "r89" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable.", "label": "Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block]", "verboseLabel": "Summary of Warrant Activity" } } }, "localname": "ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xcelbrands.com/role/DisclosureStockholdersEquityTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_SellingGeneralAndAdministrativeExpense": { "auth_ref": [ "r43" ], "calculation": { "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfOperations": { "order": 2.0, "parentTag": "us-gaap_CostsAndExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.", "label": "Selling, General and Administrative Expense", "verboseLabel": "Other selling, general and administrative expenses" } } }, "localname": "SellingGeneralAndAdministrativeExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_SellingGeneralAndAdministrativeExpensesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Primary financial statement caption encompassing selling, general and administrative expense.", "label": "Selling, General and Administrative Expenses [Member]", "terseLabel": "Selling, general and administrative expenses" } } }, "localname": "SellingGeneralAndAdministrativeExpensesMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xcelbrands.com/role/DisclosureLeasesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ShareBasedCompensation": { "auth_ref": [ "r50" ], "calculation": { "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfCashFlows": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of noncash expense for share-based payment arrangement.", "label": "Share-based Compensation", "terseLabel": "Operating cost", "verboseLabel": "Stock-based compensation" } } }, "localname": "ShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xcelbrands.com/role/DisclosureStockholdersEquityStockBasedCompensationDetails", "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdditionalDisclosuresAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Additional Disclosures [Abstract]", "terseLabel": "Other disclosures" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdditionalDisclosuresAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xcelbrands.com/role/DisclosureStockholdersEquityStockAwardsDetails", "http://www.xcelbrands.com/role/DisclosureStockholdersEquityStockOptionsDetails", "http://www.xcelbrands.com/role/DisclosureStockholdersEquityWarrantsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod": { "auth_ref": [ "r322" ], "lang": { "en-us": { "role": { "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period", "terseLabel": "Expired/Forfeited (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xcelbrands.com/role/DisclosureStockholdersEquityStockAwardsDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue": { "auth_ref": [ "r322" ], "lang": { "en-us": { "role": { "documentation": "Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value", "terseLabel": "Expired/Forfeited (in dollars per share)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xcelbrands.com/role/DisclosureStockholdersEquityStockAwardsDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": { "auth_ref": [ "r320" ], "lang": { "en-us": { "role": { "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period", "terseLabel": "Granted (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xcelbrands.com/role/DisclosureStockholdersEquityStockAwardsDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": { "auth_ref": [ "r320" ], "lang": { "en-us": { "role": { "documentation": "The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value", "terseLabel": "Granted (in dollars per share)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xcelbrands.com/role/DisclosureStockholdersEquityStockAwardsDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber": { "auth_ref": [ "r317", "r318" ], "lang": { "en-us": { "role": { "documentation": "The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number", "periodEndLabel": "Outstanding, ending balance (in shares)", "periodStartLabel": "Outstanding, beginning balance (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xcelbrands.com/role/DisclosureStockholdersEquityStockAwardsDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]", "terseLabel": "Number of Other than Options" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xcelbrands.com/role/DisclosureStockholdersEquityStockAwardsDetails", "http://www.xcelbrands.com/role/DisclosureStockholdersEquityWarrantsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue": { "auth_ref": [ "r317", "r318" ], "lang": { "en-us": { "role": { "documentation": "Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value", "periodEndLabel": "Outstanding, ending balance (in dollars per share)", "periodStartLabel": "Outstanding, beginning balance (in dollars per share)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xcelbrands.com/role/DisclosureStockholdersEquityStockAwardsDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]", "terseLabel": "Weighted Average Exercise Price" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xcelbrands.com/role/DisclosureStockholdersEquityStockAwardsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod": { "auth_ref": [ "r321" ], "lang": { "en-us": { "role": { "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period", "negatedLabel": "Vested (in shares)", "verboseLabel": "Number of shares vested" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xcelbrands.com/role/DisclosureRelatedPartyTransactionsIsaacMizrahiDetails", "http://www.xcelbrands.com/role/DisclosureStockholdersEquityStockAwardsDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue": { "auth_ref": [ "r321" ], "lang": { "en-us": { "role": { "documentation": "The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value", "terseLabel": "Vested (in dollars per share)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xcelbrands.com/role/DisclosureStockholdersEquityStockAwardsDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]", "terseLabel": "Stockholders' Equity" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xcelbrands.com/role/DisclosureStockholdersEquityEquityIncentivePlansDetails", "http://www.xcelbrands.com/role/DisclosureStockholdersEquityNonVestedOptionsDetails", "http://www.xcelbrands.com/role/DisclosureStockholdersEquityRestrictedStockDetails", "http://www.xcelbrands.com/role/DisclosureStockholdersEquityStockAwardsDetails", "http://www.xcelbrands.com/role/DisclosureStockholdersEquityStockBasedCompensationDetails", "http://www.xcelbrands.com/role/DisclosureStockholdersEquityStockOptionsDetails", "http://www.xcelbrands.com/role/DisclosureStockholdersEquityWarrantsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized": { "auth_ref": [ "r521" ], "lang": { "en-us": { "role": { "documentation": "Number of shares authorized for issuance under share-based payment arrangement.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized", "terseLabel": "Number of common stock eligible for issuance" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xcelbrands.com/role/DisclosureStockholdersEquityEquityIncentivePlansDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant": { "auth_ref": [ "r95" ], "lang": { "en-us": { "role": { "documentation": "The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant", "verboseLabel": "Shares are granted available for issuance (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xcelbrands.com/role/DisclosureStockholdersEquityEquityIncentivePlansDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber": { "auth_ref": [ "r311" ], "lang": { "en-us": { "role": { "documentation": "The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number", "verboseLabel": "Exercisable (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xcelbrands.com/role/DisclosureStockholdersEquityStockOptionsDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice": { "auth_ref": [ "r311" ], "lang": { "en-us": { "role": { "documentation": "The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price", "verboseLabel": "Exercisable (in dollars per share)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xcelbrands.com/role/DisclosureStockholdersEquityStockOptionsDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod": { "auth_ref": [ "r569" ], "lang": { "en-us": { "role": { "documentation": "For presentations that combine terminations, the number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan or that expired.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period", "negatedLabel": "Expired/Forfeited (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xcelbrands.com/role/DisclosureStockholdersEquityStockOptionsDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice": { "auth_ref": [ "r569" ], "lang": { "en-us": { "role": { "documentation": "Weighted average price of options that were either forfeited or expired.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price", "terseLabel": "Expired/Forfeited (in dollars per share)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xcelbrands.com/role/DisclosureStockholdersEquityStockOptionsDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": { "auth_ref": [ "r313" ], "lang": { "en-us": { "role": { "documentation": "Gross number of share options (or share units) granted during the period.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross", "terseLabel": "Granted (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xcelbrands.com/role/DisclosureStockholdersEquityNonVestedOptionsDetails", "http://www.xcelbrands.com/role/DisclosureStockholdersEquityStockOptionsDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue": { "auth_ref": [ "r95" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value", "terseLabel": "Aggregate Intrinsic Value, Outstanding" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xcelbrands.com/role/DisclosureStockholdersEquityStockOptionsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": { "auth_ref": [ "r309", "r310" ], "lang": { "en-us": { "role": { "documentation": "Number of options outstanding, including both vested and non-vested options.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number", "periodEndLabel": "Outstanding, ending balance (in shares)", "periodStartLabel": "Outstanding, beginning balance (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xcelbrands.com/role/DisclosureStockholdersEquityStockOptionsDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": { "auth_ref": [ "r309", "r310" ], "lang": { "en-us": { "role": { "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price", "periodEndLabel": "Outstanding, ending balance (in dollars per share)", "periodStartLabel": "Outstanding, beginning balance (in dollars per share)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xcelbrands.com/role/DisclosureStockholdersEquityStockOptionsDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]", "terseLabel": "Weighted Average Exercise Price" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xcelbrands.com/role/DisclosureStockholdersEquityStockOptionsDetails", "http://www.xcelbrands.com/role/DisclosureStockholdersEquityWarrantsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": { "auth_ref": [ "r306", "r307", "r308", "r309", "r310", "r311", "r312", "r313", "r314", "r315", "r316", "r317", "r318", "r319", "r320", "r321", "r322", "r323", "r324", "r325", "r326", "r327", "r328", "r329", "r330", "r331" ], "lang": { "en-us": { "role": { "documentation": "Award under share-based payment arrangement.", "label": "Equity Award [Domain]" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xcelbrands.com/role/DisclosureRelatedPartyTransactionsIsaacMizrahiDetails", "http://www.xcelbrands.com/role/DisclosureStockholdersEquityEquityIncentivePlansDetails", "http://www.xcelbrands.com/role/DisclosureStockholdersEquityNonVestedOptionsDetails", "http://www.xcelbrands.com/role/DisclosureStockholdersEquityRestrictedStockDetails", "http://www.xcelbrands.com/role/DisclosureStockholdersEquityStockAwardsDetails", "http://www.xcelbrands.com/role/DisclosureStockholdersEquityStockOptionsDetails", "http://www.xcelbrands.com/role/DisclosureStockholdersEquityWarrantsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": { "auth_ref": [ "r314" ], "lang": { "en-us": { "role": { "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares.", "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price", "terseLabel": "Exercised (in dollars per share)" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xcelbrands.com/role/DisclosureStockholdersEquityStockOptionsDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": { "auth_ref": [ "r313" ], "lang": { "en-us": { "role": { "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.", "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price", "verboseLabel": "Granted (in dollars per share)" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xcelbrands.com/role/DisclosureStockholdersEquityStockOptionsDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1": { "auth_ref": [ "r95" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value", "verboseLabel": "Aggregate Intrinsic Value, Exercisable" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xcelbrands.com/role/DisclosureStockholdersEquityStockOptionsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1": { "auth_ref": [ "r95" ], "lang": { "en-us": { "role": { "documentation": "Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term", "terseLabel": "Exercisable Weighted Average Remaining Contractual Life (in Years)" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xcelbrands.com/role/DisclosureStockholdersEquityStockOptionsDetails" ], "xbrltype": "durationItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of non-vested options outstanding.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Number of Shares", "periodEndLabel": "Ending Balance (in shares)", "periodStartLabel": "Beginning Balance (in shares)" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xcelbrands.com/role/DisclosureStockholdersEquityNonVestedOptionsDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfSharesRollForward": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Number of Shares [Roll Forward]", "terseLabel": "Number of Options", "verboseLabel": "Number of Options" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfSharesRollForward", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xcelbrands.com/role/DisclosureStockholdersEquityNonVestedOptionsDetails", "http://www.xcelbrands.com/role/DisclosureStockholdersEquityStockOptionsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Weighted average grant-date fair value of non-vested options outstanding.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Option, Nonvested, Weighted Average Exercise Price", "periodEndLabel": "Ending Balance (in dollars per share)", "periodStartLabel": "Beginning Balance (in dollars per share)" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xcelbrands.com/role/DisclosureStockholdersEquityNonVestedOptionsDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]", "verboseLabel": "Weighted Average Grant Date Fair Value" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xcelbrands.com/role/DisclosureStockholdersEquityNonVestedOptionsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2": { "auth_ref": [ "r94" ], "lang": { "en-us": { "role": { "documentation": "Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term", "verboseLabel": "Outstanding Weighted Average Remaining Contractual Life (in Years)" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xcelbrands.com/role/DisclosureStockholdersEquityStockOptionsDetails" ], "xbrltype": "durationItemType" }, "us-gaap_SharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of shares issued which are neither cancelled nor held in the treasury.", "label": "Shares, Outstanding", "periodEndLabel": "Balances (in shares)", "periodStartLabel": "Balances (in shares)" } } }, "localname": "SharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfStockholdersEquity" ], "xbrltype": "sharesItemType" }, "us-gaap_StatementEquityComponentsAxis": { "auth_ref": [ "r32", "r83", "r142", "r160", "r161", "r162", "r177", "r178", "r179", "r182", "r190", "r192", "r206", "r238", "r297", "r334", "r335", "r336", "r346", "r347", "r375", "r391", "r392", "r393", "r394", "r395", "r396", "r419", "r488", "r489", "r490" ], "lang": { "en-us": { "role": { "documentation": "Information by component of equity.", "label": "Equity Components [Axis]" } } }, "localname": "StatementEquityComponentsAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfStockholdersEquity" ], "xbrltype": "stringItemType" }, "us-gaap_StatementLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Statement [Line Items]", "terseLabel": "Statement [Line Items]" } } }, "localname": "StatementLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfOperations", "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfStockholdersEquity" ], "xbrltype": "stringItemType" }, "us-gaap_StatementOfCashFlowsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Cash Flows [Abstract]" } } }, "localname": "StatementOfCashFlowsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_StatementOfFinancialPositionAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Financial Position [Abstract]" } } }, "localname": "StatementOfFinancialPositionAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_StatementOfStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Stockholders' Equity [Abstract]" } } }, "localname": "StatementOfStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_StatementTable": { "auth_ref": [ "r177", "r178", "r179", "r206", "r461" ], "lang": { "en-us": { "role": { "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.", "label": "Statement [Table]", "terseLabel": "Statement [Table]" } } }, "localname": "StatementTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfOperations", "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfStockholdersEquity" ], "xbrltype": "stringItemType" }, "us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross": { "auth_ref": [ "r83", "r84" ], "lang": { "en-us": { "role": { "documentation": "Total number of shares issued during the period, including shares forfeited, as a result of Restricted Stock Awards.", "label": "Stock Issued During Period, Shares, Restricted Stock Award, Gross", "terseLabel": "Shares issued to consultant in connection with stock grant (in shares)" } } }, "localname": "StockIssuedDuringPeriodSharesRestrictedStockAwardGross", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfStockholdersEquity" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": { "auth_ref": [ "r18", "r19", "r83", "r84", "r314" ], "lang": { "en-us": { "role": { "documentation": "Number of share options (or share units) exercised during the current period.", "label": "Share Based Compensation Arrangement By Share Based Payment Award Option Exercises In Period", "terseLabel": "Shares issued on exercise of stock options, net (in shares)", "verboseLabel": "Exercised (in shares)" } } }, "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xcelbrands.com/role/DisclosureStockholdersEquityStockOptionsDetails", "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfStockholdersEquity" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross": { "auth_ref": [ "r18", "r19", "r83", "r84" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate value of stock related to Restricted Stock Awards issued during the period.", "label": "Stock Issued During Period, Value, Restricted Stock Award, Gross", "terseLabel": "Shares issued to consultant in connection with stock grant" } } }, "localname": "StockIssuedDuringPeriodValueRestrictedStockAwardGross", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised": { "auth_ref": [ "r32", "r83", "r84" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value of stock issued as a result of the exercise of stock options.", "label": "Stock Issued During Period, Value, Stock Options Exercised", "terseLabel": "Shares issued on exercise of stock options, net" } } }, "localname": "StockIssuedDuringPeriodValueStockOptionsExercised", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquity": { "auth_ref": [ "r19", "r22", "r23", "r64", "r525", "r540", "r550", "r593" ], "calculation": { "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.", "label": "Stockholders' Equity Attributable to Parent", "totalLabel": "Total Xcel Brands, Inc. stockholders' equity" } } }, "localname": "StockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Stockholders' Equity Attributable to Parent [Abstract]", "verboseLabel": "Stockholders' Equity:" } } }, "localname": "StockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest": { "auth_ref": [ "r100", "r101", "r106", "r142", "r143", "r161", "r177", "r178", "r179", "r182", "r190", "r238", "r297", "r334", "r335", "r336", "r346", "r347", "r375", "r391", "r392", "r396", "r419", "r489", "r490", "r540", "r550", "r593" ], "calculation": { "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.", "label": "Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest", "periodEndLabel": "Balances", "periodStartLabel": "Balances", "totalLabel": "Total Stockholders' Equity" } } }, "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedBalanceSheets", "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquityNoteAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Stockholders' Equity Note [Abstract]" } } }, "localname": "StockholdersEquityNoteAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_StockholdersEquityNoteDisclosureTextBlock": { "auth_ref": [ "r86", "r170", "r282", "r284", "r285", "r286", "r287", "r288", "r289", "r290", "r291", "r292", "r293", "r295", "r297", "r366" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.", "label": "Stockholders' Equity Note Disclosure [Text Block]", "verboseLabel": "Stockholders' Equity" } } }, "localname": "StockholdersEquityNoteDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xcelbrands.com/role/DisclosureStockholdersEquity" ], "xbrltype": "textBlockItemType" }, "us-gaap_SubsequentEventLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.", "label": "Subsequent Event [Line Items]" } } }, "localname": "SubsequentEventLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xcelbrands.com/role/DisclosureSubsequentEventsNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventMember": { "auth_ref": [ "r397", "r428" ], "lang": { "en-us": { "role": { "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued.", "label": "Subsequent Events", "terseLabel": "Subsequent Events" } } }, "localname": "SubsequentEventMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xcelbrands.com/role/DisclosureNatureOfOperationsBackgroundAndBasisOfPresentationLiquidityDetails", "http://www.xcelbrands.com/role/DisclosureSubsequentEventsNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SubsequentEventTable": { "auth_ref": [ "r397", "r428" ], "lang": { "en-us": { "role": { "documentation": "Discloses pertinent information about one or more significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued.", "label": "Subsequent Event [Table]" } } }, "localname": "SubsequentEventTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xcelbrands.com/role/DisclosureSubsequentEventsNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventTypeAxis": { "auth_ref": [ "r397", "r428" ], "lang": { "en-us": { "role": { "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued.", "label": "Subsequent Event Type [Axis]" } } }, "localname": "SubsequentEventTypeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xcelbrands.com/role/DisclosureNatureOfOperationsBackgroundAndBasisOfPresentationLiquidityDetails", "http://www.xcelbrands.com/role/DisclosureSubsequentEventsNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventTypeDomain": { "auth_ref": [ "r397", "r428" ], "lang": { "en-us": { "role": { "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued.", "label": "Subsequent Event Type [Domain]" } } }, "localname": "SubsequentEventTypeDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xcelbrands.com/role/DisclosureNatureOfOperationsBackgroundAndBasisOfPresentationLiquidityDetails", "http://www.xcelbrands.com/role/DisclosureSubsequentEventsNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SubsequentEventsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Subsequent Events." } } }, "localname": "SubsequentEventsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventsTextBlock": { "auth_ref": [ "r427", "r429" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.", "label": "Subsequent Events [Text Block]", "terseLabel": "Subsequent Events" } } }, "localname": "SubsequentEventsTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xcelbrands.com/role/DisclosureSubsequentEvents" ], "xbrltype": "textBlockItemType" }, "us-gaap_SupplementalCashFlowInformationAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Supplemental Cash Flow Information [Abstract]", "verboseLabel": "Supplemental disclosure of cash flow information:" } } }, "localname": "SupplementalCashFlowInformationAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_TrademarksMember": { "auth_ref": [ "r98" ], "lang": { "en-us": { "role": { "documentation": "Rights acquired through registration of a trademark to gain or protect exclusive use of a business name, symbol or other device or style.", "label": "Trademarks" } } }, "localname": "TrademarksMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xcelbrands.com/role/DisclosureTrademarksAndOtherIntangiblesScheduleOfTrademarksAndOtherIntangiblesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain": { "auth_ref": [ "r230", "r231", "r279", "r294", "r365", "r430", "r431", "r432", "r433", "r434", "r435", "r436", "r437", "r438", "r439", "r440", "r441", "r442", "r443", "r444", "r445", "r446", "r447", "r448", "r449", "r450", "r451", "r452", "r453", "r454", "r455", "r456", "r457", "r458", "r459", "r547", "r548", "r549", "r611", "r612", "r613", "r614", "r615", "r616", "r617" ], "lang": { "en-us": { "role": { "documentation": "Instrument or contract that imposes a contractual obligation to deliver cash or another financial instrument or to exchange other financial instruments on potentially unfavorable terms and conveys a contractual right to receive cash or another financial instrument or to exchange other financial instruments on potentially favorable terms.", "label": "Financial Instruments [Domain]" } } }, "localname": "TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xcelbrands.com/role/DisclosureSubsequentEventsNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_TypeOfArrangementAxis": { "auth_ref": [ "r590" ], "lang": { "en-us": { "role": { "documentation": "Information by collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.", "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Axis]" } } }, "localname": "TypeOfArrangementAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xcelbrands.com/role/DisclosureEquityMethodInvestmentImTopcoLlcDetails", "http://www.xcelbrands.com/role/DisclosureRelatedPartyTransactionsIsaacMizrahiDetails" ], "xbrltype": "stringItemType" }, "us-gaap_VariableInterestEntityOwnershipPercentage": { "auth_ref": [ "r105" ], "lang": { "en-us": { "role": { "documentation": "Percentage of the Variable Interest Entity's (VIE) voting interest owned by (or beneficial interest in) the reporting entity (directly or indirectly).", "label": "Variable Interest Entity, Qualitative or Quantitative Information, Ownership Percentage" } } }, "localname": "VariableInterestEntityOwnershipPercentage", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xcelbrands.com/role/DisclosureNatureOfOperationsBackgroundAndBasisOfPresentationDetails" ], "xbrltype": "percentItemType" }, "us-gaap_VariableInterestEntityPrimaryBeneficiaryMember": { "auth_ref": [ "r104", "r359", "r360", "r363", "r364" ], "lang": { "en-us": { "role": { "documentation": "Variable Interest Entities (VIE) in which the entity has a controlling financial interest (as defined) and of which it is therefore the primary beneficiary. A controlling financial interest is determined based on both: (a) the entity's power to direct activities of the VIE that most significantly impact the VIE's economic performance and (b) the entity's obligation to absorb losses of the VIE that could potentially be significant to the VIE or the right to receive benefits from the VIE that could potentially be significant to the VIE. VIEs of which the entity is the primary beneficiary are included in the consolidated financial statements of the entity.", "label": "Variable Interest Entity, Primary Beneficiary" } } }, "localname": "VariableInterestEntityPrimaryBeneficiaryMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xcelbrands.com/role/DisclosureNatureOfOperationsBackgroundAndBasisOfPresentationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_WarrantMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Security that gives the holder the right to purchase shares of stock in accordance with the terms of the instrument, usually upon payment of a specified amount.", "label": "Warrants", "terseLabel": "Warrants" } } }, "localname": "WarrantMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xcelbrands.com/role/DisclosureEarningsLossPerShareAntiDilutiveSecuritiesExcludedDetails", "http://www.xcelbrands.com/role/DisclosureStockholdersEquityWarrantsDetails", "http://www.xcelbrands.com/role/DisclosureSubsequentEventsNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_WarrantsAndRightsOutstandingTerm": { "auth_ref": [ "r592" ], "lang": { "en-us": { "role": { "documentation": "Period between issuance and expiration of outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Warrants and Rights Outstanding, Term", "terseLabel": "Warrant term" } } }, "localname": "WarrantsAndRightsOutstandingTerm", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xcelbrands.com/role/DisclosureSubsequentEventsNarrativeDetails" ], "xbrltype": "durationItemType" }, "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": { "auth_ref": [ "r195", "r200" ], "calculation": { "http://www.xcelbrands.com/role/DisclosureEarningsLossPerShareBasicAndDilutedEarningsPerShareDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "lang": { "en-us": { "role": { "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.", "label": "Weighted Average Number of Shares Outstanding, Diluted", "totalLabel": "Diluted weighted average number of shares outstanding", "verboseLabel": "Diluted weighted average common shares outstanding" } } }, "localname": "WeightedAverageNumberOfDilutedSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xcelbrands.com/role/DisclosureEarningsLossPerShareBasicAndDilutedEarningsPerShareDetails", "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfOperations" ], "xbrltype": "sharesItemType" }, "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": { "auth_ref": [ "r194", "r200" ], "calculation": { "http://www.xcelbrands.com/role/DisclosureEarningsLossPerShareBasicAndDilutedEarningsPerShareDetails": { "order": 1.0, "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.", "label": "Weighted Average Number of Shares Outstanding, Basic", "verboseLabel": "Basic weighted average number of shares outstanding" } } }, "localname": "WeightedAverageNumberOfSharesOutstandingBasic", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.xcelbrands.com/role/DisclosureEarningsLossPerShareBasicAndDilutedEarningsPerShareDetails", "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfOperations" ], "xbrltype": "sharesItemType" }, "xelb_AccountsReceivableAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "No definition available.", "label": "Accounts Receivable [Abstract]" } } }, "localname": "AccountsReceivableAbstract", "nsuri": "http://www.xcelbrands.com/20230331", "xbrltype": "stringItemType" }, "xelb_AccountsReceivableAssignedToThirdPartyAgentForCollection": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of outstanding balance in accounts receivables which is assigned to third party agent for collection purposes.", "label": "Accounts Receivable, Assigned to Third Party Agent for Collection", "terseLabel": "Accounts receivable, assigned to third party agent for collection" } } }, "localname": "AccountsReceivableAssignedToThirdPartyAgentForCollection", "nsuri": "http://www.xcelbrands.com/20230331", "presentation": [ "http://www.xcelbrands.com/role/DisclosureAccountsReceivableDetails", "http://www.xcelbrands.com/role/DisclosureSummaryOfSignificantAccountingPoliciesAccountsReceivableDetails10k" ], "xbrltype": "monetaryItemType" }, "xelb_AccountsReceivableCollectionAgentFees": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of fees paid to agent for collection of accounts receivables.", "label": "Accounts Receivable, Collection Agent Fees", "terseLabel": "Accounts receivable, collection agent fees" } } }, "localname": "AccountsReceivableCollectionAgentFees", "nsuri": "http://www.xcelbrands.com/20230331", "presentation": [ "http://www.xcelbrands.com/role/DisclosureAccountsReceivableDetails", "http://www.xcelbrands.com/role/DisclosureSummaryOfSignificantAccountingPoliciesAccountsReceivableDetails10k" ], "xbrltype": "monetaryItemType" }, "xelb_AccountsReceivableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for accounts receivable.", "label": "Accounts Receivable [Text Block]", "terseLabel": "Accounts Receivable" } } }, "localname": "AccountsReceivableTextBlock", "nsuri": "http://www.xcelbrands.com/20230331", "presentation": [ "http://www.xcelbrands.com/role/DisclosureAccountsReceivable" ], "xbrltype": "textBlockItemType" }, "xelb_AcquisitionsAndDivestituresAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "No definition available.", "label": "Acquisitions, Divestitures and Variable Interest Entities[Abstract]" } } }, "localname": "AcquisitionsAndDivestituresAbstract", "nsuri": "http://www.xcelbrands.com/20230331", "xbrltype": "stringItemType" }, "xelb_AdditionalRoyaltyPayableTerm": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Additional amount of time that that royalties will be payable.", "label": "Additional Royalty Payable Term", "terseLabel": "Additional royalty payable term" } } }, "localname": "AdditionalRoyaltyPayableTerm", "nsuri": "http://www.xcelbrands.com/20230331", "presentation": [ "http://www.xcelbrands.com/role/DisclosureNatureOfOperationsBackgroundAndBasisOfPresentationLiquidityDetails", "http://www.xcelbrands.com/role/DisclosureSubsequentEventsNarrativeDetails" ], "xbrltype": "durationItemType" }, "xelb_AdjustmentToPurchasePricePayable": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount payable as adjustment to purchase price previously received by the company.", "label": "Adjustment to Purchase Price Payable", "terseLabel": "Adjustments to purchase price payable" } } }, "localname": "AdjustmentToPurchasePricePayable", "nsuri": "http://www.xcelbrands.com/20230331", "presentation": [ "http://www.xcelbrands.com/role/DisclosureCommitmentsAndContingenciesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "xelb_AssetAcquisitionAdditionalConsiderationPayableToSeller": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount of additional consideration payable to seller.", "label": "Asset Acquisition, Additional Consideration Payable To Seller", "terseLabel": "Additional consideration is payable to the seller" } } }, "localname": "AssetAcquisitionAdditionalConsiderationPayableToSeller", "nsuri": "http://www.xcelbrands.com/20230331", "presentation": [ "http://www.xcelbrands.com/role/DisclosureCommitmentsAndContingenciesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "xelb_AssetAcquisitionContingentObligation": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Asset Acquisition, Contingent Obligation", "label": "Asset Acquisition, Contingent Obligation", "verboseLabel": "Contingent obligation (Lori Goldstein Earn-Out)" } } }, "localname": "AssetAcquisitionContingentObligation", "nsuri": "http://www.xcelbrands.com/20230331", "presentation": [ "http://www.xcelbrands.com/role/DisclosureCommitmentsAndContingenciesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "xelb_AssetAcquisitionPrice": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of purchase price of asset acquired.", "label": "Asset Acquisition Price", "terseLabel": "Total purchase price" } } }, "localname": "AssetAcquisitionPrice", "nsuri": "http://www.xcelbrands.com/20230331", "presentation": [ "http://www.xcelbrands.com/role/DisclosureSubsequentEventsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "xelb_AssetAcquisitionRoyaltiesTerm": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Asset Acquisition, Royalties Term", "label": "Asset Acquisition, Royalties Term", "terseLabel": "Royalties earned" } } }, "localname": "AssetAcquisitionRoyaltiesTerm", "nsuri": "http://www.xcelbrands.com/20230331", "presentation": [ "http://www.xcelbrands.com/role/DisclosureCommitmentsAndContingenciesNarrativeDetails" ], "xbrltype": "durationItemType" }, "xelb_AssetAcquisitionsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Asset Acquisitions [Abstract]", "label": "Asset Acquisitions [Abstract]" } } }, "localname": "AssetAcquisitionsAbstract", "nsuri": "http://www.xcelbrands.com/20230331", "xbrltype": "stringItemType" }, "xelb_AssetAcquisitionsContingentConsiderationAmount": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Represents the maximum aggregate amount of contingent considerations.", "label": "Asset Acquisitions, Contingent Consideration, Amount", "terseLabel": "Contingent consideration" } } }, "localname": "AssetAcquisitionsContingentConsiderationAmount", "nsuri": "http://www.xcelbrands.com/20230331", "presentation": [ "http://www.xcelbrands.com/role/DisclosureCommitmentsAndContingenciesNarrativeDetails", "http://www.xcelbrands.com/role/DisclosureRelatedPartyTransactionsIsaacMizrahiDetails" ], "xbrltype": "monetaryItemType" }, "xelb_BusinessVentureAgreementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents the information pertaining to Business Venture Agreement.", "label": "Business Venture Agreement [Member]", "terseLabel": "Business Venture Agreement" } } }, "localname": "BusinessVentureAgreementMember", "nsuri": "http://www.xcelbrands.com/20230331", "presentation": [ "http://www.xcelbrands.com/role/DisclosureEquityMethodInvestmentImTopcoLlcDetails" ], "xbrltype": "domainItemType" }, "xelb_ClassOfWarrantOrRightCanceled": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of share warrants that were canceled during the reporting period.", "label": "Class Of Warrant Or Right, Canceled", "terseLabel": "Canceled (in shares)" } } }, "localname": "ClassOfWarrantOrRightCanceled", "nsuri": "http://www.xcelbrands.com/20230331", "presentation": [ "http://www.xcelbrands.com/role/DisclosureStockholdersEquityWarrantsDetails" ], "xbrltype": "sharesItemType" }, "xelb_ClassOfWarrantOrRightCanceledInPeriodWeightedAverageGrantDateFairValue": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Class Of Warrant Or Right, Canceled In Period, Weighted Average Grant Date Fair Value", "label": "Class Of Warrant Or Right, Canceled In Period, Weighted Average Grant Date Fair Value", "terseLabel": "Canceled (in dollars per share)" } } }, "localname": "ClassOfWarrantOrRightCanceledInPeriodWeightedAverageGrantDateFairValue", "nsuri": "http://www.xcelbrands.com/20230331", "presentation": [ "http://www.xcelbrands.com/role/DisclosureStockholdersEquityWarrantsDetails" ], "xbrltype": "perShareItemType" }, "xelb_ClassOfWarrantOrRightExercised": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of share warrants that were exercised during the reporting period.", "label": "Class Of Warrant Or Right, Exercised", "terseLabel": "Exercised (in shares)" } } }, "localname": "ClassOfWarrantOrRightExercised", "nsuri": "http://www.xcelbrands.com/20230331", "presentation": [ "http://www.xcelbrands.com/role/DisclosureStockholdersEquityWarrantsDetails" ], "xbrltype": "sharesItemType" }, "xelb_ClassOfWarrantOrRightExercisedInPeriodWeightedAverageGrantDateFairValue": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Class Of Warrant Or Right, Exercised In Period, Weighted Average Grant Date Fair Value", "label": "Class Of Warrant Or Right, Exercised In Period, Weighted Average Grant Date Fair Value", "terseLabel": "Exercised (in dollars per share)" } } }, "localname": "ClassOfWarrantOrRightExercisedInPeriodWeightedAverageGrantDateFairValue", "nsuri": "http://www.xcelbrands.com/20230331", "presentation": [ "http://www.xcelbrands.com/role/DisclosureStockholdersEquityWarrantsDetails" ], "xbrltype": "perShareItemType" }, "xelb_ClassOfWarrantOrRightExpiredForfeitedInPeriodWeightedAverageGrantDateFairValue": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Class of warrant or right expired, forfeited in period weighted average grant date fair value.", "label": "Class Of Warrant Or Right Expired, Forfeited In Period Weighted Average Grant Date Fair Value", "terseLabel": "Expired/Forfeited (in dollars per share)" } } }, "localname": "ClassOfWarrantOrRightExpiredForfeitedInPeriodWeightedAverageGrantDateFairValue", "nsuri": "http://www.xcelbrands.com/20230331", "presentation": [ "http://www.xcelbrands.com/role/DisclosureStockholdersEquityWarrantsDetails" ], "xbrltype": "perShareItemType" }, "xelb_ClassOfWarrantOrRightForfeited": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of share warrants that were forfeited during the reporting period.", "label": "Class Of Warrant Or Right, Forfeited", "terseLabel": "Expired/Forfeited (in shares)" } } }, "localname": "ClassOfWarrantOrRightForfeited", "nsuri": "http://www.xcelbrands.com/20230331", "presentation": [ "http://www.xcelbrands.com/role/DisclosureStockholdersEquityWarrantsDetails" ], "xbrltype": "sharesItemType" }, "xelb_ClassOfWarrantOrRightGranted": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of share warrants that were granted during the reporting period.", "label": "Class Of Warrant Or Right, Granted", "terseLabel": "Granted (in shares)" } } }, "localname": "ClassOfWarrantOrRightGranted", "nsuri": "http://www.xcelbrands.com/20230331", "presentation": [ "http://www.xcelbrands.com/role/DisclosureStockholdersEquityWarrantsDetails" ], "xbrltype": "sharesItemType" }, "xelb_ClassOfWarrantOrRightGrantedInPeriodWeightedAverageGrantDateFairValue": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Class Of Warrant Or Right, Granted In Period, Weighted Average Grant Date Fair Value", "label": "Class Of Warrant Or Right, Granted In Period, Weighted Average Grant Date Fair Value", "terseLabel": "Granted (in dollars per share)" } } }, "localname": "ClassOfWarrantOrRightGrantedInPeriodWeightedAverageGrantDateFairValue", "nsuri": "http://www.xcelbrands.com/20230331", "presentation": [ "http://www.xcelbrands.com/role/DisclosureStockholdersEquityWarrantsDetails" ], "xbrltype": "perShareItemType" }, "xelb_ClassOfWarrantOrRightOutstandingInPeriodWeightedAverageGrantDateFairValue": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Class Of Warrant Or Right, Outstanding In Period, Weighted Average Grant Date Fair Value", "label": "Class Of Warrant Or Right, Outstanding In Period, Weighted Average Grant Date Fair Value", "periodEndLabel": "Outstanding and exercisable, ending balance (in dollars per share)", "periodStartLabel": "Outstanding and exercisable, beginning balance (in dollars per share)" } } }, "localname": "ClassOfWarrantOrRightOutstandingInPeriodWeightedAverageGrantDateFairValue", "nsuri": "http://www.xcelbrands.com/20230331", "presentation": [ "http://www.xcelbrands.com/role/DisclosureStockholdersEquityWarrantsDetails" ], "xbrltype": "perShareItemType" }, "xelb_ClassOfWarrantOrRightOutstandingInPeriodWeightedAverageRemainingContractualTerm": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Class Of Warrant Or Right, Outstanding In Period, Weighted Average Remaining Contractual Term", "label": "Class Of Warrant Or Right, Outstanding In Period, Weighted Average Remaining Contractual Term", "terseLabel": "Weighted Average Remaining Contractual Life (in Years), Outstanding and exercisable" } } }, "localname": "ClassOfWarrantOrRightOutstandingInPeriodWeightedAverageRemainingContractualTerm", "nsuri": "http://www.xcelbrands.com/20230331", "presentation": [ "http://www.xcelbrands.com/role/DisclosureStockholdersEquityWarrantsDetails" ], "xbrltype": "durationItemType" }, "xelb_ClassOfWarrantOrRightOutstandingIntrinsicValue": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Class Of Warrant Or Right, Outstanding Intrinsic Value", "label": "Class Of Warrant Or Right, Outstanding Intrinsic Value", "terseLabel": "Aggregate Intrinsic Value, Outstanding and exercisable" } } }, "localname": "ClassOfWarrantOrRightOutstandingIntrinsicValue", "nsuri": "http://www.xcelbrands.com/20230331", "presentation": [ "http://www.xcelbrands.com/role/DisclosureStockholdersEquityWarrantsDetails" ], "xbrltype": "monetaryItemType" }, "xelb_CommitmentsAndContingenciesLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Commitments and Contingencies [Line Items]", "terseLabel": "Commitments and Contingencies" } } }, "localname": "CommitmentsAndContingenciesLineItems", "nsuri": "http://www.xcelbrands.com/20230331", "presentation": [ "http://www.xcelbrands.com/role/DisclosureCommitmentsAndContingenciesNarrativeDetails" ], "xbrltype": "stringItemType" }, "xelb_CommitmentsAndContingenciesTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about obligations resulting from commitments and contingencies.", "label": "Commitments and Contingencies [Table]", "terseLabel": "Commitments and Contingencies [Table]" } } }, "localname": "CommitmentsAndContingenciesTable", "nsuri": "http://www.xcelbrands.com/20230331", "presentation": [ "http://www.xcelbrands.com/role/DisclosureCommitmentsAndContingenciesNarrativeDetails" ], "xbrltype": "stringItemType" }, "xelb_ConsultantMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "No definition available.", "label": "Consultant" } } }, "localname": "ConsultantMember", "nsuri": "http://www.xcelbrands.com/20230331", "presentation": [ "http://www.xcelbrands.com/role/DisclosureStockholdersEquityStockAwardsDetails" ], "xbrltype": "domainItemType" }, "xelb_EmployeeMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Employee [Member]", "label": "Employee" } } }, "localname": "EmployeeMember", "nsuri": "http://www.xcelbrands.com/20230331", "presentation": [ "http://www.xcelbrands.com/role/DisclosureStockholdersEquityStockAwardsDetails", "http://www.xcelbrands.com/role/DisclosureStockholdersEquityStockBasedCompensationDetails", "http://www.xcelbrands.com/role/DisclosureStockholdersEquityStockOptionsDetails" ], "xbrltype": "domainItemType" }, "xelb_EquityIncentivePlan2011Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents information relate to the 2011 Equity Incentive Plan.", "label": "2011 Equity Incentive Plan" } } }, "localname": "EquityIncentivePlan2011Member", "nsuri": "http://www.xcelbrands.com/20230331", "presentation": [ "http://www.xcelbrands.com/role/DisclosureStockholdersEquityEquityIncentivePlansDetails" ], "xbrltype": "domainItemType" }, "xelb_EquityIncentivePlan2021Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents information relate to the 2021 Equity Incentive Plan.", "label": "2021 Equity Incentive Plan" } } }, "localname": "EquityIncentivePlan2021Member", "nsuri": "http://www.xcelbrands.com/20230331", "presentation": [ "http://www.xcelbrands.com/role/DisclosureStockholdersEquityEquityIncentivePlansDetails" ], "xbrltype": "domainItemType" }, "xelb_FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Finite Lived And Indefinite Lived Intangible Assets By Major Class [Line Items]", "terseLabel": "Trademarks and Other Intangibles" } } }, "localname": "FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassLineItems", "nsuri": "http://www.xcelbrands.com/20230331", "presentation": [ "http://www.xcelbrands.com/role/DisclosureTrademarksAndOtherIntangiblesScheduleOfTrademarksAndOtherIntangiblesDetails" ], "xbrltype": "stringItemType" }, "xelb_FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of finite-lived and indefinite-lived intangible assets, excluding goodwill, in total and by major class.", "label": "Finite Lived And Indefinite Lived Intangible Assets By Major Class [Table]" } } }, "localname": "FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassTable", "nsuri": "http://www.xcelbrands.com/20230331", "presentation": [ "http://www.xcelbrands.com/role/DisclosureTrademarksAndOtherIntangiblesScheduleOfTrademarksAndOtherIntangiblesDetails" ], "xbrltype": "stringItemType" }, "xelb_HalstonBrandMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents information pertaining to the Halston Brand (the \"Halston License\").", "label": "Halston Brand [Member]", "terseLabel": "Halston License" } } }, "localname": "HalstonBrandMember", "nsuri": "http://www.xcelbrands.com/20230331", "presentation": [ "http://www.xcelbrands.com/role/DisclosureNatureOfOperationsBackgroundAndBasisOfPresentationLiquidityDetails", "http://www.xcelbrands.com/role/DisclosureSubsequentEventsNarrativeDetails" ], "xbrltype": "domainItemType" }, "xelb_IMTopcoLLCMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents information pertaining to IM Topco, LLC.", "label": "IM Topco, LLC" } } }, "localname": "IMTopcoLLCMember", "nsuri": "http://www.xcelbrands.com/20230331", "presentation": [ "http://www.xcelbrands.com/role/DisclosureEquityMethodInvestmentImTopcoLlcDetails", "http://www.xcelbrands.com/role/DisclosureEquityMethodInvestmentSummarizedFinancialInformationDetails", "http://www.xcelbrands.com/role/DisclosureNatureOfOperationsBackgroundAndBasisOfPresentationDetails", "http://www.xcelbrands.com/role/DisclosureSubsequentEventsNarrativeDetails" ], "xbrltype": "domainItemType" }, "xelb_ImTopcoMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents the information pertaining to IM Topco.", "label": "IM Topco [Member]", "terseLabel": "IM Topco" } } }, "localname": "ImTopcoMember", "nsuri": "http://www.xcelbrands.com/20230331", "presentation": [ "http://www.xcelbrands.com/role/DisclosureRelatedPartyTransactionsIsaacMizrahiDetails" ], "xbrltype": "domainItemType" }, "xelb_ImWhpLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents the information pertaining to IM WHP LLC.", "label": "WHP" } } }, "localname": "ImWhpLlcMember", "nsuri": "http://www.xcelbrands.com/20230331", "presentation": [ "http://www.xcelbrands.com/role/DisclosureCommitmentsAndContingenciesNarrativeDetails", "http://www.xcelbrands.com/role/DisclosureEquityMethodInvestmentImTopcoLlcDetails" ], "xbrltype": "domainItemType" }, "xelb_IsaacMizrahiBrandTrademarksAndOtherIntellectualPropertyMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents information pertaining to Isaac Mizrahi Brand trademarks and other intellectual property.", "label": "IM Intellectual Property", "terseLabel": "IM Brand trademarks and other intellectual property rights" } } }, "localname": "IsaacMizrahiBrandTrademarksAndOtherIntellectualPropertyMember", "nsuri": "http://www.xcelbrands.com/20230331", "presentation": [ "http://www.xcelbrands.com/role/DisclosureEquityMethodInvestmentImTopcoLlcDetails", "http://www.xcelbrands.com/role/DisclosureSubsequentEventsNarrativeDetails" ], "xbrltype": "domainItemType" }, "xelb_IsaacMizrahiSaleTransactionWithImTopcoMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents the information pertaining to Isaac Mizrahi sale transaction with IM Topco.", "label": "Isaac Mizrahi Sale Transaction with IM Topco [Member]", "terseLabel": "Isaac Mizrahi sale transaction with IM Topco" } } }, "localname": "IsaacMizrahiSaleTransactionWithImTopcoMember", "nsuri": "http://www.xcelbrands.com/20230331", "presentation": [ "http://www.xcelbrands.com/role/DisclosureCommitmentsAndContingenciesNarrativeDetails" ], "xbrltype": "domainItemType" }, "xelb_LesseeOperatingLeaseLiabilityPaymentsDueYearFiveAndAfterYearFive": { "auth_ref": [], "calculation": { "http://www.xcelbrands.com/role/DisclosureLeasesMaturitiesOfLeaseLiabilitiesDetailsCalc2": { "order": 1.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year and after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessee Operating Lease Liability Payments Due Year Five And After Year Five", "terseLabel": "Thereafter (through 2028)" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFiveAndAfterYearFive", "nsuri": "http://www.xcelbrands.com/20230331", "presentation": [ "http://www.xcelbrands.com/role/DisclosureLeasesMaturitiesOfLeaseLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "xelb_LicenseAgreementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents the information pertaining to license agreement.", "label": "License Agreement [Member]", "terseLabel": "License Agreement" } } }, "localname": "LicenseAgreementMember", "nsuri": "http://www.xcelbrands.com/20230331", "presentation": [ "http://www.xcelbrands.com/role/DisclosureRelatedPartyTransactionsIsaacMizrahiDetails" ], "xbrltype": "domainItemType" }, "xelb_LongabergerLicensingLLCMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Longaberger Licensing, LLC [Member]", "label": "Longaberger Licensing, LLC" } } }, "localname": "LongabergerLicensingLLCMember", "nsuri": "http://www.xcelbrands.com/20230331", "presentation": [ "http://www.xcelbrands.com/role/DisclosureNatureOfOperationsBackgroundAndBasisOfPresentationDetails" ], "xbrltype": "domainItemType" }, "xelb_LoriGoldsteinBrandMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents information relating to Lori Goldstein Brand.", "label": "Lori Goldstein Brand" } } }, "localname": "LoriGoldsteinBrandMember", "nsuri": "http://www.xcelbrands.com/20230331", "presentation": [ "http://www.xcelbrands.com/role/DisclosureCommitmentsAndContingenciesNarrativeDetails" ], "xbrltype": "domainItemType" }, "xelb_LossFromEquityMethodInvestments": { "auth_ref": [], "calculation": { "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfOperations": { "order": 2.0, "parentTag": "us-gaap_OtherOperatingIncomeExpenseNet", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.", "label": "Loss From Equity Method Investments", "terseLabel": "Loss from equity method investment" } } }, "localname": "LossFromEquityMethodInvestments", "nsuri": "http://www.xcelbrands.com/20230331", "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "xelb_NonManagementDirectorsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Non Management Directors" } } }, "localname": "NonManagementDirectorsMember", "nsuri": "http://www.xcelbrands.com/20230331", "presentation": [ "http://www.xcelbrands.com/role/DisclosureStockholdersEquityStockAwardsDetails", "http://www.xcelbrands.com/role/DisclosureStockholdersEquityStockBasedCompensationDetails", "http://www.xcelbrands.com/role/DisclosureStockholdersEquityStockOptionsDetails" ], "xbrltype": "domainItemType" }, "xelb_NumberOfConsecutiveQuartersForRoyaltyPayableTerm": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of consecutive quarters for royalty payable term.", "label": "Number of Consecutive Quarters for Royalty Payable Term", "terseLabel": "Number of consecutive quarters for royalty payable term" } } }, "localname": "NumberOfConsecutiveQuartersForRoyaltyPayableTerm", "nsuri": "http://www.xcelbrands.com/20230331", "presentation": [ "http://www.xcelbrands.com/role/DisclosureCommitmentsAndContingenciesNarrativeDetails" ], "xbrltype": "integerItemType" }, "xelb_OperatingIncomeLossBeforeOtherExpense": { "auth_ref": [], "calculation": { "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfOperations": { "order": 1.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The net result for the period of deducting operating expenses from operating revenues before the inclusion of other expenses.", "label": "Operating Income Loss Before Other Expense", "totalLabel": "Operating loss before other expense (income), including non-cash expenses" } } }, "localname": "OperatingIncomeLossBeforeOtherExpense", "nsuri": "http://www.xcelbrands.com/20230331", "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "xelb_OtherInterestAndFinanceChargesIncomeNet": { "auth_ref": [], "calculation": { "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfOperations": { "order": 2.0, "parentTag": "us-gaap_InterestIncomeExpenseNet", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of other interest and finance charges (income), net incurred during the period.", "label": "Other Interest And Finance Charges (Income) Net", "terseLabel": "Other interest and finance charges, net" } } }, "localname": "OtherInterestAndFinanceChargesIncomeNet", "nsuri": "http://www.xcelbrands.com/20230331", "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "xelb_PercentageOfNetCashFlowDistributableToMembers": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The percentage of net cash flow distributable to members.", "label": "Percentage of Net Cash Flow Distributable to Members", "terseLabel": "Net cash flow distributable to members (in percent)" } } }, "localname": "PercentageOfNetCashFlowDistributableToMembers", "nsuri": "http://www.xcelbrands.com/20230331", "presentation": [ "http://www.xcelbrands.com/role/DisclosureEquityMethodInvestmentImTopcoLlcDetails" ], "xbrltype": "percentItemType" }, "xelb_ProceedsFromEarnOutPayment": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of proceeds from earn out payment.", "label": "Proceeds from Earn Out Payment", "terseLabel": "WHP earned in cashflow" } } }, "localname": "ProceedsFromEarnOutPayment", "nsuri": "http://www.xcelbrands.com/20230331", "presentation": [ "http://www.xcelbrands.com/role/DisclosureCommitmentsAndContingenciesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "xelb_QOptixLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents information pertaining to Q Optix, LLC.", "label": "Q Optix, LLC" } } }, "localname": "QOptixLlcMember", "nsuri": "http://www.xcelbrands.com/20230331", "presentation": [ "http://www.xcelbrands.com/role/DisclosureNatureOfOperationsBackgroundAndBasisOfPresentationDetails" ], "xbrltype": "domainItemType" }, "xelb_QurateRetailGroupMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents the information pertaining to Qurate Retail Group.", "label": "Qurate" } } }, "localname": "QurateRetailGroupMember", "nsuri": "http://www.xcelbrands.com/20230331", "presentation": [ "http://www.xcelbrands.com/role/DisclosureSignificantContractsAndConcentrationsNarrativeDetails" ], "xbrltype": "domainItemType" }, "xelb_ReconciliationToAmountsOnConsolidatedBalanceSheetsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "", "label": "Reconciliation to amounts on consolidated balance sheets [Abstract]", "verboseLabel": "Reconciliation to amounts on consolidated balance sheets:" } } }, "localname": "ReconciliationToAmountsOnConsolidatedBalanceSheetsAbstract", "nsuri": "http://www.xcelbrands.com/20230331", "presentation": [ "http://www.xcelbrands.com/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "xelb_ReductionInOperatingExpensesOverNextYear": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense for operating activities to be reduced over the next year. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.", "label": "Reduction in Operating Expenses Over Next Year", "terseLabel": "Reduction in operating expenses" } } }, "localname": "ReductionInOperatingExpensesOverNextYear", "nsuri": "http://www.xcelbrands.com/20230331", "presentation": [ "http://www.xcelbrands.com/role/DisclosureNatureOfOperationsBackgroundAndBasisOfPresentationLiquidityDetails" ], "xbrltype": "monetaryItemType" }, "xelb_ReductionInPayrollCostsOverNextYear": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense for salary and wage arising from service rendered by nonofficer and officer employees to be reduced over the next year. Excludes allocated cost, labor-related nonsalary expense, and direct and overhead labor cost included in cost of good and service sold.", "label": "Reduction in Payroll Costs Over the Next Year", "terseLabel": "Reduction in payroll costs" } } }, "localname": "ReductionInPayrollCostsOverNextYear", "nsuri": "http://www.xcelbrands.com/20230331", "presentation": [ "http://www.xcelbrands.com/role/DisclosureNatureOfOperationsBackgroundAndBasisOfPresentationLiquidityDetails" ], "xbrltype": "monetaryItemType" }, "xelb_RoyaltyPayableTerm": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The amount of time that royalties will be payable.", "label": "Royalty Payable Term", "terseLabel": "Royalty payable term" } } }, "localname": "RoyaltyPayableTerm", "nsuri": "http://www.xcelbrands.com/20230331", "presentation": [ "http://www.xcelbrands.com/role/DisclosureCommitmentsAndContingenciesNarrativeDetails", "http://www.xcelbrands.com/role/DisclosureNatureOfOperationsBackgroundAndBasisOfPresentationLiquidityDetails", "http://www.xcelbrands.com/role/DisclosureSubsequentEventsNarrativeDetails" ], "xbrltype": "durationItemType" }, "xelb_ServicesAgreementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents the information pertaining to Services Agreement.", "label": "Services Agreement [Member]", "terseLabel": "Services Agreement" } } }, "localname": "ServicesAgreementMember", "nsuri": "http://www.xcelbrands.com/20230331", "presentation": [ "http://www.xcelbrands.com/role/DisclosureRelatedPartyTransactionsIsaacMizrahiDetails" ], "xbrltype": "domainItemType" }, "xelb_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsCanceledInPeriod": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that were canceled during the reporting period.", "label": "Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Canceled In Period", "verboseLabel": "Canceled (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsCanceledInPeriod", "nsuri": "http://www.xcelbrands.com/20230331", "presentation": [ "http://www.xcelbrands.com/role/DisclosureStockholdersEquityStockAwardsDetails" ], "xbrltype": "sharesItemType" }, "xelb_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsCanceledWeightedAverageGrantDateFairValue": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The weighted average exercise price for warrants canceled during the period.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Canceled, Weighted Average Grant Date Fair Value", "terseLabel": "Canceled (in dollars per share)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsCanceledWeightedAverageGrantDateFairValue", "nsuri": "http://www.xcelbrands.com/20230331", "presentation": [ "http://www.xcelbrands.com/role/DisclosureStockholdersEquityStockAwardsDetails" ], "xbrltype": "perShareItemType" }, "xelb_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsCancellationsInPeriod": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of options or other stock instruments for which the right to exercise has been cancelled.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Cancellations in Period", "verboseLabel": "Canceled (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsCancellationsInPeriod", "nsuri": "http://www.xcelbrands.com/20230331", "presentation": [ "http://www.xcelbrands.com/role/DisclosureStockholdersEquityStockOptionsDetails" ], "xbrltype": "sharesItemType" }, "xelb_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageCancelledPrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were cancelled.", "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Cancelled Price", "verboseLabel": "Canceled (in dollars per share)" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageCancelledPrice", "nsuri": "http://www.xcelbrands.com/20230331", "presentation": [ "http://www.xcelbrands.com/role/DisclosureStockholdersEquityStockOptionsDetails" ], "xbrltype": "perShareItemType" }, "xelb_ThresholdAmountOfNetCashFlowDistributableToMembers": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Threshold amount of net cash flow distributable to members.", "label": "Threshold Amount of Net Cash Flow Distributable to Members", "terseLabel": "Net cash flow distributable to members" } } }, "localname": "ThresholdAmountOfNetCashFlowDistributableToMembers", "nsuri": "http://www.xcelbrands.com/20230331", "presentation": [ "http://www.xcelbrands.com/role/DisclosureEquityMethodInvestmentImTopcoLlcDetails" ], "xbrltype": "monetaryItemType" }, "xelb_UnexercisedStockOptionsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents the information relating to unexercised stock options.", "label": "Unexercised Stock Options" } } }, "localname": "UnexercisedStockOptionsMember", "nsuri": "http://www.xcelbrands.com/20230331", "presentation": [ "http://www.xcelbrands.com/role/DisclosureStockholdersEquityEquityIncentivePlansDetails" ], "xbrltype": "domainItemType" }, "xelb_WorkingCapitalNet": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of net of current asset and liabilities.", "label": "Working Capital, Net", "terseLabel": "Working capital, Net" } } }, "localname": "WorkingCapitalNet", "nsuri": "http://www.xcelbrands.com/20230331", "presentation": [ "http://www.xcelbrands.com/role/DisclosureNatureOfOperationsBackgroundAndBasisOfPresentationLiquidityDetails" ], "xbrltype": "monetaryItemType" } }, "unitCount": 5 } }, "std_ref": { "r0": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222160&loc=SL51721533-107759", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r1": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r10": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r100": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4568447-111683", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r101": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4568740-111683", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r102": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4569616-111683", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r103": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r104": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r105": { "Name": "Accounting Standards Codification", "Paragraph": "5A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=SL6759159-111685", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r106": { "Name": "Accounting Standards Codification", "Paragraph": "4I", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4590271-111686", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r107": { "Name": "Accounting Standards Codification", "Paragraph": "4J", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4591551-111686", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r108": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "810", "URI": "https://asc.fasb.org/topic&trid=2197479", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r109": { "Name": "Accounting Standards Codification", "Paragraph": "4D", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r11": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "205", "URI": "https://asc.fasb.org/topic&trid=2122149", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r110": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13531-108611", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r111": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13537-108611", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r112": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13537-108611", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r113": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "230", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r114": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28551-108399", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r115": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "25", "SubTopic": "20", "Topic": "940", "URI": "https://asc.fasb.org/extlink&oid=126941158&loc=d3e41242-110953", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r116": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(1)(a))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r117": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(11))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r118": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(15)(1))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r119": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(22))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r12": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 201.5-02(24))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r120": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(23))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r121": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03.10(3))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r122": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03.17)", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r123": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(13)(f))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r124": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(15))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r125": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(22))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r126": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04.10)", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r127": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(12))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r128": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(15)(b)(1))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r129": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(2))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r13": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 201.5-02(25))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r130": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r131": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(24))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r132": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(25))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r133": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(8))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r134": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03.(a),19)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r135": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03.3)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r136": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(10))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r137": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(18))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r138": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(8))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r139": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07.1(c))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=120401555&loc=SL114874292-224272", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r14": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 201.5-02(26))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r140": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "105", "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r141": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "105", "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r142": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "105", "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r143": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "105", "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r144": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "105", "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r145": { "Name": "Accounting Standards Codification", "Paragraph": "5C", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(2)", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721675-107760", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r146": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r147": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r148": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6904-107765", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r149": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(1))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r15": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(20))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r150": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(15))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r151": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(16))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r152": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(17))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r153": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(18))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r154": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(3)(a)(2))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r155": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(4))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r156": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r157": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(9))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r158": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r159": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r16": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(22))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r160": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r161": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r162": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r163": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(1))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r164": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(25))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r165": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3367-108585", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r166": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3000-108585", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r167": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r168": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r169": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4297-108586", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r17": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(23))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r170": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(e)(1))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r171": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r172": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h)(2))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r173": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r174": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(m)(1)(iii))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r175": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(m)(2)(ii))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r176": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.12-04(a))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r177": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r178": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r179": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r18": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(28))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r180": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21728-107793", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r181": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r182": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(3)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r183": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(4)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r184": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r185": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r186": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r187": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r188": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r189": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r19": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(29))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r190": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r191": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r192": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r193": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.M.Q2)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=122038215&loc=d3e31137-122693", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r194": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1448-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r195": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1505-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r196": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1252-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r197": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r198": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r199": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1337-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r2": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=d3e1474-107760", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r20": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(1))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r200": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r201": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r202": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r203": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r204": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e3842-109258", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r205": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "260", "URI": "https://asc.fasb.org/topic&trid=2144383", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r206": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r207": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r208": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r209": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r21": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(3))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r210": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r211": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r212": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r213": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8813-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r214": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r215": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r216": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r217": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r218": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r219": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r22": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r220": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r221": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r222": { "Name": "Accounting Standards Codification", "Paragraph": "40", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9031-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r223": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r224": { "Name": "Accounting Standards Codification", "Paragraph": "42", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9054-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r225": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4428-111522", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r226": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4531-111522", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r227": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=d3e5074-111524", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r228": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=126986314&loc=SL124402458-218513", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r229": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=126986314&loc=SL124402458-218513", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r23": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(31))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r230": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "320", "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27232-111563", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r231": { "Name": "Accounting Standards Codification", "Paragraph": "5A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "320", "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=SL120269820-111563", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r232": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "323", "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r233": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "323", "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r234": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "323", "URI": "https://asc.fasb.org/topic&trid=2196965", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r235": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r236": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r237": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r238": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r239": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)(3)", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r24": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(32))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r240": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)(4)", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r241": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124255206&loc=SL82895884-210446", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r242": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919244-210447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r243": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r244": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(f)", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r245": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r246": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919253-210447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r247": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919258-210447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r248": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919230-210447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r249": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922888-210455", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r25": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19,20)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r250": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922895-210455", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r251": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922900-210455", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r252": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r253": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r254": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(1)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r255": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r256": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r257": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "420", "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r258": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "440", "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r259": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "440", "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r26": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19-26)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r260": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r261": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r262": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "20", "Subparagraph": "(SAB Topic 5.Y.Q2)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r263": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "20", "Subparagraph": "(SAB Topic 5.Y.Q4)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r264": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(i))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r265": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r266": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(B))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r267": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iv))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r268": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(5))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r269": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(i))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r27": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.20)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r270": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r271": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r272": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(C))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r273": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iv))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r274": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(5))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r275": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(e)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r276": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r277": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r278": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r279": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r28": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.21)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r280": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466204&loc=SL6036836-161870", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r281": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r282": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r283": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r284": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r285": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r286": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(i)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r287": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r288": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r289": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r29": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22(a)(1))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r290": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r291": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496180-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r292": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r293": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r294": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r295": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r296": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21475-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r297": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.3-04)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r298": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130543-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r299": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130545-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r3": { "Name": "Accounting Standards Codification", "Paragraph": "3A", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721659-107760", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r30": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.25)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r300": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(i)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r301": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(n)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r302": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(d)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r303": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "35", "SubTopic": "10", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=SL116886442-113899", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r304": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "35", "SubTopic": "10", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=d3e4534-113899", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r305": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "35", "SubTopic": "10", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=d3e4549-113899", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r306": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r307": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r308": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(3)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r309": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r31": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r310": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(ii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r311": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r312": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r313": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(01)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r314": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(02)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r315": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(03)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r316": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(04)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r317": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r318": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(ii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r319": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r32": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29-31)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r320": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(01)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r321": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(02)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r322": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(03)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r323": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r324": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r325": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r326": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r327": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r328": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(ii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r329": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r33": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.31)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r330": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iv)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r331": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(v)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r332": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)(1)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r333": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r334": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r335": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r336": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r337": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e31917-109318", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r338": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e31931-109318", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r339": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32672-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r34": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(10))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r340": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r341": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32705-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r342": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r343": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32857-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r344": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r345": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r346": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r347": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(3)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r348": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 6.I.5.Q1)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r349": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 6.I.7)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r35": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(12))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r350": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.C)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330215-122817", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r351": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r352": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "270", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r353": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r354": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "740", "URI": "https://asc.fasb.org/topic&trid=2144680", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r355": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=128092918&loc=SL128093175-196984", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r356": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=128092918&loc=SL128093175-196984", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r357": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=128092918&loc=SL128093175-196984", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r358": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4569616-111683", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r359": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r36": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(20))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r360": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r361": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r362": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r363": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bb)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r364": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r365": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(f)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126731327&loc=d3e90205-114008", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r366": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(a)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126731327&loc=SL126733271-114008", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r367": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(a)(1)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r368": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(a)(2)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r369": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(a)(3)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r37": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(8))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r370": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(b)(1)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r371": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(b)(2)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r372": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(c)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r373": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(d)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r374": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(2)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r375": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(3)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r376": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(4)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r377": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r378": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(a)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL126732908-238011", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r379": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r38": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r380": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r381": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19279-110258", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r382": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r383": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL120254526-165497", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r384": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL120254526-165497", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r385": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL121967933-165497", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r386": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL121967933-165497", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r387": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL121967933-165497", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r388": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)(2)", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL121967933-165497", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r389": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL122642865-165497", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r39": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.1(e))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r390": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL122642865-165497", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r391": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r392": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r393": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r394": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(c)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r395": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r396": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r397": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32618-110901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r398": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "832", "URI": "https://asc.fasb.org/extlink&oid=128342835&loc=SL128342857-244232", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r399": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "832", "URI": "https://asc.fasb.org/extlink&oid=128342835&loc=SL128342857-244232", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r4": { "Name": "Accounting Standards Codification", "Paragraph": "4A", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721663-107760", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r40": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.1,2)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r400": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28555-108399", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r401": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128293352&loc=SL126838806-209984", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r402": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128293352&loc=SL126838806-209984", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r403": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128293352&loc=SL126838806-209984", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r404": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(1)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128293352&loc=SL126838806-209984", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r405": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r406": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r407": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918643-209977", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r408": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918673-209980", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r409": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)(1)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r41": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.2(a),(d))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r410": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)(3)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r411": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)(4)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r412": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918701-209980", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r413": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "SubTopic": "20", "Topic": "842", "URI": "https://asc.fasb.org/subtopic&trid=77888251", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r414": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "848", "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL122150809-237846", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r415": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "848", "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r416": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "848", "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r417": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "848", "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r418": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)(3)(iii)(01)", "Topic": "848", "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r419": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)(3)(iii)(03)", "Topic": "848", "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r42": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.3)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r420": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r421": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r422": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r423": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r424": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39691-107864", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r425": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "850", "URI": "https://asc.fasb.org/topic&trid=2122745", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r426": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "852", "URI": "https://asc.fasb.org/extlink&oid=124437977&loc=d3e55792-112764", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r427": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "855", "URI": "https://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r428": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "855", "URI": "https://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r429": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "855", "URI": "https://asc.fasb.org/topic&trid=2122774", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r43": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.4)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r430": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)(i)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r431": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)(ii)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r432": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r433": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r434": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(2)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r435": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r436": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r437": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(2)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r438": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r439": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r44": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.8)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r440": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r441": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r442": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r443": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=66007379&loc=d3e113888-111728", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r444": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=109249958&loc=SL34722452-111729", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r445": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122625-111746", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r446": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(2)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122625-111746", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r447": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122625-111746", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r448": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(4)(i)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122625-111746", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r449": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r45": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r450": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(2)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r451": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r452": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(4)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r453": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(5)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r454": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(6)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r455": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(7)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r456": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(b)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r457": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(e)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r458": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(e)(2)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r459": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(e)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r46": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r460": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "910", "URI": "https://asc.fasb.org/extlink&oid=126937589&loc=SL119991595-234733", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r461": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.L)", "Topic": "924", "URI": "https://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r462": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "926", "URI": "https://asc.fasb.org/extlink&oid=120154696&loc=d3e54445-107959", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r463": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "926", "URI": "https://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r464": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "926", "URI": "https://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r465": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "926", "URI": "https://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r466": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "340", "Topic": "928", "URI": "https://asc.fasb.org/extlink&oid=6473545&loc=d3e61844-108004", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r467": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "440", "Topic": "928", "URI": "https://asc.fasb.org/extlink&oid=6473578&loc=d3e63223-108013", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r468": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61929-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r469": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61929-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r47": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r470": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62059-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r471": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62059-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r472": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62395-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r473": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62395-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r474": { "Name": "Accounting Standards Codification", "Paragraph": "33", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62479-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r475": { "Name": "Accounting Standards Codification", "Paragraph": "33", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62479-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r476": { "Name": "Accounting Standards Codification", "Paragraph": "35A", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=SL6807758-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r477": { "Name": "Accounting Standards Codification", "Paragraph": "35A", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=SL6807758-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r478": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(c)(1)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61872-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r479": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(c)(2)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61872-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r48": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r480": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(27))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r481": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "235", "Subparagraph": "(SX 210.9-05(b)(2))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r482": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=124429447&loc=SL124453093-239630", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r483": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(23))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r484": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(9))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r485": { "Name": "Accounting Standards Codification", "Paragraph": "7A", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(d)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r486": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(a)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r487": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(b)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r488": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r489": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(1)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r49": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r490": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(2)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r491": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(1)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r492": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(i)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r493": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(ii)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r494": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(iii)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r495": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(iv)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r496": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(h)(1)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r497": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(h)(2)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r498": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "825", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=123600520&loc=SL75241803-196195", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r499": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Topic": "954", "URI": "https://asc.fasb.org/extlink&oid=126942805&loc=d3e3115-115594", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r5": { "Name": "Accounting Standards Codification", "Paragraph": "4B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721665-107760", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r50": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r500": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "440", "Subparagraph": "(a)", "Topic": "954", "URI": "https://asc.fasb.org/extlink&oid=6491277&loc=d3e6429-115629", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r501": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Footnote 4))", "Topic": "970", "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r502": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Subparagraph": "(c)", "Topic": "976", "URI": "https://asc.fasb.org/extlink&oid=6497875&loc=d3e22274-108663", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r503": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Subparagraph": "(b)", "Topic": "978", "URI": "https://asc.fasb.org/extlink&oid=126945304&loc=d3e27327-108691", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r504": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r505": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r506": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226024-175313", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r507": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226049-175313", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r508": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226052-175313", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r509": { "Name": "Accounting Standards Codification", "Paragraph": "52", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e4984-109258", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r51": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r510": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r511": { "Name": "Accounting Standards Codification", "Paragraph": "31", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r512": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "30", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=121590138&loc=SL82922954-210456", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r513": { "Name": "Accounting Standards Codification", "Paragraph": "69E", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495743-112612", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r514": { "Name": "Accounting Standards Codification", "Paragraph": "69F", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495745-112612", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r515": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r516": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r517": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r518": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(a)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r519": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(a)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r52": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r520": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "80", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r521": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(3)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r522": { "Name": "Accounting Standards Codification", "Paragraph": "4J", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4591551-111686", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r523": { "Name": "Accounting Standards Codification", "Paragraph": "4K", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4591552-111686", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r524": { "Name": "Accounting Standards Codification", "Paragraph": "53", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=123414884&loc=SL77918982-209971", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r525": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "852", "URI": "https://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r526": { "Name": "Accounting Standards Codification", "Paragraph": "13H", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Subparagraph": "(a)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117783719-158441", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r527": { "Name": "Accounting Standards Codification", "Paragraph": "29F", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117819544-158441", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r528": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r529": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r53": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3044-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r530": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r531": { "Name": "Form 10-Q", "Number": "240", "Publisher": "SEC", "Section": "308", "Subsection": "a", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r532": { "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Publisher": "SEC", "Section": "13", "Subsection": "a-1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r533": { "Name": "Regulation S-T", "Number": "232", "Publisher": "SEC", "Section": "405", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r534": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(10))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r535": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(9))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r536": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r537": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(b)(4))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r538": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r539": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r54": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4297-108586", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r540": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r541": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(k)(1))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r542": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r543": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r544": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r545": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r546": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4647-111522", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r547": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "321", "URI": "https://asc.fasb.org/extlink&oid=126980263&loc=SL75117539-209714", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r548": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "321", "URI": "https://asc.fasb.org/extlink&oid=126980263&loc=SL75117539-209714", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r549": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "321", "URI": "https://asc.fasb.org/extlink&oid=126980263&loc=SL75117539-209714", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r55": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=SL98516268-108586", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r550": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "323", "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r551": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(c)", "Topic": "410", "URI": "https://asc.fasb.org/extlink&oid=6393242&loc=d3e13237-110859", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r552": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r553": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "20", "Subparagraph": "(SAB Topic 5.Y.Q2)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r554": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "450", "URI": "https://asc.fasb.org/topic&trid=2127136", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r555": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(i))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r556": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(ii))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r557": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r558": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iv))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r559": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iv))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r56": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r560": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r561": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130545-203045", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r562": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r563": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r564": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r565": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(3)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r566": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r567": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(ii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r568": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r569": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r57": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r570": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(01)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r571": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(02)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r572": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(03)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r573": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(04)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r574": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r575": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(ii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r576": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r577": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(01)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r578": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(02)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r579": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(03)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r58": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6327-108592", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r580": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r581": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r582": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r583": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r584": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r585": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(ii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r586": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r587": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iv)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r588": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(v)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r589": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "15", "SubTopic": "50", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=6911878&loc=d3e8732-128492", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r59": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r590": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "808", "URI": "https://asc.fasb.org/extlink&oid=6931272&loc=SL5834143-161434", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r591": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(3)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r592": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bbb)(2)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r593": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r594": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918638-209977", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r595": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(1)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918673-209980", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r596": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)(1)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r597": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918701-209980", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r598": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39599-107864", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r599": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r6": { "Name": "Accounting Standards Codification", "Paragraph": "5A", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721671-107760", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r60": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r600": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "852", "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r601": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "852", "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r602": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r603": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(2)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r604": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r605": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r606": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r607": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r608": { "Name": "Accounting Standards Codification", "Paragraph": "4H", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r609": { "Name": "Accounting Standards Codification", "Paragraph": "13H", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Subparagraph": "(c)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117783719-158441", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r61": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6404-108592", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r610": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "825", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=123600520&loc=SL75241803-196195", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r611": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(a)", "Publisher": "SEC", "Section": "1402", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r612": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(b)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(1)", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r613": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(b)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(2)", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r614": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(b)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(3)", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r615": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(c)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(2)(i)", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r616": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(c)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(2)(ii)", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r617": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(c)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(2)(iii)", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r62": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6442-108592", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r63": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "275", "URI": "https://asc.fasb.org/topic&trid=2134479", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r64": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 4.E)", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r65": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "323", "URI": "https://asc.fasb.org/extlink&oid=109237563&loc=d3e33749-111570", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r66": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "323", "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r67": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "323", "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r68": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r69": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=6388964&loc=d3e16212-109274", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r7": { "Name": "Accounting Standards Codification", "Paragraph": "5B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721673-107760", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r70": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=6388964&loc=d3e16225-109274", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r71": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r72": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "((a)(1),(b))", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r73": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r74": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(1)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r75": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(2)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r76": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "350", "URI": "https://asc.fasb.org/topic&trid=2144416", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r77": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=126905981&loc=d3e2443-110228", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r78": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r79": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r8": { "Name": "Accounting Standards Codification", "Paragraph": "5C", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721675-107760", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r80": { "Name": "Accounting Standards Codification", "Paragraph": "3A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=SL51724579-110230", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r81": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "440", "URI": "https://asc.fasb.org/topic&trid=2144648", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r82": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "470", "URI": "https://asc.fasb.org/topic&trid=2208564", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r83": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r84": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.3-04)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r85": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "50", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=6784392&loc=d3e188667-122775", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r86": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "505", "URI": "https://asc.fasb.org/topic&trid=2208762", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r87": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "30", "SubTopic": "10", "Topic": "710", "URI": "https://asc.fasb.org/extlink&oid=6409875&loc=d3e20015-108363", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r88": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "710", "URI": "https://asc.fasb.org/extlink&oid=6409961&loc=d3e20517-108367", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r89": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5047-113901", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r9": { "Name": "Accounting Standards Codification", "Paragraph": "5D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721677-107760", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r90": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5047-113901", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r91": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r92": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r93": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r94": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r95": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r96": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=126964447&loc=d3e11149-113907", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r97": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=126964447&loc=d3e11178-113907", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r98": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=123410050&loc=d3e5263-128473", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r99": { "Name": "Accounting Standards Codification", "Paragraph": "44", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=123410050&loc=d3e5558-128473", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" } }, "version": "2.2" } ZIP 68 0001558370-23-010200-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001558370-23-010200-xbrl.zip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end